Prevalence Estimate Name,Publication Date,Grade of Estimate Scope,Country,Specific Geography,Sampling Start Date,Sampling End Date,Sample Frame (groups of interest),Sample Frame (age),Denominator Value,Serum positive prevalence,"Serum pos prevalence, 95pct CI Lower","Serum pos prevalence, 95pct CI Upper",Sampling Method,Test Manufacturer,Test Type,Isotype(s) Reported,Sensitivity,Specificity,Overall Risk of Bias (JBI),Source Type,First Author Full Name,Lead Institution,URL,Date Created,Last modified time,Data Quality Status
210331_Bulawayo_UniversityofEdinburgh_Primary,"March 31, 2021",Regional,Zimbabwe,Zimbabwe; Bulawayo,"June 9, 2020","June 22, 2020",Health care workers and caregivers,Multiple groups,635,8.90%,6.90%,11.50%,Self-referral,"Wuhan UNscience Biotechnology Co., Ltd",LFIA,"IgG,IgM",98.51%,88.21%,High,Journal Article (Peer-Reviewed),Simbarashe Rusakaniko,University of Edinburgh,https://dx.doi.org/10.1371/journal.pntd.0009254,4/16/2021,7/30/2021,Verified
210309_Zambia_ZambiaMinistryofHealth_overall,"March 9, 2021, August 1, 2021",National,Zambia,"Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi","July 4, 2020","July 27, 2020",Household and community samples,Multiple groups,2704,2.10%,1.10%,3.10%,Stratified probability,EUROIMMUN AG,ELISA,IgG,,,Moderate,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Lloyd B Mulenga, Jonas Z Hines",Zambia Ministry of Health,"https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext, http://scholar.google.ca/scholar_url?url=https://wwwnc.cdc.gov/eid/article/27/8/pdfs/21-0502-combined.pdf&hl=en&sa=X&ei=w2QAYd7ZLdiJ6rQP6PWyuA0&scisig=AAGBfm1gNe14wbxN4qar_Leqv_BA18zCGQ&nossl=1&oi=scholarr",3/13/2021,6/17/2021,Verified
210330_Zambia_ZambiaMinistryofHealth_HCW,"March 30, 2021",National,Zambia,"Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi, Pooled","July 2, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,575,2.20%,0.50%,3.90%,Stratified non-probability,EUROIMMUN AG,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sombo Fwoloshi,Zambia Ministry of Health,https://dx.doi.org/10.1093/cid/ciab273,5/2/2021,6/17/2021,Unverified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Lusaka2_Infants,"May 6, 2021",Local,Zambia,Zambia; Lusaka Province; Lusaka,"August 15, 2020","December 15, 2020",Household and community samples,Children and Youth (0-17 years),150,6.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,5/19/2021,6/17/2021,Verified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Kalulushi1_HCW,"May 6, 2021",Local,Zambia,Zambia; Copperbelt Province ; Kalulushi,"August 1, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),237,8.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,5/19/2021,7/7/2021,Verified
210801_Zambia_USCDC_Outpatient_Primary,"August 1, 2021",National,Zambia,"Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi","July 2, 2020","July 31, 2020",Residual sera,Not reported,1490,8.20%,5.10%,11.40%,Unclear,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonas Z Hines,US Centers for Disease Control and Prevention,http://scholar.google.ca/scholar_url?url=https://wwwnc.cdc.gov/eid/article/27/8/pdfs/21-0502-combined.pdf&hl=en&sa=X&ei=w2QAYd7ZLdiJ6rQP6PWyuA0&scisig=AAGBfm1gNe14wbxN4qar_Leqv_BA18zCGQ&nossl=1&oi=scholarr,7/27/2021,8/4/2021,Unverified
201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall,"November 18, 2020",Local,Viet Nam,Viet Nam; Đông Nam Bộ; Ho Chi Minh City,"August 23, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),408,0.00%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Nguyen Van Vinh Chau,Oxford University Clinical Research Unit,https://dx.doi.org/10.1016/j.jinf.2020.11.018,1/23/2021,7/16/2021,Verified
210302_Vietnam_UniversitatsklinikumTubingen_HCW_ELISA_TotalAb,"March 2, 2021",Local,Viet Nam,Viet Nam; Red River Delta; Hanoi,"March 1, 2020","January 8, 2021",Health care workers and caregivers,Adults (18-64 years),1065,0.56%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/10/2021,8/4/2021,Verified
210302_Vietnam_UniversitatsklinikumTubingen_patients_ELISA_TotalAb,"March 2, 2021",Local,Viet Nam,Viet Nam; Red River Delta; Hanoi,"March 1, 2020","January 8, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/10/2021,8/4/2021,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_overall,"June 11, 2021",National,Viet Nam,Viet Nam,"September 4, 2020","November 23, 2020",Household and community samples,Multiple groups,3034,0.40%,,,Unclear,Roche Diagnostics,CLIA,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,6/21/2021,7/17/2021,Unverified
210610_Vietnam_TheUniversityOfSydney_HCW2_overall,"June 11, 2021",Local,Viet Nam,Viet Nam; Quang Nam; Da Nang,"November 24, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),148,0.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,6/21/2021,7/17/2021,Unverified
210302_Vietnam_UniversitatsklinikumTubingen_patients_RDT,"March 2, 2021",Local,Viet Nam,Viet Nam; Red River Delta; Hanoi,"March 1, 2020","January 8, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,LFIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,6/30/2021,8/4/2021,Verified
210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall,"February 3, 2021",National,Vatican City,Vatican City; Vatican City State; Vatican City,"June 8, 2020","January 4, 2021",Household and community samples,Multiple groups,1539,4.35%,,,Convenience,Siemens,CLIA,Total Antibody,97.48%,99.80%,Moderate,Journal Article (Peer-Reviewed),Massimo Ralli,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.ejim.2021.01.029,3/24/2021,7/7/2021,Verified
210301_Uzbekistan_ResearchInstituteofVirology,"March 1, 2021",National,Uzbekistan,Uzbekistan,"August 27, 2020","September 11, 2020",Residual sera,Multiple groups,86879,23.10%,23.00%,23.20%,Convenience,Beijing Wantai Biological,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),R A Rakhimov ,Research Institute of Virology,https://ejmcm.com/article_9453.html,5/17/2021,6/28/2021,Unverified
200424_Brevard_OMNI_GeneralPopulation,"April 24, 2020, April 17, 2020",Local,United States of America,United States of America; Florida,"April 17, 2020","April 24, 2020",Household and community samples,Not reported,1000,1.00%,,,Self-referral,NA,LFIA,"IgM,IgG",100.00%,100.00%,High,"News and Media, News and Media","Alessandro Sassoon, Jim Waymer",OMNI Healthcare,"https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/, https://www.floridatoday.com/story/news/2020/04/17/omni-healthcare-announces-coronavirus-immunity-testing/5147092002/",5/2/2020,6/24/2021,Verified
200422_Idaho_CrushTheCurveIdaho_Patients,"April 22, 2020",Regional,United States of America,United States of America; Idaho,,"April 22, 2020",Residual sera,Multiple groups,1946,1.75%,,,Convenience,NA,Not reported,IgG,100.00%,99.60%,High,News and Media,Ryan Morrison,Crush The Curve Idaho,https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity,5/2/2020,7/6/2021,Verified
200423_BatonRouge_BatonRougeGeneralHospital_GenPop,"April 28, 2020",Local,United States of America,United States of America; Louisiana; Baton Rouge,,"April 21, 2020",Household and community samples,Not reported,432,4.40%,,,Unclear,NA,Not reported,Not reported,,98.60%,Unclear,News and Media,Blake Paterson,Baton Rouge General Hospital,https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html,5/3/2020,6/17/2021,Verified
200508_Seattle_UniversityofWashington_Adults,"May 8, 2020",Local,United States of America,United States of America; Washington; Seattle,"March 1, 2020","March 31, 2020",Residual sera,Adults (18-64 years),221,0.40%,,,Convenience,NA,Not reported,Not reported,,,High,Institutional Report,Anne Schuchat,University of Washington,https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf,5/3/2020,6/17/2021,Verified
200503_SaltLakeCity_UniversityofUtah_HCW,"May 3, 2020",Local,United States of America,United States of America; Utah; Salt Lake City,"April 13, 2020","April 19, 2020",Health care workers and caregivers,Adults (18-64 years),270,5.90%,,,Convenience,EUROIMMUN AG,ELISA,IgG,95.40%,98.30%,High,Journal Article (Peer-Reviewed),Troy Madsen,University of Utah,https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext,5/14/2020,8/4/2021,Verified
200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG,"May 6, 2020",Local,United States of America,United States of America; Georgia; Atlanta,"April 17, 2020","April 27, 2020",Household and community samples,Not reported,127,2.36%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Jun Zou,Georgia State University,https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1,5/14/2020,6/17/2021,Verified
200515_Winona_WinonaHealth_GeneralPopulation,"May 15, 2020",Local,United States of America,United States of America; Minnesota; Winona,"May 10, 2020","May 15, 2020",Household and community samples,Multiple groups,1000,7.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Mal Meyer,Winona Health,https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA,5/18/2020,6/24/2021,Verified
200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj,"July 24, 2020, May 13, 2020, May 17, 2020",Regional,United States of America,United States of America; Indiana,"April 25, 2020","April 29, 2020",Household and community samples,Multiple groups,3518,1.09%,0.80%,1.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.60%,Moderate,"Institutional Report, News and Media, News and Media","Nir Menachemi, Aaron Carroll, Dariush Shafa",Indiana University Fairbanks School of Public Health,"https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",5/19/2020,6/17/2021,Verified
200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj,"May 18, 2020",Local,United States of America,United States of America; California,"April 10, 2020","April 14, 2020",Household and community samples,Multiple groups,863,4.65%,2.52%,7.07%,Stratified probability,Premier Biotech,LFIA,"IgG,IgM",82.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Neeraj Sood,Stanford University School of Medicine,https://jamanetwork.com/journals/jama/fullarticle/2766367,5/21/2020,6/17/2021,Verified
200523_SouthCarolina_MUSCHealthLancaster_HCW,"May 23, 2020",Local,United States of America,United States of America; South Carolina; Lancaster,"March 16, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),230,2.17%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Lisa Geraci ,MUSC Health-Lancaster,https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA,5/26/2020,8/4/2021,Verified
200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation,"May 20, 2020",Regional,United States of America,United States of America; Iowa,"April 1, 2020","May 20, 2020",Household and community samples,Adults (18-64 years),18160,10.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Jeff Montgomery,Iowa Department of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q,5/30/2020,8/4/2021,Verified
200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,"June 17, 2020",Regional,United States of America,United States of America; New York,"April 19, 2020","April 28, 2020",Household and community samples,Multiple groups,15101,14.00%,13.30%,14.70%,Convenience,NA,CLIA,IgG,87.90%,99.75%,Moderate,Journal Article (Peer-Reviewed),Eli Rosenberg,New York State Department of Health,https://dx.doi.org/10.1016/j.annepidem.2020.06.004,5/30/2020,7/6/2021,Verified
200510_US_StanfordUniversity_MajorLeagueBaseballEmployees,"May 10, 2020, May 11, 2020",National,United States of America,United States of America,"April 8, 2020","April 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),5603,0.70%,0.28%,1.15%,Convenience,NA,Not reported,Not reported,,,Unclear,"News and Media, News and Media","Susan Slusser, John McCormack",Stanford University,"https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php, https://www.nationalreview.com/2020/05/coronavirus-antibody-study-major-league-baseball-herd-immunity/",6/2/2020,6/17/2021,Verified
200601_LongHillTownship_SummitMedicalCenter_FirstResponders,"June 1, 2020",Local,United States of America,United States of America; New Jersey; Long Hill Township,"May 1, 2020","May 14, 2020",Essential non-healthcare workers,Adults (18-64 years),70,4.29%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Alex Parker Magyar,Summit Medical Center,https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw,6/3/2020,7/31/2021,Verified
200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers,"June 3, 2020",Local,United States of America,United States of America; New York; New York City,"March 24, 2020","April 4, 2020",Health care workers and caregivers,Multiple groups,285,32.63%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mayce Mansour,Icahn School of Medicine at Mount Sinai,https://link.springer.com/article/10.1007/s11606-020-05926-8,6/4/2020,8/4/2021,Verified
200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop,"June 2, 2020",Local,United States of America,United States of America; California,,"May 26, 2020",Household and community samples,Not reported,1000,1.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Shomik Mukherjee ,Humboldt County Department of Health and Human Services,https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA,6/7/2020,6/17/2021,Verified
200612_Guam_USNavy,"June 12, 2020",Local,United States of America,United States of America; Guam,"April 20, 2020","April 24, 2020",Essential non-healthcare workers,Adults (18-64 years),382,59.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Daniel Payne,US Navy,https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm,6/12/2020,7/31/2021,Verified
200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj,"June 12, 2020",Local,United States of America,United States of America; New Jersey; Long Branch,"May 14, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),121,0.83%,,,Convenience,SD Biosensor,LFIA,IgG,96.20%,96.60%,High,Journal Article (Peer-Reviewed),Mohsin Mughal ,Monmouth Medical Centre,https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7,6/13/2020,8/4/2021,Verified
200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop,"June 14, 2020",Local,United States of America,United States of America; Colorado; Steamboat Springs,,"June 10, 2020",Household and community samples,Not reported,649,2.60%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Kari Harden ,Routt County Board of Health,https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ,6/15/2020,6/24/2021,Verified
200617_Indiana_IndianaUniversity_Wave2GenPop,"June 17, 2020",Regional,United States of America,United States of America; Indiana,"June 3, 2020","June 8, 2020",Household and community samples,Multiple groups,3600,1.50%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Shari Rudavsky,Indiana University Fairbanks School of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ,6/23/2020,6/17/2021,Verified
200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders,"June 22, 2020",Local,United States of America,United States of America; Nevada,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),132,14.00%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Anh Gray,Truckee Meadows Fire Protection District,https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0,6/24/2020,7/31/2021,Verified
200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders,"May 4, 2020",Local,United States of America,United States of America; South Carolina; Charleston,"April 27, 2020","May 2, 2020",Multiple populations,Adults (18-64 years),920,2.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Nick Reagan,Medical University South Carolina,https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/,6/27/2020,8/5/2021,Verified
200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees,"May 22, 2020",Local,United States of America,United States of America; Florida; Coral Springs,"May 17, 2020","May 22, 2020",Essential non-healthcare workers,Not reported,700,0.00%,,,Self-referral,Cellex Inc.,Not reported,Not reported,,,Unclear,News and Media,Jenny Staletovich,Coral Springs City Government,https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw,6/27/2020,7/31/2021,Verified
200520_LosAngeles_UniSouthernCalifornia_GenPop,"May 20, 2020",Local,United States of America,United States of America; California,"May 8, 2020","May 12, 2020",Household and community samples,Not reported,1014,2.10%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,CBS Los Angeles,University of Southern California,https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg,6/27/2020,6/24/2021,Verified
200520_Madison_UWHealth_UniWisconsinHealthClinic,"May 20, 2020",Local,United States of America,United States of America; Wisconsin; Madison,"May 13, 2020","May 20, 2020",Household and community samples,Not reported,5303,1.50%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,6/24/2021,Verified
200520_Madison_UWHealth_UnityPointClinic,"May 20, 2020",Local,United States of America,United States of America; Wisconsin; Madison,"May 13, 2020","May 20, 2020",Household and community samples,Not reported,433,0.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,6/24/2021,Verified
200624_BaskingRidge_FellowshipVillage_Residents2_Overall,"June 24, 2020",Local,United States of America,United States of America; New Jersey; Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Seniors (65+ years),371,34.77%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,6/29/2020,8/4/2021,Verified
201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall,"November 3, 2020",Local,United States of America,United States of America; New York; New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,6590,11.10%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,6/29/2020,7/6/2021,Verified
200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop,"May 29, 2020",Local,United States of America,United States of America; North Carolina,"May 29, 2020","May 29, 2020",Household and community samples,Not reported,329,1.52%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Steve Ohnesorge,Psalms/Solid Rock Medicine Group,https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA,7/4/2020,6/24/2021,Verified
200529_CoachellaValley_Desert Healthcare District_GenPop,"May 29, 2020",Local,United States of America,United States of America; California,,"May 28, 2020",Household and community samples,Not reported,896,6.00%,,,Self-referral,Phamatech,LFIA,"IgG,IgM",,,Unclear,News and Media,Nicole Hayden,Desert Healthcare District,https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg,7/4/2020,6/24/2021,Verified
200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa,"May 28, 2020",Local,United States of America,United States of America; Michigan,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,1248,92.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,6/17/2021,Verified
200528_Michigan_MichiganDepartmentofCorrections_MacombCF,"May 28, 2020",Local,United States of America,United States of America; Michigan; Lenox Township,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,1201,65.60%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,6/17/2021,Verified
200528_Michigan_MichiganDepartmentofCorrections_DetroitRC,"May 28, 2020",Local,United States of America,United States of America; Michigan; Detroit,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,57,35.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,6/17/2021,Verified
200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF,"May 28, 2020",Local,United States of America,United States of America; Michigan,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,867,12.22%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,6/17/2021,Verified
200707_Lousiana_TulaneUniversity_AllChildren,"July 8, 2020",Local,United States of America,United States of America; Louisiana; Orleans,"March 18, 2020","May 15, 2020",Residual sera,Children and Youth (0-17 years),812,7.60%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Monika Dietrich,Tulane University,https://www.medrxiv.org/content/10.1101/2020.07.07.20147884v1,7/9/2020,7/6/2021,Verified
200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj,"July 29, 2020",Local,United States of America,United States of America; Pennsylvania; Philadelphia,"April 4, 2020","June 3, 2020",Pregnant or parturient women,Adults (18-64 years),1293,5.20%,,,Sequential,NA,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Dustin Flannery,University of Pennsylvania,https://immunology.sciencemag.org/content/5/49/eabd5709,7/13/2020,6/17/2021,Verified
200529_Washington_CDC_KnownContacts,"May 29, 2020",Regional,United States of America,United States of America; Washington,"January 20, 2020","February 3, 2020",Contacts of COVID patients,Multiple groups,32,0.00%,,,Convenience,NA,ELISA,Not reported,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Victoria Chu,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article,7/16/2020,7/6/2021,Verified
200507_Boise_UniversityofWashington_GenPop,"May 7, 2020",Local,United States of America,United States of America; Idaho; Boise,"April 20, 2020","April 26, 2020",Household and community samples,Multiple groups,4856,1.79%,,,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Andrew Bryan,University of Washington School of Medicine,https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20,7/19/2020,6/24/2021,Verified
200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW,"June 9, 2020",Local,United States of America,United States of America; New York; New York City,"March 1, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),91,12.10%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",93.10%,99.20%,High,Journal Article (Peer-Reviewed),Miguel Morcuende,Columbia University Irving Medical Center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/,7/19/2020,8/5/2021,Verified
200717_Chittenden_UniversityVermont_GenPop,"July 17, 2020",Local,United States of America,United States of America; Vermont,,"June 30, 2020",Household and community samples,Not reported,455,2.20%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Cat Viglienzoni,University of Vermont,https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw,8/1/2020,6/17/2021,Verified
200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop,"July 8, 2020",Local,United States of America,United States of America; Nevada,"June 9, 2020","June 10, 2020",Household and community samples,Adults (18-64 years),234,2.30%,,,Stratified probability,NA,Not reported,Not reported,,99.60%,High,News and Media,Mary Hynes,Washoe County Health District,https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw,8/1/2020,6/17/2021,Verified
200614_Ohio_OhioStateUniversity_Period 2,"June 14, 2020",Local,United States of America,United States of America; Ohio; Columbus,"April 23, 2020","April 23, 2020",Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Miranda Kiefer,Ohio State University College of Medicine,https://www.ajog.org/article/S0002-9378(20)30649-9/fulltext,8/2/2020,8/4/2021,Verified
200715_WashintonDC_DCPublicHealth_GenPop,"July 15, 2020",Local,United States of America,United States of America; Washington D.C; Washington DC,"June 15, 2020","July 15, 2020",Household and community samples,Not reported,13706,5.90%,,,Self-referral,DiaSorin SpA,CLIA,Not reported,,,High,News and Media,Julie Zauzmer,Washington DC Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw,8/2/2020,6/24/2021,Verified
200721_Idaho_UniversityofWashington_TotalPopTestAdj,"July 21, 2020",Local,United States of America,United States of America; Idaho,"May 4, 2020","May 19, 2020",Household and community samples,Multiple groups,917,23.10%,19.80%,26.50%,Self-referral,Abbott Laboratories,CLIA,IgG,92.90%,99.60%,Moderate,Preprint,Colleen McLaughlin, University of Washington,https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1,8/3/2020,8/5/2021,Verified
200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj,"July 24, 2020, May 13, 2020, May 17, 2020",Local,United States of America,United States of America; Indiana; Indianapolis,"May 2, 2020","May 3, 2020",Household and community samples,Multiple groups,898,5.80%,,,Convenience,NA,CLIA,IgG,100.00%,99.60%,High,"Institutional Report, News and Media, News and Media","Nir Menachemi, Aaron Carroll, Dariush Shafa",Indiana University Fairbanks School of Public Health,"https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",8/4/2020,6/24/2021,Verified
201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,"October 28, 2020",Regional,United States of America,United States of America; Connecticut,"June 4, 2020","June 23, 2020",Household and community samples,Multiple groups,567,4.00%,2.00%,6.00%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,9/24/2020,6/17/2021,Verified
200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall,"August 4, 2020",Local,United States of America,United States of America; Florida; Miami,"April 23, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,677,5.60%,4.00%,7.60%,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",57.10%,85.00%,High,Preprint,Dena Cohen,DaVita Clinical Research,https://doi.org/10.1101/2020.08.03.20163642,9/24/2020,8/5/2021,Verified
200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop,"July 27, 2020, July 29, 2020, July 27, 2020",Local,United States of America,United States of America; California,"July 6, 2020","July 20, 2020",Household and community samples,Not reported,1726,5.90%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,"News and Media, News and Media, News and Media","Nicole Hayden, Rob McMillan, ABC7 com staff",Riverside University Health System,"https://eu.desertsun.com/story/news/health/2020/07/27/riverside-county-estimates-175-000-residents-could-have-been-infected/5522612002/, https://abc7.com/riverside-county-covid-update-coronavirus-ie-covid-19/6340600/, https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/",9/26/2020,6/17/2021,Verified
200721_NewYork_ShermanAbramsLaboratory_Overall,"July 21, 2020",Local,United States of America,United States of America; New York; New York,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,28523,44.00%,,,Unclear,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Josh Reifer,Sherman Abrams Laboratory ,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128,9/26/2020,6/17/2021,Verified
200726_RhodeIsland_NewYorkBloodCenter_BloodDonors,"July 26, 2020",Regional,United States of America,United States of America; Rhode Island,"April 27, 2020","May 11, 2020",Blood donors,Multiple groups,1996,3.86%,,,Sequential,"Ortho Clinical Diagnostics Inc.,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Preprint,Daniel Nesbitt,New York Blood Center,https://www.medrxiv.org/content/10.1101/2020.07.20.20157743v1,9/27/2020,8/4/2021,Verified
200904_USA_CDC_HCWs_Overall,"September 4, 2020",National,United States of America,"United States of America; New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio; Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus","April 3, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),3248,5.97%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Wesley Self,CDC COVID-19 Response Team,https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm,9/28/2020,7/6/2021,Verified
200723_JeffersonCounty_UniversityofLouisville_genpop,"July 23, 2020",Local,United States of America,United States of America; Kentucky,"June 10, 2020","June 19, 2020",Household and community samples,Multiple groups,2237,4.00%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Spectrum News Staff, University of Louisville,https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results,9/30/2020,6/24/2021,Verified
200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj,"July 24, 2020",Local,United States of America,United States of America; Georgia,"April 28, 2020","May 3, 2020",Household and community samples,Multiple groups,696,2.50%,1.40%,4.50%,Stratified probability,Ortho Clinical Diagnostics Inc.,Not reported,"IgG,IgA,IgM",93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Holly Biggs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm6929e2,10/2/2020,8/5/2021,Verified
200803_Indiana_IndianaUniversity_healthcareworkers,"August 3, 2020",Regional,United States of America,United States of America; Indiana; Indianapolis,"April 29, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),734,1.63%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Benton Hunter, Indiana University,https://dx.doi.org/10.1017/ice.2020.390,10/4/2020,6/17/2021,Verified
200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,"July 30, 2020",Local,United States of America,United States of America; Louisiana,"May 9, 2020","May 15, 2020",Household and community samples,Adults (18-64 years),2640,6.90%,6.80%,6.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Oschner Clinic Foundation,https://dx.doi.org/10.3201/eid2611.203029,10/5/2020,6/17/2021,Verified
200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,"August 14, 2020",Local,United States of America,United States of America; New York; New York City,"May 7, 2020","June 25, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,952,5.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Sean McBride,Memorial Sloan Kettering Cancer Center,https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1,10/9/2020,6/17/2021,Verified
200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,"August 6, 2020",Local,United States of America,United States of America; Florida,"April 16, 2020","April 17, 2020",Essential non-healthcare workers,Multiple groups,203,8.90%,,,Convenience,"BioMedomics, Inc.",LFIA,"IgG,IgM",88.66%,90.63%,High,Journal Article (Peer-Reviewed),Alberto J Caban Martinez,University of Miami,http://dx.doi.org/10.1136/oemed-2020-106676,10/10/2020,8/4/2021,Verified
200811_NewYork_StFrancisHospital_Overall,"August 11, 2020",Local,United States of America,United States of America; New York; New York City,"March 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1699,9.80%,,,Convenience,"EUROIMMUN AG,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Allen Jeremias,St Francis Hospital,http://dx.doi.org/10.1001/jamainternmed.2020.4214,10/10/2020,8/4/2021,Verified
200814_Oregon_OregonHealthAuthority_Overall_UnAdj,"August 14, 2020",Regional,United States of America,United States of America; Oregon,"May 11, 2020","June 15, 2020",Residual sera,Multiple groups,897,1.00%,0.20%,1.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.80%,99.10%,High,Journal Article (Peer-Reviewed),Melissa Sutton,Oregon Health Authority,https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm,10/10/2020,6/17/2021,Verified
200918_UnitedStates_Vitalant_Overall,"September 18, 2020",National,United States of America,"United States of America; New Mexico, Montana, Wyoming, Colorado, Texas, North Dakota, Louisiana, Nevada, Tennessee, Arizona, South Dakota, California, Washington, Mississippi; Albuquerque, Billings, Cheyenne, Denver, El Paso, Fargo, Lafayette, Las Vegas, Lubbock, McAllen, Memphis, Phoenix, Rapid City, Reno, Sacramento, San Francisco, Spokane, Tupelo, ventura, Newark","June 1, 2020","July 31, 2020",Blood donors,Multiple groups,252882,1.83%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,"IgA,IgG,IgM,Total Antibody",,,Moderate,Preprint,Ralph Vassallo ,Vitalant,https://www.medrxiv.org/content/10.1101/2020.09.17.20195131v1.full.pdf,10/13/2020,6/17/2021,Verified
200818_Cambridge_CambridgeHealthAllianceOverall,"August 18, 2020",Local,United States of America,United States of America; Massachusetts; Cambridge,"April 13, 2020","May 24, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),24,16.70%,,,Convenience,"DiaSorin SpA,EUROIMMUN AG,Abbott Laboratories",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Robert Stavert,Cambridge Health Alliance,http://dx.doi.org/10.1016/j.jaad.2020.08.049,10/15/2020,8/4/2021,Verified
200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,"August 21, 2020",Local,United States of America,United States of America; California; San Francisco,"April 25, 2020","April 28, 2020",Household and community samples,Multiple groups,3861,3.40%,2.90%,4.10%,Self-referral,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriel Chamie,"University of California, San Francisco",http://dx.doi.org/10.1093/cid/ciaa1234,10/17/2020,8/5/2021,Verified
200818_Oregon_EarleA.ChilesResearchInstitute_Overall,"August 18, 2020",Regional,United States of America,"United States of America; Oregon; Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie","April 8, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,10019,2.53%,,,Convenience,NA,ELISA,IgG,80.00%,100.00%,High,Preprint,Rom Leidner,Chiles Research Institute,https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1,10/18/2020,7/6/2021,Verified
200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,"August 26, 2020",Local,United States of America,United States of America; New York; New York City,"April 28, 2020","May 4, 2020",Health care workers and caregivers,Multiple groups,1700,19.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elana Sydney,Jacobi Medical Center,http://dx.doi.org/10.1017/ice.2020.437,10/21/2020,6/17/2021,Verified
200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,"August 28, 2020",Local,United States of America,United States of America; California; Los Angeles,"June 5, 2020","June 12, 2020",Assisted living and long-term care facilities,Multiple groups,150,17.30%,,,Convenience,DiaSorin SpA,CLIA,IgG,92.00%,98.00%,High,Journal Article (Peer-Reviewed),Amy V Dora,Veterans Affairs Healthcare System,http://dx.doi.org/10.1093/cid/ciaa1286,10/21/2020,6/17/2021,Verified
200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj,"September 9, 2020",Local,United States of America,United States of America; Massachusetts; Chelsea,"April 14, 2020","April 15, 2020",Household and community samples,Adults (18-64 years),200,32.80%,27.20%,38.80%,Convenience,"BioMedomics, Inc.",LFIA,"IgM,IgG",90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Vivek Naranbhai,Massachusetts General Hospital,http://dx.doi.org/10.1093/infdis/jiaa579,10/21/2020,8/5/2021,Verified
200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,"August 21, 2020",Local,United States of America,United States of America; New York; New York City,"April 4, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),98,15.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ariel D Stock,Albert Einstein College of Medicine,https://dx.doi.org/10.3389/fmed.2020.00471,10/24/2020,6/17/2021,Verified
200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall,"September 20, 2020",Regional,United States of America,United States of America; New York,"May 27, 2020","July 24, 2020",Pregnant or parturient women,Adults (18-64 years),1671,16.10%,,,Unclear,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Donald and Barbara Zucker School of Medicine,https://dx.doi.org/10.1016/j.ajog.2020.09.022,10/30/2020,7/16/2021,Verified
200911_NewYorkCity_WeillCornellMedicine_IgGorIgM,"September 11, 2020",Local,United States of America,United States of America; New York; New York City,"April 17, 2020","May 7, 2020",Health care workers and caregivers,Adults (18-64 years),2274,35.40%,,,Convenience,ET Healthcare,Other,"IgG,IgM",,98.80%,Moderate,Journal Article (Peer-Reviewed),Sabrina Racine Brzostek,Weill Cornell Medicine,http://dx.doi.org/10.1093/ajcp/aqaa142,11/2/2020,8/4/2021,Verified
201023_BatonRouge_LouisianaStateUniversity_Total_popadj,"October 23, 2020",Local,United States of America,United States of America; Louisiana; Baton Rouge,"July 15, 2020","July 31, 2020",Household and community samples,Multiple groups,2138,3.60%,2.80%,4.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Louisiana State University,https://dx.doi.org/10.3201/eid2701.203808,11/4/2020,6/17/2021,Verified
200917_SanFrancisco_UniversityofCalifornia_BloodDonors,"September 17, 2020",Local,United States of America,United States of America; California; San Francisco,"March 1, 2020","March 31, 2020",Blood donors,Multiple groups,1000,0.10%,0.00%,0.56%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,8/4/2021,Verified
200917_SanFrancisco_UniversityofCalifornia_Patients,"September 17, 2020",Local,United States of America,United States of America; California; San Francisco,"March 17, 2020","April 13, 2020",Residual sera,Multiple groups,387,0.26%,0.00%,0.76%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,99.80%,High,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,6/17/2021,Verified
200925_UnitedStates_StanfordUniversity_OverallPopAdj,"September 25, 2020",National,United States of America,United States of America,"June 15, 2020","June 15, 2020",Residual sera,Multiple groups,28503,9.30%,8.80%,9.90%,Stratified probability,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext,11/22/2020,6/17/2021,Verified
200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem,"September 23, 2020",Local,United States of America,United States of America; Michigan,"June 8, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1476,4.90%,3.80%,6.10%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Derek Dimcheff,Veterans Affairs Ann Arbor Healthcare System,https://dx.doi.org/10.1017/ice.2020.1220,11/23/2020,6/17/2021,Verified
200918_Arizona_VincereCancerCenter_Total,"September 18, 2020",Regional,United States of America,"United States of America; Arizona; Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler","April 24, 2020","May 21, 2020",Essential non-healthcare workers,Multiple groups,3326,1.50%,,,Convenience,RayBiotech,LFIA,IgG,90.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Vershalee Shukla,Vincere Cancer Center,https://dx.doi.org/10.1097/JOM.0000000000002027,11/23/2020,8/4/2021,Verified
200914_UnitedStates_AmericanRedCrossScientificAffairs_Overall,"September 14, 2020",National,United States of America,United States of America,"June 15, 2020","June 15, 2020",Blood donors,Multiple groups,953926,1.82%,,,Sequential,Ortho Clinical Diagnostics Inc.,Not reported,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross Scientific Affairs,http://dx.doi.org/10.1001/jama.2020.18598,11/23/2020,6/17/2021,Verified
200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall,"September 17, 2020",Local,United States of America,United States of America; Tennessee; Nashville,"June 2, 2020","June 27, 2020",Health care workers and caregivers,Multiple groups,230,3.48%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Manish Patel,Vanderbilt University Medical Center,http://dx.doi.org/10.1001/jama.2020.18796,11/24/2020,7/6/2021,Verified
200921_Detroit_Region2SouthHealthcareCoalition_Overall,"September 21, 2020",Local,United States of America,United States of America; Michigan; Detroit,"May 18, 2020","June 13, 2020",Health care workers and caregivers,Adults (18-64 years),16397,6.90%,6.50%,7.30%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Region 2 South Healthcare Coalition,https://dx.doi.org/10.3201/eid2612.203764,12/4/2020,6/17/2021,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall,"September 29, 2020",Regional,United States of America,United States of America; North Carolina,"March 3, 2020","June 4, 2020",Residual sera,Adults (18-64 years),1449,0.70%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,6/17/2021,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj,"September 29, 2020",Regional,United States of America,United States of America; North Carolina,"April 28, 2020","June 19, 2020",Residual sera,Adults (18-64 years),2973,0.00%,0.00%,0.90%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,6/17/2021,Verified
200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts,"August 16, 2020",Local,United States of America,"United States of America; Utah, Wisconsin; Salt Lake City, Milwaukee","March 22, 2020","April 25, 2020",Contacts of COVID patients,Multiple groups,178,25.80%,,,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Nathaniel M Lewis,Centers for Disease Control ,https://dx.doi.org/10.1093/cid/ciaa1166,12/16/2020,7/6/2021,Verified
201127_Utah_UniversityOfUtah_GenPop_testadj_popadj,"October 27, 2020",Regional,United States of America,United States of America; Utah,"May 4, 2020","June 30, 2020",Household and community samples,Multiple groups,8108,0.80%,0.10%,1.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,86.40%,99.60%,Moderate,Preprint,Matthew Samore,University of Utah,https://www.medrxiv.org/content/10.1101/2020.10.26.20219907v1,12/16/2020,6/17/2021,Verified
201116_Tennessee_VanderbiltUniversity_HCW_Overall,"November 16, 2020",Regional,United States of America,United States of America; Tennessee,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),11787,0.98%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Peter Rebeiro,Vanderbilt University,https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1,12/16/2020,6/17/2021,Verified
201105_Michigan_OaklandUniversity_testadj,"November 5, 2020",Local,United States of America,"United States of America; Michigan; Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton","April 13, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,20614,8.10%,6.80%,8.90%,Convenience,EUROIMMUN AG,ELISA,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew D Sims,Oakland University,https://dx.doi.org/10.1093/cid/ciaa1684,12/17/2020,6/17/2021,Verified
201030_Indianapolis_IndianaUniversity_Overall,"October 30, 2020",Local,United States of America,United States of America; Indiana; Indianapolis ,"May 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),31,3.20%,,,Convenience,"Abnova,NA",ELISA,"IgM,IgG",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Corina Nailescu,Indiana University ,https://dx.doi.org/10.3389/fped.2020.601327,12/17/2020,8/4/2021,Verified
201201_NewHeaven_Yale_SchoolofMedicine_newborns,"December 12, 2020",Local,United States of America,United States of America; Connecticut; New Haven,"February 19, 2020","May 26, 2020",Residual sera,Children and Youth (0-17 years),3048,5.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Feimei  Liu,Yale School of Medicine,https://dx.doi.org/10.1097/INF.0000000000002918,12/18/2020,6/17/2021,Verified
201021_NewYork_Serimmune_Overall,"October 21, 2020",Local,United States of America,United States of America; New York; New York City,"March 1, 2020","July 7, 2020",Blood donors,Multiple groups,1559,4.36%,,,Sequential,Serimmune,Not reported,IgG,91.00%,99.30%,High,Preprint,Kathy Kamath,Serimmune,https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1,12/18/2020,7/6/2021,Verified
201107_Lubbock_TexasTechUniversity_Overall,"November 7, 2020",Local,United States of America,United States of America; Texas; Lubbock,"May 12, 2020","May 13, 2020",Essential non-healthcare workers,Multiple groups,683,0.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Kenneth Iwuji,Texas Tech University,https://dx.doi.org/10.1177/2150132720971390,12/18/2020,8/4/2021,Verified
201013_PimaCounty_UniversityofArizona_Overall,"October 13, 2020",Local,United States of America,United States of America; Arizona,"April 30, 2020","May 7, 2020",Household and community samples,Multiple groups,5882,1.24%,,,Self-referral,NA,ELISA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Tyler Ripperger,University of Arizona,http://dx.doi.org/10.1016/j.immuni.2020.10.004,12/18/2020,6/17/2021,Verified
201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall,"October 15, 2020",Local,United States of America,United States of America; New York; New York City,"March 1, 2020","May 1, 2020",Health care workers and caregivers,Adults (18-64 years),500,27.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Usha Venugopal,NYC Health + Hospitals/Lincoln,http://dx.doi.org/10.1016/j.ijid.2020.10.036,12/19/2020,6/17/2021,Verified
201030_Cleveland_CaseWesternReserveUniversity_Overall,"October 30, 2020",Local,United States of America,United States of America; Ohio; Cleveland,"April 20, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),296,5.40%,3.10%,8.60%,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yasir Tarabichi,Case Western Reserve University,https://dx.doi.org/10.1080/10903127.2020.1831668,12/21/2020,8/4/2021,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall,"October 26, 2020",Local,United States of America,United States of America; New York; Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Multiple groups,764,2.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,12/28/2020,6/17/2021,Verified
201027_Indiana_Harvard_Overall_testadj,"November 27, 2020",Local,United States of America,United States of America; Indiana; St. John Township,"July 15, 2020","July 20, 2020",Essential non-healthcare workers,Multiple groups,753,1.70%,0.27%,3.30%,Self-referral,NA,Not reported,IgG,100.00%,99.00%,Moderate,Preprint,Lilah Lopez,Harvard Medical School,https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1,1/5/2021,8/4/2021,Verified
201119_LosAngeles_CedarsSinaiMedicalCenter_Overall,"November 19, 2020",Local,United States of America,United States of America; California; Los Angeles,"May 11, 2020","June 28, 2020",Health care workers and caregivers,Adults (18-64 years),6201,3.50%,,,Self-referral,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Moderate,Journal Article (Peer-Reviewed),Magali Rivas,Cedars-Sinai Medical Center,https://dx.doi.org/10.1172/JCI145157,1/5/2021,6/17/2021,Verified
201120_Rochester_MayoClinic_HighRiskCohort_1_Overall,"November 20, 2020",Local,United States of America,United States of America; Minnesota; Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),320,0.63%,,,Unclear,"EUROIMMUN AG,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,8/4/2021,Verified
201120_Rochester_MayoClinic_LowRiskCohort_2_Overall,"November 20, 2020",Local,United States of America,United States of America; Minnesota; Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),248,0.00%,,,Unclear,"EUROIMMUN AG,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,8/4/2021,Verified
201004_USA_RedCross_genpop_unadj,"October 4, 2020",National,United States of America,United States of America,"June 15, 2020","July 27, 2020",Blood donors,Multiple groups,573586,1.50%,,,Sequential,Ortho Clinical Diagnostics Inc.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Bryan Spencer,American Red Cross,https://aabb.confex.com/aabb/2020/meetingapp.cgi/Paper/8581,1/6/2021,6/17/2021,Verified
200810_USA_Illinois_PhysicianPractice_Overall,"August 6, 2020",Local,United States of America,United States of America; Illinois; Chicago,"April 22, 2020","May 26, 2020",Residual sera,Multiple groups,113,15.90%,,,Convenience,CLUNGENE,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gerald Osher,BioSolutions Services LLC,https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007,1/6/2021,6/17/2021,Verified
201027_Illinois_CDC_Contacts,"October 27, 2020",Regional,United States of America,United States of America; Illinois,"March 3, 2020","March 6, 2020",Contacts of COVID patients,Adults (18-64 years),59,0.00%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",96.00%,99.00%,High,Journal Article (Peer-Reviewed),Tristan McPherson,US Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/0033354920966064,1/7/2021,7/6/2021,Verified
201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall,"October 13, 2020",Local,United States of America,United States of America; Pennsylvania; Pittsburgh,"March 15, 2020","July 4, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),485,1.00%,0.30%,2.40%,Convenience,"EUROIMMUN AG,Beckman Coulter,Siemens",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Megan Freeman,University of Pittsburgh School of Medicine,http://dx.doi.org/10.1093/jpids/piaa123,1/7/2021,8/4/2021,Verified
201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall,"December 1, 2020",Local,United States of America,United States of America; California; Los Angeles,"April 29, 2020","May 8, 2020",Students and Daycares,Adults (18-64 years),790,4.00%,3.00%,5.10%,Convenience,EUROIMMUN AG,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kimberly Tilley,University of Southern California,http://dx.doi.org/10.1016/j.jadohealth.2020.09.001,1/7/2021,6/17/2021,Verified
201103_NewYorkCity_MountSinai_UrgentCare_2_Overall,"November 3, 2020",Local,United States of America,United States of America; New York; New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,4101,26.00%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,1/8/2021,7/6/2021,Verified
200624_BaskingRidge_FellowshipVillage_Staff1_Overall,"June 24, 2020",Local,United States of America,United States of America; New Jersey; Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Adults (18-64 years),305,23.60%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,1/9/2021,8/4/2021,Verified
201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients,"October 15, 2020",Local,United States of America,United States of America; New York; New York City,"May 3, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),912,16.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yorg Azzi,Albert Einstein College of Medicine,http://dx.doi.org/10.1016/j.kint.2020.10.004,1/13/2021,6/17/2021,Verified
210105_USA_ClinicalReferenceLaboratory_GenPop_Overall,"January 5, 2021",National,United States of America,United States of America,"May 12, 2020","December 6, 2020",Residual sera,Multiple groups,126587,5.87%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Preprint,Robert Stout,Clinical Reference Laboratory Inc.,https://www.medrxiv.org/content/10.1101/2020.11.10.20215145v3.full.pdf,1/18/2021,7/17/2021,Verified
201120_LosAngeles_TheLundquistInstitute_genpop,"November 25, 2020",Local,United States of America,United States of America; California,"April 21, 2020","May 22, 2020",Multiple populations,Not reported,244,20.90%,,,Unclear,"Hangzhou Testsea Biotechnology Co., Ltd",LFIA,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Khadije Ahmad,The Lundquist Institute ,https://dx.doi.org/10.1007/s10096-020-04111-3,1/19/2021,8/5/2021,Verified
201130_USA_AmericanRedCross_BloodDonors,"November 30, 2020",National,United States of America,"United States of America; Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin","December 13, 2019","January 17, 2020",Blood donors,Multiple groups,7389,1.40%,,,Sequential,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Sridhar V Basavaraju,American Red Cross,https://dx.doi.org/10.1093/cid/ciaa1785,1/20/2021,7/6/2021,Verified
201123_OrangeCounty_StJudeMedicalCenter_Overall,"November 23, 2020",Local,United States of America,United States of America; California; Fullerton,"July 15, 2020","July 27, 2020",Residual sera,Multiple groups,865,9.40%,8.00%,12.00%,Sequential,Abbott Laboratories,Not reported,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Jason Yamaki,St. Jude Medical Center,https://dx.doi.org/10.1007/s40615-020-00918-0,1/21/2021,6/17/2021,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW,"November 21, 2020",Local,United States of America,United States of America; California,"April 8, 2020","August 31, 2020",Health care workers and caregivers,Multiple groups,1108,3.90%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,6/17/2021,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders,"November 21, 2020",Local,United States of America,United States of America; California,"May 19, 2020","August 31, 2020",Essential non-healthcare workers,Multiple groups,679,8.10%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,8/4/2021,Verified
201127_DistrictofColumbia_DCHealth_Overall,"November 27, 2020",Regional,United States of America,United States of America; Washington D.C; Washington,"May 28, 2020","July 15, 2020",Essential non-healthcare workers,Adults (18-64 years),310,3.55%,,,Self-referral,DiaSorin SpA,CLIA,IgG,97.00%,,High,Preprint,Jacqueline Reuben,District of Columbia Department of Health (DC Health),https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1,1/21/2021,8/4/2021,Verified
201130_SanFrancisco_StanfordUniversity_Overall,"November 30, 2020",Local,United States of America,United States of America; California; San Francisco,"April 20, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),12418,0.90%,0.70%,1.10%,Self-referral,NA,ELISA,IgG,,99.75%,High,Journal Article (Peer-Reviewed),Catherine Hogan,Stanford University,https://dx.doi.org/10.3201/eid2701.203892,1/22/2021,7/6/2021,Verified
200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall,"June 22, 2020",Local,United States of America,United States of America; New York; New York City,"February 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),50,46.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jordan Jeong,Columbia University Medical Center,https://dx.doi.org/10.1016/j.annemergmed.2020.06.038,1/22/2021,8/4/2021,Verified
201210_Atlanta_CDC_Community_OverallPopTestAdj,"December 10, 2020",Local,United States of America,United States of America; Georgia; Atlanta,"April 28, 2020","May 3, 2020",Household and community samples,Multiple groups,669,3.18%,1.49%,6.67%,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Low,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,7/6/2021,Verified
201210_Atlanta_CDC_Lab_OverallPopTestAdj,"December 10, 2020",Local,United States of America,United States of America; Georgia; Atlanta,"April 27, 2020","May 1, 2020",Residual sera,Multiple groups,1343,4.94%,3.34%,6.64%,Convenience,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,7/6/2021,Verified
201215_SanDiego_SharpHealthCare_Overall,"December 15, 2020",Local,United States of America,United States of America; California; San Diego,"May 20, 2020","June 8, 2020",Health care workers and caregivers,Multiple groups,1770,2.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Norihiro Yogo,Sharp Healthcare,https://dx.doi.org/10.1017/ice.2020.1370,1/23/2021,7/17/2021,Verified
210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall,"January 1, 2021",Local,United States of America,United States of America; Washington ; Seattle,"July 6, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),481,1.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Yekaterina Tokareva,Seattle Childrens Research Institute,https://dx.doi.org/10.1542/hpeds.2020-003517,1/23/2021,6/17/2021,Verified
201119_USA_QuestDiagnostics_Overall,"November 19, 2020",National,United States of America,United States of America,"April 21, 2020","July 10, 2020",Household and community samples,Multiple groups,2402282,11.81%,,,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,EUROIMMUN AG",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Harvey W Kaufman,Quest Diagnostics,http://dx.doi.org/10.1089/pop.2020.0256,1/23/2021,8/4/2021,Verified
201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall,"December 14, 2020",Local,United States of America,United States of America; Virginia; Richmond,"July 27, 2020","October 2, 2020",Health care workers and caregivers,Multiple groups,1962,1.37%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Emily Godbout,Virginia Commonwealth University,https://dx.doi.org/10.1017/ice.2020.1374,1/23/2021,6/17/2021,Verified
201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants,"December 7, 2020",Local,United States of America,United States of America; Massachusetts; Boston,"May 29, 2020","July 23, 2020",Multiple populations,Multiple groups,143,6.30%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,8/5/2021,Verified
201207_Massachusetts_MassachusettsGeneralHospital_MS,"December 7, 2020",Local,United States of America,United States of America; Massachusetts; Boston,"May 29, 2020","July 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,227,3.50%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,7/6/2021,Verified
201203_AraphoeCounty_UniversityofColorado,"December 3, 2020",Local,United States of America,United States of America; Colorado,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),264,4.00%,,,Convenience,Exsera BioLabs,ELISA,IgG,85.00%,98.60%,High,Journal Article (Peer-Reviewed),Katherine Sabourin,University of Colorado,https://pubmed.ncbi.nlm.nih.gov/33298759/,1/28/2021,8/4/2021,Verified
200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium,"August 6, 2020",Local,United States of America,United States of America; New York; New York City,"April 20, 2020","June 23, 2020",Health care workers and caregivers,Multiple groups,40329,13.70%,,,Convenience,"EUROIMMUN AG,AnshLabs ,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,DiaSorin SpA,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Joseph Moscola,Northwell Health COVID-19 Research Consortium,https://pubmed.ncbi.nlm.nih.gov/32780804/,1/28/2021,8/4/2021,Verified
201230_SanDiego_ScrippsClinic_Overall,"December 30, 2020",Local,United States of America,United States of America; California; San Diego,"April 14, 2020","July 28, 2020",Health care workers and caregivers,Adults (18-64 years),11993,0.94%,,,Convenience,"Diazyme Laboratories Inc,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Nicholson,Scripps Clinic,https://dx.doi.org/10.1016/j.ajic.2020.12.017,1/29/2021,8/4/2021,Verified
201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj,"December 22, 2020",Regional,United States of America,United States of America; Wisconsin,"July 1, 2020","August 31, 2020",Household and community samples,Multiple groups,996,1.60%,0.60%,2.50%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,6/17/2021,Verified
201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj,"December 22, 2020",Regional,United States of America,United States of America; Wisconsin,"October 18, 2020","December 14, 2020",Household and community samples,Multiple groups,994,6.80%,4.30%,9.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,6/17/2021,Verified
210105_USA_MayoClinic_overall,"January 5, 2021",Local,United States of America,United States of America; Minnesota; Rochester,"May 16, 2020","May 17, 2020",Essential non-healthcare workers,Adults (18-64 years),255,1.20%,,,Convenience,NA,ELISA,IgG,88.10%,99.60%,High,Journal Article (Peer-Reviewed),Sarayna S McGuire,Mayo Clinic,https://dx.doi.org/10.1017/S1049023X2000151X,2/3/2021,7/6/2021,Unverified
201209_SantaClara_StanfordHealthCare,"December 9, 2020",Local,United States of America,United States of America; California; San Francisco Bay Area,"April 20, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),10449,1.30%,,,Convenience,NA,CLIA,IgG,87.00%,99.75%,High,Journal Article (Peer-Reviewed),Joelle Rosser,Stanford Health Care,https://dx.doi.org/10.1017/ice.2020.1358,2/4/2021,6/17/2021,Verified
201223_NewYork_MemorialSloanKetteringCancerCenter,"December 23, 2020",Local,United States of America,United States of America; New York; New York City,"May 5, 2020","September 10, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),257,7.80%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Jimenez Kurlander,Memorial Sloan Kettering Cancer Center,https://dx.doi.org/10.1002/pbc.28857,2/4/2021,6/17/2021,Verified
210119_NewJersey_CooperUniversityHospital_overall,"January 19, 2021",Local,United States of America,United States of America; New Jersey ,"June 10, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),172,5.20%,2.40%,9.70%,Convenience,"EUROIMMUN AG,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Snehal Gandhi,Cooper University Hospital,https://dx.doi.org/10.1007/s11606-020-06462-1,2/4/2021,8/4/2021,Unverified
201106_Utah_UniversityofUtah_immunosupressed_primary,"November 6, 2020",Local,United States of America,United States of America; Utah; Salt Lake City ,"April 18, 2020","May 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,39,2.60%,,,Unclear,NA,Not reported,IgG,,,High,Preprint,Quinn Pritchett,University of Utah,https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/,2/4/2021,6/17/2021,Verified
210111_Michigan_ UniversityofMichigan_overall,"January 11, 2021",Local,United States of America,United States of America; Michigan,"August 17, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),1385,1.88%,,,Convenience,"Siemens,Eagle Bioscience",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jeffrey J Fletcher,Metro Health University of Michigan Health,http://dx.doi.org/10.1017/ice.2020.1438,2/4/2021,8/4/2021,Unverified
201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool,"October 31, 2020",Local,United States of America,"United States of America; New Jersey; New Brunswick, Somerville","April 28, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),3907,9.60%,,,Convenience,Abbott Laboratories,Not reported,IgG,96.90%,99.60%,Moderate,Journal Article (Peer-Reviewed),Emily Barrett,Rutgers Robert Wood Johnson Medical School,https://dx.doi.org/10.1093/ofid/ofaa534,2/5/2021,6/17/2021,Verified
210115_Massachusetts_HarvardUniversity_Overall,"January 15, 2021",Regional,United States of America,United States of America; Massachusetts,"June 16, 2020","August 24, 2020",Household and community samples,Multiple groups,1872,3.15%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,Moderate,Preprint,Aishani Aatresh,Harvard University,https://www.medrxiv.org/content/10.1101/2021.01.14.21249824v1,2/11/2021,6/23/2021,Unverified
210202_Indiana_IndianaUniversity_GenPop_PopAdjTestAdj,"February 2, 2021",Regional,United States of America,United States of America; Indiana,"April 25, 2020","April 29, 2020",Household and community samples,Multiple groups,3625,2.60%,2.08%,3.35%,Stratified probability,Abbott Laboratories,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Constantin Yiannoutsos,Indiana University,https://dx.doi.org/10.1073/pnas.2013906118,2/13/2021,7/7/2021,Unverified
201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy,"October 21, 2020",Local,United States of America,United States of America; Washington; Seattle,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),120,2.50%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Amin Addetia,University of Washington,https://jcm.asm.org/content/58/11/e02107-20,2/17/2021,8/4/2021,Verified
201209_Chicago_NorthwesternUniversity_OverallPopAdj,"December 9, 2020",Local,United States of America,United States of America; Illinois; Chicago,"May 28, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,6510,5.30%,4.80%,5.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),John T Wilkins,Northwestern University ,https://dx.doi.org/10.1093/ofid/ofaa582,2/19/2021,6/17/2021,Verified
210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj,"January 29, 2021",Local,United States of America,United States of America; Pennsylvania; Philadelphia,"April 9, 2020","August 8, 2020",Pregnant or parturient women,Adults (18-64 years),1471,6.00%,,,Convenience,NA,ELISA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Dustin D Flannery,University of Pennsylvania,https://dx.doi.org/10.1001/jamapediatrics.2021.0038,2/20/2021,6/17/2021,Verified
210117_Maryland_UniversityofMaryland_overall_adj,"January 17, 2021",Local,United States of America,United States of America; Maryland; Baltimore,"June 3, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),8399,3.52%,3.01%,3.98%,Convenience,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Kristin E Mullins,University of Maryland,http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004,2/22/2021,8/4/2021,Verified
210131_USA_NIH_primary,"January 31, 2021",National,United States of America,United States of America,"April 1, 2020","August 4, 2020",Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,NA,ELISA,"IgG,IgM,IgA",,,Moderate,Preprint,Heather Kalish,National Institute of Health,https://pubmed.ncbi.nlm.nih.gov/33532807/,2/22/2021,6/17/2021,Verified
210201_Minnesota_UniversityofMinnesota_HCW_Primary,"February 1, 2021",Regional,United States of America,United States of America; Minnesota,"April 13, 2020","May 21, 2020",Health care workers and caregivers,Multiple groups,1282,2.96%,2.04%,3.89%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/25/2021,6/17/2021,Verified
210201_Minnesota_UniversityofMinnesota_OutPatients_Primary ,"February 1, 2021",Regional,United States of America,United States of America; Minnesota,"April 13, 2020","May 21, 2020",Residual sera,Multiple groups,2379,4.46%,3.63%,5.28%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/25/2021,6/17/2021,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall copy,"October 26, 2020",Local,United States of America,United States of America; New York; Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),762,4.50%,,,Unclear,Ortho Clinical Diagnostics Inc.,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,2/27/2021,6/17/2021,Verified
0201_Washington_ChildrensNationalHospital_Overall_TestAdj,"February 1, 2021",Local,United States of America,"United States of America; Washington, D.C, Maryland, Virginia, West Virginia; Washington D.C","July 7, 2020","October 29, 2020",Residual sera,Children and Youth (0-17 years),385,9.46%,6.68%,13.00%,Convenience,DiaSorin SpA,CLIA,IgG,97.60%,99.30%,High,Journal Article (Peer-Reviewed),Burak Bahar,Children's National Hospital,https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text,3/4/2021,7/29/2021,Verified
210203_NewYorkCity_IcahnSchoolOfMedicine_Overall,"February 3, 2021",Local,United States of America,United States of America; New York; New York City,"April 20, 2020","August 15, 2020",Pregnant or parturient women,Adults (18-64 years),696,15.00%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Preprint,Nina Molenaar,Icahn School of Medicine at Mount Sinai,10.1101/2021.02.01.21250943,3/4/2021,6/17/2021,Verified
210125_NewYork_CDC+NewYorkCity_Total,"January 25, 2021",Local,United States of America,United States of America; New York; New York City,"May 18, 2020","July 2, 2020",Essential non-healthcare workers,Multiple groups,22647,22.50%,21.90%,23.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Samira Sami,CDC and New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.3201/eid2703.204340,3/5/2021,7/7/2021,Unverified
201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall,"December 14, 2020",Local,United States of America,United States of America; Arizona,"September 11, 2020","September 21, 2020",Household and community samples,Multiple groups,260,10.70%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Fountain Hills Times,Maricopa County Department of Public Health,https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html,3/6/2021,6/17/2021,Verified
201203_Florida_FloridaDepartmentOfHealth_primary,"December 3, 2020",Regional,United States of America,United States of America; Florida,"May 1, 2020","November 30, 2020",Household and community samples,Multiple groups,630838,11.03%,,,Self-referral,NA,Not reported,"IgG,Total Antibody",,,Unclear,News and Media,Frank Jolley,Florida Department of Health,https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/,3/7/2021,6/17/2021,Verified
201005_Wisconsin_UW-Madison_overall,"October 5, 2020",Regional,United States of America,United States of America; Wisconsin,"July 15, 2020","August 15, 2020",Household and community samples,Multiple groups,1056,1.60%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Madeline Heim,UW-Madison,https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/,3/7/2021,6/17/2021,Verified
200830_VenturaCounty_OxnardFireDepartment_overall,"August 30, 2020",Local,United States of America,United States of America; California,"June 22, 2020","July 6, 2020",Household and community samples,Multiple groups,6794,1.30%,,,Self-referral,"Abbott Laboratories,Bio-rad",Not reported,Not reported,,,High,News and Media,Jeremy Childs,Oxnard Fire Department,https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/,3/7/2021,8/4/2021,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_July,"August 24, 2020",Local,United States of America,United States of America; Kentucky; Louiseville,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1100,2.20%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/8/2021,6/17/2021,Verified
201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling,"November 24, 2020",Local,United States of America,United States of America; Kentucky,"November 9, 2020","November 16, 2020",Household and community samples,Not reported,1091,2.00%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,6/17/2021,Verified
201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall,"November 24, 2020",Local,United States of America,United States of America; Kentucky,"November 9, 2020","November 16, 2020",Household and community samples,Not reported,1709,3.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,6/17/2021,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay,"August 24, 2020",Local,United States of America,United States of America; Kentucky; Louiseville,"April 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1372,1.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/9/2021,6/17/2021,Verified
210123_Norfolk_NavalMedicalCenterPortsmouth_Overall,"January 23, 2021",Local,United States of America,United States of America; Virginia; Norfolk,"April 28, 2020","May 12, 2020",Essential non-healthcare workers,Adults (18-64 years),432,3.01%,1.61%,5.09%,Convenience,LakePharma Inc.,Other,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tahaniyat Lalani,Naval Medical Center Portsmouth,https://dx.doi.org/10.1093/ofid/ofaa654,3/13/2021,6/17/2021,Verified
201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj,"October 28, 2020",Regional,United States of America,United States of America; Connecticut,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,148,6.40%,0.90%,11.90%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,6/17/2021,Verified
201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj,"October 28, 2020",Regional,United States of America,United States of America; Connecticut,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,171,19.90%,13.20%,26.60%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,6/17/2021,Verified
210122_USA_YourCareChoice_GenPop,"January 22, 2021",National,United States of America,United States of America,"April 24, 2020","May 13, 2020",Household and community samples,Multiple groups,407,21.62%,,,Stratified probability,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Robert Morlock,YourCareChoice,https://dx.doi.org/10.1371/journal.pone.0245586,3/13/2021,6/17/2021,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj,"February 3, 2021",Local,United States of America,United States of America; Missouri; St Louis,"April 14, 2020","May 8, 2020",Residual sera,Children and Youth (0-17 years),15,1.71%,0.04%,3.38%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,6/17/2021,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj,"February 3, 2021",Local,United States of America,United States of America; Missouri; St Louis,"April 27, 2020","May 12, 2020",Residual sera,Multiple groups,21,3.11%,0.92%,5.32%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,6/17/2021,Verified
210212_Arizona_KingmanRegionalMedicalCenter_Overall,"February 12, 2021",Local,United States of America,United States of America; Arizona; Kingman,"September 28, 2020","October 9, 2020",Household and community samples,Adults (18-64 years),566,8.00%,,,Self-referral,Ortho Clinical Diagnostics Inc.,LFIA,IgG,87.50%,100.00%,High,Journal Article (Peer-Reviewed),Anthony Santarelli,Kingman Regional Medical Center,https://dx.doi.org/10.1515/jom-2020-0287,3/14/2021,6/24/2021,Verified
210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel,"January 20, 2021",Regional,United States of America,"United States of America; North Dakota; Fargo, Grand Forks","July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),247,14.60%,10.40%,19.60%,Convenience,BioSys Laboratories,LFIA,"IgG,IgM",93.50%,100.00%,High,Journal Article (Peer-Reviewed),Amanda Johnson,North Dakota State University,https://www.japha.org/article/S1544-3191(21)00025-X/abstract,3/14/2021,6/17/2021,Verified
210225_Denver_UniversityofColorado_NewOnsetDiabetes,"February 25, 2021",Local,United States of America,United States of America; Colorado; Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,129,0.80%,0.10%,4.20%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,8/4/2021,Verified
210225_Denver_UniversityofColorado_EstablishedDiabetes,"February 25, 2021",Local,United States of America,United States of America; Colorado; Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,94,4.30%,1.70%,10.40%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,8/4/2021,Verified
210225_Denver_UniversityofColorado_GenPopChildren,"February 25, 2021",Local,United States of America,United States of America; Colorado; Denver,"July 8, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),562,2.80%,1.80%,4.60%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,6/17/2021,Verified
210225_Denver_UniversityofColorado_GenPopAdults,"February 25, 2021",Local,United States of America,United States of America; Colorado; Denver,"July 8, 2020","October 23, 2020",Household and community samples,Adults (18-64 years),102,3.90%,1.50%,9.70%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,7/7/2021,Verified
210209_Atlanta_EmoryUniversity,"February 9, 2021",Local,United States of America,United States of America; Georgia; Atlanta,"May 6, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),353,6.50%,,,Convenience,NA,ELISA,IgG,86.70%,99.30%,High,Journal Article (Peer-Reviewed),Jessica Howard Anderson,Emory University,https://dx.doi.org/10.1017/ice.2021.54,3/17/2021,6/17/2021,Unverified
210216_USA_CityUniversityOfNewYork_overall_TestAdj,"February 16, 2021",National,United States of America,United States of America,"May 15, 2020","January 15, 2021",Household and community samples,Multiple groups,4459,6.30%,5.50%,7.10%,Stratified non-probability,Bio-rad,ELISA,Total Antibody,100.00%,100.00%,Moderate,Preprint,Denis Nash,City University of New York,https://www.medrxiv.org/content/10.1101/2021.02.12.21251659v1,3/17/2021,7/4/2021,Verified
210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai,"February 2, 2021",Local,United States of America,United States of America; North Carolina; Parris Island,"May 11, 2020","September 7, 2020",Essential non-healthcare workers,Adults (18-64 years),3196,9.00%,,,Convenience,NA,ELISA,IgG,96.08%,97.14%,Moderate,Journal Article (Peer-Reviewed),Andrew Letizia,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.3201/eid2704.204732,3/17/2021,6/17/2021,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Students,"February 26, 2021",Local,United States of America,United States of America; Pennsylvania,"October 26, 2020","November 23, 2020",Students and Daycares,Adults (18-64 years),625,31.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,Moderate,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,6/17/2021,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Community,"February 26, 2021",Local,United States of America,United States of America; Pennsylvania,"August 7, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),345,8.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,High,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,6/17/2021,Verified
210204_UnitedStates_DaVitaClinicalResearch_Overall,"February 4, 2021",National,United States of America,United States of America,"May 27, 2020","July 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,12932,5.78%,5.40%,6.20%,Simplified probability,Diazyme Laboratories Inc,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Adam Walker,DaVita Clinical Research,https://dx.doi.org/10.1016/j.xkme.2021.01.002,3/18/2021,6/24/2021,Verified
210201_NewYorkCity_ColumbiaUniversity,"February 1, 2021",Local,United States of America,"United States of America; New York
; New York City","June 24, 2020","July 16, 2020",Pregnant or parturient women,Adults (18-64 years),47,40.40%,,,Sequential,NA,ELISA,"IgG,IgM",92.00%,,High,Journal Article (Peer-Reviewed),Caitlin Baptiste,Columbia University,http://dx.doi.org/10.1016/j.ajog.2020.12.944,3/18/2021,7/2/2021,Verified
210208_Virginia_UniversityOfVirginia_Overall_PopAdj,"February 8, 2021",Regional,United States of America,United States of America; Virginia,"June 1, 2020","August 14, 2020",Residual sera,Multiple groups,4675,2.40%,1.80%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Elizabeth T Rogawski McQuade,"University of Virginia
",https://dx.doi.org/10.1001/jamanetworkopen.2020.35234,3/18/2021,6/17/2021,Verified
210130_USA_UniversityofArizona_primary,"January 30, 2021",Local,United States of America,United States of America,"May 17, 2020","July 2, 2020",Health care workers and caregivers,Multiple groups,40938,16.20%,15.90%,16.60%,Self-referral,Ortho Clinical Diagnostics Inc.,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lara J Akinbami,University of Arizona ,https://dx.doi.org/10.1093/cid/ciab080,3/19/2021,6/17/2021,Verified
210129_Atlanta_EmoryUniversityHospital_primary,"January 29, 2021",Local,United States of America,United States of America; Georgia; Atlanta,"April 19, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),10275,3.80%,3.40%,4.30%,Self-referral,NA,ELISA,IgG,97.50%,98.00%,Moderate,Journal Article (Peer-Reviewed),Julia M Baker,Emory University Hospital,https://dx.doi.org/10.7326/M20-7145,3/19/2021,7/6/2021,Verified
210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall,"February 18, 2021",Local,United States of America,United States of America,"July 27, 2020","August 21, 2020",Household and community samples,Multiple groups,671,7.60%,5.70%,9.90%,Convenience,DiaSorin SpA,CLIA,IgG,97.00%,,High,Preprint,Adrienne Sherman,Government of the District of Columbia,10.1101/2021.02.15.21251764,3/19/2021,6/24/2021,Verified
210129_NewYork_NorthwellHealth,"January 29, 2021",Regional,United States of America,United States of America; New York,"May 27, 2020","August 23, 2020",Pregnant or parturient women,Adults (18-64 years),2930,15.30%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Northwell Health,http://dx.doi.org/10.1016/j.ajog.2020.12.631,3/20/2021,6/17/2021,Verified
201124_USA_CDC_July/August1_Alaska,"November 24, 2020",Regional,United States of America,United States of America; Alaska,"August 6, 2020","August 11, 2020",Residual sera,Multiple groups,242,0.30%,0.00%,1.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Alaska,"November 24, 2020",Regional,United States of America,United States of America; Alaska,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,704,1.30%,0.50%,2.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Alaska,"November 24, 2020",Regional,United States of America,United States of America; Alaska,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,610,1.00%,0.24%,2.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Alaska,"November 24, 2020",Regional,United States of America,United States of America; Alaska,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,681,0.40%,0.11%,0.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Alabama,"November 24, 2020",Regional,United States of America,United States of America; Alabama,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,955,9.90%,7.19%,12.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Arkansas,"November 24, 2020",Regional,United States of America,United States of America; Arkansas,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,992,4.90%,3.50%,6.41%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Arizona,"November 24, 2020",Regional,United States of America,United States of America; Arizona,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,1030,4.90%,3.05%,7.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_California,"November 24, 2020",Regional,United States of America,United States of America; California,"August 28, 2020","September 9, 2020",Residual sera,Multiple groups,983,6.00%,4.20%,7.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Connecticut,"November 24, 2020",Regional,United States of America,United States of America; Connecticut,"August 26, 2020","September 4, 2020",Residual sera,Multiple groups,983,4.30%,2.90%,5.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Colorado,"November 24, 2020",Regional,United States of America,United States of America; Colorado,"August 24, 2020","September 4, 2020",Residual sera,Multiple groups,1025,3.60%,2.31%,5.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_WashingtonD.C,"November 24, 2020",Regional,United States of America,United States of America; Washington D.C,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,643,5.00%,2.83%,7.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Florida,"November 24, 2020",Regional,United States of America,United States of America; Florida,"August 27, 2020","September 9, 2020",Residual sera,Multiple groups,981,5.70%,3.93%,7.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Iowa,"November 24, 2020",Regional,United States of America,United States of America; Iowa,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1006,8.40%,6.15%,10.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Delaware,"November 24, 2020",Regional,United States of America,United States of America; Delaware,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,914,4.50%,2.42%,7.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Georgia,"November 24, 2020",Regional,United States of America,United States of America; Georgia,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1020,8.70%,6.69%,11.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Idaho,"November 24, 2020",Regional,United States of America,United States of America; Idaho,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,790,5.70%,2.90%,9.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Maine,"November 24, 2020",Regional,United States of America,United States of America;  Maine,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,759,1.50%,0.44%,3.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Kansas,"November 24, 2020",Regional,United States of America,United States of America; Kansas,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,1025,2.90%,1.57%,4.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Massachusetts,"November 24, 2020",Regional,United States of America,United States of America;  Massachusetts,"August 27, 2020","September 5, 2020",Residual sera,Multiple groups,981,3.60%,2.36%,5.08%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Indiana,"November 24, 2020",Regional,United States of America,United States of America; Indiana,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,984,2.40%,1.36%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Maryland,"November 24, 2020",Regional,United States of America,United States of America;  Maryland,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,980,7.90%,5.72%,10.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Minnesota,"November 24, 2020",Regional,United States of America,United States of America;  Minnesota,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,974,9.20%,6.71%,11.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Michigan,"November 24, 2020",Regional,United States of America,United States of America;  Michigan,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,976,3.40%,2.16%,4.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Illinois,"November 24, 2020",Regional,United States of America,United States of America; Illinois,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,979,5.60%,3.90%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Missouri,"November 24, 2020",Regional,United States of America,United States of America;  Missouri,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,1024,2.90%,1.74%,4.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Louisiana,"November 24, 2020",Regional,United States of America,United States of America;  Louisiana,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1001,8.60%,6.65%,11.30%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Kentucky,"November 24, 2020",Regional,United States of America,United States of America;  Kentucky,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,983,3.10%,1.91%,4.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Mississippi,"November 24, 2020",Regional,United States of America,United States of America;  Mississippi,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,987,8.40%,4.89%,12.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NewHampshire,"November 24, 2020",Regional,United States of America,United States of America;  New Hampshire,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,1147,1.60%,0.73%,2.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Ohio,"November 24, 2020",Regional,United States of America,United States of America;  Ohio,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,983,5.00%,3.17%,7.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Nebraska,"November 24, 2020",Regional,United States of America,United States of America;  Nebraska,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,938,6.30%,4.47%,8.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Virginia,"November 24, 2020",Regional,United States of America,United States of America;  Virginia,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1007,3.50%,1.97%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NewMexico,"November 24, 2020",Regional,United States of America,United States of America;  New Mexico,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,985,3.70%,2.28%,5.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Vermont,"November 24, 2020",Regional,United States of America,United States of America;  Vermont,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,485,0.40%,0.00%,0.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Oregon,"November 24, 2020",Regional,United States of America,United States of America;  Oregon,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,968,1.90%,0.92%,2.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_PuertoRico,"November 24, 2020",Regional,United States of America,United States of America; Puerto Rico,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,980,2.50%,1.36%,3.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NewJersey,"November 24, 2020",Regional,United States of America,United States of America;  New Jersey,"August 26, 2020","September 7, 2020",Residual sera,Multiple groups,944,12.80%,10.49%,15.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_SouthDakota,"November 24, 2020",Regional,United States of America,United States of America;  South Dakota,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,97,0.70%,0.00%,2.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NewYork,"November 24, 2020",Regional,United States of America,United States of America;  New York,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1043,19.50%,16.88%,22.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Montana,"November 24, 2020",Regional,United States of America,United States of America;  Montana,"August 24, 2020","September 9, 2020",Residual sera,Multiple groups,518,0.90%,0.23%,1.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Nevada,"November 24, 2020",Regional,United States of America,United States of America;  Nevada,"August 27, 2020","August 29, 2020",Residual sera,Multiple groups,980,6.50%,4.63%,8.58%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NorthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  North Carolina,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Tennessee,"November 24, 2020",Regional,United States of America,United States of America;  Tennessee,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,950,5.40%,3.62%,7.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_SouthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  South Carolina,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,927,7.20%,5.12%,9.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_RhodeIsland,"November 24, 2020",Regional,United States of America,United States of America;  Rhode Island,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,786,3.10%,1.73%,4.64%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Oklahoma,"November 24, 2020",Regional,United States of America,United States of America;  Oklahoma,"August 24, 2020","September 1, 2020",Residual sera,Multiple groups,979,5.40%,3.83%,7.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Utah,"November 24, 2020",Regional,United States of America,United States of America;  Utah,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,1104,4.90%,2.82%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_NorthDakota,"November 24, 2020",Regional,United States of America,United States of America;  North Dakota,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,109,0.20%,0.00%,0.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Texas,"November 24, 2020",Regional,United States of America,United States of America;  Texas,"August 25, 2020","September 2, 2020",Residual sera,Multiple groups,979,5.80%,4.04%,7.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Pennsylvania,"November 24, 2020",Regional,United States of America,United States of America;  Pennsylvania,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,845,9.50%,6.58%,13.56%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Washington,"November 24, 2020",Regional,United States of America,United States of America; Washington,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,820,4.50%,2.63%,6.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_Wisconsin,"November 24, 2020",Regional,United States of America,United States of America;  Wisconsin,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,976,2.60%,1.48%,3.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August/September3_WestVirginia,"November 24, 2020",Regional,United States of America,United States of America;  West Virginia,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1128,1.50%,0.78%,2.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Minnesota,"November 24, 2020",Regional,United States of America,United States of America;  Minnesota,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,978,4.50%,3.05%,5.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_WestVirginia,"November 24, 2020",Regional,United States of America,United States of America;  West Virginia,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,637,2.20%,0.52%,4.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Wisconsin,"November 24, 2020",Regional,United States of America,United States of America;  Wisconsin,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,838,3.30%,2.03%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Washington,"November 24, 2020",Regional,United States of America,United States of America; Washington,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1238,3.00%,1.79%,4.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Arizona,"November 24, 2020",Regional,United States of America,United States of America; Arizona,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1304,4.70%,2.70%,7.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Pennsylvania,"November 24, 2020",Regional,United States of America,United States of America;  Pennsylvania,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,887,10.10%,7.53%,13.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_California,"November 24, 2020",Regional,United States of America,United States of America; California,"August 13, 2020","August 19, 2020",Residual sera,Multiple groups,980,4.30%,2.85%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Missouri,"November 24, 2020",Regional,United States of America,United States of America;  Missouri,"August 12, 2020","August 21, 2020",Residual sera,Multiple groups,1021,3.50%,2.23%,5.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Iowa,"November 24, 2020",Regional,United States of America,United States of America; Iowa,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,9.40%,7.12%,11.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Georgia,"November 24, 2020",Regional,United States of America,United States of America; Georgia,"August 13, 2020","August 26, 2020",Residual sera,Multiple groups,1031,7.40%,5.52%,9.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NewYork,"November 24, 2020",Regional,United States of America,United States of America;  New York,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1122,20.60%,18.04%,23.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NewJersey,"November 24, 2020",Regional,United States of America,United States of America;  New Jersey,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1127,12.20%,10.15%,14.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Nevada,"November 24, 2020",Regional,United States of America,United States of America;  Nevada,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,972,7.90%,6.13%,9.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Indiana,"November 24, 2020",Regional,United States of America,United States of America; Indiana,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,906,3.10%,1.53%,4.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Ohio,"November 24, 2020",Regional,United States of America,United States of America;  Ohio,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,2.10%,1.06%,3.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Idaho,"November 24, 2020",Regional,United States of America,United States of America; Idaho,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,651,4.60%,1.67%,9.05%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NorthDakota,"November 24, 2020",Regional,United States of America,United States of America;  North Dakota,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,135,0.60%,0.00%,1.45%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Florida,"November 24, 2020",Regional,United States of America,United States of America; Florida,"August 14, 2020","August 14, 2020",Residual sera,Multiple groups,978,4.50%,3.15%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Alabama,"November 24, 2020",Regional,United States of America,United States of America; Alabama,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,974,7.60%,5.33%,9.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Vermont,"November 24, 2020",Regional,United States of America,United States of America;  Vermont,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,382,0.30%,0.00%,0.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_SouthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  South Carolina,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1063,6.00%,4.37%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Virginia,"November 24, 2020",Regional,United States of America,United States of America;  Virginia,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1243,4.70%,2.51%,7.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_PuertoRico,"November 24, 2020",Regional,United States of America,United States of America; Puerto Rico,"August 10, 2020","August 17, 2020",Residual sera,Multiple groups,986,2.20%,1.18%,3.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Massachusetts,"November 24, 2020",Regional,United States of America,United States of America;  Massachusetts,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,3.70%,2.27%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_RhodeIsland,"November 24, 2020",Regional,United States of America,United States of America;  Rhode Island,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,570,3.60%,1.69%,5.89%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Delaware,"November 24, 2020",Regional,United States of America,United States of America; Delaware,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1004,8.50%,5.79%,11.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Texas,"November 24, 2020",Regional,United States of America,United States of America;  Texas,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,1001,6.50%,4.69%,8.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Michigan,"November 24, 2020",Regional,United States of America,United States of America;  Michigan,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,983,4.20%,2.88%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Oregon,"November 24, 2020",Regional,United States of America,United States of America;  Oregon,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,1086,2.40%,1.41%,3.60%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Kansas,"November 24, 2020",Regional,United States of America,United States of America; Kansas,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,1016,3.70%,2.02%,5.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Maine,"November 24, 2020",Regional,United States of America,United States of America;  Maine,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,609,0.60%,0.00%,1.44%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Montana,"November 24, 2020",Regional,United States of America,United States of America;  Montana,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,383,1.30%,0.38%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Maryland,"November 24, 2020",Regional,United States of America,United States of America;  Maryland,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1174,7.00%,4.92%,9.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Tennessee,"November 24, 2020",Regional,United States of America,United States of America;  Tennessee,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1029,6.70%,5.11%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NorthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  North Carolina,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Kentucky,"November 24, 2020",Regional,United States of America,United States of America;  Kentucky,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1126,3.10%,2.05%,4.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NewMexico,"November 24, 2020",Regional,United States of America,United States of America;  New Mexico,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,976,2.50%,1.47%,3.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Mississippi,"November 24, 2020",Regional,United States of America,United States of America;  Mississippi,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,968,10.00%,6.69%,14.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Oklahoma,"November 24, 2020",Regional,United States of America,United States of America;  Oklahoma,"August 10, 2020","August 18, 2020",Residual sera,Multiple groups,979,4.00%,2.72%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Utah,"November 24, 2020",Regional,United States of America,United States of America;  Utah,"August 15, 2020","August 25, 2020",Residual sera,Multiple groups,871,5.50%,2.94%,8.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Colorado,"November 24, 2020",Regional,United States of America,United States of America; Colorado,"August 10, 2020","August 25, 2020",Residual sera,Multiple groups,1019,3.30%,1.83%,4.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_NewHampshire,"November 24, 2020",Regional,United States of America,United States of America;  New Hampshire,"August 13, 2020","August 25, 2020",Residual sera,Multiple groups,1125,0.80%,0.30%,1.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Washington D.C,"November 24, 2020",Regional,United States of America,United States of America; Washington D.C,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,781,6.80%,4.59%,9.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Louisiana,"November 24, 2020",Regional,United States of America,United States of America;  Louisiana,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,989,11.80%,9.27%,14.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_SouthDakota,"November 24, 2020",Regional,United States of America,United States of America;  South Dakota,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,83,0.00%,0.00%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Wyoming,"November 24, 2020",Regional,United States of America,United States of America;  Wyoming,"August 13, 2020","August 24, 2020",Residual sera,Multiple groups,86,0.80%,0.00%,3.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Illinois,"November 24, 2020",Regional,United States of America,United States of America; Illinois,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,4.90%,3.40%,6.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Connecticut,"November 24, 2020",Regional,United States of America,United States of America; Connecticut,"August 11, 2020","August 24, 2020",Residual sera,Multiple groups,983,2.40%,1.45%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Arkansas,"November 24, 2020",Regional,United States of America,United States of America; Arkansas,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,998,3.00%,1.76%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_August2_Nebraska,"November 24, 2020",Regional,United States of America,United States of America;  Nebraska,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,990,7.90%,5.51%,10.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Pennsylvania,"November 24, 2020",Regional,United States of America,United States of America;  Pennsylvania,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,575,10.20%,5.71%,17.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_SouthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  South Carolina,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,840,8.10%,5.79%,10.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NewJersey,"November 24, 2020",Regional,United States of America,United States of America;  New Jersey,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,871,14.80%,12.23%,17.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Texas,"November 24, 2020",Regional,United States of America,United States of America;  Texas,"July 29, 2020","August 5, 2020",Residual sera,Multiple groups,986,5.90%,4.04%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NewYork,"November 24, 2020",Regional,United States of America,United States of America;  New York,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,846,23.30%,20.07%,26.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Montana,"November 24, 2020",Regional,United States of America,United States of America;  Montana,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,199,0.50%,0.00%,1.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_PuertoRico,"November 24, 2020",Regional,United States of America,United States of America; Puerto Rico,"July 27, 2020","August 7, 2020",Residual sera,Multiple groups,984,1.10%,0.43%,1.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Washington D.C,"November 24, 2020",Regional,United States of America,United States of America; Washington D.C,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,717,3.90%,2.18%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Vermont,"November 24, 2020",Regional,United States of America,United States of America;  Vermont,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,346,0.50%,0.00%,1.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Maine,"November 24, 2020",Regional,United States of America,United States of America;  Maine,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,598,0.50%,0.00%,1.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NewHampshire,"November 24, 2020",Regional,United States of America,United States of America;  New Hampshire,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,809,0.80%,0.22%,1.48%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Nevada,"November 24, 2020",Regional,United States of America,United States of America;  Nevada,"July 30, 2020","August 2, 2020",Residual sera,Multiple groups,979,5.10%,3.63%,6.66%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NorthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  North Carolina,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,928,2.50%,1.31%,3.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Idaho,"November 24, 2020",Regional,United States of America,United States of America; Idaho,"August 4, 2020","August 11, 2020",Residual sera,Multiple groups,246,4.50%,1.80%,7.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Colorado,"November 24, 2020",Regional,United States of America,United States of America; Colorado,"July 30, 2020","August 7, 2020",Residual sera,Multiple groups,1001,2.40%,0.89%,4.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Florida,"November 24, 2020",Regional,United States of America,United States of America; Florida,"July 31, 2020","August 3, 2020",Residual sera,Multiple groups,980,4.30%,2.77%,5.86%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Nebraska,"November 24, 2020",Regional,United States of America,United States of America;  Nebraska,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,954,7.40%,5.25%,9.75%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Kentucky,"November 24, 2020",Regional,United States of America,United States of America;  Kentucky,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,975,2.40%,1.32%,3.62%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_WestVirginia,"November 24, 2020",Regional,United States of America,United States of America;  West Virginia,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,317,1.20%,0.23%,2.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Alabama,"November 24, 2020",Regional,United States of America,United States of America; Alabama,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,938,5.80%,4.16%,7.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Mississippi,"November 24, 2020",Regional,United States of America,United States of America;  Mississippi,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,769,7.10%,3.75%,11.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Louisiana,"November 24, 2020",Regional,United States of America,United States of America;  Louisiana,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,1002,9.60%,6.88%,12.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Kansas,"November 24, 2020",Regional,United States of America,United States of America; Kansas,"July 29, 2020","August 8, 2020",Residual sera,Multiple groups,962,1.60%,0.70%,2.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Massachusetts,"November 24, 2020",Regional,United States of America,United States of America;  Massachusetts,"July 30, 2020","August 10, 2020",Residual sera,Multiple groups,978,4.20%,2.89%,5.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Indiana,"November 24, 2020",Regional,United States of America,United States of America; Indiana,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,579,2.20%,1.10%,3.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Oklahoma,"November 24, 2020",Regional,United States of America,United States of America;  Oklahoma,"July 28, 2020","August 4, 2020",Residual sera,Multiple groups,979,1.60%,0.85%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Wisconsin,"November 24, 2020",Regional,United States of America,United States of America;  Wisconsin,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,814,1.80%,0.76%,3.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Delaware,"November 24, 2020",Regional,United States of America,United States of America; Delaware,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,804,5.70%,3.55%,8.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Iowa,"November 24, 2020",Regional,United States of America,United States of America; Iowa,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,811,8.60%,5.98%,11.34%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Maryland,"November 24, 2020",Regional,United States of America,United States of America;  Maryland,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,783,9.70%,7.26%,12.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Connecticut,"November 24, 2020",Regional,United States of America,United States of America; Connecticut,"July 30, 2020","August 3, 2020",Residual sera,Multiple groups,994,3.40%,2.04%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Michigan,"November 24, 2020",Regional,United States of America,United States of America;  Michigan,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,982,3.40%,2.16%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NewMexico,"November 24, 2020",Regional,United States of America,United States of America;  New Mexico,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,964,2.00%,1.09%,3.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Arizona,"November 24, 2020",Regional,United States of America,United States of America; Arizona,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,591,8.20%,4.11%,13.59%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Missouri,"November 24, 2020",Regional,United States of America,United States of America;  Missouri,"July 28, 2020","August 10, 2020",Residual sera,Multiple groups,979,2.50%,1.44%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Tennessee,"November 24, 2020",Regional,United States of America,United States of America;  Tennessee,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,1003,6.30%,4.41%,8.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Washington,"November 24, 2020",Regional,United States of America,United States of America; Washington,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,684,2.10%,0.81%,3.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Virginia,"November 24, 2020",Regional,United States of America,United States of America;  Virginia,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,730,4.10%,1.80%,6.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Georgia,"November 24, 2020",Regional,United States of America,United States of America; Georgia,"August 2, 2020","August 11, 2020",Residual sera,Multiple groups,985,6.80%,4.83%,8.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_RhodeIsland,"November 24, 2020",Regional,United States of America,United States of America;  Rhode Island,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,684,3.00%,1.23%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Illinois,"November 24, 2020",Regional,United States of America,United States of America; Illinois,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,1004,3.90%,2.52%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_NorthDakota,"November 24, 2020",Regional,United States of America,United States of America;  North Dakota,"July 29, 2020","August 12, 2020",Residual sera,Multiple groups,121,7.30%,1.30%,14.28%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Arkansas,"November 24, 2020",Regional,United States of America,United States of America; Arkansas,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,937,4.10%,2.74%,5.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Utah,"November 24, 2020",Regional,United States of America,United States of America;  Utah,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,880,3.20%,1.70%,5.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Ohio,"November 24, 2020",Regional,United States of America,United States of America;  Ohio,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,786,2.30%,1.11%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_California,"November 24, 2020",Regional,United States of America,United States of America; California,"July 30, 2020","August 5, 2020",Residual sera,Multiple groups,980,5.70%,4.05%,7.77%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Minnesota,"November 24, 2020",Regional,United States of America,United States of America;  Minnesota,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,879,3.50%,2.06%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_July/August1_Oregon,"November 24, 2020",Regional,United States of America,United States of America;  Oregon,"August 5, 2020","August 11, 2020",Residual sera,Multiple groups,658,2.30%,1.03%,3.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Connecticut,"November 24, 2020",Regional,United States of America,United States of America; Connecticut,"September 9, 2020","September 14, 2020",Residual sera,Multiple groups,982,3.10%,2.06%,4.37%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Wisconsin,"November 24, 2020",Regional,United States of America,United States of America;  Wisconsin,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,976,3.80%,2.20%,5.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NorthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  North Carolina,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,925,6.80%,4.83%,8.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NewHampshire,"November 24, 2020",Regional,United States of America,United States of America;  New Hampshire,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,1034,0.70%,0.26%,1.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Ohio,"November 24, 2020",Regional,United States of America,United States of America;  Ohio,"September 10, 2020","September 22, 2020",Residual sera,Multiple groups,978,2.80%,1.69%,4.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_PuertoRico,"November 24, 2020",Regional,United States of America,United States of America; Puerto Rico,"September 8, 2020","September 15, 2020",Residual sera,Multiple groups,970,3.00%,1.78%,4.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NorthDakota,"November 24, 2020",Regional,United States of America,United States of America;  North Dakota,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,113,1.20%,0.00%,3.40%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Michigan,"November 24, 2020",Regional,United States of America,United States of America;  Michigan,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,980,3.70%,2.54%,4.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Minnesota,"November 24, 2020",Regional,United States of America,United States of America;  Minnesota,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1033,8.00%,4.74%,11.43%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_SouthCarolina,"November 24, 2020",Regional,United States of America,United States of America;  South Carolina,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,975,7.80%,5.58%,10.19%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Florida,"November 24, 2020",Regional,United States of America,United States of America; Florida,"September 11, 2020","September 11, 2020",Residual sera,Multiple groups,979,8.50%,6.55%,10.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Washington D.C,"November 24, 2020",Regional,United States of America,United States of America; Washington D.C,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,976,6.50%,4.47%,8.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_WestVirginia,"November 24, 2020",Regional,United States of America,United States of America;  West Virginia,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,1.30%,0.51%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NewMexico,"November 24, 2020",Regional,United States of America,United States of America;  New Mexico,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1014,2.40%,1.19%,3.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Arkansas,"November 24, 2020",Regional,United States of America,United States of America; Arkansas,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,990,6.30%,4.60%,8.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Nevada,"November 24, 2020",Regional,United States of America,United States of America;  Nevada,"September 9, 2020","September 12, 2020",Residual sera,Multiple groups,979,7.80%,5.90%,9.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NewYork,"November 24, 2020",Regional,United States of America,United States of America;  New York,"September 11, 2020","September 24, 2020",Residual sera,Multiple groups,1168,17.00%,14.72%,19.23%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Maryland,"November 24, 2020",Regional,United States of America,United States of America;  Maryland,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1242,10.20%,7.91%,12.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Colorado,"November 24, 2020",Regional,United States of America,United States of America; Colorado,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1032,3.30%,1.90%,4.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Oregon,"November 24, 2020",Regional,United States of America,United States of America;  Oregon,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,971,2.60%,1.51%,4.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Oklahoma,"November 24, 2020",Regional,United States of America,United States of America;  Oklahoma,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,5.00%,3.44%,6.54%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Montana,"November 24, 2020",Regional,United States of America,United States of America;  Montana,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,508,2.20%,0.67%,4.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Kansas,"November 24, 2020",Regional,United States of America,United States of America; Kansas,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,1007,3.50%,2.31%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Alabama,"November 24, 2020",Regional,United States of America,United States of America; Alabama,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,905,8.70%,6.19%,11.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Maine,"November 24, 2020",Regional,United States of America,United States of America;  Maine,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,987,0.50%,0.09%,0.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Georgia,"November 24, 2020",Regional,United States of America,United States of America; Georgia,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1100,13.00%,10.51%,15.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Massachusetts,"November 24, 2020",Regional,United States of America,United States of America;  Massachusetts,"September 9, 2020","September 15, 2020",Residual sera,Multiple groups,988,3.70%,2.23%,5.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Wyoming,"November 24, 2020",Regional,United States of America,United States of America;  Wyoming,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,111,1.50%,0.00%,3.97%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Vermont,"November 24, 2020",Regional,United States of America,United States of America;  Vermont,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,497,1.70%,0.27%,4.15%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Illinois,"November 24, 2020",Regional,United States of America,United States of America; Illinois,"September 8, 2020","September 17, 2020",Residual sera,Multiple groups,992,4.50%,3.10%,6.07%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Nebraska,"November 24, 2020",Regional,United States of America,United States of America;  Nebraska,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,976,6.70%,4.80%,8.88%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Arizona,"November 24, 2020",Regional,United States of America,United States of America; Arizona,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1208,5.40%,3.08%,8.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Texas,"November 24, 2020",Regional,United States of America,United States of America;  Texas,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,988,8.20%,6.16%,10.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Louisiana,"November 24, 2020",Regional,United States of America,United States of America;  Louisiana,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,952,12.50%,10.02%,15.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_SouthDakota,"November 24, 2020",Regional,United States of America,United States of America;  South Dakota,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,99,1.80%,0.00%,4.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Tennessee,"November 24, 2020",Regional,United States of America,United States of America;  Tennessee,"September 8, 2020","September 16, 2020",Residual sera,Multiple groups,1028,6.70%,4.96%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Hawaii,"November 24, 2020",Regional,United States of America,United States of America; Hawaii,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,516,0.80%,0.00%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Indiana,"November 24, 2020",Regional,United States of America,United States of America; Indiana,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1155,4.00%,1.44%,8.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Utah,"November 24, 2020",Regional,United States of America,United States of America;  Utah,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1022,5.10%,3.29%,7.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_RhodeIsland,"November 24, 2020",Regional,United States of America,United States of America;  Rhode Island,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,795,2.70%,1.15%,4.91%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Mississippi,"November 24, 2020",Regional,United States of America,United States of America;  Mississippi,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,980,7.90%,5.35%,10.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_California,"November 24, 2020",Regional,United States of America,United States of America; California,"September 10, 2020","September 16, 2020",Residual sera,Multiple groups,979,4.90%,3.17%,6.85%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Virginia,"November 24, 2020",Regional,United States of America,United States of America;  Virginia,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1111,3.20%,1.81%,5.13%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Iowa,"November 24, 2020",Regional,United States of America,United States of America; Iowa,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,977,7.60%,5.56%,10.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Idaho,"November 24, 2020",Regional,United States of America,United States of America; Idaho,"September 8, 2020","September 18, 2020",Residual sera,Multiple groups,732,5.20%,2.74%,8.46%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Kentucky,"November 24, 2020",Regional,United States of America,United States of America;  Kentucky,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,3.60%,2.33%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Delaware,"November 24, 2020",Regional,United States of America,United States of America; Delaware,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,980,7.50%,4.89%,10.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Missouri,"November 24, 2020",Regional,United States of America,United States of America;  Missouri,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1031,3.50%,2.15%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_NewJersey,"November 24, 2020",Regional,United States of America,United States of America;  New Jersey,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1050,15.10%,12.65%,17.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Pennsylvania,"November 24, 2020",Regional,United States of America,United States of America;  Pennsylvania,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1341,11.10%,8.85%,13.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
201124_USA_CDC_September4_Washington,"November 24, 2020",Regional,United States of America,United States of America; Washington,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,2.50%,1.29%,3.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,8/4/2021,Verified
210305_Chicago_NorthwesternUniversity_overall,"March 5, 2021",Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","November 23, 2020",Household and community samples,Multiple groups,1667,18.70%,,,Stratified non-probability,NA,ELISA,IgG,,,Moderate,Preprint,Brian Mustanski,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1,3/22/2021,6/17/2021,Verified
210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj,"February 12, 2021",Local,United States of America,United States of America,"May 11, 2020","May 11, 2020",Health care workers and caregivers,Multiple groups,6062,4.10%,3.10%,5.70%,Convenience,Abbott Laboratories,CLIA,IgG,88.30%,,Moderate,Journal Article (Peer-Reviewed),Joseph E Ebinger,Cedars-Sinai Medical Center,https://dx.doi.org/10.1136/bmjopen-2020-043584,3/22/2021,6/17/2021,Verified
210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop,"March 16, 2021",National,United States of America,United States of America,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,61910,6.60%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Robert Stout,Clinical Reference Laboratory Inc,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621,3/22/2021,7/17/2021,Verified
210205_UnitedStates_BrownUniversity,"February 5, 2021",National,United States of America,United States of America; Multiple states,,"August 1, 2020",Assisted living and long-term care facilities,Seniors (65+ years),272,43.00%,,,Convenience,NA,Not reported,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Elizabeth White,Brown University,http://dx.doi.org/10.1111/jgs.17061,3/22/2021,8/4/2021,Verified
210201_Indianapolis_IndianaUniversity_HCW_primary,"February 1, 2021",Local,United States of America,United States of America; Indiana; Indianapolis,"April 1, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),34,35.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/24/2021,8/4/2021,Verified
210201_Indianapolis_IndianaUniversity_HDpatients_primary,"February 1, 2021",Local,United States of America,United States of America; Indiana; Indianapolis,"April 1, 2020","June 24, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),14,36.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/24/2021,8/4/2021,Verified
210221_Iowa_UniversityofIowa,"February 21, 2021",Local,United States of America,United States of America; Iowa,"May 1, 2020","September 22, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.80%,,,Sequential,"DiaSorin SpA,Roche Diagnostics,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haley Steffen,University of Iowa,https://dx.doi.org/10.1055/s-0041-1723938,3/27/2021,8/4/2021,Verified
210310_USA_GeorgeWashingtonUniversity_CT,"March 10, 2021",Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,120,29.20%,21.00%,37.30%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
210310_USA_GeorgeWashingtonUniversity_CA,"March 10, 2021",Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,684,23.80%,20.60%,27.00%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
210310_USA_GeorgeWashingtonUniversity_MI,"March 10, 2021",Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,339,15.00%,11.20%,18.90%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
210310_USA_GeorgeWashingtonUniversity_NJ,"March 10, 2021",Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,3323,32.50%,30.90%,34.10%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
210310_USA_GeorgeWashingtonUniversity_NY,"March 10, 2021",Regional,United States of America,United States of America; New York; New York City,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,2202,30.50%,28.50%,32.40%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
210310_USA_GeorgeWashingtonUniversity_OtherStates,"March 10, 2021",National,United States of America,"United States of America; Colorado, Florida, Maryland, North Carolina, Ohio, Pennsylvania, Washington","May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,13,30.80%,5.70%,55.90%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,7/10/2021,Verified
120301_RhodeIsland_CDC,"March 1, 2021",Regional,United States of America,United States of America; Rhode Island,"July 17, 2020","August 28, 2020",Health care workers and caregivers,Multiple groups,9863,4.60%,4.20%,5.00%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara J Akinbami,Centers for Disease Control,https://dx.doi.org/10.3201/eid2703.204508,3/27/2021,6/29/2021,Verified
210208_Chicago_NorthwesternUniversity_overall,"February 8, 2021",Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","November 11, 2020",Household and community samples,Multiple groups,3365,17.80%,,,Self-referral,NA,ELISA,IgG,,,High,Preprint,Thomas McDade,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.02.04.21251170v1,3/27/2021,6/17/2021,Verified
210215_USA_SpaceX_overall,"February 15, 2021",Local,United States of America,United States of America; Multiple; Multiple,"April 1, 2020","June 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),4300,2.80%,,,Convenience,NA,ELISA,IgG,99.50%,,Unclear,Journal Article (Peer-Reviewed),Yannic Bartsch,"Ragon Institute of MGH, MIT and Harvard",https://dx.doi.org/10.1038/s41467-021-21336-8,3/27/2021,6/17/2021,Verified
210226_Washington_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Washington,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7544,2.00%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Florida_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Florida,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7787,4.80%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_NewYork_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,United States of America; New York; New York City,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7746,17.20%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,United States of America; Pennsylvania; Philadelphia,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8657,4.30%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Missouri_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Missouri,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,9356,2.50%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Utah_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Utah,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8769,2.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_California_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,United States of America; California,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,4980,1.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Connecticut_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Connecticut,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8929,5.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Minnesota_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,"United States of America; Minnesota; Minneapolis, St. Paul, St. Cloud","March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7944,4.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210226_Louisiana_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,United States of America; Louisiana,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,2849,7.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,7/8/2021,Verified
210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj,"February 4, 2021",Local,United States of America,United States of America; California,"July 10, 2020","August 16, 2020",Household and community samples,Multiple groups,2979,11.30%,8.10%,13.20%,Stratified probability,NA,Other,"IgG,IgM",94.00%,100.00%,Low,Journal Article (Peer-Reviewed),Tim Bruckner,University of California Irvine,https://dx.doi.org/10.1038/s41598-021-82662-x,3/28/2021,6/17/2021,Verified
210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,"February 22, 2021",Local,United States of America,United States of America; California,"April 3, 2020","April 4, 2020",Household and community samples,Multiple groups,3328,2.76%,1.32%,4.22%,Stratified non-probability,Premier Biotech,LFIA,"IgG,IgM",85.56%,99.53%,High,Journal Article (Peer-Reviewed),Eran Bendavid,Stanford University School of Medicine,https://dx.doi.org/10.1093/ije/dyab010,3/28/2021,6/17/2021,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW,"January 17, 2021",Local,United States of America,United States of America; California,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),2754,2.76%,2.18%,3.44%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,3/28/2021,6/17/2021,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders,"January 17, 2021",Local,United States of America,United States of America; California,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),92,4.35%,1.20%,10.76%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,3/28/2021,6/17/2021,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_Undergrad_Primary,"March 9, 2021",Local,United States of America,United States of America; Massachusetts ; Amherst,"July 15, 2020","August 15, 2020",Multiple populations,Multiple groups,779,5.30%,3.10%,7.50%,Stratified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/30/2021,6/23/2021,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary,"March 9, 2021",Local,United States of America,United States of America; Massachusetts ; Amherst,"July 15, 2020","August 15, 2020",Non-essential workers and unemployed persons,Multiple groups,292,4.00%,1.60%,6.50%,Simplified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/30/2021,6/23/2021,Verified
210312_Cincinnati_UniversityOfCincinnati_overall,"March 12, 2021",Local,United States of America,United States of America; Ohio; Greater Cincinnati Metropolitan Area,"August 13, 2020","December 8, 2020",Blood donors,Multiple groups,9550,8.40%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Greg Davis,University of Cincinnati,10.1101/2021.03.11.21253263,3/31/2021,7/22/2021,Verified
210203_Monterey_UniversityofCalifornia_primary,"February 3, 2021",Local,United States of America,United States of America; California,"July 16, 2020","November 30, 2020",Essential non-healthcare workers,Multiple groups,1058,18.99%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Ana Mora," University of California, Berkely",10.1101/2021.02.01.21250963,4/1/2021,7/6/2021,Verified
210131_NorthernVirginia_InovaChildren’sHospital_primary,"January 31, 2021",Local,United States of America,United States of America; Virginia; Northern Virginia,"July 31, 2020","October 13, 2020",Multiple general populations,Children and Youth (0-17 years),1038,8.50%,6.90%,10.30%,Convenience,Ortho Clinical Diagnostics Inc.,ELISA,Total Antibody,,100.00%,High,Preprint,Rebecca E Levorson,Inova Children’s Hospital,https://www.medrxiv.org/content/10.1101/2021.01.28.21250466v1,4/1/2021,6/23/2021,Verified
210218_RhodeIsland_BrownUniversity_overall_adj,"February 18, 2021",Regional,United States of America,United States of America; Rhode Island,"May 5, 2020","May 22, 2020",Household and community samples,Multiple groups,1032,2.90%,1.00%,6.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,88.40%,99.60%,Low,Journal Article (Peer-Reviewed),Philip A Chan,Brown University,https://dx.doi.org/10.2105/AJPH.2020.306115,4/2/2021,6/29/2021,Verified
210309_UnitedStates_StanfordUniversity_OverallPopAdj,"March 9, 2021",National,United States of America,United States of America,"January 1, 2021","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,21424,21.30%,20.30%,22.30%,Unclear,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Preprint,Shuchi Anand,Stanford University,https://doi.org/10.1101/2021.03.07.21252786,4/2/2021,7/3/2021,Verified
210321_NewYork_WeillCornellMedicine_Pediatrics,"March 22, 2021",Local,United States of America,United States of America; New York ; New York City ,"April 9, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),1194,16.50%,14.40%,18.70%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/3/2021,6/24/2021,Verified
210321_NewYork_WeillCornellMedicine_Adults,"March 22, 2021",Local,United States of America,United States of America; New York ; New York City ,"April 9, 2020","August 31, 2020",Residual sera,Multiple groups,30232,18.60%,18.20%,19.10%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/4/2021,6/24/2021,Verified
210116_Philadelphia_UniversityofPennsylvania_Overall,"January 16, 2021",Local,United States of America,United States of America; Pennsylvania; Philadelphia,"May 21, 2020","October 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,124,1.60%,,,Sequential,NA,ELISA,"IgG,IgM",,,High,Preprint,Lova Sun,University of Pennsylvania,https://dx.doi.org/10.1101/2021.01.15.21249810,4/5/2021,6/17/2021,Verified
200901_Seattle_FredHutchinsonCancerResearchCenter_Overall,"September 1, 2020",Local,United States of America,United States of America; Washington; Seattle,"March 3, 2020","April 24, 2020",Residual sera,Children and Youth (0-17 years),1076,0.93%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Adam S Dingens,Fred Hutchinson Cancer Research Center,https://www.nature.com/articles/s41467-020-18178-1,4/8/2021,8/4/2021,Verified
2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA,"October 30, 2020",Local,United States of America,United States of America; California; Bolinas,"April 20, 2020","April 24, 2020",Household and community samples,Multiple groups,1880,0.63%,,,Self-referral,"NA,Abbott Laboratories",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ayesha Appa,University of California San Francisco,http://dx.doi.org/10.1093/ofid/ofaa531,4/8/2021,8/4/2021,Verified
210305_EssexCounty_RutgersUniversity_overall_unadj,"March 5, 2021",Local,United States of America,United States of America; New Jersey,"September 15, 2020","December 22, 2020",Household and community samples,Multiple groups,924,9.00%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Henry F Raymond,Rutgers University,10.1101/2021.03.02.21252766,4/9/2021,7/21/2021,Verified
210224_USA_NationalInstitutesofHealth_primary,"February 24, 2021",National,United States of America,United States of America,"January 1, 2020","August 26, 2020",Residual sera,Multiple groups,3257478,11.60%,,,Convenience,NA,Not reported,"IgG,IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Raymond Harvey,National Institutes of Health,https://dx.doi.org/10.1001/jamainternmed.2021.0366,4/9/2021,8/4/2021,Verified
210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall,"March 12, 2021",Local,United States of America,United States of America; Georgia; Atlanta,"April 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),642,4.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Claudia Morris,Emory University School of Medicine,https://dx.doi.org/10.1016/j.ijid.2021.03.017,4/9/2021,6/17/2021,Verified
210302_NewYork_RenaissanceStonyBrookSchoolofMedicine,"March 2, 2021",Local,United States of America,United States of America; New York,"April 2, 2020","April 18, 2020",Health care workers and caregivers,Adults (18-64 years),474,16.90%,13.60%,20.60%,Convenience,ChemBio Diagnostics Inc.,Not reported,"IgG,IgM",84.30%,88.90%,High,Journal Article (Peer-Reviewed),Lilian Talbot,Renaissance Stony Brook School of Medicine,https://dx.doi.org/10.1186/s13741-021-00177-5,4/16/2021,6/17/2021,Verified
210226_SouthBronx_IcahnSchoolOfMedicine_Phase1_In-houseELISA,"February 26, 2021",Local,United States of America,United States of America; New York; New York City,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),501,28.40%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Preprint,Juan Carreno,Icahn School of Medicine at Mount Sinai,10.1101/2021.02.24.21252340,4/17/2021,7/15/2021,Verified
210311_USA_IgenomixUSAandCanada_Overall,"March 11, 2021",National,United States of America,"United States of America; Utah, Massachuetts; Boston","June 18, 2020","July 30, 2020",Multiple populations,Adults (18-64 years),337,1.48%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Russel Foulk,Igenomix USA and Canada,https://dx.doi.org/10.1016/j.ajog.2021.03.008,4/17/2021,7/9/2021,Verified
210317_Boston_HarvardMedicalSchool_Primary,"March 17, 2021",Local,United States of America,United States of America; Massachusetts; Boston,"June 16, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),433,11.30%,,,Self-referral,NA,ELISA,"IgG,IgM",80.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Lou Ann Bruno-Murtha,"Harvard Medical School
",https://dx.doi.org/10.1080/20477724.2021.1901041,4/17/2021,7/16/2021,Verified
201217_UnitedStates_UniversityofIowa,"December 17, 2020",National,United States of America,United States of America,"May 13, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1606,1.74%,,,Stratified non-probability,"Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nicholas M Mohr,University of Iowa,http://dx.doi.org/10.1016/j.annemergmed.2020.12.007,4/18/2021,8/4/2021,Verified
201125_Washington_GeorgeWashingtonUniversity_hcw,"February 1, 2021",Local,United States of America,United States of America; District of Columbia; Washington ,"May 26, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),138,5.07%,,,Convenience,"Biolidics Ltd,NA",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eric Murakami,George Washington University,https://pubmed.ncbi.nlm.nih.gov/33340874/,4/19/2021,8/4/2021,Verified
210111_Burlington_UniversityOfVermont_overall,"January 11, 2021",Local,United States of America,United States of America; Vermont; Burlington,"June 25, 2020","June 28, 2020",Household and community samples,Multiple groups,454,2.20%,0.80%,3.60%,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eline M van den Broek Altenburg,University of Vermont,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/,4/22/2021,6/17/2021,Verified
210312_NorthCarolina_WakeForestBaptistHealth,"March 12, 2021",Regional,United States of America,United States of America; North Carolina,"April 16, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),17688,32.60%,28.40%,35.00%,Stratified non-probability,"Syntron Bioresearch Inc. ,Innovita Biological Technology Co. Ltd",LFIA,"IgM,IgG",,,Moderate,Preprint,John Williamson,Wake Forest Baptist Health,https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1,4/22/2021,8/4/2021,Verified
210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall,"March 3, 2021",Local,United States of America,United States of America; California,"July 16, 2020","November 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Joseph Lewnard,"University of California, Berkeley",https://dx.doi.org/10.3201/eid2705.204949,4/23/2021,8/4/2021,Verified
210305_Illinois-Wisconsin_AdvocateAuroraHealth,"March 5, 2021",Regional,United States of America,"United States of America; Illinois, Wisconsin (Midwest)","June 8, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,16233,3.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Veronica Fitzpatrick,Advocate Aurora Health,https://dx.doi.org/10.1177/0033354921999168,4/30/2021,6/17/2021,Unverified
210310_UnitedStatesofAmerica_EmoryUniversity,"March 10, 2021",Regional,United States of America,"United States of America; Georgia, Maryland, Illinois; Atlanta, Baltimore, Chicago","April 19, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),24749,4.40%,4.10%,4.60%,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jesse Jacob,Emory University,https://dx.doi.org/10.1001/jamanetworkopen.2021.1283,4/30/2021,8/4/2021,Unverified
210225_Florida_FloridaDepartmentOfHealth_overall,"April 12, 2021",Regional,United States of America,United States of America; Florida,"May 6, 2020","June 3, 2020",Health care workers and caregivers,Multiple groups,5776,4.10%,2.60%,8.20%,Convenience,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,Moderate,Journal Article (Peer-Reviewed),James Matthias,Florida Department of Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040388/,5/2/2021,8/4/2021,Verified
210405_California_StanfordUniversitySchoolofMedicine_overall,"May 6, 2021",Local,United States of America,United States of America; California,"June 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),983,2.54%,1.65%,3.73%,Convenience,"Abbott Laboratories,EUROIMMUN AG,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jennifer Newberry,Stanford University,http://dx.doi.org/10.1080/10903127.2021.1912227,5/3/2021,8/4/2021,Verified
211231_Denver_DenverPublicHealth,"December 20, 2020",Local,United States of America,United States of America; Colorado; Denver,"June 2, 2020","July 28, 2020",Persons experiencing homelessness,Adults (18-64 years),334,16.72%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),David McCormick,Denver Public Health,http://dx.doi.org/10.1093/ofid/ofaa515.1909,5/3/2021,6/17/2021,Verified
210415_NewYork_NewYorkUniversity_hcw,"April 15, 2021",Local,United States of America,United States of America; New York ; New York ,"April 30, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),727,29.00%,,,Convenience,NA,Not reported,Not reported,,,High,Preprint,Alexander Bryan,New York University,https://www.medrxiv.org/content/10.1101/2021.04.12.21255344v1,5/3/2021,6/17/2021,Unverified
201204_SantaClara_O’ConnorHospital_Overall,"December 4, 2020",Local,United States of America,United States of America; California; San Jose,"May 6, 2020","May 6, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,24,0.00%,,,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Brian D McBeth,O'Connor Hospital,https://dx.doi.org/10.1177/1757177420976814,5/4/2021,8/5/2021,Unverified
200501_SanMiguelCounty_UnitedBiomedical_overall,"May 1, 2020, June 8, 2020",Local,United States of America,United States of America; Colorado,"March 26, 2020","April 15, 2020",Household and community samples,Multiple groups,5283,0.53%,,,Entire sample,NA,Not reported,IgG,,,Moderate,"Institutional Report, News and Media","San Miguel County, San Miguel County Colorado ",United Biomedical Group,"https://www.sanmiguelcountyco.gov/DocumentCenter/View/5717/San-Miguel-County-IgG-Antibody-Test-Statistics-and-Demographics-PDF, http://web.archive.org/web/20200727075113/https:/www.sanmiguelcountyco.gov/CivicAlerts.aspx?AID=586",5/5/2021,7/8/2021,Verified
201231_WestVirginia_WestVirginiaUniversityMedicine_HCW,"December 31, 2020",Local,United States of America,United States of America; West Virginia; Morgantown,"May 26, 2020","June 5, 2020",Health care workers and caregivers,Adults (18-64 years),1042,0.86%,,,Simplified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Joy J Juskowich,West Virginia University Medicine,http://dx.doi.org/10.1093/ofid/ofaa439.694,5/5/2021,7/6/2021,Verified
201231_SanDiego_UniversityofCaliforniaSanDiegoHealth_HCW,"December 31, 2020",Local,United States of America,United States of America; California; San Diego,"April 22, 2020","June 2, 2020",Health care workers and caregivers,Adults (18-64 years),5589,1.02%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lucy E Horton,University of California San Diego Health,http://dx.doi.org/10.1093/ofid/ofaa439.630,5/5/2021,7/6/2021,Verified
200831_KingCounty_UniversityOfWashington_overall,"August 31, 2020",Local,United States of America,United States of America; Washington,"August 8, 2020","August 29, 2020",Household and community samples,Multiple groups,1364,3.90%,2.40%,6.00%,Stratified probability,"Bio-rad,EUROIMMUN AG",ELISA,"IgG,IgM,IgA",82.94%,100.00%,Moderate,Institutional Report,Karen Cowgill,University of Washington,https://www.kingcounty.gov/depts/health/covid-19/data/~/media/depts/health/communicable-diseases/documents/C19/serosurvey-report-covid19.ashx https://kingcounty.gov/depts/health/covid-19/seroprevalence.aspx https://www.kingcounty.gov/depts/health/covid-19/seroprevalence-study.aspx page 9: http://www.co.cowlitz.wa.us/DocumentCenter/View/20793/8122020-Cowlitz-County-COVID-update-to-Board-of-County-Commissioners,5/5/2021,8/4/2021,Verified
201231_LosAngeles_UniversityofCaliforniaLosAngeles,"December 31, 2020",Local,United States of America,United States of America; California; Los Angeles,"June 1, 2020","June 15, 2020",Assisted living and long-term care facilities,Adults (18-64 years),121,1.65%,,,Convenience,DiaSorin SpA,Not reported,IgG,,,High,Presentation or Conference,Debika Bhattacharya,University of California Los Angeles,https://academic.oup.com/ofid/article/7/Supplement_1/S165/6058251,5/6/2021,7/7/2021,Unverified
201231_Charleston_MedicalUniversityofSouthCarolina,"December 31, 2020",Local,United States of America,United States of America; South Carolina ; Charleston,"April 14, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),439,1.37%,,,Convenience,RayBiotech,LFIA,IgG,76.00%,95.00%,High,Presentation or Conference,Eric G Meissner,Medical University of South Carolina,http://dx.doi.org/10.1093/ofid/ofaa439.653,5/8/2021,7/6/2021,Unverified
210312_UnitedStatesOlympicandParalympicTrainingfacilities_MassachusettsGeneralHospital,"March 12, 2021",National,United States of America,United States of America; Colorado; Colorado Springs,"July 1, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),301,3.65%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Ankit B Shah,Massachusetts General Hospital,https://dx.doi.org/10.1177/19417381211002761,5/9/2021,7/7/2021,Unverified
210309_HarrisCounty_HarrisCountyPublicHealth_genpop,"March 9, 2021",Local,United States of America,United States of America; Texas,"November 15, 2020","December 15, 2020",Household and community samples,Not reported,646,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Harris County Public Health,Harris County Public Health,https://publichealth.harriscountytx.gov/Portals/27/Documents/HCPH%20Antibody%20Results%20NR.pdf?ver=ZkoB5qeX0P1G--8gfGH8fg%3d%3d,5/10/2021,6/28/2021,Verified
210429_Houston_HoustonHealthDepartment,"April 29, 2021",Local,United States of America,United States of America; Texas; Houston,"September 1, 2020","September 19, 2020",Household and community samples,Multiple groups,678,13.50%,9.00%,18.10%,Stratified probability,"Bio-rad,NA",ELISA,"IgG,IgM,IgA",,,Low,Journal Article (Peer-Reviewed),Elaine Symanski,Houston Health Department,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab203/6258999,5/16/2021,8/4/2021,Unverified
201225_Seattle_UniversityofWashington_GenPop_ELISA+Neutralizaion,"December 25, 2020",Local,United States of America,United States of America; Washington; Seattle,"March 26, 2020","April 15, 2020",Household and community samples,Multiple groups,100,4.00%,,,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jennifer Rathe,University of Washington,http://dx.doi.org/10.1093/infdis/jiaa797,5/17/2021,8/4/2021,Verified
210427_NewYorkCity_AlbertEinsteinCollegeofMedicine,"April 27, 2021",Local,United States of America,United States of America; New York state; New York City,"June 1, 2020","August 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,232,13.36%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Snehal R Patel,Albert Einstein College of Medicine,https://onlinelibrary.wiley.com/doi/10.1111/ctr.14329,5/17/2021,7/6/2021,Unverified
210315_NewYork_DiaSorinInc_overall_unadj,"March 15, 2021",Regional,United States of America,United States of America; New York,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,1491,24.40%,,,Sequential,"Siemens,DiaSorin SpA",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,5/18/2021,8/4/2021,Verified
210315_NewMexico_DiaSorinInc_overall_unadj,"March 15, 2021",Regional,United States of America,United States of America; New Mexico,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,1931,1.97%,,,Sequential,"DiaSorin SpA,Beckman Coulter",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,5/18/2021,8/4/2021,Verified
210104_Louisville_UniversityOfLouisville,"January 4, 2021",Regional,United States of America,United States of America; Kentucky; Louisville,"December 10, 2020","December 14, 2020",Household and community samples,Multiple groups,700,11.16%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louisville,https://www.uoflnews.com/post/uofltoday/covid-19-rates-continue-to-increase-with-highest-rates-among-18-34-year-olds/,5/18/2021,7/6/2021,Unverified
210401_Colorado_AnschutzMedicalCampus_primary,"April 1, 2021",Local,United States of America,United States of America; Colorado; Aurora,"July 1, 2020","August 31, 2020",Essential non-healthcare workers,Adults (18-64 years),264,4.20%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan S Schultz,Anschutz Medical Campus,https://dx.doi.org/10.1128/JCM.00290-21,5/18/2021,8/4/2021,Verified
210429_SanFrancisco_UniversityOfCaliforniaSanFrancisco_HIV1_TestAdj,"April 29, 2021",Local,United States of America,United States of America; California; San Francisco,"August 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,955,3.70%,2.40%,5.00%,Sequential,ET Healthcare,Other,IgG,89.00%,100.00%,High,Journal Article (Peer-Reviewed),Matthew A Spinelli,University of California San Francisco,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext,5/18/2021,6/17/2021,Unverified
210423_Connecticut_YaleUniversity,"April 23, 2021",Regional,United States of America,United States of America; Connecticut,"April 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),995,10.30%,,,Self-referral,NA,ELISA,IgG,,,High,Preprint,Joseph Zell,Yale University,https://www.medrxiv.org/content/10.1101/2021.04.21.21255881v1,5/19/2021,8/4/2021,Unverified
210315_SanFranciscoBayArea_StanfordUniversity_overall_unadj,"March 15, 2021",Local,United States of America,United States of America; California,"August 3, 2020","August 15, 2020",Residual sera,Multiple groups,1080,10.65%,,,Convenience,"Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Wang,Stanford University ,https://dx.doi.org/10.1093/clinchem/hvab045,5/19/2021,8/4/2021,Verified
210519_Rochester_MayoClinic_primary,"April 5, 2021",Local,United States of America,United States of America; Minesota; Rochester,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,1339,1.90%,,,Convenience,"EUROIMMUN AG,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elizabeth B Habermann,Mayo Clinic,https://dx.doi.org/10.1017/ice.2021.38,5/19/2021,8/4/2021,Unverified
210330_NorthCarolina_UniversityOfNorthCarolina_Cohort1_PopTestAdj,"March 30, 2021",Regional,United States of America,United States of America; North Carolina,"April 19, 2020","June 13, 2020",Residual sera,Multiple groups,3463,2.90%,1.70%,4.30%,Convenience,"NA,Abbott Laboratories",ELISA,"IgG,IgM",,,Moderate,Preprint,Cesar Lopez,University of North Carolina,https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2,5/19/2021,8/4/2021,Verified
210330_NorthCarolina_UniversityOfNorthCarolina_Cohort2_PopTestAdj,"March 30, 2021",Regional,United States of America,United States of America; North Carolina,"June 14, 2020","August 8, 2020",Residual sera,Multiple groups,3528,8.80%,7.10%,10.60%,Convenience,"NA,Abbott Laboratories",ELISA,"IgG,IgM",,,Moderate,Preprint,Cesar Lopez,University of North Carolina,https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2,5/19/2021,8/4/2021,Verified
210330_NorthCarolina_UniversityOfNorthCarolina_Cohort3_PopTestAdj,"March 30, 2021",Regional,United States of America,United States of America; North Carolina,"August 9, 2020","October 3, 2020",Residual sera,Multiple groups,2633,9.10%,7.20%,11.10%,Convenience,"NA,Abbott Laboratories",ELISA,"IgG,IgM",,,Moderate,Preprint,Cesar Lopez,University of North Carolina,https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2,5/19/2021,8/4/2021,Verified
210419_Philadelphia_UniversityofPennsylvania,"April 19, 2021",Local,United States of America,"United States of America; Pennsylvania
; Philadelphia","April 13, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),2043,2.00%,,,Convenience,NA,ELISA,"IgG,IgM",,,Moderate,Preprint,Sigrid Gouma,University of Pennsylvania,https://www.medrxiv.org/content/10.1101/2021.04.12.21255324v1.full-text,5/19/2021,8/4/2021,Unverified
210422_Orlando_JohnsHopkinsUniversity,"April 22, 2021",Local,United States of America,United States of America; Florida; Orlando,"June 11, 2020","October 19, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),3648,0.90%,,,Convenience,"Siemens,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Christina Mack,Johns Hopkins University School of Medicine,https://dx.doi.org/10.1001/jamainternmed.2021.2114,5/19/2021,8/4/2021,Unverified
210413_NewOrleans_OchsnerClinicFoundation_HospitalStaff,"April 13, 2021",Local,United States of America,United States of America; Louisiana; New Orleans,"April 22, 2020","May 1, 2020",Health care workers and caregivers,Adults (18-64 years),13343,8.00%,7.50%,8.50%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,5/20/2021,6/17/2021,Unverified
210413_NewOrleans_OchsnerClinicFoundation_Surgeons,"April 13, 2021",Local,United States of America,United States of America; Louisiana; New Orleans,"March 1, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),105,1.90%,0.20%,6.70%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,5/20/2021,8/4/2021,Unverified
210111_SanFrancisco_UniversityofCalifornia_EDproviders,"January 11, 2021",Local,United States of America,United States of America; California; San Francisco,"September 1, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),139,2.90%,0.80%,7.20%,Convenience,"Abbott Laboratories,DiaSorin SpA",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ralph Wang,University of California,https://dx.doi.org/10.1016/j.annemergmed.2021.01.010,5/20/2021,8/4/2021,Verified
210419_Milwakee_UniversityOfWisconsin,"April 19, 2021",Local,United States of America,United States of America; Wisconsin; Milwaukee,"June 15, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),43,7.00%,2.00%,20.00%,Convenience,Abbott Laboratories,CLIA,IgG,,99.20%,High,Journal Article (Peer-Reviewed),Renuka Jain,University of Wisconsin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060043/,5/20/2021,6/17/2021,Unverified
210309_Texas_UTSouthwesternMedicalCenter_Tarrant_overall_unadj,"March 9, 2021",Local,United States of America,United States of America,"August 15, 2020","February 15, 2021",Household and community samples,Multiple groups,5697,8.50%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/20/2021,7/9/2021,Verified
210309_Texas_UTSouthwesternMedicalCenter_Employees_overall_unadj,"March 9, 2021",Local,United States of America,United States of America,"August 15, 2020","February 15, 2021",Essential non-healthcare workers,Multiple groups,4098,5.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/20/2021,7/9/2021,Verified
210309_Texas_UTSouthwesternMedicalCenter_Dallas_overall_unadj,"March 9, 2021",Local,United States of America,United States of America,"August 15, 2020","February 15, 2021",Household and community samples,Multiple groups,11580,7.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/20/2021,7/9/2021,Verified
201202_Utah_UniversityofUtah_Phase1BWashington_TestAdj,"December 2, 2020",Local,United States of America,United States of America; Utah; NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1594,0.51%,0.00%,1.59%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/20/2021,6/17/2021,Unverified
201202_Utah_UniversityofUtah_Phase1BCache_TestAdj,"December 2, 2020",Local,United States of America,United States of America; Utah; NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1622,2.31%,0.68%,5.71%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/20/2021,6/17/2021,Unverified
201202_Utah_UniversityofUtah_Phase1BWeber_TestAdj,"December 2, 2020",Local,United States of America,United States of America; Utah; NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1211,1.39%,0.27%,3.66%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/20/2021,6/17/2021,Unverified
201202_Utah_UniversityofUtah_Phase2Prelim_TestAdj,"December 2, 2020",Local,United States of America,United States of America; Utah; NR,"July 7, 2020","August 15, 2020",Household and community samples,Multiple groups,1622,2.81%,1.00%,6.36%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/20/2021,6/17/2021,Unverified
210429_Phoenix_VincereCancerCenter_October_IgG_Unadj,"April 29, 2021",Regional,United States of America,United States of America; Arizona; Phoenix Metropolitan Area,"October 10, 2020","October 16, 2020",Household and community samples,Multiple groups,1635,8.74%,,,Self-referral,"Assure Tech. (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine S M Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,6/24/2021,Unverified
210429_Phoenix_VincereCancerCenter_November_IgG_Unadj,"April 29, 2021",Regional,United States of America,United States of America; Arizona; Phoenix Metropolitan Area,"November 7, 2020","November 13, 2020",Household and community samples,Multiple groups,2037,16.65%,,,Self-referral,"Assure Tech. (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine S M Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,6/24/2021,Unverified
210429_Phoenix_VincereCancerCenter_December_IgG_Unadj,"April 29, 2021",Regional,United States of America,United States of America; Arizona; Phoenix Metropolitan Area,"December 5, 2020","December 11, 2020",Household and community samples,Multiple groups,3038,16.50%,,,Self-referral,"Assure Tech. (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine S M Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,6/24/2021,Unverified
210112_PlacerCounty_StanfordUniversity,"January 12, 2021",Local,United States of America,United States of America; California,"November 1, 2020","November 30, 2020",Household and community samples,Multiple groups,810,2.34%,,,Simplified probability,NA,LFIA,Not reported,,,High,Institutional Report,Julie Parsonnet,Stanford University,https://www.placer.ca.gov/DocumentCenter/View/49523/2021-011221-PowerPoint-Item-02A,5/21/2021,7/6/2021,Verified
210415_KentCounty_UniversityofMichigan_S1,"April 15, 2021",Local,United States of America,United States of America; Michigan; NR,"August 17, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),1385,1.90%,,,Convenience,"Siemens,Biomerieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,5/21/2021,8/4/2021,Unverified
210415_KentCounty_UniversityofMichigan_S2,"April 15, 2021",Local,United States of America,United States of America; Michigan; NR,"December 2, 2020","December 23, 2020",Health care workers and caregivers,Adults (18-64 years),1445,13.70%,,,Convenience,"Siemens,Biomerieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,5/21/2021,8/4/2021,Unverified
210409_NewYorkCity_NYCdepthealth_overall,"April 9, 2021",Local,United States of America,United States of America; New York; New York,"May 13, 2020","July 21, 2020",Household and community samples,Multiple groups,45367,23.60%,23.20%,24.00%,Convenience,DiaSorin SpA,CLIA,IgG,97.60%,99.30%,Moderate,Journal Article (Peer-Reviewed),Preeti Pathela,New York City Department of Health and Mental Hygiene,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab200/6219118,5/22/2021,8/4/2021,Verified
210412_NewYork_CityUniversityofNewYork,"April 12, 2021",Regional,United States of America,"United States of America; New York ; New York City
Bronx
Brooklyn
Long Island
Manhatten
Metro North
Queens
Staten Island","March 8, 2020","January 1, 2021",Household and community samples,Multiple groups,693205,21.60%,21.50%,21.70%,Sequential,NA,Not reported,IgG,,,High,Preprint,Madhura S Rane,City University of New York,https://www.medrxiv.org/content/10.1101/2021.04.06.21255009v3,5/22/2021,8/4/2021,Unverified
210317_NewYorkCity_IcahnSchoolOfMedicine,"March 17, 2021",Local,United States of America,United States of America; New York; Mount Sinai,"May 26, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,383,10.44%,,,Convenience,NA,Not reported,Not reported,,,High,Preprint,Serre Yu Wong,Icahn School Of Medicine,https://www.medrxiv.org/content/10.1101/2021.03.15.21253615v1,5/23/2021,7/16/2021,Verified
210428_NewYorkCity_NewYorkBloodCenter,"April 28, 2021",Local,United States of America,United States of America; New York; New York City,"June 15, 2020","July 15, 2020",Blood donors,Multiple groups,1000,9.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,Vyriad IMMUNO-COV,NA",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Daniel Jin,New York Blood Centre,https://dx.doi.org/10.1371/journal.pone.0250319,5/23/2021,8/4/2021,Unverified
210415_ParrisIsland_IchanSchoolofMedicine,"April 15, 2021",Local,United States of America,United States of America; South Carolina; Port Royal,"May 11, 2020","November 2, 2020",Essential non-healthcare workers,Adults (18-64 years),3076,7.30%,,,Convenience,NA,ELISA,IgG,,100.00%,High,Journal Article (Peer-Reviewed),Andrew G Letizia,Icahn School of Medicine at Mount Sinai,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext,5/23/2021,7/23/2021,Unverified
210422_Illinois+Wisconsin_AdvocateAuroraHealth_Overall,"April 22, 2021",Regional,United States of America,"United States of America; Illinois, Wisconsin","June 8, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),14921,3.59%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Fitzpatrick Veronica,Advocate Aurora Health,https://dx.doi.org/10.1016/j.annepidem.2021.04.005,5/25/2021,6/17/2021,Unverified
210501_UnitedStates_MayoClinic,"May 1, 2021",Regional,United States of America,"United States of America; Minnesota, Wisconsin, Florida, Arizona, Iowa","June 15, 2020","August 8, 2020",Health care workers and caregivers,Adults (18-64 years),29606,0.60%,,,Convenience,"EUROIMMUN AG,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Rickey Carter,The Mayo Clinic,https://dx.doi.org/10.1016/j.mayocp.2021.03.015,5/25/2021,8/4/2021,Unverified
210420_NewYorkCity_BronxCareHealthSystem,"April 20, 2021",Local,United States of America,United States of America; New York State; New York City,"May 18, 2020","June 26, 2020",Health care workers and caregivers,Multiple groups,2749,30.20%,29.00%,32.00%,Convenience,Roche Diagnostics,Not reported,Not reported,97.10%,100.00%,High,Journal Article (Peer-Reviewed), Murli U Purswani,BronxCare Health System,https://dx.doi.org/10.12788/jhm.3627,5/26/2021,7/17/2021,Unverified
201205_Maryland_MarylandDepartmentOfHealth_overall,"December 15, 2020",Regional,United States of America,United States of America; Maryland,"May 24, 2020","June 30, 2020",Residual sera,Multiple groups,500,10.00%,,,Sequential,"Hangzhou Biotest Biotech Co., Ltd",LFIA,"IgG,IgM",95.00%,100.00%,High,Journal Article (Peer-Reviewed),Keri N Althoff,The Maryland Department of Health,https://dx.doi.org/10.1093/ofid/ofaa611,5/27/2021,6/28/2021,Unverified
210506_Boston_BostonMedicalCenter_overall,"May 6, 2021",Local,United States of America,United States of America; Massachusetts; Boston,"July 13, 2020","July 26, 2020",Health care workers and caregivers,Adults (18-64 years),1743,5.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yachana Kataria,Boston Medical Center,https://dx.doi.org/10.1038/s41598-021-89107-5,5/27/2021,6/17/2021,Unverified
210426_LosAngeles_UniversityofCaliforniaLosAngeles,"April 26, 2021",Local,United States of America,United States of America; California; Los Angeles,,"August 11, 2020",Household and community samples,Not reported,3075,8.80%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Douglas Murad,"University of California, Los Angeles, California",https://jcm.asm.org/content/early/2021/04/28/JCM.00431-21,5/27/2021,7/6/2021,Unverified
210427_Connecticut_HartfordHealthcare_overall,"April 27, 2021",Regional,United States of America,United States of America; Connecticut; Hartford,"May 11, 2020","August 16, 2020",Health care workers and caregivers,Multiple groups,6863,6.30%,5.70%,6.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pavlos Papasavas,Hartford Healthcare,https://dx.doi.org/10.1016/j.jhin.2021.04.021,5/27/2021,6/25/2021,Verified
210508_NorthCarolina_FirstHealthoftheCarolinas_Overall,"May 8, 2021",Regional,United States of America,United States of America; North Carolina,"June 10, 2020","July 17, 2020",Health care workers and caregivers,Multiple groups,2076,3.00%,1.90%,3.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),GS Arnoczy,FirstHealth of the Carolinas,https://dx.doi.org/10.1016/j.ajic.2021.04.086,5/28/2021,6/17/2021,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_Dallas1,"April 13, 2021",Local,United States of America,United States of America; Texas; Dallas,"March 1, 2020","March 31, 2021",Residual sera,Not reported,2533,38.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,5/30/2021,8/4/2021,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_DallasFortWorth2,"April 13, 2021",Local,United States of America,United States of America; Texas; Dallas-Fort Worth,"June 1, 2020","February 28, 2021",Residual sera,Not reported,21101,7.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,5/30/2021,6/17/2021,Unverified
210430_Baltimore_JohnsHopkinsUniversity_overall,"April 30, 2021",Local,United States of America,United States of America; Maryland; Baltimore,"March 16, 2020","May 31, 2020",Residual sera,Multiple groups,3255,3.50%,2.90%,4.20%,Sequential,"Hangzhou Biotest Biotech Co., Ltd,EUROIMMUN AG",Multiple Types,"IgG,IgM",84.00%,100.00%,High,Journal Article (Peer-Reviewed),Oliver Laeyendecker,Johns Hopkins University ,https://dx.doi.org/10.1016/j.ajem.2021.04.081,6/1/2021,8/4/2021,Unverified
210519_UnitedStates_QuestDiagnostics,"May 19, 2021",National,United States of America,United States of America,"August 15, 2020","November 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),18148,5.00%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Yonghong Li,Quest Diagnostics,https://dx.doi.org/10.1001/jamanetworkopen.2021.11634,6/3/2021,8/4/2021,Unverified
210430_UnitedStates_MedicalUniversityofSouthCarolina,"April 30, 2021",Regional,United States of America,"United States of America; South Carolina, North Carolina, Georgia","May 15, 2020","July 15, 2020",Blood donors,Multiple groups,60835,2.60%,,,Sequential,"GenScript,NA",Multiple Types,"IgG,Neutralizing ,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Connor Dwyer,Medical University of South Carolina,https://dx.doi.org/10.1016/j.isci.2021.102489,6/3/2021,8/4/2021,Unverified
210316_MetropolitanDetroit_HenryFordHealthSystem,"March 16, 2021",Local,United States of America,United States of America; Michigan; Detroit,"June 17, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),374,2.41%,1.27%,4.51%,Simplified probability,Beckman Coulter,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christine C Johnson,Henry Ford Health System,https://dx.doi.org/10.1016/j.jcv.2021.104794,6/4/2021,7/6/2021,Unverified
210525_UnitedStates_RutgersUniversity_Primary,"May 25, 2021",National,United States of America,United States of America,"May 7, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),124,36.30%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Richard J. Martino,Rutgers University,https://dx.doi.org/10.1177/00333549211018190,6/5/2021,7/28/2021,Unverified
210601_Providence_BrownUniversity,"June 1, 2021",Local,United States of America,United States of America; Rhode Island; Providence,"June 8, 2020","June 23, 2020",Health care workers and caregivers,Adults (18-64 years),101,2.90%,,,Convenience,"Abbott Laboratories,NA",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Matthew Murphy,Brown University,http://rimed.org/rimedicaljournal/2021/06/2021-06-20-contribution-murphy.pdf,6/5/2021,7/6/2021,Unverified
210504_Texas_UniversityofTexasSouthwestern,"May 4, 2021",Local,United States of America,United States of America; Texas; Dallas,"June 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),549,3.28%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,Unclear,Presentation or Conference,Gilberto Salazar,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249,6/5/2021,7/6/2021,Unverified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Staff2,"May 24, 2021",Regional,United States of America,United States of America; California,"August 18, 2020","September 24, 2020",Health care workers and caregivers,Multiple groups,856,40.00%,,,Convenience,"Abbott Laboratories,DiaSorin SpA",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason H Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,6/7/2021,8/4/2021,Unverified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Residents1,"May 24, 2021",Regional,United States of America,United States of America; California,"August 18, 2020","September 24, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1806,25.00%,,,Convenience,"Abbott Laboratories,DiaSorin SpA",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason H Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,6/7/2021,8/4/2021,Unverified
210527_Seattle_UniversityofWashington_Oct19,"May 27, 2021",Local,United States of America,United States of America,"October 1, 2019","October 4, 2019",Residual sera,Adults (18-64 years),87,0.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Denise J McCulloch,University of Washington,https://dx.doi.org/10.1371/journal.pone.0252235,6/7/2021,8/4/2021,Unverified
210527_Seattle_UniversityofWashington_Nov19,"May 27, 2021",Local,United States of America,United States of America,"November 4, 2019","November 8, 2019",Residual sera,Adults (18-64 years),89,0.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Denise J McCulloch,University of Washington,https://dx.doi.org/10.1371/journal.pone.0252235,6/7/2021,8/4/2021,Unverified
210527_Seattle_UniversityofWashington_Dec19,"May 27, 2021",Local,United States of America,United States of America,"December 2, 2019","December 6, 2019",Residual sera,Adults (18-64 years),87,0.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Denise J McCulloch,University of Washington,https://dx.doi.org/10.1371/journal.pone.0252235,6/7/2021,8/4/2021,Unverified
210527_Seattle_UniversityofWashington_Jan20,"May 27, 2021",Local,United States of America,United States of America,"January 6, 2020","January 10, 2020",Residual sera,Adults (18-64 years),90,0.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Denise J McCulloch,University of Washington,https://dx.doi.org/10.1371/journal.pone.0252235,6/7/2021,8/4/2021,Unverified
210527_Seattle_UniversityofWashington_MarchApril20,"May 27, 2021",Local,United States of America,United States of America,"March 2, 2020","April 3, 2020",Residual sera,Adults (18-64 years),413,1.21%,0.40%,2.80%,Sequential,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Denise J McCulloch,University of Washington,https://dx.doi.org/10.1371/journal.pone.0252235,6/7/2021,8/4/2021,Unverified
210504_DallasTexas_UniversityofTexasSouthwestern,"May 4, 2021",Local,United States of America,United States of America,"October 1, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),37,0.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Diercks,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249 ,6/7/2021,7/6/2021,Unverified
210503_USA_HIV_ClinicalReferenceLaboratory,"May 3, 2021",National,United States of America,United States of America,"January 1, 2020","March 31, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1191,12.80%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,99.50%,99.80%,Moderate,Preprint,Robert Stout,Clinical Reference Laboratory ,10.1101/2021.04.29.21256302,6/7/2021,8/4/2021,Verified
210603_OrangeCounty_UCIrvineHealthcare,"June 3, 2021",Local,United States of America,United States of America,"May 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),645,13.30%,,,Stratified non-probability,"Beckman Coulter,Abbott Laboratories,NA,Diazyme Laboratories Inc",Multiple Types,"IgG,IgM",,,High,Preprint,Shruti Gohil,UC Irvine Healthcare,https://www.researchsquare.com/article/rs-566927/v1,6/7/2021,8/4/2021,Unverified
210429_Indianapolis_IndianaUniversity_overall,"April 29, 2021",Local,United States of America,United States of America; Indiana; Indianapolis,"May 18, 2020","May 22, 2020",Health care workers and caregivers,Adults (18-64 years),44,27.27%,,,Convenience,Abnova,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Timothy Crisci,Indiana Univeristy,https://dx.doi.org/10.3389/fped.2021.633082,6/7/2021,7/6/2021,Unverified
210519_OrangeCounty_SantaAna_UCIrvine,"May 19, 2021",Local,United States of America,United States of America,"December 1, 2020","December 31, 2020",Household and community samples,Adults (18-64 years),3347,26.00%,,,Stratified probability,NA,Other,"IgG,IgM",,,Unclear,Preprint,Rafael Assis,University of California Irvine,https://www.biorxiv.org/content/10.1101/2021.04.15.440089v4,6/7/2021,8/4/2021,Unverified
210527_NewYorkCity_NewYorkUniversityGrossmanSchoolofMedicine_primary,"May 27, 2021",Local,United States of America,United States of America; New York; New York City,"April 29, 2020","February 9, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,329,16.00%,,,Convenience,"NA,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Amit Saxena,New York University Grossman School of Medicine,https://dx.doi.org/10.1016/S2665-9913(21)00114-4,6/7/2021,8/4/2021,Unverified
210603_UnitedStates_EmoryUniversity,"June 3, 2021",National,United States of America,United States of America; NR; NR,"August 9, 2020","December 8, 2020",Household and community samples,Multiple groups,1454,4.68%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Aaron Siegler,"Emory University
",https://www.croiconference.org/abstract/us-population-based-survey-of-vaccine-willingness-and-sars-cov-2-antibody-prevalence/,6/7/2021,7/6/2021,Verified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_NewYork1,"May 3, 2021",Local,United States of America,United States of America; New York; New York,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,3664,15.70%,13.60%,18.00%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_SanFrancisco2,"May 3, 2021",Local,United States of America,United States of America; California; San Francisco,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,2000,1.50%,0.60%,3.10%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_Seattle3,"May 3, 2021",Local,United States of America,United States of America; Washington; Seattle,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,2008,1.90%,1.20%,2.90%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_LosAngeles4,"May 3, 2021",Local,United States of America,United States of America; California; Los Angeles,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,4000,4.50%,3.80%,5.30%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_Boston5,"May 3, 2021",Local,United States of America,United States of America; Massachusetts; Boston,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,2000,4.20%,2.80%,6.00%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210503_UnitedStates_UniversityofCaliforniaSanFrancisco_Minneapolis6,"May 3, 2021",Local,United States of America,United States of America; Minnesota; Minneapolis,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,2000,1.50%,0.90%,2.30%,Convenience,"Ortho Clinical Diagnostics Inc.,NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Mars Stone,"University of California, San Francisco",https://www.medrxiv.org/content/10.1101/2021.05.01.21255576v1,6/8/2021,8/4/2021,Unverified
210508_SouthDakota_SouthDakotaStateUniversity_Phase3,"June 8, 2021",Regional,United States of America,"United States of America; South Dakota, Minnesota","October 16, 2020","December 22, 2020",Health care workers and caregivers,Adults (18-64 years),7,14.80%,,,Convenience,Roche Diagnostics,Other,"IgG,IgM,IgA",,,High,Preprint,Jordan Z. Neises,South Dakota State University,https://www.medrxiv.org/content/10.1101/2021.06.07.21258375v1,6/17/2021,7/17/2021,Unverified
210607_LosAngeles_UniversityofSouthernCalifornia,"June 7, 2021",Local,United States of America,United States of America; California; Los Angeles,"October 20, 2020","October 28, 2020",Essential non-healthcare workers,Adults (18-64 years),686,8.90%,,,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Preprint,Karen Mulligan,University of Southern California,10.1101/2021.06.03.21258299,6/18/2021,7/6/2021,Unverified
210409_OrangeCounty_UniversityofCaliforniaIrvine_Primary,"April 9, 2021",Local,United States of America,United States of America; California; Orange County ,"April 14, 2020","May 13, 2020",Health care workers and caregivers,Adults (18-64 years),143,10.50%,,,Convenience,Superbio Biomedical Company ,Other,"IgM,IgG",100.00%,83.80%,High,Journal Article (Peer-Reviewed),Theodore W. Heyming,University of California Irvine,https://dx.doi.org/10.5811/westjem.2021.1.50058,6/20/2021,7/26/2021,Verified
210611_SanFrancisco_UniversityofCaliforniaSanFrancisco_mostadj,"June 11, 2021",Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Multiple groups,4735,4.20%,2.10%,6.30%,Stratified non-probability,NA,Multiple Types,IgG,93.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Isobel Routledge,University of California San Francisco,https://dx.doi.org/10.1038/s41467-021-23651-6,6/21/2021,8/4/2021,Unverified
210602_USA_MontantaStateUniversity_Primary,"June 2, 2021",Local,United States of America,United States of America; Montana; Bozeman,"April 15, 2020","November 15, 2020",Blood donors,Adults (18-64 years),168,19.00%,,,Self-referral,NA,Neutralization,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jodi F. Hedges,Montana State University,http://dx.doi.org/10.3390/vaccines9060587,6/21/2021,6/24/2021,Unverified
210503_USA_IndianaUniversity_Primary,"June 7, 2021",Local,United States of America,United States of America; Indiada,"September 8, 2020","September 30, 2020",Students and Daycares,Adults (18-64 years),1076,4.60%,3.30%,5.80%,Simplified probability,NA,Not reported,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Sina Kianersi,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1016/j.jadohealth.2021.05.003,6/21/2021,7/6/2021,Unverified
210610_USA_BostonHeartDiagnostics,"June 10, 2021",National,United States of America,United States of America,"April 6, 2020","December 1, 2020",Residual sera,Multiple groups,81624,5.21%,,,Unclear,Diazyme Laboratories Inc,CLIA,IgG,98.40%,97.40%,High,Journal Article (Peer-Reviewed),Ernst J. Schaefer,Boston Heart Diagnostics,http://dx.doi.org/10.1371/journal.pone.0252818,6/22/2021,6/22/2021,Unverified
210604_NewYorkCity_NewYorkCityDepartmentOfHealthAndMentalHygiene,"June 4, 2021",Local,United States of America,United States of America; New York State; New York City,"June 1, 2020","October 9, 2020",Household and community samples,Multiple groups,1074,24.30%,,,Stratified probability,DiaSorin SpA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jannae C Parrott,New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.1093/infdis/jiab296,6/22/2021,7/6/2021,Unverified
210615_USA_JohnsHopkinsUniversity,"June 15, 2021",National,United States of America,United States of America,"January 2, 2020","March 18, 2020",Household and community samples,Multiple groups,24079,0.04%,,,Sequential,"Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,90.70%,100.00%,High,Journal Article (Peer-Reviewed),Keri N. Althoff ,Johns Hopkins University,https://dx.doi.org/10.1093/cid/ciab519,6/22/2021,8/4/2021,Unverified
210606_Pennsylvania_UniversityOfPittsburgh_Fall1_overall,"June 6, 2021",Regional,United States of America,United States of America; Pennsylvania,"September 21, 2020","November 4, 2020",Multiple general populations,Multiple groups,199,2.01%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,6/29/2021,8/4/2021,Unverified
210606_Pennsylvania_UniversityOfPittsburgh_Feb2,"June 6, 2021",Local,United States of America,United States of America; Pennsylvania; Pittsburgh,"February 1, 2021","February 5, 2021",Residual sera,Multiple groups,194,16.49%,,,Sequential,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,6/29/2021,8/4/2021,Unverified
210622_UnitedStatesOfAmerica_NationalInstitutesOfHealth_PopAdj,"June 22, 2021",National,United States of America,United States of America,"April 1, 2020","August 4, 2020",Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,NA,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Heather Kalish,National Institutes of Health,https://dx.doi.org/10.1126/scitranslmed.abh3826,6/29/2021,7/6/2021,Unverified
210621_Jacksonville_MayoClinic,"June 21, 2021",Local,United States of America,United States of America; Florida; Jacksonville,"May 6, 2020","July 1, 2020",Health care workers and caregivers,Adults (18-64 years),292,2.70%,1.20%,5.30%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Martin L.De Ruyter,Mayo Clinic,https://dx.doi.org/10.1093/bjs/znab109,6/30/2021,6/30/2021,Unverified
210615_Nashville_VanderbiltUniversityMedicalCenter_FollowUp2_Overall,"June 15, 2021",Local,United States of America,United States of America; Tennessee; Nashville,"January 27, 2021","January 27, 2021",Essential non-healthcare workers,Adults (18-64 years),34,14.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sophie E. Katz,Vanderbilt University Medical Center,https://dx.doi.org/10.1016/j.jpeds.2021.06.015,7/1/2021,7/1/2021,Unverified
210414_Holyoke_CityofHolyoke_Overall_PopAdj,"June 23, 2021",Local,United States of America,United States of America; Massachusetts; Holyoke,"November 5, 2020","January 31, 2021",Household and community samples,Multiple groups,328,13.90%,7.80%,21.80%,Simplified probability,NA,Not reported,"IgM,IgG",,,Moderate,Institutional Report,City of Holyoke,City of Holyoke,https://www.holyoke.org/documents/city-of-holyoke-serosurvey-report/,7/5/2021,7/15/2021,Verified
210602_UnitedStates_TranslationalPulmonaryAndImmunologyResearchCenter_Overall,"June 2, 2021",National,United States of America,United States of America,"February 1, 2020","April 20, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),172,4.00%,,,Convenience,"InBios International, Inc.",ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Nathan Marsteller,Translational Pulmonary and Immunology Research Center,http://dx.doi.org/10.3390/antib10020022,7/6/2021,8/4/2021,Unverified
210618_LosAngeles_UniversityCaliforniaLosAngeles,"June 18, 2021",Local,United States of America,United States of America; California; Los Angeles,,"August 10, 2020",Residual sera,Not reported,3075,8.81%,,,Convenience,DiaSorin SpA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Douglas Murad,University of California Los Angeles,http://dx.doi.org/10.1128/JCM.00431-21,7/7/2021,7/7/2021,Unverified
210707_Monrovia_OakCrestInstituteOfScience_Overall,"July 7, 2021",Local,United States of America,United States of America; California; Monrovia,"March 27, 2020","May 26, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),33,6.10%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Manjula Gunawardana,Oak Crest Institute of Science,https://dx.doi.org/10.1128/mSphere.00542-21,7/13/2021,8/4/2021,Verified
210702_USA_DaVitaClinicalResearch,"July 2, 2021",National,United States of America,"United States of America; California, Connecticut, Minnesota, Nevada, New York, Ohio, Texas, Virginia, and Wisconsin","July 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,2337,9.50%,,,Convenience,Diazyme Laboratories Inc,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dena Cohen,DaVita Clinical Research,https://dx.doi.org/10.1681/ASN.2021030387,7/13/2021,7/23/2021,Verified
210703_Atlanta_CentersForDiseaseControlAndPrevention,"July 3, 2021",Local,United States of America,United States of America; Atlanta; Georgia,"August 31, 2020","November 23, 2020",Residual sera,Multiple groups,592,17.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Talya Shragai,United States Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/infdis/jiab349,7/14/2021,8/4/2021,Unverified
210702_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall,"July 2, 2021",Regional,United States of America,United States of America; Northeastern Ohio,"May 22, 2020","September 15, 2020",Essential non-healthcare workers,Multiple groups,3080,2.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Xiaochun Zhang,University Hospitals Cleveland Medical Center,https://www.medrxiv.org/content/10.1101/2021.06.27.21259432v1.full-text,7/16/2021,7/16/2021,Unverified
210616_LomaLinda_LomaLindaUniversityChildren'sHospital_Overall,"June 16, 2021",Local,United States of America,United States of America; California; Loma Linda,"March 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),146,6.16%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Matthew J. Bock,Loma Linda University Children's Hospital ,https://dx.doi.org/10.1016/j.healun.2021.06.009,7/18/2021,7/21/2021,Unverified
210710_USA_EmoryUniversity_overall_PopAdj_TestAdj,"July 10, 2021",National,United States of America,United States of America,"August 9, 2020","December 8, 2020",Household and community samples,Multiple groups,4654,4.71%,3.30%,6.11%,Stratified probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,Low,Journal Article (Peer-Reviewed),Patrick Sean Sullivan,Emory University,https://dx.doi.org/10.1093/cid/ciab626,7/19/2021,7/19/2021,Unverified
210707_UnitedStates_NationalInstitutesOfHealth_Overall,"July 7, 2021",National,United States of America,United States of America,"April 1, 2020","August 4, 2020",Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Heather Kalish,National Institutes of Health,http://dx.doi.org/10.1126/scitranslmed.abh3826,7/19/2021,7/19/2021,Unverified
210712_UnitedStates_StanfordUniversity_Overall,"July 12, 2021",National,United States of America,United States of America,"January 1, 2021","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,21464,18.70%,18.10%,19.20%,Convenience,Siemens,CLIA,"IgG,IgM",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16572,7/21/2021,7/21/2021,Unverified
210710_Athens_UniversityofGeorgia_PopTestAdj,"July 10, 2021",Local,United States of America,United States of America; Georgia; Athens,"January 22, 2021","March 22, 2021",Students and Daycares,Adults (18-64 years),432,41.00%,31.40%,50.70%,Convenience,NA,ELISA,IgA,88.89%,88.89%,Moderate,Preprint,Mark H Ebell,University of Georgia,https://www.medrxiv.org/content/10.1101/2021.07.08.21260201v1,7/21/2021,7/21/2021,Unverified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_1_Overall,"July 19, 2021",Regional,United States of America,"United States of America; Arkansas; Little Rock, Springdale, Pine Bluff","August 15, 2020","September 5, 2020",Residual sera,Multiple groups,1301,2.60%,1.70%,3.50%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/26/2021,8/5/2021,Unverified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_2_Overall,"July 19, 2021",Regional,United States of America,"United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","September 12, 2020","October 24, 2020",Residual sera,Multiple groups,2098,4.10%,3.10%,5.10%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/26/2021,8/5/2021,Unverified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_3_Overall,"July 19, 2021",Regional,United States of America,"United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","November 7, 2020","December 19, 2020",Residual sera,Multiple groups,2405,7.40%,6.00%,8.70%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/26/2021,8/5/2021,Unverified
210720_LongIsland_StonyBrookUniversity_Totaladj,"July 20, 2021",Local,United States of America,United States of America; New York; Long Island,"March 25, 2020","September 18, 2020",Household and community samples,Multiple groups,1042,21.30%,19.50%,23.20%,Convenience,Abbott Laboratories,CLIA,IgG,93.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Olga Morozova,Stony Brook University,https://dx.doi.org/10.1371/journal.pone.0254713,7/28/2021,7/28/2021,Unverified
210621_OrangeCounty_UniversityOfCaliforniaIrvine_Dec_HCW2_Multiplex,"June 21, 2021",Local,United States of America,United States of America; California; Orange,"December 1, 2020","December 30, 2020",Health care workers and caregivers,Adults (18-64 years),313,11.00%,,,Convenience,NA,Other,IgG,,,Unclear,Preprint,Rafael Ramiro de Assis,University of California Irvine,https://www.researchsquare.com/article/rs-591752/v1,7/31/2021,7/31/2021,Unverified
210621_SantaAna_UniversityOfCaliforniaIrvine_3_Multiplex,"June 21, 2021",Local,United States of America,United States of America; California; Santa Ana,"December 1, 2020","December 30, 2020",Household and community samples,Multiple groups,3347,26.00%,,,Stratified probability,NA,Other,IgG,,,High,Preprint,Rafael Ramiro de Assis,University of California Irvine,https://www.researchsquare.com/article/rs-591752/v1,7/31/2021,7/31/2021,Unverified
210527_NewYorkCity_HospitalForSpecialSurgery_overall,"May 27, 2021",Local,United States of America,United States of America; New York; New York City,"May 6, 2020","June 5, 2020",Health care workers and caregivers,Adults (18-64 years),143,9.79%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ellen Soffin,Hospital for Special Surgery,http://dx.doi.org/10.1097/JOM.0000000000002182,8/1/2021,8/1/2021,Unverified
210721_FortCollins_ColoradoStateUniversity,"July 21, 2021",Local,United States of America,United States of America; Colorado; Fort Collins,"July 13, 2020","September 2, 2020",Essential non-healthcare workers,Adults (18-64 years),508,0.40%,0.10%,1.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Tracy Nelson,Colorado State University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16543,8/2/2021,8/2/2021,Unverified
210715_USA_GeorgeWashingtonUniversity_Overall,"July 15, 2021",National,United States of America,"United States of America; California, Connecticut, Michigan, New Jersey, New York","May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,6665,34.80%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan Silverberg,Johns Hopkins University,https://dx.doi.org/10.1016/j.jaip.2021.06.046,8/3/2021,8/4/2021,Unverified
210728_NewYorkCity_WeillCornellMedicine_Pre-Transplant copy,"July 28, 2021",Local,United States of America,United States of America; New York ; New York City,"May 28, 2020","December 12, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,72,31.94%,,,Sequential,NA,Not reported,IgG,,,High,Preprint,Michelle Lubetzky,Weill Cornell Medicine,10.1101/2021.07.25.21261066,8/4/2021,8/4/2021,Unverified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_Households_TestAdj.,"April 24, 2021",Regional,United Arab Emirates,"United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","July 19, 2020","August 14, 2020",Household and community samples,Multiple groups,8831,10.40%,9.50%,11.40%,Stratified probability,"DiaSorin SpA,Roche Diagnostics",Not reported,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,5/14/2021,8/4/2021,Unverified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_LabourCamps_TestAdj.,"April 24, 2021",Regional,United Arab Emirates,"United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","July 19, 2020","August 14, 2020",Essential non-healthcare workers,Multiple groups,4855,68.60%,61.70%,74.70%,Stratified probability,Roche Diagnostics,Not reported,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,5/14/2021,7/17/2021,Unverified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgG2,"May 1, 2021",Local,Ukraine,Ukraine; Poltava Oblast; Poltava,"July 15, 2020","December 15, 2020",Household and community samples,Not reported,468,47.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla V. Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,6/21/2021,7/6/2021,Unverified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgM1,"May 1, 2021",Local,Ukraine,Ukraine; Poltava Oblast; Poltava,"July 15, 2020","December 15, 2020",Household and community samples,Not reported,2375,5.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla V. Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,6/21/2021,7/6/2021,Unverified
210920_Serdivan_SakaryaUniversity,"January 15, 2021",Local,Turkey,Turkey; Sakarya; Serdivan,"April 7, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),198,3.50%,,,Unclear,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cemil Bilir,Sakarya University ,http://dx.doi.org/10.19193/0393-6384_2021_1_103,3/27/2021,6/17/2021,Verified
210303_Turkey_UniversityofHealthSciences_Overall,"March 3, 2021",National,Turkey,Turkey,"May 30, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),813,2.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gizem Alkurt,University of Health Sciences,https://dx.doi.org/10.1371/journal.pone.0247865,4/17/2021,6/30/2021,Verified
210310_Ankara_HacettepeUniversity_Overall,"March 10, 2021",Local,Turkey,Turkey; Central Anatolia; Ankara,"March 24, 2020","September 10, 2020",Health care workers and caregivers,Adults (18-64 years),774,7.40%,,,Unclear,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Adem Ozdemir,Hacettepe University,http://www.mikrobiyolbul.org/linkout.aspx?pmid=33882653,5/17/2021,6/19/2021,Verified
210427_Turkey_SakaryaUniversity_Overall,"April 27, 2021",Local,Turkey,Turkey,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),2988,3.60%,,,Convenience,"Beijing Hotgen Biotech Co. Ltd, China",Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Aziz Ogutlu,Sakarya University,https://dx.doi.org/10.1186/s12941-021-00436-9,5/25/2021,7/6/2021,Unverified
210523_Istanbul_KocUniversity,"May 23, 2021",Regional,Turkey,Turkey; Istanbul; Istanbul,"May 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),1732,15.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,Fatihan Pınarlık,Koc University,10.1101/2021.05.20.21257518,6/7/2021,7/17/2021,Unverified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_PROMPatients,"July 6, 2021",Local,Turkey,Turkey,"June 1, 2020","July 31, 2020",Pregnant or parturient women,Adults (18-64 years),205,2.93%,,,Sequential,"Assure Tech. (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,7/19/2021,7/19/2021,Unverified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_MiscarriagePatients,"July 6, 2021",Local,Turkey,Turkey,"June 1, 2020","July 31, 2020",Pregnant or parturient women,Adults (18-64 years),230,0.00%,,,Sequential,"Assure Tech. (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,7/19/2021,7/19/2021,Unverified
210707_Istanbul_FlorenceNightingaleHospital_primary,"July 7, 2021",Local,Turkey,Turkey,"March 20, 2020","June 20, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,83,3.60%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Savas Comlek,Florence Nightingale Hospital,http://dx.doi.org/10.22514/sv.2021.008,7/28/2021,8/4/2021,Unverified
210522_Adana_AdanaDr.TurgutNoyanTeachingandResearchHospital,"May 22, 2021",Local,Turkey,Turkey; Mediterranean Region; Adana,"May 18, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),572,3.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hatice Hale GUMUS,Adana Dr. Turgut Noyan Teaching and Research Hospital,http://mikrobiyolbul.org/managete/fu_folder/2021-03/357-373%20Hatice%20Hale%20Gumus.pdf,8/2/2021,8/2/2021,Unverified
200807_Lome_UniversiteDeLome_Overall,"August 7, 2020",Local,Togo,Togo,"April 23, 2020","May 8, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),955,0.90%,0.40%,1.80%,Convenience,"Hangzhou Clongene Biotech Co., Ltd ",LFIA,"IgM,IgG",77.10%,95.40%,High,Journal Article (Peer-Reviewed),Wemboo Halatoko,Universite de Lome,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124,9/23/2020,6/17/2021,Verified
200520_England_RutherfordHealth_HCW_IgG,"May 20, 2020",Local,The United Kingdom,"The United Kingdom; England; Reading, Newport, Liverpool, Bedlington","April 14, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),161,1.24%,,,Convenience,"Sugentech, Inc.",LFIA,IgG,,,High,Preprint,Karol Sikora,Rutherford Health,https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html,5/21/2020,8/4/2021,Verified
200617_Gibraltar_GibraltarGovernment_HCW,"June 17, 2020",Regional,The United Kingdom,The United Kingdom; Gibraltar,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),1247,1.40%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Priya Gulraj,Gibraltar Government ,https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg,6/23/2020,8/4/2021,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,"August 21, 2020",National,The United Kingdom,The United Kingdom; England,"February 1, 2020","March 31, 2020",Residual sera,Children and Youth (0-17 years),443,0.80%,0.00%,2.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,6/17/2021,Verified
200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,"August 21, 2020",National,The United Kingdom,The United Kingdom; England,"February 1, 2020","March 31, 2020",Household and community samples,Children and Youth (0-17 years),106,0.50%,0.00%,3.60%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,6/17/2021,Verified
200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England; London,"March 26, 2020","March 27, 2020",Blood donors,Adults (18-64 years),757,2.60%,1.10%,4.40%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,6/17/2021,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,"July 9, 2020",National,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 28, 2020",Blood donors,Multiple groups,10318,7.20%,6.60%,7.80%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,6/17/2021,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,"July 9, 2020",National,The United Kingdom,The United Kingdom; England,"May 4, 2020","May 31, 2020",Blood donors,Adults (18-64 years),7686,8.30%,7.50%,9.20%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,6/17/2021,Verified
200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England; London,"April 9, 2020","April 13, 2020",Blood donors,Adults (18-64 years),1085,11.10%,8.90%,13.60%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,"August 7, 2020",National,The United Kingdom,The United Kingdom; England,"March 16, 2020","June 30, 2020",Residual sera,Seniors (65+ years),6000,3.90%,,,Stratified probability,EUROIMMUN AG,ELISA,IgG,,,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"April 2, 2020","April 3, 2020",Blood donors,Adults (18-64 years),916,2.40%,1.00%,4.00%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"April 23, 2020","April 24, 2020",Blood donors,Adults (18-64 years),1043,7.30%,5.40%,9.40%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"April 24, 2020","April 26, 2020",Blood donors,Adults (18-64 years),865,5.00%,3.20%,7.00%,Stratified probability,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"April 14, 2020","April 16, 2020",Blood donors,Adults (18-64 years),1017,4.60%,3.00%,6.40%,Stratified probability,EUROIMMUN AG,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"April 15, 2020","April 20, 2020",Blood donors,Adults (18-64 years),936,6.20%,4.40%,8.40%,Stratified probability,EUROIMMUN AG,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,"September 11, 2020",National,The United Kingdom,The United Kingdom; England,"May 1, 2020","May 31, 2020",Residual sera,Children and Youth (0-17 years),1061,7.30%,5.60%,9.20%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200821_England_PHE_WhatsTheStory_TestAdj_April,"August 21, 2020",National,The United Kingdom,The United Kingdom; England,"April 1, 2020","April 30, 2020",Household and community samples,Children and Youth (0-17 years),201,3.80%,1.20%,7.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,"August 21, 2020",National,The United Kingdom,The United Kingdom; England,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),647,6.10%,4.10%,8.40%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,6/17/2021,Verified
200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,"July 7, 2020",Local,The United Kingdom,The United Kingdom; England,"May 4, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),281,6.00%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dimitrios Poulikakos,Salford Royal NHS Foundation Trust,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/,7/20/2020,8/4/2021,Verified
200709_London_UniversityCollegeLondonHospitals_HCW,"July 9, 2020",Local,The United Kingdom,The United Kingdom; England; London,"March 26, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),181,45.30%,,,Convenience,NA,Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Catherine Houlihan,University College London Hospitals,https://dx.doi.org/10.1016/S0140-6736(20)31484-7,7/30/2020,8/5/2021,Verified
201004_SEEngland_King’sCollegeLondon,"October 14, 2020",Regional,The United Kingdom,The United Kingdom; South East England,"April 27, 2020","June 2, 2020",Household and community samples,Multiple groups,431,12.00%,9.10%,15.20%,Unclear,NA,ELISA,"IgG,IgM",90.00%,100.00%,High,Journal Article (Peer-Reviewed),Philippa M Wells,King’s College London,http://dx.doi.org/10.1016/j.jinf.2020.10.011,9/28/2020,6/17/2021,Verified
200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj,"July 25, 2020",Local,The United Kingdom,The United Kingdom; England; King's Lynn,"June 1, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),70,21.40%,,,Unclear,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),D M Favara,The Queen Elizabeth Hospital,https://dx.doi.org/10.1016/j.clon.2020.07.015,9/29/2020,8/4/2021,Verified
200808_UK_PortlandHospitalforWomenandChildren_HCW,"August 8, 2020",Local,The United Kingdom,The United Kingdom; England; London,"May 15, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,22.00%,,,Convenience,Abbott Laboratories,ELISA,IgG,96.90%,99.90%,High,Journal Article (Peer-Reviewed),Asma Khalil,St George’s University of London,http://dx.doi.org/10.1093/cid/ciaa893,10/3/2020,6/17/2021,Verified
200810_London_UniversityCollegeLondon_Total,"August 10, 2020",Local,The United Kingdom,The United Kingdom; England; London,"May 11, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,200,14.50%,9.90%,20.10%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),S Bampoe,University College London,https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229,10/4/2020,6/17/2021,Verified
200729_London_WhittingtonHealthNHSTrust_Overall,"August 4, 2020",Local,The United Kingdom,The United Kingdom; England; London,"May 15, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,2004,31.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,99.80%,High,Journal Article (Peer-Reviewed),Joseph Grant,Whittington Health NHS Trust,https://dx.doi.org/10.1017/ice.2020.402,10/5/2020,7/16/2021,Verified
200922_Gateshead_NHSFoundationTrust_Overall,"September 22, 2020",Local,The United Kingdom,The United Kingdom; England; Gateshead,"May 28, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),2521,19.40%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Salman Razvi,Gateshead Health NHS Foundation Trust,https://dx.doi.org/10.7861/clinmed.2020-0566,10/14/2020,7/16/2021,Verified
200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,"August 7, 2020",National,The United Kingdom,The United Kingdom; England,"June 29, 2020","July 28, 2020",Blood donors,Multiple groups,9388,5.90%,5.30%,6.50%,Stratified probability,EUROIMMUN AG,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,6/17/2021,Verified
200724_UK_ChelseaandWestminsterHospital_HCW,"July 24, 2020",Local,The United Kingdom,The United Kingdom; England; London,"April 8, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,504,10.60%,7.60%,13.60%,Convenience,"CTK Biotech, Inc.,NA,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Scott Pallett,Chelsea and Westminster Hospital NHS Trust,https://dx.doi.org/10.1016/S2213-2600(20)30315-5,10/28/2020,8/4/2021,Verified
200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall,"September 11, 2020",Local,The United Kingdom,The United Kingdom; England; Birmingham,"April 24, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),516,24.40%,,,Self-referral,NA,ELISA,"IgA,IgG,IgM",100.00%,97.80%,High,Journal Article (Peer-Reviewed),Adrian Shields,University Hospitals Birmingham NHS Foundation Trust,http://dx.doi.org/10.1136/thoraxjnl-2020-215414,11/3/2020,7/6/2021,Verified
200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex,"September 20, 2020",Regional,The United Kingdom,The United Kingdom; East of England,"June 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),434,18.40%,,,Convenience,NA,ELISA,IgG,84.00%,100.00%,High,Preprint,David Favara,Cambridge University Hospitals NHS Foundation Trust,https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1,1/14/2021,8/4/2021,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients,"November 13, 2020, November 25, 2020",Local,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,10.40%,8.50%,12.60%,Sequential,"Abbott Laboratories,Fortress Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Michelle Willicombe, Maria Prendecki",Imperial College London,"https://dx.doi.org/10.1097/TP.0000000000003526, https://dx.doi.org/10.1681/ASN.2020081152",1/16/2021,8/4/2021,Verified
201113_Cambridge_RoyalPapworthHospitalNHSTrust_HCW,"November 13, 2020",Local,The United Kingdom,The United Kingdom; England; Cambridge,"April 20, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),500,14.00%,,,Convenience,NA,ELISA,IgG,97.00%,100.00%,High,Preprint,Helen Baxendale,Royal Papworth Hospital NHS Trust,https://www.medrxiv.org/content/10.1101/2020.11.12.20145318v1,1/16/2021,8/4/2021,Verified
201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren,"November 10, 2020",National,The United Kingdom,"The United Kingdom; Ireland, Wales, Scotland, England; Belfast, Cardiff, Glasgow, London, Manchester","April 16, 2020","July 3, 2020",Family of essential workers,Children and Youth (0-17 years),992,6.90%,5.40%,8.60%,Convenience,"Abbott Laboratories,DiaSorin SpA,Roche Diagnostics",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Thomas Waterfield,Royal Belfast Hospital for Sick Children,https://dx.doi.org/10.1136/archdischild-2020-320558,1/17/2021,8/4/2021,Verified
201022_Oxford_UniversityOfOxford_unadj,"October 22, 2020",Local,The United Kingdom,The United Kingdom,"April 14, 2020","June 15, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.30%,4.00%,6.90%,Sequential,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila F Lumley,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721,1/21/2021,6/17/2021,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj,"October 27, 2020",National,The United Kingdom,The United Kingdom,"July 31, 2020","August 13, 2020",Household and community samples,Multiple groups,105829,4.83%,4.67%,5.00%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/21/2021,8/5/2021,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj,"October 27, 2020",National,The United Kingdom,The United Kingdom,"September 15, 2020","September 28, 2020",Household and community samples,Multiple groups,159367,4.38%,4.25%,4.51%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/21/2021,8/5/2021,Verified
201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW,"November 17, 2020",National,The United Kingdom,The United Kingdom,"May 1, 2020","May 31, 2020",Contacts of COVID patients,Children and Youth (0-17 years),44,36.20%,9.00%,63.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Immunisation and Countermeasures Division,https://dx.doi.org/10.1093/cid/ciaa1737,1/22/2021,7/7/2021,Verified
200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35,"September 11, 2020",National,The United Kingdom,The United Kingdom; England,"July 27, 2020","August 30, 2020",Blood donors,Multiple groups,8764,5.30%,4.80%,5.80%,Stratified probability,EUROIMMUN AG,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,6/17/2021,Verified
201103_London_PHE_LTCStaff,"November 3, 2020",Local,The United Kingdom,The United Kingdom; Greater London; London,"June 3, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,327,47.10%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Thomas Rowland,Public Health England,https://dx.doi.org/10.1016/j.jinf.2020.10.035,1/23/2021,6/17/2021,Verified
201223_Oxford_OxfordUniversityHospitals_HCW_Spike,"December 23, 2020",Local,The United Kingdom,The United Kingdom,"April 23, 2020","November 30, 2020",Health care workers and caregivers,Multiple groups,12541,10.08%,,,Convenience,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila Lumley,Oxford University Hospitals,https://dx.doi.org/10.1056/NEJMoa2034545,1/23/2021,6/17/2021,Verified
201119_UK_QueensUniversityBelfast_adj,"November 19, 2020",National,The United Kingdom,The United Kingdom,"June 26, 2020","August 15, 2020",Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Convenience,"Roche Diagnostics,DiaSorin SpA",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,https://dx.doi.org/10.1016/S1473-3099(20)30884-7,1/23/2021,8/4/2021,Verified
200911_England_PHE_WhatsTheStory_Summary_5_May_August,"September 11, 2020",National,The United Kingdom,The United Kingdom; England,"May 1, 2020","August 5, 2020",Household and community samples,Children and Youth (0-17 years),568,5.20%,3.20%,7.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,6/17/2021,Verified
201002_England_PHE_BloodDonors_Summary_Final,"October 2, 2020",National,The United Kingdom,The United Kingdom; England,"August 24, 2020","September 18, 2020",Blood donors,Multiple groups,8230,6.10%,5.40%,6.80%,Stratified probability,EUROIMMUN AG,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,6/17/2021,Verified
201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott,"October 2, 2020",National,The United Kingdom,The United Kingdom; England,"June 15, 2020","August 16, 2020",Residual sera,Seniors (65+ years),4315,6.50%,5.50%,7.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,6/17/2021,Verified
201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott,"October 2, 2020",National,The United Kingdom,The United Kingdom; England,"June 15, 2020","August 16, 2020",Residual sera,Multiple groups,1212,5.20%,3.90%,7.00%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Low,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,6/17/2021,Verified
200826_London_ImperialCollegeLondon_LTC,"August 26, 2020",Local,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","June 30, 2020",Assisted living and long-term care facilities,Seniors (65+ years),241,71.80%,66.00%,77.00%,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Neil Graham,Imperial College London,https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext,1/23/2021,6/17/2021,Verified
201109_UK_WatfordGeneralHospital_ACU,"November 9, 2020",Local,The United Kingdom,The United Kingdom; NR; Watford,"March 27, 2020","June 8, 2020",Residual sera,Multiple groups,443,1.58%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Muhammad Arif,Watford General Hospital,https://dx.doi.org/10.7759/cureus.11398,1/23/2021,6/17/2021,Verified
201215_Leicester_UniversityHospitalsofLeicesterNHSTrust,"December 15, 2020",Local,The United Kingdom,The United Kingdom; England; Leicester ,"May 29, 2020","August 3, 2020",Health care workers and caregivers,Adults (18-64 years),200,12.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,92.70%,100.00%,High,Journal Article (Peer-Reviewed),John Black,University Hospitals of Leicester NHS Trust,https://dx.doi.org/10.1111/tri.13791,1/27/2021,6/17/2021,Verified
201130_Bristol_NorthBristolNHSTrust_hcw,"November 30, 2020",Local,The United Kingdom,"The United Kingdom; England; Bristol, South Gloucestershire, North Somerset","January 15, 2020","June 15, 2020",Health care workers and caregivers,Multiple groups,6858,9.30%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Christopher Jones,North Bristol NHS Trust,https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext,1/31/2021,8/4/2021,Verified
201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust,"December 22, 2020",Local,The United Kingdom,The United Kingdom; England ; Newcastle-Upon-Tyne,"May 29, 2020","July 6, 2020",Health care workers and caregivers,Adults (18-64 years),11103,8.40%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Preprint,Aidan Hanrath,Newcastle-upon-Tyne Hospitals NHS Trust,https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1,2/2/2021,7/17/2021,Verified
201211_London_RichmondPharmacologyLtd,"December 11, 2020",Local,The United Kingdom,The United Kingdom; England; London,"March 19, 2020","December 2, 2020",Multiple populations,Multiple groups,6061,6.40%,,,Unclear,NA,Other,IgG,,,High,Preprint,Jorg Taubel,Richmond Pharmacology Ltd,https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2,2/4/2021,8/5/2021,Verified
201226_Glasgow_FrancisCrickInstitute_primaryadj,"December 26, 2020",Local,The United Kingdom,The United Kingdom; Scotland; Glasgow,"March 16, 2020","May 24, 2020",Residual sera,Multiple groups,6635,5.29%,0.13%,15.10%,Sequential,NA,ELISA,IgG,95.31%,97.20%,Moderate,Journal Article (Peer-Reviewed),Ellen C Hughes,The Francis Crick Institute,https://dx.doi.org/10.1093/infdis/jiaa788,2/4/2021,7/6/2021,Verified
201022_Scotland_UniversityOfOxford_overall,"October 22, 2020",Regional,The United Kingdom,The United Kingdom; Scotland,"March 17, 2020","May 18, 2020",Blood donors,Adults (18-64 years),3500,3.17%,,,Simplified probability,NA,Neutralization,Not reported,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Craig P Thompson,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685,2/6/2021,7/6/2021,Verified
210111_UK_PublicHealthEngland_Round1_overall,"January 20, 2021",National,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 15, 2020",Multiple populations,Multiple groups,2198,13.60%,12.40%,15.10%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,6/23/2021,Unverified
210111_UK_PublicHealthEngland_Round2_overall ,"January 20, 2021",National,The United Kingdom,The United Kingdom; England,"July 7, 2020","July 21, 2020",Household and community samples,Multiple groups,1431,12.10%,10.50%,13.90%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,6/17/2021,Unverified
201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff,"November 4, 2020",Local,The United Kingdom,The United Kingdom; England; Cambridge,"June 10, 2020","August 7, 2020",Health care workers and caregivers,Multiple groups,5698,7.20%,,,Convenience,Siemens,CLIA,Total Antibody,98.10%,99.90%,Moderate,Preprint,Daniel Cooper,Cambridge University Hospitals NHS Foundation Trust,https://doi.org/10.1101/2020.11.03.20220699,2/13/2021,6/17/2021,Verified
201116_Leicester_UniversityofLeicester_HCW,"November 16, 2020",Local,The United Kingdom,The United Kingdom; East Midlands; Leicester,"May 29, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),10662,10.77%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Christopher Martin,University of Leicester,https://dx.doi.org/10.1093/pubmed/fdaa199,2/13/2021,6/17/2021,Verified
210203_England_TheUniversityofNottingham_HCW_primary,"February 3, 2021",Local,The United Kingdom,The United Kingdom; East Midlands,"April 24, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),633,18.00%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,6/17/2021,Unverified
210203_England_TheUniversityofNottingham_HHC_primary,"February 3, 2021",Local,The United Kingdom,The United Kingdom; England,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),178,7.30%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,6/17/2021,Unverified
201021_London_BartsHealthNHSTrust_primary,"October 21, 2020",Local,The United Kingdom,The United Kingdom,"May 1, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,1253,18.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Kieran McCafferty,Barts Health NHS Trust ,http://dx.doi.org/10.1111/hdi.12883,2/24/2021,7/16/2021,Verified
210203_UK_LondonSchoolofHygiene&TropicalMedicine_OrthodoxJews,"February 3, 2021",Local,The United Kingdom,The United Kingdom,"October 17, 2020","December 13, 2020",Household and community samples,Multiple groups,1242,64.30%,61.60%,67.00%,Simplified probability,NA,CLIA,IgG,96.20%,97.40%,Moderate,Preprint,Katherine Gaskell,London School of Hygiene & Tropical Medicine,https://doi.org/10.1101/2021.02.01.21250839,2/27/2021,6/17/2021,Verified
210101_London_LewishamGreenwichNHSTrust_HCW_Overall,"January 1, 2021",Local,The United Kingdom,"The United Kingdom; England; Lewisham, Greenwich ","May 27, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),6212,26.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mehool Patel,Lewisham and greenwich NHS Trust ,https://dx.doi.org/10.7861/clinmed.2020-0619,3/1/2021,6/17/2021,Verified
201101_London_PublicHealthEngland_Overall,"November 1, 2020, October 2, 2020",Local,The United Kingdom,The United Kingdom; England; London,"April 10, 2020","April 13, 2020",Assisted living and long-term care facilities,Multiple groups,394,77.90%,73.60%,81.70%,Convenience,NA,ELISA,Not reported,99.20%,,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Shamez Ladhani, Joan Shang",Public Health England,"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30341-2/fulltext, http://dx.doi.org/10.1038/s41577-020-00463-1",3/5/2021,6/17/2021,Verified
200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop,"June 25, 2020",Regional,The United Kingdom,The United Kingdom; England,"May 8, 2020","June 4, 2020",Household and community samples,Multiple groups,1575,6.30%,4.50%,8.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop,"July 31, 2020",Regional,The United Kingdom,The United Kingdom; England,"June 5, 2020","July 2, 2020",Household and community samples,Multiple groups,2392,4.18%,,,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
200826_UK_OfficeforNationalStatistics_July_020_England_genpop,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"July 3, 2020","July 30, 2020",Household and community samples,Multiple groups,3236,6.50%,5.20%,8.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop,"August 28, 2020",Regional,The United Kingdom,The United Kingdom; England,"July 31, 2020","August 27, 2020",Household and community samples,Multiple groups,6189,5.60%,4.70%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop,"September 25, 2020",Regional,The United Kingdom,The United Kingdom; England,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,8742,5.80%,5.10%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop,"October 23, 2020",Regional,The United Kingdom,The United Kingdom; England,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,15687,6.90%,6.40%,7.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop,"November 26, 2020",Regional,The United Kingdom,The United Kingdom; England,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,15834,8.70%,8.10%,9.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop,"December 24, 2020",Regional,The United Kingdom,The United Kingdom; England,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,21684,10.10%,9.60%,10.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop,"January 29, 2021",Regional,The United Kingdom,The United Kingdom; England,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,24150,15.30%,14.70%,15.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop,"September 25, 2020",Regional,The United Kingdom,The United Kingdom; Wales,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,236,4.70%,2.00%,9.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop,"October 23, 2020",Regional,The United Kingdom,The United Kingdom; Northern Ireland,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,249,2.80%,1.20%,5.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop,"October 23, 2020",Regional,The United Kingdom,"The United Kingdom; Scotland
","September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,383,6.80%,4.30%,10.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop,"October 23, 2020",Regional,The United Kingdom,The United Kingdom; Wales,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,473,4.70%,2.90%,7.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop,"November 26, 2020",Regional,The United Kingdom,"The United Kingdom; Scotland
","October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,397,7.80%,5.00%,11.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop,"November 26, 2020",Regional,The United Kingdom,The United Kingdom; Northern Ireland,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,333,3.50%,1.60%,6.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop,"November 26, 2020",Regional,The United Kingdom,The United Kingdom; Wales,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,497,6.10%,4.00%,9.00%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop,"December 24, 2020",Regional,The United Kingdom,The United Kingdom; Northern Ireland,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,248,3.70%,1.70%,7.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop,"December 24, 2020",Regional,The United Kingdom,The United Kingdom; Scotland,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,1034,5.90%,4.40%,7.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop,"December 24, 2020",Regional,The United Kingdom,The United Kingdom; Wales,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,631,7.20%,5.10%,9.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop,"January 29, 2021",Regional,The United Kingdom,The United Kingdom; Northern Ireland,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,313,12.00%,7.80%,17.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop,"January 29, 2021",Regional,The United Kingdom,"The United Kingdom; Scotland
","December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,1832,10.70%,9.10%,12.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,6/17/2021,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop,"January 29, 2021",Regional,The United Kingdom,The United Kingdom; Wales,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,732,11.50%,8.60%,14.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,7/7/2021,Verified
210107_London_UniversityCollegeLondon_June_PaediatricHCW,"January 27, 2021",Local,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1134,16.93%,14.86%,19.22%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210107_London_UniversityCollegeLondon_May_PaediatricHCW,"January 27, 2021",Local,The United Kingdom,The United Kingdom; England; London,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1754,15.34%,13.73%,17.10%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Unverified
210219_England_PHE_UniversityStudents_Overall,"February 19, 2021",Regional,The United Kingdom,The United Kingdom; England,"December 2, 2020","December 11, 2020",Students and Daycares,Adults (18-64 years),2905,17.80%,16.50%,19.30%,Convenience,"Abbott Laboratories,NA",CLIA,IgG,,,Moderate,Preprint,Amoolya Vusirikala,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684,3/15/2021,8/4/2021,Verified
210127_UK_UniversityCollegeLondon_overall,"January 27, 2021",Regional,The United Kingdom,The United Kingdom; England; Nottingham; London,"March 23, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),1364,19.94%,,,Convenience,"EUROIMMUN AG,Roche Diagnostics,NA",ELISA,IgG,,,High,Preprint,Ana Valdes,University College London,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805,3/17/2021,8/4/2021,Verified
210115_UK_UKBiobank_Overall,"January 15, 2021",National,The United Kingdom,"The United Kingdom; England, Scotland, Wales","May 27, 2020","December 4, 2020",Household and community samples,Multiple groups,18893,8.99%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,UK Biobank,UK Biobank,https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf,3/19/2021,6/17/2021,Unverified
210301_London_King’sCollegeHospital_primary,"March 1, 2021",Local,The United Kingdom,The United Kingdom,"April 22, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),625,21.00%,,,Convenience,NA,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Kat El Bouzidi,King’s College Hospital,https://dx.doi.org/10.1097/CCM.0000000000004878,3/19/2021,6/17/2021,Verified
210127_London_King'sCollegeLondon_September_PostgradStudents&Staff,"January 27, 2021",Local,The United Kingdom,The United Kingdom,"September 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1675,5.40%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Preprint,Daniel Leightley,King's College London,https://doi.org/10.1101/2021.01.26.21249744,3/21/2021,6/17/2021,Verified
210225_England_ImperialCollegeLondon_Round4_overall_adj,"February 25, 2021",National,The United Kingdom,The United Kingdom; England,"October 27, 2020","November 10, 2020",Household and community samples,Multiple groups,161537,5.56%,5.43%,5.71%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,3/24/2021,6/18/2021,Verified
210119_Lacashire_PublicHealthEngland_overall,"January 19, 2021",Local,The United Kingdom,The United Kingdom; England; Lacashire,"June 3, 2020","June 4, 2020",Essential non-healthcare workers,Adults (18-64 years),195,9.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ranya Mulchandani,Public Health England,http://dx.doi.org/10.1016/j.jcv.2021.104739,3/25/2021,7/17/2021,Verified
210202_UK_SalfordRoyalNHS_primary,"February 2, 2021",Local,The United Kingdom,The United Kingdom,"March 15, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,237,5.10%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd),Siemens",CLIA,IgG,,,High,Preprint,Olivia Wickens,Salford Royal NHS ,https://www.researchsquare.com/article/rs-154513/v1,3/26/2021,8/4/2021,Verified
210212_Oxford_UniversityofOxford,"February 12, 2021",Local,The United Kingdom,The United Kingdom,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,404,3.00%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,3/27/2021,6/17/2021,Verified
210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall,"March 3, 2021",Local,The United Kingdom,The United Kingdom; England; London,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),3285,35.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Emily Martin,North Middlesex University Hospital NHS Trust,https://dx.doi.org/10.1016/j.jinf.2021.02.027,3/31/2021,7/20/2021,Verified
210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients,"February 11, 2021",Local,The United Kingdom,The United Kingdom,"May 19, 2020","July 21, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,493,7.70%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tabitha Turner Stokes,Imperial College Healthcare NHS Trust,https://dx.doi.org/10.1016/j.ekir.2021.02.006,4/2/2021,6/24/2021,Verified
201105_London_ImperialCollegeLondon,"November 5, 2020",Local,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","July 27, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),161,11.20%,,,Convenience,NA,Other,Total Antibody,94.80%,,High,Journal Article (Peer-Reviewed),Simone Claudiani,Imperial College London,http://dx.doi.org/10.1182/blood-2020-142454,4/4/2021,6/19/2021,Verified
210210_London_KingsCollegeLondon,"February 10, 2021",Local,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","June 30, 2020",Multiple populations,Adults (18-64 years),1882,7.00%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",94.00%,96.30%,High,Preprint,Katrina Davis,King's College London,https://www.medrxiv.org/content/10.1101/2020.12.07.20245183v2,4/5/2021,6/17/2021,Verified
210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall,"March 22, 2021",National,The United Kingdom,The United Kingdom,"September 22, 2020","December 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,6935,4.30%,3.80%,4.80%,Sequential,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Nicholas Kennedy,Royal Devon and Exeter NHS Foundation Trust,https://dx.doi.org/10.1136/gutjnl-2021-324388,4/9/2021,7/17/2021,Verified
210212_London_RoyalFreeHospital,"February 12, 2021",Local,The United Kingdom,The United Kingdom,"March 26, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),43,18.60%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Natarajan Angamuthu,Royal Free Hospital,https://dx.doi.org/10.1016/j.surge.2021.01.007,4/10/2021,7/6/2021,Verified
210401_London_PublicHealthEngland_Overall,"April 1, 2021",Local,The United Kingdom,The United Kingdom,"March 30, 2020","July 21, 2020",Health care workers and caregivers,Multiple groups,1069,29.00%,26.00%,32.00%,Unclear,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Madhumita Shrotri,Public Health England,https://dx.doi.org/10.3201/eid2704.204554,4/11/2021,8/4/2021,Verified
210302_London_UniversityCollegeLondon_HCW_Overall,"March 2, 2021",Local,The United Kingdom,The United Kingdom; England; London,"March 23, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),729,21.50%,,,Convenience,"EUROIMMUN AG,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Manisty,University College London,https://dx.doi.org/10.1016/j.ebiom.2021.103259,4/12/2021,8/4/2021,Unverified
210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline,"February 26, 2021",Local,The United Kingdom,The United Kingdom,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1507,16.30%,,,Convenience,The Binding Site,ELISA,"IgG,IgM,IgA",98.60%,98.30%,Moderate,Preprint,Adrian Shields,Birmingham Community Healthcare Trust,10.1101/2021.02.24.21252368,4/15/2021,7/9/2021,Verified
210316_Sussex_UniversityofSussex_RocheBSUH,"March 16, 2021",Local,The United Kingdom,The United Kingdom; England; Brighton and Sussex,"May 19, 2020","September 29, 2020",Health care workers and caregivers,Adults (18-64 years),14473,12.99%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/16/2021,7/22/2021,Verified
210316_Sussex_UniversityofSussex_AbbottWSHT,"March 16, 2021",Local,The United Kingdom,The United Kingdom; England; West Sussex,"May 19, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),12388,7.89%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/16/2021,7/22/2021,Verified
210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens,"March 17, 2021",Local,The United Kingdom,The United Kingdom; England; NR,"October 1, 2019","March 31, 2020",Residual sera,Multiple groups,428,0.00%,,,Simplified probability,"DiaSorin SpA,Siemens",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1016/j.jinf.2021.03.007,4/16/2021,8/4/2021,Unverified
210323_Surrey_RoyalHollowayUniversityofLondon,"March 23, 2021",Local,The United Kingdom,The United Kingdom; England; Chertsey,"October 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),3119,19.65%,,,Convenience,Abbott Laboratories,CLIA,IgG,82.50%,95.00%,High,Journal Article (Peer-Reviewed),Gie Ken Dror,Royal Holloway University of London,https://dx.doi.org/10.7861/clinmed.2020-1096,4/17/2021,7/23/2021,Verified
210212_London_UniversityofOxford_Overall,"February 12, 2021",Local,The United Kingdom,The United Kingdom,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,236,8.47%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,4/19/2021,6/17/2021,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy,"November 13, 2020, November 25, 2020",Local,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,8.10%,6.40%,10.10%,Sequential,Abbott Laboratories,CLIA,IgG,68.40%,100.00%,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Michelle Willicombe, Maria Prendecki",Imperial College London,"https://dx.doi.org/10.1097/TP.0000000000003526, https://dx.doi.org/10.1681/ASN.2020081152",4/21/2021,6/17/2021,Verified
210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW,"March 16, 2021",Local,The United Kingdom,"The United Kingdom; England; Chorley, Preston, South Ribble","May 29, 2020","July 4, 2020",Health care workers and caregivers,Adults (18-64 years),4474,17.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Robert Shorten ,Lancashire Teaching Hospitals NHS Foundation Trust,https://dx.doi.org/10.1136/bmjopen-2020-045384,4/21/2021,7/17/2021,Verified
210310_England_UCLInstituteOfHealthInformatics_Staff,"March 10, 2021",Local,The United Kingdom,The United Kingdom; England,"October 1, 2020","February 28, 2021",Health care workers and caregivers,Adults (18-64 years),1429,29.00%,,,Convenience,"Abbott Laboratories,Meso Scale Discovery",CLIA,IgG,,,Moderate,Preprint,Maria Krutikov,UCL Institute of Health Informatics,10.1101/2021.03.08.21253110,5/6/2021,8/4/2021,Unverified
210310_England_UCLInstituteOfHealthInformatics_Residents,"March 10, 2021",Local,The United Kingdom,The United Kingdom; England,"October 1, 2020","February 28, 2021",Assisted living and long-term care facilities,Seniors (65+ years),682,33.00%,,,Convenience,"Abbott Laboratories,Meso Scale Discovery",CLIA,IgG,,,Moderate,Preprint,Maria Krutikov,UCL Institute of Health Informatics,10.1101/2021.03.08.21253110,5/6/2021,8/4/2021,Unverified
210322_England_PublicHealthEnglandColindale_Overall,"March 22, 2021",Local,The United Kingdom,The United Kingdom; England; London; Wythenshawe; Porton,"March 23, 2020","November 18, 2020",Multiple populations,Adults (18-64 years),2246,11.80%,,,Convenience,"EUROIMMUN AG,Abbott Laboratories,NA,Roche Diagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Robert Harris,Public Health England Colindale ,https://dx.doi.org/10.1016/j.jinf.2021.03.015,5/13/2021,8/4/2021,Unverified
201221_London_PublicHealthEngland_overall_unadj,"December 21, 2020",Local,The United Kingdom,The United Kingdom,"May 5, 2020","May 5, 2020",Multiple populations,Adults (18-64 years),193,13.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Taylor,Public Health England,https://dx.doi.org/10.1016/j.lanepe.2020.100015,5/17/2021,8/5/2021,Verified
210423_Blackpool_NHSFoundationTrust_primaryAbbott,"April 23, 2021",Local,The United Kingdom,The United Kingdom,"August 1, 2020","August 31, 2020",Residual sera,Multiple groups,225,5.30%,,,Convenience,Abbott Laboratories,ELISA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Jane Oakey,NHS Foundation Trust ,https://dx.doi.org/10.1177/00045632211015711,5/20/2021,6/23/2021,Unverified
210421_London_DMGDental-MaterialGesellschaftmbH_overall_unadj,"April 21, 2021",Local,The United Kingdom,The United Kingdom; England; London,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),14,21.40%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Linda Greenwall,DMG Dental-Material Gesellschaft mbH,https://dx.doi.org/10.1038/s41415-021-2849-7,5/20/2021,7/7/2021,Unverified
210408_London_St.Thomas’NHSFoundationTrust,"April 8, 2021",Local,The United Kingdom,The United Kingdom,"July 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,697,18.22%,,,Convenience,DiaSorin SpA,Not reported,IgG,97.40%,,High,Journal Article (Peer-Reviewed),Caroline Dudreuilh,St. Thomas’ NHS Foundation Trust,https://dx.doi.org/10.1016/j.ekir.2021.03.900,5/22/2021,6/17/2021,Unverified
210225_London_PublicHealthEngland_primary,"January 22, 2021",Local,The United Kingdom,The United Kingdom; England; London,"April 1, 2020","April 30, 2020",Assisted living and long-term care facilities,Multiple groups,651,90.00%,,,Convenience,"Abbott Laboratories,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Jeffery Smith,Public Health England,https://dx.doi.org/10.1016/j.lanepe.2021.100038,5/22/2021,8/4/2021,Verified
210409_England_PublicHealthEngland,"April 9, 2021",National,The United Kingdom,The United Kingdom,"June 18, 2020","December 31, 2020",Health care workers and caregivers,Multiple groups,25661,29.43%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Victoria Jane Hall,Public Health England,https://dx.doi.org/10.1016/S0140-6736(21)00675-9,5/22/2021,7/27/2021,Verified
210316_UK_OfficeForNationalStatistics_England_overall,"March 16, 2021",Regional,The United Kingdom,The United Kingdom; England,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,34623,34.60%,34.00%,35.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/7/2021,Unverified
210316_UK_OfficeForNationalStatistics_NorthernIreland_overall,"March 16, 2021",Regional,The United Kingdom,The United Kingdom; Northern Ireland,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,632,31.20%,27.30%,35.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/7/2021,Unverified
210316_UK_OfficeForNationalStatistics_Scotland_overall,"March 16, 2021",Regional,The United Kingdom,"The United Kingdom; Scotland
","February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,2737,22.30%,20.60%,24.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/7/2021,Unverified
210316_UK_OfficeForNationalStatistics_Wales_overall,"March 16, 2021",Regional,The United Kingdom,The United Kingdom; Wales,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,1224,30.50%,27.50%,33.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/7/2021,Unverified
201226_Scotland_UniversityofGlasgow_overall_unaj,"December 26, 2020",Local,The United Kingdom,The United Kingdom; Scotland; Greater Glasgow area,"March 16, 2020","May 24, 2020",Residual sera,Multiple groups,6635,7.81%,7.17%,8.48%,Simplified probability,NA,ELISA,IgG,95.31%,97.20%,Low,Journal Article (Peer-Reviewed),Ellen C Hughes,University of Glasgow,http://dx.doi.org/10.1093/infdis/jiaa788,5/23/2021,7/6/2021,Verified
210324_London_ImperialCollegeLondon_Overall,"March 24, 2021",Local,The United Kingdom,The United Kingdom; England; London,"February 24, 2020","January 1, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,301,42.86%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Candice L Clarke,Imperial College London,https://dx.doi.org/10.1016/j.kint.2021.03.009,5/23/2021,8/4/2021,Verified
210426_England_CambridgeUniversityHospitalsNHS,"April 24, 2021",Regional,The United Kingdom,The United Kingdom; England,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),434,7.80%,,,Convenience,Abbexa,LFIA,"IgG,IgM",98.50%,97.94%,Moderate,Journal Article (Peer-Reviewed),DM Favara,Cambridge University Hospitals NHS Foundation Trust,https://dx.doi.org/10.1016/j.clon.2021.04.005,5/27/2021,6/17/2021,Unverified
210522_UK_UniversityCollegeLondon_overall,"May 22, 2021",National,The United Kingdom,The United Kingdom; England and Wales,"February 1, 2021","May 3, 2021",Household and community samples,Multiple groups,10330,8.20%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,,,Moderate,Preprint,Robert W Aldridge,University College London,10.1101/2021.05.10.21256912,5/27/2021,7/17/2021,Unverified
210428_London_SorbonneUniversité_6,"April 28, 2021",Regional,The United Kingdom,The United Kingdom; London; London,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,239,14.60%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/31/2021,8/4/2021,Unverified
210427_EastLondon_QueenMaryUniversityofLondon,"April 27, 2021",Local,The United Kingdom,The United Kingdom,"June 15, 2020","August 15, 2020",Health care workers and caregivers,Multiple groups,2001,25.30%,,,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Naheed Choudhry,Queen Mary University of London,https://dx.doi.org/10.3389/fmed.2021.642723,6/1/2021,8/4/2021,Unverified
210510_UK_PublicHealthEngland_Primary_RocheS,"May 10, 2021",National,The United Kingdom,The United Kingdom,"February 22, 2021","March 21, 2021",Blood donors,Multiple groups,7720,46.40%,45.40%,47.50%,Unclear,Roche Diagnostics,Not reported,Not reported,97.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Heather J Whitaker,Public Health England,http://dx.doi.org/10.1016/j.jinf.2021.04.037,6/5/2021,7/31/2021,Verified
201212_Europe_UniversityOfGlasgow_UK1,"December 12, 2020",National,The United Kingdom,The United Kingdom,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),311,6.75%,4.46%,10.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,6/17/2021,Verified
210602_UK_dental_UniversityBirmingham_Follow-up,"June 2, 2021",Regional,The United Kingdom,The United Kingdom; West midlands,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),944,51.40%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",98.60%,98.30%,High,Journal Article (Peer-Reviewed),A M Shields,University of Birmingham,https://dx.doi.org/10.1177/00220345211020270,6/7/2021,7/6/2021,Unverified
210518_UK_UniversityCollegeLondon_overall,"May 18, 2021",National,The United Kingdom,The United Kingdom; England and Wales,"February 1, 2021","April 28, 2021",Household and community samples,Adults (18-64 years),3761,11.59%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Preprint,Sarah Beale,University College London,10.1101/2021.05.13.21257161,6/7/2021,7/17/2021,Unverified
210502_England_ImperialCollegeLondon_TestPopAdj,"May 2, 2021",National,The United Kingdom,The United Kingdom; England,"June 20, 2020","September 28, 2020",Household and community samples,Multiple groups,365104,4.94%,4.85%,5.03%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Journal Article (Peer-Reviewed),Helen Ward,Imperial College London,https://dx.doi.org/10.1016/j.lanepe.2021.100098,6/8/2021,6/17/2021,Unverified
210225_England_ImperialCollegeLondon_Round5_overall_Primary,"February 25, 2021",National,The United Kingdom,The United Kingdom; England,"January 25, 2021","February 8, 2021",Household and community samples,Multiple groups,155172,13.90%,13.70%,14.10%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,6/18/2021,6/18/2021,Verified
210609_England_PublicHealthEngland_Students_Round2,"June 9, 2021",National,The United Kingdom,The United Kingdom; England,"December 3, 2020","December 17, 2020",Students and Daycares,Children and Youth (0-17 years),893,13.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shamez N Ladhani,Public Health England,http://dx.doi.org/10.1016/j.eclinm.2021.100948,6/21/2021,6/21/2021,Unverified
210609_England_PublicHealthEngland_Staff_Round2,"June 9, 2021",National,The United Kingdom,The United Kingdom; England,"December 3, 2020","December 17, 2020",Essential non-healthcare workers,Adults (18-64 years),872,13.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shamez N Ladhani,Public Health England,http://dx.doi.org/10.1016/j.eclinm.2021.100948,6/21/2021,6/21/2021,Unverified
210607_EastScotland_UniversityofDundee_HCW1,"June 7, 2021",Regional,The United Kingdom,The United Kingdom; Scotland; Dundee,"May 28, 2020","September 2, 2020",Health care workers and caregivers,Adults (18-64 years),2063,14.50%,,,Convenience,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,Moderate,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,6/21/2021,6/21/2021,Unverified
210607_EastScotland_UniversityofDundee_Control2,"June 7, 2021",Regional,The United Kingdom,The United Kingdom; Scotland; Dundee,"May 28, 2020","September 2, 2020",Residual sera,Multiple groups,231,4.80%,,,Convenience,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,High,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,6/21/2021,6/21/2021,Unverified
210525_London_PublicHealthEngland_Week13_Euroimmun_Primary,"May 25, 2021",Local,The United Kingdom,The United Kingdom; England; London,"March 26, 2020","March 27, 2020",Blood donors,Multiple groups,757,2.30%,0.40%,4.30%,Convenience,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Journal Article (Peer-Reviewed),Gayatri Amirthalingam,Public Health England,https://dx.doi.org/10.3201/eid2707.203167,7/1/2021,8/4/2021,Unverified
210525_London_PublicHealthEngland_Week15/16_Euroimmun_Primary ,"May 25, 2021",Local,The United Kingdom,The United Kingdom; England; London,"April 9, 2020","April 13, 2020",Blood donors,Multiple groups,1085,11.00%,8.60%,13.60%,Convenience,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Journal Article (Peer-Reviewed),Gayatri Amirthalingam,Public Health England,https://dx.doi.org/10.3201/eid2707.203167,7/1/2021,8/4/2021,Unverified
210525_London_PublicHealthEngland_Week18_Euroimmun_Primary ,"May 25, 2021",Local,The United Kingdom,The United Kingdom; England; London,"May 1, 2020","May 3, 2020",Blood donors,Multiple groups,974,14.90%,12.10%,18.00%,Convenience,EUROIMMUN AG,ELISA,IgG,82.50%,99.10%,Moderate,Journal Article (Peer-Reviewed),Gayatri Amirthalingam,Public Health England,https://dx.doi.org/10.3201/eid2707.203167,7/1/2021,8/4/2021,Unverified
210626_Leicester_UniversityOfLeicester,"June 26, 2021",Local,The United Kingdom,The United Kingdom; East Midlands; Leicester,"March 16, 2020","June 3, 2020",Household and community samples,Multiple groups,1779,11.35%,,,Sequential,DiaSorin SpA,CLIA,IgG,97.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1002/jmv.27162,7/7/2021,7/7/2021,Unverified
210713_England_DepartmentofHealthandSocialCare,"July 13, 2021",Regional,The United Kingdom,The United Kingdom; England; NR,"May 26, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),1146310,16.30%,16.20%,16.40%,Convenience,NA,Multiple Types,"IgM,IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Cordelia Coltart,"Department of Health and Social
Care",https://dx.doi.org/10.1136/bmjopen-2021-049703,7/21/2021,8/4/2021,Unverified
210316_England_PublicHealthEngland_Round1_Students_Primary,"June 1, 2021",Regional,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 19, 2020",Students and Daycares,Children and Youth (0-17 years),816,11.20%,7.90%,15.10%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez N Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,7/22/2021,7/22/2021,Verified
210316_England_PublicHealthEngland_Round1_Staff_Primary,"June 1, 2021",Regional,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 19, 2020",Essential non-healthcare workers,Adults (18-64 years),1379,15.10%,11.90%,18.90%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shamez N Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,7/22/2021,7/22/2021,Verified
210622_London_LondonSchoolOfHygieneAndTropicalMedicine_HCWs,"June 22, 2021",Local,The United Kingdom,The United Kingdom; England; London,"May 4, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),615,40.70%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,CTK Biotech, Inc.,Zhejiang Orient Gene Biotech,VivaChek Biotech (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Admire Murongazvombo,London School Of Hygiene And Tropical Medicine,http://dx.doi.org/10.1016/j.infpip.2021.100157,7/28/2021,8/4/2021,Verified
210601_England_UniversityCollegeLondon_residents_primary,"June 1, 2021",Regional,The United Kingdom,The United Kingdom; England,"October 1, 2020","February 1, 2021",Assisted living and long-term care facilities,Seniors (65+ years),682,33.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,7/28/2021,7/28/2021,Unverified
210601_England_UniversityCollegeLondon_staff_primary,"June 1, 2021",Regional,The United Kingdom,The United Kingdom; England,"October 1, 2020","February 1, 2021",Health care workers and caregivers,Adults (18-64 years),1429,28.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,7/28/2021,7/28/2021,Unverified
210708_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_Adjusted,"July 8, 2021",,The United Kingdom,The United Kingdom; England; Sheffield,"May 15, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),1275,23.10%,14.10%,33.30%,Convenience,NA,ELISA,"IgG,IgA",99.47%,99.56%,High,Preprint,David Hodgson,Sheffield Teaching Hospitals NHS Foundation Trust,https://dx.doi.org/10.1101/2021.07.07.21260151,7/29/2021,8/4/2021,Unverified
210701_England_OfficeForNationalStatistics_StaffPrimary1_overall,"July 1, 2021",National,The United Kingdom,The United Kingdom; England,"May 5, 2021","May 21, 2021",Essential non-healthcare workers,Adults (18-64 years),1023,24.37%,19.75%,29.47%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round5englandmay2021,7/29/2021,7/29/2021,Unverified
210701_England_OfficeForNationalStatistics_StaffSecondary2_overall,"July 1, 2021",National,The United Kingdom,The United Kingdom; England,"May 5, 2021","May 21, 2021",Essential non-healthcare workers,Adults (18-64 years),1902,21.79%,19.42%,24.30%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round5englandmay2021,7/29/2021,7/29/2021,Unverified
210716_England_PublicHealthEngland,"July 16, 2021",National,The United Kingdom,"The United Kingdom; NR; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham. ","March 23, 2021","April 21, 2021",Students and Daycares,Multiple groups,1800,20.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Shamez Ladhani,Public Health England,10.1101/2021.07.14.21260496,7/31/2021,7/31/2021,Unverified
210727_UK_UniversityHospitalSouthampton_Primary,"July 27, 2021",National,The United Kingdom,The United Kingdom,"February 15, 2021","March 15, 2021",Blood donors,Children and Youth (0-17 years),478,9.80%,,,Self-referral,"NA,Roche Diagnostics,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Preprint,H Chappell,University Hospital Southampton,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893560,8/3/2021,8/4/2021,Unverified
210718_England_ImperialCollegeLondon_Round6,"July 18, 2021",National,The United Kingdom,The United Kingdom,"May 12, 2021","May 25, 2021",Household and community samples,Multiple groups,207337,61.10%,60.90%,61.40%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Preprint,Helen Ward,Imperial College London,10.1101/2021.07.14.21260497,8/4/2021,8/4/2021,Unverified
210706_London_LondonSchoolofHygiene&TropicalMedicine,"July 6, 2021",Local,The United Kingdom,The United Kingdom; England; London,"October 19, 2020","December 7, 2020",Household and community samples,Multiple groups,1242,64.30%,61.60%,67.00%,Simplified probability,NA,CLIA,IgG,96.20%,97.40%,Moderate,Journal Article (Peer-Reviewed),Katherine Gaskell,London School of Hygiene & Tropical Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/,8/4/2021,8/4/2021,Unverified
201214_UnitedKingdom_UniversityOfSouthamptonSchoolOfMedicine,"December 14, 2020",National,The United Kingdom,The United Kingdom,"May 13, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),135,13.00%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kordo Saeed,University of Southampton School of Medicine,https://dx.doi.org/10.1177/1757177420976798,8/4/2021,8/4/2021,Unverified
200704_Thailand_ChulalongkornUniversity_OverallAdj,"July 4, 2020",National,Thailand,Thailand,"April 8, 2020","June 26, 2020",Multiple populations,Adults (18-64 years),857,6.30%,,,Convenience,Baiya Phytopharm,LFIA,IgM,94.10%,98.00%,Moderate,Preprint,Tanawin Nopsopon,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2020.06.24.20139188v3,10/8/2020,8/4/2021,Verified
210401_Ranong_ChulalongkornUniversity,"April 1, 2021",Local,Thailand,Thailand; Ranong,"April 17, 2020","May 17, 2020",Health care workers and caregivers,Adults (18-64 years),844,0.80%,0.40%,1.70%,Convenience,Baiya Phytopharm,LFIA,"IgG,IgM",94.10%,98.00%,Moderate,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088,4/5/2021,6/17/2021,Unverified
210714_Thailand_MinistryOfPublicHealthThailand_Overall,"July 14, 2021",National,Thailand,"Thailand; Eastern, Western, Central Thailand","January 18, 2021","March 5, 2021",Health care workers and caregivers,Adults (18-64 years),600,0.20%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Wanitchaya Kittikraisak,"Ministry of Public Health, Thailand",https://dx.doi.org/10.1371/journal.pone.0254563,7/19/2021,8/4/2021,Unverified
210720_Bangkok_ChulalongkornUniversity,"July 20, 2021",Local,Thailand,Thailand,"August 15, 2020","January 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,210,0.95%,,,Unclear,Baiya Phytopharm,LFIA,"IgG,IgM",88.66%,90.63%,,Preprint,Amarin Narkwichean,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2021.07.16.21259725v1.full-text,8/4/2021,8/4/2021,Unverified
200807_Zurich_UniversityofZurich_USZCohort_MarchQDA,"August 7, 2020",Local,Switzerland,Switzerland; Zurich; Zurich,"March 15, 2020","March 31, 2020",Residual sera,Adults (18-64 years),3806,0.30%,0.10%,0.50%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/6/2021,Verified
200807_Zurich_UniversityofZurich_USZCohort_AprilQDA,"August 7, 2020",Local,Switzerland,Switzerland; Zurich; Zurich,"April 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),4275,1.40%,1.00%,1.70%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/6/2021,Verified
200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA,"August 7, 2020",Local,Switzerland,Switzerland; Zurich; Zurich,"May 15, 2020","July 15, 2020",Residual sera,Adults (18-64 years),12831,0.90%,,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/6/2021,Verified
200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA,"August 7, 2020",Local,Switzerland,Switzerland; Zurich; Zurich,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),1469,1.20%,0.70%,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/6/2021,Verified
200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA,"August 7, 2020",Local,Switzerland,Switzerland; Zurich; Zurich,"July 1, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1067,0.70%,0.30%,1.20%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/6/2021,Verified
201008_StGallen_CantonalHospitalStGallen_hcw,"October 8, 2020",Regional,Switzerland,Switzerland; St. Gallen; St. Gallen,"March 19, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),1012,0.99%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Sugentech, Inc.",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Phillipp Kohler,Cantonal Hospital St. Gallen,https://dx.doi.org/10.1017/ice.2020.1244,1/17/2021,8/4/2021,Verified
201108_Geneva_GenevaUniversityHospital_Overall,"November 8, 2020",Local,Switzerland,Switzerland,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),208,8.70%,,,Sequential,"EUROIMMUN AG,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Klara Posfay Barbe,Geneva University Hospital,https://dx.doi.org/10.1093/cid/ciaa1702,1/17/2021,8/4/2021,Verified
201104_Geneva_JohnHopkins_Overall,"January 16, 2021",Regional,Switzerland,Switzerland; Geneva,"April 3, 2020","June 30, 2020",Household and community samples,Multiple groups,4534,6.57%,6.00%,7.00%,Convenience,EUROIMMUN AG,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,Qifang Bi,Johns Hopkins Bloomberg School of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.04.20225573v2,1/18/2021,6/17/2021,Verified
201103_Vaud_UniversityofLausanne_GenPop1_Roche,"November 3, 2020",Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Household and community samples,Multiple groups,311,3.90%,,,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,7/16/2021,Verified
201103_Vaud_UniversityofLausanne_CloseContacts2_Roche,"November 3, 2020",Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,177,32.20%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,7/16/2021,Verified
201130_Vaud_ UniversityofLausanne_Household1_adj,"November 30, 2020",Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,302,57.20%,49.50%,64.30%,Simplified probability,NA,ELISA,IgG,96.70%,99.20%,Moderate,Preprint,Julien Dupraz,University of Lausanne,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,6/17/2021,Verified
201130_Vaud_ UniversityofLausanne_CloseContactsOutsideHousehold2_adj,"November 30, 2020",Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,69,19.00%,10.00%,33.20%,Simplified probability,NA,ELISA,IgG,96.70%,99.20%,Moderate,Preprint,Julien Dupraz,University of Lausanne,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,6/17/2021,Verified
201222_Zurich_UniversityofZurich_OverallAdj,"December 22, 2020",Regional,Switzerland,Switzerland; Zurich; Zurich,"June 16, 2020","November 19, 2020",Household and community samples,Children and Youth (0-17 years),2507,7.80%,6.20%,9.50%,Stratified probability,NA,ELISA,"IgG,IgM,IgA",94.30%,99.00%,Low,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.12.19.20248513v1,2/27/2021,7/6/2021,Verified
210201_Geneva_GenevaUniversityHospitals_overall_adj,"February 1, 2021",Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Multiple groups,4000,21.10%,19.20%,23.10%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,6/17/2021,Verified
201130_Fribourg_UniversitéDeFribourg_overall,"November 30, 2020",Regional,Switzerland,Switzerland; Canton of Fribourg,"July 8, 2020","October 14, 2020",Household and community samples,Multiple groups,418,8.00%,4.00%,12.00%,Simplified probability,NA,Not reported,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,Daniela Anker,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf,3/13/2021,7/6/2021,Verified
201218_Geneva_GenevaUniversityHospitals_overall_adj,"December 18, 2020",Regional,Switzerland,Switzerland; Canton of Geneva,"April 6, 2020","June 30, 2020",Household and community samples,Multiple groups,8344,7.80%,6.80%,8.90%,Stratified probability,EUROIMMUN AG,ELISA,IgG,93.00%,100.00%,Low,Preprint,Aude Richard,Geneva University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full.pdf,3/21/2021,8/5/2021,Verified
210419_Fribourg_UniversitédeFribourg_Overall,"April 1, 2021",Regional,Switzerland,Switzerland; Canton of Fribourg,"November 30, 2020","February 5, 2021",Household and community samples,Multiple groups,449,19.00%,15.00%,23.00%,Simplified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,Emna El May,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf,4/19/2021,8/4/2021,Unverified
210319_Geneva_GenevaUniversityHospitals_HospitalEmployees,"March 19, 2021",Local,Switzerland,Switzerland,"March 30, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),3421,7.90%,7.00%,8.80%,Convenience,"EUROIMMUN AG,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Romain Martischang,Geneva University Hospitals,https://dx.doi.org/10.1017/ice.2021.117,4/23/2021,8/4/2021,Unverified
200929_Ticino_InstituteofPublicHealth_primary,"September 29, 2020",Local,Switzerland,Switzerland,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),647,11.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Universita della Svizzera Italiana,The Institute of Public Health on the Università della Svizzera italiana,https://www.biomed.usi.ch/en/feeds/8913,4/23/2021,6/17/2021,Verified
210402_Switzerland_UniversitàdellaSvizzeraItaliana_overall,"April 2, 2021",Regional,Switzerland,Switzerland; Southern Switzerland ,"July 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),301,3.30%,,,Sequential,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elena Giuliano,Università della Svizzera Italiana,https://dx.doi.org/10.1136/bmjmilitary-2021-001828,4/24/2021,8/5/2021,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall,"March 31, 2021",Regional,Switzerland,Switzerland; Canton of Neuchâtel ,"August 21, 2020","October 29, 2020",Household and community samples,Multiple groups,381,4.90%,2.38%,8.14%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/27/2021,8/4/2021,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII,"March 31, 2021",Regional,Switzerland,Switzerland; Canton of Neuchâtel ,"December 23, 2020","March 17, 2021",Household and community samples,Multiple groups,559,22.00%,17.90%,26.30%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/27/2021,8/4/2021,Verified
20210226_Zurich_UniversityofZurich_carehomeworkers,"February 26, 2021",Regional,Switzerland,Switzerland; Canton of Zurich,"September 9, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),296,14.90%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,5/10/2021,7/7/2021,Unverified
20210226_Zurich_UniversityofZurich_spitexworkers,"February 26, 2021",Regional,Switzerland,Switzerland; Canton of Zurich,"September 9, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),131,3.80%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,5/10/2021,7/7/2021,Unverified
210203_Ticino_UniversitàdellaSvizzeraitaliana_primary,"February 3, 2021",Regional,Switzerland,Switzerland; Ticino,"November 1, 2020","January 13, 2021",Household and community samples,Multiple groups,1463,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Institute of Public Health of the Universita della Svizzera italiana,Università della Svizzera italiana,https://www.biomed.usi.ch/it/feeds/9035,5/18/2021,6/18/2021,Verified
210320_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth,"March 20, 2021",Local,Switzerland,Switzerland; NR; Geneva,"April 15, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),187,12.30%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",99.80%,99.60%,Moderate,Preprint,Javier Perez Saez,Johns Hopkins Bloomberg School of Public Health,https://www.medrxiv.org/content/10.1101/2021.03.16.21253710v1,5/18/2021,6/17/2021,Unverified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana_HCW,"April 12, 2021",Local,Switzerland,Switzerland; Grisons; NR,"May 15, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),289,15.90%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,5/19/2021,6/17/2021,Unverified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana__Genpop,"April 12, 2021",Local,Switzerland,Switzerland; Grisons; NR,"May 15, 2020","May 31, 2020",Household and community samples,Multiple groups,423,2.60%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,5/19/2021,6/17/2021,Unverified
210521_Zurich_UniversityofZurich_overall,"May 21, 2021",Local,Switzerland,Switzerland,"June 15, 2020","April 15, 2021",Students and Daycares,Children and Youth (0-17 years),1355,8.04%,,,Simplified probability,NA,Not reported,"IgG,IgM,IgA",94.30%,99.00%,Moderate,Preprint,Thomas Radtke,University of Zurich,https://www.medrxiv.org/content/10.1101/2021.05.16.21257255v2,6/6/2021,8/4/2021,Unverified
210612_Switzerland_CantonalHospitalStGallen_overall,"June 12, 2021",National,Switzerland,Switzerland,"June 22, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),4818,3.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Preprint,Philipp Kohler,Cantonal Hospital St-Gallen,https://doi.org/10.1101/2021.06.09.21258422,6/21/2021,7/17/2021,Unverified
210608_Geneva_UniversityOfGeneva_overall,"June 8, 2021",Regional,Switzerland,Switzerland; Canton of Geneva,"May 18, 2020","September 18, 2020",Essential non-healthcare workers,Adults (18-64 years),10513,9.80%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Silvia Stringhini,The University of Geneva,http://dx.doi.org/10.1038/s41467-021-23796-4,6/30/2021,6/30/2021,Unverified
210621_Geneva_GenevaUniversityHospitals_overall,"June 21, 2021",Local,Switzerland,Switzerland,"June 1, 2020","June 30, 2020",Residual sera,Multiple groups,1167,5.90%,4.70%,7.40%,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Stephanie Baggio,Geneva University Hospitals,http://dx.doi.org/10.1016/j.ypmed.2021.106696,7/7/2021,7/7/2021,Unverified
201207_Ticino_UniversitaDellaSvizzeraItaliana,"December 17, 2020",Regional,Switzerland,Switzerland; Canton of Ticino,"April 16, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,4726,9.60%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Luca Piccoli,Università della Svizzera italiana,https://dx.doi.org/10.1016/j.lanepe.2020.100013,7/7/2021,7/7/2021,Unverified
210705_Lausanne_UniversityOfLausanne_Overall,"July 5, 2021",Local,Switzerland,Switzerland,"May 18, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,1874,10.00%,8.70%,11.50%,Stratified non-probability,NA,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Sylvain Meylan,Lausanne University Hospital and University of Lausanne,https://dx.doi.org/10.1136/bmjopen-2021-049232,7/13/2021,8/4/2021,Unverified
210719_Zurich_UniversityofZurich_T3_overallTestPopAdj,"July 19, 2021",Local,Switzerland,Switzerland; NR; Zurich,"March 15, 2021","April 16, 2021",Students and Daycares,Children and Youth (0-17 years),2450,16.40%,12.10%,19.50%,Simplified probability,NA,Other,"IgG,IgM,IgA",98.20%,99.40%,Low,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2021.07.19.21260644v1.full-text,7/29/2021,8/4/2021,Unverified
210728_Grisons_KantonsspitalGraubunden_followup_HCW,"July 28, 2021",Regional,Switzerland,"Switzerland; Grisons
","January 4, 2021","February 19, 2021",Health care workers and caregivers,Multiple groups,2315,16.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,High,Preprint,Katarzyna Szajek,Kantonsspital Graubunden,10.21203/rs.3.rs-722792/v1,8/3/2021,8/3/2021,Unverified
200702_Stockhom_KTHRoyalInstituteofTechnology_genpop,"July 2, 2020",Local,Sweden,Sweden; Uppland; Stockholm,"April 1, 2020","May 21, 2020",Household and community samples,Multiple groups,878,5.40%,,,Simplified probability,NA,ELISA,"IgG,IgM",100.00%,100.00%,Moderate,Preprint,Niclas Roxhed,KTH Royal Institute of Technology,https://www.medrxiv.org/content/10.1101/2020.07.01.20143966v1,7/14/2020,7/6/2021,Verified
200720_Uppsala_UppsalaUniversity_Total,"July 20, 2020",Regional,Sweden,Sweden; Uppsala,"May 27, 2020","June 25, 2020",Health care workers and caregivers,Multiple groups,8679,6.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna-Karin Lidstrom,Uppsala University ,https://dx.doi.org/10.1080/03009734.2020.1793039,8/1/2020,8/5/2021,Verified
200723_Sweden_Werlabs_GenPop,"July 23, 2020",Local,Sweden,"Sweden; Skåne, Västra Götaland, Uppland; Stockholm, Gothenburg, Malmo","July 1, 2020","July 22, 2020",Household and community samples,Not reported,83000,14.40%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Local,Werlabs,https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ,8/2/2020,6/17/2021,Verified
200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,"August 5, 2020",Local,Sweden,Sweden,"April 1, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),1005,22.90%,20.40%,25.70%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Johanna Lindahl,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1789036,10/14/2020,6/17/2021,Verified
200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,"August 11, 2020",Local,Sweden,"Sweden; Södermanland, Uppland; Stockholm","June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),123,4.10%,0.60%,7.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,6/17/2021,Verified
200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,"August 11, 2020",Local,Sweden,"Sweden; Södermanland, Uppland; Stockholm","June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),90,30.00%,20.30%,39.70%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","April 20, 2020","April 26, 2020",Residual sera,Multiple groups,1200,5.30%,3.80%,7.10%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/24/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","April 27, 2020","May 3, 2020",Residual sera,Multiple groups,1200,4.00%,2.71%,5.67%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 4, 2020","May 10, 2020",Residual sera,Multiple groups,1200,3.90%,2.61%,5.42%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 11, 2020","May 17, 2020",Residual sera,Multiple groups,1200,4.50%,3.07%,6.15%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 18, 2020","May 24, 2020",Residual sera,Multiple groups,1200,5.20%,3.67%,7.00%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 25, 2020","May 31, 2020",Residual sera,Multiple groups,1200,5.70%,3.98%,7.72%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","June 1, 2020","June 7, 2020",Residual sera,Multiple groups,1200,6.80%,5.07%,8.80%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall,"June 18, 2020",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","June 8, 2020","June 14, 2020",Residual sera,Multiple groups,1200,5.20%,3.74%,7.06%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,6/17/2021,Verified
200716_Stockholm_RegionStockholm,"July 16, 2020",Local,Sweden,Sweden; Uppland; Stockholm,"June 15, 2020","July 15, 2020",Household and community samples,Multiple groups,149616,17.60%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,Stockholm Region,Sweden Public Health Authority,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,10/25/2020,6/24/2021,Verified
201008_Stockholm_DanderydHospital,"October 8, 2020",Local,Sweden,Sweden; Sodermanland; Stockholm,"April 14, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),2149,19.10%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ann Sofie Rudberg,Danderyd Hospital,http://dx.doi.org/10.1038/s41467-020-18848-0,12/10/2020,7/6/2021,Verified
201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary,"December 22, 2020",Local,Sweden,Sweden,"May 11, 2020","June 17, 2020",Assisted living and long-term care facilities,Multiple groups,403,20.10%,,,Convenience,NA,CLIA,IgG,99.20%,99.80%,High,Preprint,Sadaf Sakina Hassan,Karolinska University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1,2/2/2021,8/4/2021,Verified
210129_Stockholm_KarolinskaInstitutet_HCW,"January 29, 2021",Local,Sweden,Sweden; Uppland; Stockholm,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),3981,17.70%,,,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,Preprint,Susanna Klevebro,Karolinska Institutet,https://doi.org/10.1101/2021.01.28.21250664,2/21/2021,6/17/2021,Verified
201124_Vasteras_HospitalofVastmanland_HCW,"November 24, 2020",Local,Sweden,Sweden,"May 4, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),131,19.08%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Mulki Rashid Abdi,The Hospital of Vastmanland ,https://dx.doi.org/10.1080/23744235.2020.1849787,2/23/2021,6/17/2021,Verified
210121_Sweden_CopenhagenUniversityHospital_Sweden,"January 21, 2021",National,Sweden,Sweden,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),1248,8.30%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co., Ltd,Guangzhou Wondfo Biotech Co.， Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,8/4/2021,Verified
210309_SkåneRegion_LundUniversity_UniversityEmployees,"March 9, 2021",Local,Sweden,Sweden; Skåne Region; Lund,"September 8, 2020","November 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),192,6.00%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/1/2021,7/8/2021,Verified
210309_SkåneRegion_LundUniversity_HCWs,"March 9, 2021",Local,Sweden,Sweden; Skåne Region,"September 8, 2020","November 10, 2020",Health care workers and caregivers,Adults (18-64 years),271,5.90%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/1/2021,7/8/2021,Verified
210304_Stockholm_KarolinskaUniversityHospital_Overall,"March 4, 2021, April 4, 2021",Local,Sweden,Sweden,"April 23, 2020","May 22, 2020",Health care workers and caregivers,Adults (18-64 years),12928,11.50%,10.90%,11.80%,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,"Journal Article (Peer-Reviewed), Preprint","Joakim Dillner, Klara Miriam Elfstrom",Karolinska University Hospital,"https://dx.doi.org/10.1038/s41598-021-84356-w, https://www.medrxiv.org/content/10.1101/2021.03.30.21254653v1",4/18/2021,8/4/2021,Verified
210412_Stockholm_KarolinskaInstitutet_hcw,"April 20, 2021",Local,Sweden,Sweden; Södermanland and Uppland; Stockholm,"May 11, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),403,20.10%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),S Hassan,Karolinska Institutet,https://dx.doi.org/10.1111/joim.13274,5/3/2021,7/8/2021,Unverified
210317_Sweden_TheSwedishPublicHealthAgency_BloodDonors_overall,"March 17, 2021",National,Sweden,"Sweden; Regions of: Jämtland-Härjedalen, Jönköping, Kalmar,
Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro","November 23, 2020","December 4, 2020",Blood donors,Multiple groups,3183,7.00%,5.75%,8.48%,Unclear,Sci LifeLab / KTH,ELISA,Not reported,99.40%,98.90%,Moderate,Institutional Report,The Swedish Public Health Agency,The Swedish Public Health Agency (Folkhälsomyndigheten),https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,5/3/2021,8/4/2021,Unverified
210305_Stockholm_Västerås_primary,"March 5, 2021",Local,Sweden,Sweden,"June 4, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),70,4.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elisabet Granstam,Västerås,https://bmjophth.bmj.com/content/6/1/e000616,5/20/2021,7/8/2021,Verified
200617_Norbotten_UmeaUniversity_overall,"June 17, 2020",Regional,Sweden,"Sweden; Norbotten; Piteå, Luleå/Boden, Gällivare, Kalix, Kiruna","May 25, 2020","June 5, 2020",Household and community samples,Multiple groups,425,1.90%,0.80%,3.70%,Simplified probability,"Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Institutional Report,Mats Eliasson,Umea University,https://web.archive.org/web/20200623000020/https://www.norrbotten.se/publika/lg/kom/Corona/Rapport%20-%20förekomst%20av%20antikroppar/Förekomst%20av%20antikroppar%20mot%20covid-19%20i%20Norrbottens%20befolkning%20maj%202020%20-%20Region%20Norrbotten%20rapport%20200618.pdf,5/21/2021,8/4/2021,Verified
210518_Stockholm_KarolinskaInstitutet,"May 18, 2021",Local,Sweden,Sweden; Uppland; Stockholm,"March 14, 2020","February 28, 2021",Multiple general populations,Adults (18-64 years),5100,19.20%,15.10%,24.40%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Xaquin Castro Dopico,Karolinska Institutet,https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13304,5/28/2021,7/6/2021,Unverified
210507_Stockholm_KarolinskaUniversityHospital,"May 7, 2021",Local,Sweden,Sweden; Uppland; Stockholm,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),839,12.00%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Preprint,Maria Froberg,Karolinska University Hospital,https://www.researchsquare.com/article/rs-493146/v1,5/29/2021,6/17/2021,Unverified
210511_SkåneUniversityHospital_LundUniversity_HCW,"May 11, 2021",Local,Sweden,Sweden,"August 1, 2020","August 22, 2020",Health care workers and caregivers,Adults (18-64 years),107,35.50%,,,Convenience,ZetaGene Ltd.,LFIA,"IgG,IgM",95.00%,97.00%,High,Journal Article (Peer-Reviewed),Rasmus Strand,Lund University,https://dx.doi.org/10.1080/23744235.2021.1925739,5/31/2021,6/17/2021,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_9_Week42-43_Overall,"April 27, 2021",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","October 12, 2020","October 23, 2020",Residual sera,Multiple groups,4500,6.70%,5.67%,7.79%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,6/17/2021,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_11_Week9-10_2021_Overall,"April 27, 2021",National,Sweden,"Sweden; Jönköping, Kalmar, Skåne,Stockholm, Uppsala, Västerbotten, Västra Götaland, Örebo","March 1, 2021","March 12, 2021",Residual sera,Multiple groups,4749,20.70%,19.41%,22.08%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,6/17/2021,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_10_Week48-49_Overall,"April 27, 2021",National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","November 23, 2020","December 4, 2020",Residual sera,Multiple groups,4500,7.90%,6.79%,9.19%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,6/17/2021,Unverified
210618_Sweden_PublicHealthAgencyOfSweden,"June 18, 2021",National,Sweden,Sweden,"October 30, 2020","December 8, 2020",Household and community samples,Not reported,324,8.60%,,,Convenience,NA,Not reported,IgG,99.70%,100.00%,High,Preprint,Thomas Akerlund,Public Health Agency of Sweden,10.1101/2021.06.16.21258960,6/30/2021,7/6/2021,Unverified
210617_Stockholm_KTHRoyalInstituteofTechnology,"June 17, 2021",Local,Sweden,Sweden,"April 15, 2020","May 15, 2020",Household and community samples,Multiple groups,887,12.50%,10.30%,14.70%,Simplified probability,NA,Other,"IgG,IgM",100.00%,96.00%,Moderate,Journal Article (Peer-Reviewed),Niclas Roxhed,KTH Royal Institute of Technology,https://dx.doi.org/10.1038/s41467-021-23893-4,7/6/2021,8/4/2021,Unverified
200720_Sweden_TheSwedishPublicHealthAgency_Primary,"July 20, 2021",National,Sweden,Sweden,"April 26, 2021","May 9, 2021",Blood donors,Multiple groups,2860,32.80%,30.60%,35.10%,Self-referral,NA,ELISA,IgG,,,Moderate,Institutional Report,Public Health Agency of Sweden,The Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/45eafde72689438a8a21efa93a5591a4/forekomsten-antikroppar-mot-sars-cov-2.pdf,7/28/2021,7/28/2021,Unverified
201023_Khartoum_FederalMinistryofHealthSudan,"October 23, 2020",Regional,Sudan,Sudan; Khartoum,"May 22, 2020","July 5, 2020",Household and community samples,Multiple groups,967,18.30%,,,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,William McCollum,Federal Ministry of Health (MOH) in Sudan,https://www.tephinet.org/sudan-fetp-conducts-targeted-testing-for-covid-19-in-khartoum-state,5/3/2021,6/17/2021,Verified
210623_Colombo_UniversityOfSriJayewardenepura,"June 23, 2021",Local,Sri Lanka,Sri Lanka; Western Province; Colombo,"January 1, 2021","January 31, 2021",Household and community samples,Multiple groups,2547,24.46%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,100.00%,Moderate,Preprint,Chandima Jeewandara,University of Sri Jayewardenepura,10.1101/2021.06.18.21259143,7/5/2021,7/7/2021,Unverified
200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,"June 16, 2020",Local,Spain,Spain; Community of Madrid; Madrid,"April 26, 2020","May 16, 2020",Multiple populations,Multiple groups,674,13.80%,,,Sequential,PCL Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Soriano, Universidad Autónoma de Madrid,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269,6/18/2020,8/4/2021,Verified
200606_Leon_UniversidadedeLeon_HCWs_TestAdj2,"June 6, 2020",Local,Spain,Spain; Léon; Léon,"April 1, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),676,7.40%,5.50%,10.00%,Convenience,"Hanghzhou AllTest Biotech Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Martin,"Gerencia de Atención Primaria del Área de Salud de León, Spain",https://dx.doi.org/10.1016/j.semerg.2020.05.014,7/30/2020,6/17/2021,Verified
200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM,"August 6, 2020",Local,Spain,Spain; Valencia; Valencia,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1153,3.50%,,,Unclear,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Arantxa Valdivia,Hospital Clínico Universitario,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400,9/27/2020,6/17/2021,Verified
200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,"August 10, 2020",Local,Spain,Spain,"April 15, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),498,2.20%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Julian Olalla, Hospital Costa del Sol ,http://dx.doi.org/10.1093/qjmed/hcaa238,10/3/2020,6/24/2021,Verified
200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM,"June 17, 2020",Local,Spain,Spain,"May 29, 2020","June 3, 2020",Household and community samples,Multiple groups,104299,23.07%,,,Entire sample,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Daniel Flores,Municipality of Torrejon de Ardoz,https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml,10/8/2020,6/17/2021,Verified
200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj,"August 31, 2020",Local,Spain,Spain; Community of Madrid; Torrejon de Ardoz,"June 1, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,31.40%,,,Convenience,"Hangzhou Testsea Biotechnology Co., Ltd",Not reported,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Luis Cabezon-Gutierrez,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.1016/j.ctrv.2020.102102,10/20/2020,6/17/2021,Verified
200918_Madrid_UniversityHospitalGregorioMarañón_Overall,"September 18, 2020",Local,Spain,Spain,"May 6, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),100,13.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Vinuela,University Hospital Gregorio Marañón,http://dx.doi.org/10.37201/req/088.2020,11/12/2020,6/17/2021,Verified
200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall,"August 6, 2020",Local,Spain,Spain,"April 14, 2020","May 5, 2020",Pregnant or parturient women,Adults (18-64 years),874,14.00%,,,Convenience,"Vircell S.L.,Ortho Clinical Diagnostics Inc.",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext,1/3/2021,8/4/2021,Verified
200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall,"September 11, 2020",Local,Spain,Spain; Galicia; Santiago de Compostela,"April 14, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),175,4.00%,1.10%,6.90%,Convenience,Genobio Pharmaceutical (Shanghai China),Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ana Dacosta Urbieta,Hospital Clinico Universitario de Santiago de Compostela,http://dx.doi.org/10.3389/fped.2020.00547,1/5/2021,8/4/2021,Verified
201021_Spain_IVIRMA_Overall,"September 1, 2020",National,Spain,Spain,"April 27, 2020","June 26, 2020",Residual sera,Adults (18-64 years),6140,0.68%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgM,,,Unclear,Journal Article (Peer-Reviewed),Nicolas Prados,IVIRMA Global Headquarters,http://dx.doi.org/10.1016/j.fertnstert.2020.09.077,1/8/2021,6/17/2021,Verified
200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall,"September 11, 2020",Local,Spain,Spain; Catalonia; Barcelona,"April 21, 2020","April 24, 2020",Household and community samples,Multiple groups,311,5.47%,3.44%,8.58%,Stratified probability,"Zhuhai Livzon Diagnostics Inc,SureScreen Diagnostics,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Patricia Montenegro, Sardenya Primary Health Care Center,http://dx.doi.org/10.1093/fampra/cmaa096,1/8/2021,8/4/2021,Verified
201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall,"October 29, 2020",Local,Spain,Spain,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,"Hanghzhou AllTest Biotech Co., Ltd",LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia ,Hospital Universitario Príncipe de Asturias,https://dx.doi.org/10.1017/ice.2020.1303,1/8/2021,6/17/2021,Verified
201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest,"November 12, 2020",Local,Spain,Spain; Catalonia; Barcelona,"April 28, 2020","June 3, 2020",Contacts of COVID patients,Multiple groups,1084,17.99%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",83.30%,,Moderate,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu,https://dx.doi.org/10.1093/cid/ciaa1721,1/23/2021,6/17/2021,Verified
201125_Valencia_HospitalArnauDeVilanova_Overall,"November 25, 2020",Local,Spain,Spain; Valencia; Valencia,"May 2, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,166,1.80%,,,Sequential,DiaSorin SpA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Javier Garde Noguera,"Hospital Arnau de Vilanova de Valencia, Spain",https://dx.doi.org/10.3390/cancers12123513,1/23/2021,8/4/2021,Verified
201130_Spain_UniversityofZaragoza_unadj,"November 30, 2020",Local,Spain,Spain,"March 31, 2020","August 31, 2020",Pregnant or parturient women,Adults (18-64 years),260,6.92%,,,Sequential,"Biozek,Abbott Laboratories,Vircell S.L.",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,University of Zaragoza,https://dx.doi.org/10.1016/j.ejogrb.2020.11.069,1/23/2021,8/4/2021,Verified
201026_Zaragoza_HospitalSanJuandeDios_HCW_primary,"November 13, 2020",Local,Spain,Spain; Aragon; Zaragoza,"March 20, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),289,5.88%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,7/6/2021,Verified
201026_Zaragoza_HospitalSanJuandeDios_patients_primary,"November 13, 2020",Local,Spain,Spain; Aragon; Zaragoza,"March 20, 2020","April 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,6.99%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,7/6/2021,Verified
201014_Alicante_COVID-19GroupoftheInfectionsCommission,"October 14, 2020",Local,Spain,Spain; Alacant; Alicante,"April 24, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),4179,6.60%,5.80%,7.30%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Paula Gras-Valenti,COVID-19 Group of the Infections Commission,https://dx.doi.org/10.1016/j.eimc.2020.09.015,1/29/2021,6/17/2021,Verified
201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary,"December 28, 2020",Local,Spain,Spain,"May 4, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,7563,10.30%,,,Self-referral,"DiaSorin SpA,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jaume Barallat,Institut Català de la Salut,https://dx.doi.org/10.1371/journal.pone.0244348,1/30/2021,8/4/2021,Verified
201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary,"December 2, 2020",Local,Spain,Spain; Canary Islands; Tenerife,"April 27, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,211,1.90%,0.07%,4.80%,Sequential,"NA,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alejandro Hernandez Camba, Quironsalud Tenerife Hospital,https://dx.doi.org/10.17235/reed.2020.7434/2020,1/31/2021,8/4/2021,Verified
201130_Madrid_UniversidadComplutensedeMadrid_primary,"November 30, 2020",Local,Spain,Spain,"February 28, 2020","May 10, 2020",Pregnant or parturient women,Adults (18-64 years),769,11.20%,,,Sequential,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Cecilia Villalaın,The Universidad Complutense de Madrid,https://dx.doi.org/10.1371/journal.pone.0243029,1/31/2021,7/7/2021,Verified
210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG,"January 14, 2021",Local,Spain,Spain,"April 14, 2020","May 13, 2020",Health care workers and caregivers,Adults (18-64 years),2439,16.90%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Javier Fernandez,Hospital Universitario de Fuenlabrada,https://dx.doi.org/10.1371/journal.pone.0245001,2/4/2021,6/17/2021,Verified
210112_Spain_HMHospitales_overall,"January 12, 2021",National,Spain,Spain,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,6038,11.00%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,IgG,91.21%,97.66%,Moderate,Journal Article (Peer-Reviewed),Jose F Varona,HM Hospidales,https://dx.doi.org/10.1093/ije/dyaa277,2/6/2021,6/17/2021,Unverified
201221_Spain_HospitalClínicoUniversitarioLozanoBlesa,"December 21, 2020",Local,Spain,Spain; Zaragoza; Zaragoza,"April 27, 2020","May 29, 2020",Pregnant or parturient women,Adults (18-64 years),169,8.28%,,,Sequential,"Guangzhou Wondfo Biotech Co., Ltd,Abbott Laboratories,Vircell S.L.",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Fabre,Hospital Clínico Universitario Lozano Blesa,https://dx.doi.org/10.1177/0004563220980495,2/7/2021,8/4/2021,Verified
210127_Madrid_UH-FundacionJimenezDiazUAM_primary,"January 27, 2021",Local,Spain,Spain; Community of Madrid; Madrid,"March 1, 2020","March 30, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,28,42.90%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Soledad Pizarro Sanchez,UH-Fundacion Jimenez Diaz UAM,https://dx.doi.org/10.1159/000512535,2/27/2021,8/4/2021,Verified
210209_Madrid_HospitalUniversitarioVirgendelRocio,"February 9, 2021",Local,Spain,Spain; Community of Madrid; Madrid,"March 15, 2020","May 15, 2020",Contacts of COVID patients,Children and Youth (0-17 years),113,41.60%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ana Mendez Echevarria,Hospital Universitario Virgen del Rocio,https://dx.doi.org/10.1097/INF.0000000000003088,3/11/2021,6/17/2021,Verified
210119_Madrid_HospitalInfantilUniversitarioNiñoJesús,"January 19, 2021",Local,Spain,Spain; Community of Madrid; Madrid,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1292,17.20%,15.16%,19.35%,Convenience,"Hanghzhou AllTest Biotech Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eva Escribano Ceruelo,Hospital Infantil Universitario Niño Jesús,https://dx.doi.org/10.1016/j.eimc.2020.12.011,3/16/2021,6/17/2021,Verified
210318_Barcelona_UniversitatDeBarcelona_overall,"February 8, 2021",Local,Spain,Spain,"March 15, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),2225,14.10%,,,Sequential,"Vircell S.L.,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://dx.doi.org/10.1093/cid/ciab104,3/18/2021,8/4/2021,Unverified
201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall,"December 18, 2020",Local,Spain,Spain,"April 14, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),2590,31.60%,,,Convenience,Palex,ELISA,IgG,88.90%,91.80%,High,Journal Article (Peer-Reviewed),Isabel Galan,Hospital Universitario Fundación Alcorcón,https://dx.doi.org/10.1016/j.eimc.2020.11.015,3/24/2021,6/17/2021,Verified
210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj,"February 16, 2021",Local,Spain,Spain; Alicante; Alicante,"July 6, 2020","July 22, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1479,2.89%,2.06%,3.73%,Stratified probability,Cellex Inc.,LFIA,"IgG,IgM",87.80%,99.90%,Moderate,Journal Article (Peer-Reviewed),Jose Tuells,University of Alicante,http://dx.doi.org/10.3390/ijerph18041908,3/27/2021,7/6/2021,Verified
210223_Barcelona_UniversitatDeBarcelona_primary,"February 23, 2021",Local,Spain,Spain,"September 29, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),507,16.40%,13.30%,19.90%,Simplified probability,NA,ELISA,"IgA,IgG,IgM",95.78%,100.00%,Moderate,Preprint,Natalia Ortega,Universitat de Barcelona ,https://www.medrxiv.org/content/10.1101/2021.02.22.21252150v1,3/31/2021,8/4/2021,Verified
210226_Mallorca_SonLlatzerUniversityHospital_overall,"February 26, 2021",Local,Spain,Spain,"April 28, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),2210,2.80%,2.50%,3.10%,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",96.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Adrian Rodriguez,Son Llatzer University Hospital,https://dx.doi.org/10.1016/j.ijid.2021.02.104,4/2/2021,6/17/2021,Verified
210312_Spain_ InstitutoDeSalud CarlosIII_overall_Abbott,"March 12, 2021",National,Spain,Spain,"November 16, 2020","November 29, 2020",Household and community samples,Multiple groups,5827,4.90%,,,Stratified probability,Abbott Laboratories,CLIA,IgG,99.60%,100.00%,Low,Preprint,Mayte Perez Olmeda, Instituto de Salud Carlos III,https://www.medrxiv.org/content/10.1101/2021.03.11.21253142v1,4/3/2021,7/7/2021,Unverified
210316_Spain_HospitalUniversitarioPuertadeHierro_LymphomaPatients,"March 16, 2021",National,Spain,Spain,"May 22, 2020","June 11, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,150,6.00%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fernando Franco,Hospital Universitario Puerta de Hierro,https://dx.doi.org/10.3390/curroncol28020118,4/23/2021,7/7/2021,Unverified
210401_Madrid_HospitalUniversitarioRamonyCajal_HCW,"April 1, 2021",Local,Spain,Spain,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),5875,23.10%,22.10%,24.30%,Convenience,"Hanghzhou AllTest Biotech Co., Ltd,Vircell S.L.",ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Mario Rodriguez Dominguez,Hospital Universitario Ramon y Cajal,https://dx.doi.org/10.1016/j.cmi.2021.03.018,4/25/2021,8/4/2021,Unverified
200828_CendeadeCizur_ISGlobal_primary,"August 28, 2020",Local,Spain,Spain; Navarra; Cendea de Cizur,"June 1, 2020","June 30, 2020",Household and community samples,Multiple groups,728,7.90%,,,Unclear,NA,Not reported,"IgA,IgG,IgM",,,Unclear,News and Media,Barcelona Institute for Global Health,ISGlobla,https://www.isglobal.org/en_GB/-/coronavirus-nuevos-datos-de-seroprevalencia-para-un-municipio-en-navarra,4/30/2021,6/17/2021,Verified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_firstwave_primary,"April 1, 2021",Local,Spain,Spain,"March 15, 2020","June 30, 2020",Residual sera,Multiple groups,968,12.60%,,,Sequential,PCL Inc,Not reported,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,5/18/2021,8/4/2021,Unverified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_secondwave_primary,"April 1, 2021",Local,Spain,Spain,"September 15, 2020","December 24, 2020",Residual sera,Multiple groups,601,7.70%,,,Sequential,PCL Inc,Not reported,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,5/18/2021,7/7/2021,Unverified
210324_Seville_HospitalUniversitarioVirgendeValme_HIV,"March 24, 2021",Local,Spain,Spain; Andalusia; Seville,"February 9, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,691,2.60%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Preprint,Marta Fernandez Fuertes,Hospital Universitario Virgen de Valme,https://doi.org/10.1101/2021.03.20.21253397,5/21/2021,8/4/2021,Verified
210105_CastillaYLeon_CentroDeHemoterapiaYHemodonación,"May 1, 2021",National,Spain,Spain; Castilla y Leon,"July 15, 2019","October 15, 2020",Blood donors,Multiple groups,12719,6.73%,,,Simplified probability,Roche Diagnostics,ELISA,"IgA,IgG,IgM",,,Moderate,Preprint,Carmen Martin,Centro de Hemoterapia y Hemodonación de Castilla y León,https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1,5/21/2021,8/4/2021,Unverified
210301_Madrid_HospitalUniversitarioLaPaz_primary,"March 1, 2021",Local,Spain,Spain,"March 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),105,5.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),G Santos Simarro,Hospital Universitario La Paz,http://dx.doi.org/10.1097/01.pcc.0000741352.50491.98,5/22/2021,7/8/2021,Verified
210507_Salamanca_UniversityofSalamanca,"May 7, 2021",Local,Spain,Spain; Province of Salamanca; Salamanca,"July 15, 2020","October 15, 2020",Non-essential workers and unemployed persons,Multiple groups,8197,8.25%,,,Convenience,DiaSorin SpA,ELISA,"IgG,IgM",,,High,Preprint,Vicente Santiago Belen,University of Salamanca,https://www.researchsquare.com/article/rs-489321/v1,5/22/2021,8/4/2021,Unverified
210415_MadridZaragoza_GeneralUniversityHospital_pregnant,"April 15, 2021",Local,Spain,Spain; NA & Zaragoza; Madrid & Zaragoza,"March 31, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),1211,5.04%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,General University Hospital,http://dx.doi.org/10.1016/j.lfs.2021.119200,5/23/2021,8/4/2021,Unverified
210420_Barcelona_CIBERESP,"April 20, 2021",Local,Spain,Spain,"June 29, 2020","July 31, 2020",Students and Daycares,Multiple groups,1518,3.22%,,,Convenience,NA,Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Carlota Dobano,Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Públic,10.1101/2021.04.20.440593,5/23/2021,8/4/2021,Unverified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareResidents1,"May 4, 2021",Local,Spain,Spain,"July 7, 2020","October 23, 2020",Assisted living and long-term care facilities,Seniors (65+ years),9332,55.40%,54.40%,56.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Javier Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,5/28/2021,6/17/2021,Unverified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareWorkers2,"May 4, 2021",Local,Spain,Spain,"July 7, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),10614,31.50%,30.60%,32.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Javier Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,5/28/2021,6/17/2021,Unverified
210514_Madrid_HospitalUniversitarioLaPaz,"May 14, 2021",Local,Spain,Spain; Madrid; Madrid,"September 1, 2020","February 28, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),105,20.00%,,,Convenience,NA,CLIA,IgG,,,High,Preprint,Clara Udaondo ,Hospital Universitario La Paz,10.21203/rs.3.rs-505561/v1,5/28/2021,6/17/2021,Unverified
210510_Cantabria_UniversityofCantabria,"May 10, 2021",Regional,Spain,Spain,"April 27, 2020","May 29, 2020",Household and community samples,Multiple groups,1022,3.10%,2.20%,4.40%,Stratified probability,"Hangzhou Clongene Biotech Co., Ltd ",Other,IgG,97.40%,98.89%,Low,Journal Article (Peer-Reviewed),Paula Iruzubieta,University of Cantabria,https://dx.doi.org/10.1038/s41598-021-89236-x,5/31/2021,7/8/2021,Unverified
210428_ComunidaddeMadrid_SorbonneUniversité_5,"April 28, 2021",Regional,Spain,Spain; Comunidad de Madrid,"July 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,524,13.40%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/31/2021,8/4/2021,Unverified
210406_Spain_HospitalSantJoanDeDéu_overall,"April 6, 2021",Local,Spain,Spain,"May 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),65,6.15%,,,Unclear,NA,Not reported,"IgG,IgM,IgA",,,Unclear,Presentation or Conference,Angela Deya-Martinez,Hospital Sant Joan de Déu,http://dx.doi.org/10.1007/s10875-021-01001-x,5/31/2021,7/29/2021,Verified
210403_Majadahonda_HospitalUniversitarioPuertaDeHierro_overall_Unadj,"April 3, 2021",Local,Spain,Spain,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),50,12.00%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jesus Romero,Hospital Universitario Puerta de Hierro,10.5603/RPOR.a2021.0036,6/2/2021,8/4/2021,Unverified
210519_Catalonia_BarcelonaInstituteforGlobalHealth_Adult1,"May 19, 2021",Regional,Spain,Spain; Catalonia,"June 17, 2020","November 15, 2020",Household and community samples,Multiple groups,4740,15.30%,,,Convenience,Sino Biologicals,Not reported,"IgG,IgM,IgA",95.78%,100.00%,Moderate,Preprint,Marianna Karachaliou,Barcelona Institute for Global Health,https://www.researchsquare.com/article/rs-448363/v1,6/3/2021,6/19/2021,Unverified
210519_Catalonia_BarcelonaInstituteforGlobalHealth_Adolescent2,"May 19, 2021",Regional,Spain,Spain; Catalonia,"June 17, 2020","November 15, 2020",Household and community samples,Multiple groups,260,11.50%,,,Convenience,Sino Biologicals,Not reported,"IgA,IgG,IgM",95.78%,100.00%,Moderate,Preprint,Marianna Karachaliou,Barcelona Institute for Global Health,https://www.researchsquare.com/article/rs-448363/v1,6/4/2021,6/19/2021,Unverified
210603_Spain_HospitalGeneralUniversitarioGregorioMarañón,"June 3, 2021",National,Spain,Spain,"April 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,1076,8.50%,6.90%,10.30%,Sequential,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Juan Berenguer,Hospital General Universitario Gregorio Marañón,https://www.croiconference.org/abstract/prevalence-and-factors-associated-with-sars-cov-2-antibodies-in-a-spanish-hiv-cohort/,6/5/2021,7/15/2021,Verified
210526_HospitalUniversitarioFundacionJimenezDiaz_Madrid_hcw,"May 26, 2021",Local,Spain,Spain,"April 6, 2020","April 25, 2020",Health care workers and caregivers,Not reported,5995,16.20%,,,Convenience,Biozek,LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Fabian Vazquez Rivas,Fundación Jiménez Díaz University Hospital,https://dx.doi.org/10.1136/oemed-2020-107001,6/6/2021,8/4/2021,Unverified
210614_Barcelona_HospitalUniversitariValld’Hebron,"June 14, 2021",Local,Spain,Spain; Province of Barcelona; Barcelona,"May 10, 2020","October 26, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),294,3.10%,,,Convenience,NA,Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Isabel Campos-Varela,Hospital Universitari Vall d’Hebron,https://dx.doi.org/10.1111/tri.13946,6/21/2021,8/4/2021,Unverified
210531_Madrid_CentroDeTransfusiónDeLaComunidadDeMadrid_overall,"May 31, 2021",Local,Spain,Spain,"January 1, 2020","March 22, 2020",Blood donors,Multiple groups,2419,0.08%,,,Sequential,Quotient ,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),R. Alenda,Centro de Transfusión de la Comunidad de Madrid,http://dx.doi.org/10.1111/vox.13117,6/30/2021,8/4/2021,Verified
210105_CastillaYLeon_CentroDeHemoterapiaYHemodonación_2019,"May 1, 2021",National,Spain,Spain; Castilla y Leon,"July 15, 2019","October 31, 2019",Blood donors,Multiple groups,1142,0.26%,,,Simplified probability,Roche Diagnostics,ELISA,"IgA,IgG,IgM",,,Moderate,Preprint,Carmen Martin,Centro de Hemoterapia y Hemodonación de Castilla y León,https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1,6/30/2021,8/4/2021,Unverified
210105_CastillaYLeon_CentroDeHemoterapiaYHemodonación_2020,"May 1, 2021",National,Spain,Spain; Castilla y Leon,"January 1, 2020","October 15, 2020",Blood donors,Multiple groups,11577,7.37%,,,Simplified probability,Roche Diagnostics,ELISA,"IgA,IgG,IgM",,,Moderate,Preprint,Carmen Martin,Centro de Hemoterapia y Hemodonación de Castilla y León,https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1,6/30/2021,8/4/2021,Unverified
210617_Barcelona_UniversitatDeBarcelona_Overall_PopAdj,"June 17, 2021",Local,Spain,Spain; Catalonia; Barcelona,"December 14, 2020","February 25, 2021",Multiple populations,Adults (18-64 years),2775,14.16%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Videla,Universitat de Barcelona,http://dx.doi.org/10.3390/ijerph18126526,7/1/2021,7/31/2021,Verified
210622_Madrid_HospitalCentralDeLaDefensaGomezUlla,"June 22, 2021",Local,Spain,Spain,"April 27, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),2781,16.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Simon Sacristan,Hospital Central de la Defensa Gómez Ulla,https://dx.doi.org/10.1007/s00284-021-02541-6,7/6/2021,8/4/2021,Unverified
210626_Spain_HospitalGregorioMaranon_popadj,"June 26, 2021",National,Spain,Spain,"April 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1076,8.10%,6.50%,10.00%,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Juan Berenguer,Hospital Gregorio Maranon,https://dx.doi.org/10.1016/j.cmi.2021.06.023,7/7/2021,7/7/2021,Unverified
210309_Madrid_FundacionRenalInigoAlvarezDeToledo,"March 9, 2021",Local,Spain,Spain,"March 1, 2020","April 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,672,15.02%,,,Convenience,Vircell S.L.,ELISA,"IgM,IgA",88.00%,99.00%,High,Journal Article (Peer-Reviewed),Roberto Alcazar Arroyo,Fundación Renal Íñigo Álvarez de Toledo,https://dx.doi.org/10.1093/ckj/sfab048,7/14/2021,7/21/2021,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Children1,"November 20, 2020",Local,Spain,Spain,"April 28, 2020","June 3, 2020",Household and community samples,Multiple groups,672,17.60%,14.80%,20.70%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,7/20/2021,8/4/2021,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Adults2,"November 20, 2020",Local,Spain,Spain,"April 28, 2020","June 3, 2020",Household and community samples,Multiple groups,412,18.70%,15.00%,22.80%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,7/20/2021,8/4/2021,Unverified
201029_Madrid_HospitalUniversitarioPríncipedeAsturias,"October 29, 2020",Local,Spain,Spain; NR; Madrid,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,"Hanghzhou AllTest Biotech Co., Ltd",LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia,Hospital Universitario Príncipe de Asturias,http://dx.doi.org/10.1017/ice.2020.1303,8/2/2021,8/2/2021,Unverified
210427_Juba_WorldHealthOrganization_TestAdj2,"April 27, 2021",Regional,South Sudan,South Sudan; Central Equatoria; Juba,"August 10, 2020","September 11, 2020",Household and community samples,Multiple groups,2214,38.30%,,,Stratified probability,NA,ELISA,IgG,65.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kirsten E Wiens,World Health Organization,https://dx.doi.org/10.3201/eid2706.210568,6/2/2021,7/6/2021,Unverified
200928_CapeTown_UniversityofCapeTown_overall_testadj,"September 20, 2020",Local,South Africa,South Africa,"June 15, 2020","August 7, 2020",Residual sera,Adults (18-64 years),2791,44.60%,42.60%,46.60%,Sequential,Roche Diagnostics,CLIA,"IgG,IgM",91.20%,99.70%,High,Institutional Report,Marvin Hsiao, University of Cape Town,https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf,3/3/2021,7/16/2021,Verified
210107_CapeTown_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,South Africa,South Africa; NR; Capetown,"June 10, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),222,10.36%,7.00%,15.07%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210225_CapeTown_StellenboschUniversity_Overall,"February 25, 2021",Local,South Africa,South Africa,"August 17, 2020","September 4, 2020",Essential non-healthcare workers,Adults (18-64 years),405,23.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,98.54%,High,Journal Article (Peer-Reviewed),Jane Shaw,Stellenbosch University,https://dx.doi.org/10.1371/journal.pone.0247852,3/27/2021,6/17/2021,Verified
210429_Johannesburg_NationalHealthLaboratoryService_PopTestAdj,"April 29, 2021",Local,South Africa,South Africa; Gauteng; Johannesburg,"August 1, 2020","October 31, 2020",Residual sera,Multiple groups,4393,27.30%,23.80%,29.90%,Simplified probability,Roche Diagnostics,CLIA,"IgM,IgG",,,Low,Preprint,Jaya George,National Health Laboratory Service,https://www.medrxiv.org/content/10.1101/2021.04.27.21256099v1,5/21/2021,7/17/2021,Unverified
210312_SouthAfrica_NationalHealthLaboratoryService_overall_Unadj,"March 12, 2021",National,South Africa,"South Africa; Western Cape Province, KwaZulu-Natal Province, North West Province; Mitchell’s Plain, Pietermaritzburg, and Klerksdorp ","November 23, 2020","January 31, 2021",Household and community samples,Multiple groups,927,35.80%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Moderate,Journal Article (Peer-Reviewed),Sue Aitken,National Health Laboratory Service,https://www.nicd.ac.za/wp-content/uploads/2021/03/COVID-19-Special-Public-Health-Surveillance-Bulletin-9-12-March-2021_.pdf,5/22/2021,7/21/2021,Verified
210505_Johannesburg_UniversityoftheWitwatersrand,"May 5, 2021",Local,South Africa,South Africa; Gauteng Province; Johannesburg,"April 22, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),395,41.30%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Martha Nunes,University of the Witwatersrand,https://dx.doi.org/10.1093/cid/ciab398,5/29/2021,8/4/2021,Verified
210529_SouthAfrica_NationalReferenceLaboratory_Rural_Visit5_Primary ,"May 29, 2021",Regional,South Africa,South Africa; Mpumalanga; Bushbuckridge Municipality,"March 22, 2021","April 11, 2021",Household and community samples,Multiple groups,587,26.00%,22.00%,29.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,South Africa National Reference Laboratory,10.1101/2021.05.26.21257849,6/14/2021,7/17/2021,Unverified
210529_SouthAfrica_NationalReferenceLaboratory_Urban_Visit5_Primary,"May 29, 2021",Regional,South Africa,South Africa; North West; Matlosana Municipality,"March 22, 2021","April 11, 2021",Household and community samples,Multiple groups,510,41.00%,37.00%,45.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,South Africa National Reference Laboratory,10.1101/2021.05.26.21257849,6/14/2021,7/17/2021,Unverified
210706_SouthAfrica_SouthAfricanNationalBloodService_Overall_PopAdj,"July 6, 2021",National,South Africa,South Africa,"January 15, 2021","May 15, 2021",Blood donors,Multiple groups,16762,47.40%,46.20%,48.60%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.50%,Moderate,Preprint,Marion Vermeulen,South African National Blood Service,10.21203/rs.3.rs-690372/v1,7/13/2021,7/17/2021,Unverified
210722_SouthAfrica_NationalInstituteforCommunicableDiseases_Urban_Primary,"July 22, 2021",Local,South Africa,South Africa; North West Province,"July 16, 2020","July 27, 2020",Household and community samples,Multiple groups,498,15.00%,,,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Cheryl Cohen,National Institute for Communicable Diseases of the National Health Laboratory Service,10.1101/2021.07.20.21260855,7/28/2021,7/28/2021,Unverified
210722_SouthAfrica_NationalInstituteforCommunicableDiseases_Rural_Primary,"July 22, 2021",Regional,South Africa,South Africa; Mpumalanga Province,"July 16, 2020","July 27, 2020",Household and community samples,Multiple groups,443,1.00%,,,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Cheryl Cohen,National Institute for Communicable Diseases of the National Health Laboratory Service,10.1101/2021.07.20.21260855,7/28/2021,7/28/2021,Unverified
210407_Slovenia_UniversityofLjubljana_GenPop_ElecsysTestAdj,"April 7, 2021",National,Slovenia,Slovenia,"April 20, 2020","May 1, 2020",Household and community samples,Multiple groups,1316,0.87%,0.40%,1.38%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Mario Poljak ,University of Ljubljana,https://dx.doi.org/10.1016/j.cmi.2021.03.009,5/20/2021,7/29/2021,Unverified
200429_Singapore_NCID_GeneralPopulation,"April 29, 2020",Local,Singapore,Singapore,"February 15, 2020","April 15, 2020",Household and community samples,Multiple groups,774,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,6/17/2021,Verified
200429_Singapore_Singapore_NCID_HCW,"April 29, 2020",Local,Singapore,Singapore,"February 15, 2020","April 15, 2020",Health care workers and caregivers,Not reported,1096,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,8/4/2021,Verified
210209_Singapore_MinistryOfHealthSingapore,"February 9, 2021",Local,Singapore,Singapore; Singapore; Singapore,"March 25, 2020","July 25, 2020",Multiple populations,Adults (18-64 years),135760,60.10%,,,Convenience,"Siemens,Abbott Laboratories,Roche Diagnostics",Multiple Types,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Iain Tan,Ministry of Health Singapore,https://dx.doi.org/10.1001/jama.2020.24071,3/6/2021,8/4/2021,Verified
201102_Singapore_NationalCentreForInfectiousDiseases_overall,"November 2, 2020",National,Singapore,Singapore,"January 23, 2020","April 3, 2020",Contacts of COVID patients,Multiple groups,1150,3.80%,,,Entire sample,NA,Neutralization,Neutralizing ,98.90%,100.00%,Moderate,Journal Article (Peer-Reviewed),Oon Tek Ng,"National Centre for Infectious Diseases, Singapore",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email,3/12/2021,6/17/2021,Verified
210420_Singapore_NationalUniversityOfSingapore_MigrantWorkers_TestAdj,"April 20, 2021",Local,Singapore,Singapore,"May 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),478,63.80%,57.90%,70.30%,Simplified probability,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,Moderate,Preprint, Hannah E Clapham,National University of Singapore,10.21203/rs.3.rs-441527/v1,5/20/2021,7/7/2021,Unverified
210420_Singapore_NationalUniversityOfSingapore_Community_TestAdj,"April 20, 2021",National,Singapore,Singapore,"November 15, 2020","December 15, 2020",Household and community samples,Multiple groups,937,0.16%,0.01%,0.72%,Unclear,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,Unclear,Preprint, Hannah E Clapham,National University of Singapore,10.21203/rs.3.rs-441527/v1,5/20/2021,6/17/2021,Unverified
210705_SierraLeone_HarvardMedicalSchool_WeightedOverall,"July 5, 2021",National,Sierra Leone,Sierra Leone,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,1893,2.60%,1.90%,3.40%,Stratified probability,"Hangzhou Biotest Biotech Co., Ltd",LFIA,"IgG,IgM",100.00%,100.00%,Low,Preprint,Mohamed Bailor Barrie,Harvard Medical School,https://dx.doi.org/10.1101/2021.06.27.21259271,7/13/2021,7/13/2021,Unverified
210709_Vojvodina_UniversityOfNoviSad_Unadj_April1_Overall,"July 9, 2021",Regional,Serbia,Serbia; Vojvodina,"April 28, 2020","April 28, 2020",Household and community samples,Multiple groups,1267,2.60%,1.80%,3.63%,Stratified probability,Mikrogen GmbH,Other,IgG,87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/21/2021,8/4/2021,Unverified
210709_Vojvodina_UniversityOfNoviSad_Unadj_May2_Overall,"July 9, 2021",Regional,Serbia,Serbia; Vojvodina,"May 28, 2020","May 28, 2020",Household and community samples,Multiple groups,1068,3.93%,2.85%,5.28%,Stratified probability,Mikrogen GmbH,Other,IgG,87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/21/2021,8/4/2021,Unverified
210709_Vojvodina_UniversityOfNoviSad_Unadj_June3_Overall,"July 9, 2021",Regional,Serbia,Serbia; Vojvodina,"June 28, 2020","June 28, 2020",Household and community samples,Multiple groups,1014,6.11%,4.72%,7.77%,Stratified probability,Mikrogen GmbH,Other,IgG,87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/21/2021,8/4/2021,Unverified
210709_Vojvodina_UniversityOfNoviSad_Adj_September4_Overall,"July 9, 2021",Regional,Serbia,Serbia; Vojvodina,"September 26, 2020","September 26, 2020",Household and community samples,Multiple groups,1041,16.67%,14.45%,19.08%,Stratified probability,Mikrogen GmbH,Other,IgG,87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/21/2021,7/21/2021,Unverified
200906_Madinah_KingFahadGeneralHospital_HCWs_Overall,"September 6, 2020",Local,Saudi Arabia,Saudi Arabia; Hejaz; Madinah,"April 18, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),330,24.24%,,,Unclear,Vircell S.L.,ELISA,"IgM,IgA,IgG",,,High,Journal Article (Peer-Reviewed),Suliman Alharbi,King Fahad General Hospital,https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf,9/28/2020,6/23/2021,Verified
201120_SaudiArabia_SaudiCDC_Overall,"November 20, 2020",National,Saudi Arabia,"Saudi Arabia; Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah","May 20, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),12621,2.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haleema Ali Alserehi,Saudi Center for Disease Prevention and Control,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273,1/23/2021,6/17/2021,Verified
210112_Dammam_KingFahadSpecialistHospital_Overall,"January 12, 2021",Local,Saudi Arabia,Saudi Arabia; Eastern Province; Dammam,"August 15, 2020","October 12, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),72,12.50%,,,Sequential,"DiaSorin SpA,Abbott Laboratories",CLIA,IgG,,,High,Preprint,Alanoud Alshami,King Fahad Specialist Hospital,https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf,2/5/2021,8/4/2021,Verified
210116_SaudiArabia_MinistryofHealth_overall,"January 16, 2021",National,Saudi Arabia,Saudi Arabia,"May 20, 2020","May 25, 2020",Blood donors,Adults (18-64 years),837,1.40%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ayman Banjar,Ministry of Health (Saudi Arabia),https://dx.doi.org/10.1016/j.ijid.2021.01.028,2/7/2021,7/17/2021,Unverified
210105_Jeddah_KingAbdulazizUniversity_overall,"January 5, 2021",Local,Saudi Arabia,Saudi Arabia,"January 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),956,1.50%,,,Sequential,NA,ELISA,IgG,100.00%,98.40%,High,Journal Article (Peer-Reviewed),Thamir Alandijany,King Abdulaziz University,https://dx.doi.org/10.3390/healthcare9010051,2/10/2021,8/4/2021,Verified
201206_Al-Madinah_TaibahUniversity_Overall,"December 11, 2020",Local,Saudi Arabia,Saudi Arabia,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1212,19.31%,17.12%,21.64%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed H Mahallawi,Taibah University,https://dx.doi.org/10.1016/j.sjbs.2020.12.009,2/17/2021,7/20/2021,Verified
210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall,"January 31, 2021",National,Saudi Arabia,"Saudi Arabia; Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah","June 15, 2020","November 15, 2020",Multiple general populations,Multiple groups,11275,10.90%,10.30%,11.60%,Convenience,"EUROIMMUN AG,NA",ELISA,IgG,,,Moderate,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,3/4/2021,8/4/2021,Verified
210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall,"January 31, 2021",Local,Saudi Arabia,Saudi Arabia,"June 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),400,7.50%,4.95%,10.16%,Unclear,NA,ELISA,IgG,,,High,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,3/4/2021,6/17/2021,Verified
210213_Makkah_KingAbdulazizUniversity_HCW,"February 13, 2021",Local,Saudi Arabia,Saudi Arabia; Mecca Province; Makkah (Mecca),"June 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),204,6.30%,,,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Ahmed,King Abdulaziz University,https://www.sciencedirect.com/science/article/pii/S1018364721000276?via%3Dihub,3/29/2021,8/4/2021,Verified
210628_Jeddah_KingAbdulazizUniversity,"June 28, 2021",Local,Saudi Arabia,Saudi Arabia; Mecca; Jeddah,"August 9, 2020","November 2, 2020",Health care workers and caregivers,Adults (18-64 years),319,12.20%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Farsi,King Abdulaziz University,https://dx.doi.org/10.15537/smj.2021.42.7.20210348,7/7/2021,8/4/2021,Unverified
210720_Jeddah_KingAbdulazizUniversity_Overall,"July 20, 2021",Local,Saudi Arabia,Saudi Arabia,"June 29, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),693,32.20%,28.80%,35.80%,Convenience,NA,Neutralization,Neutralizing ,,,Moderate,Journal Article (Peer-Reviewed),Rowa Alhabbab,King Abdulaziz University,10.3390/v13071413,8/2/2021,8/2/2021,Unverified
200611_Russia_NationalCouncilCombatingCoronavirus_GenPop,"June 10, 2020",National,Russian Federation,Russian Federation,,"June 10, 2020",Household and community samples,Multiple groups,650000,14.00%,,,Unclear,NA,Not reported,Not reported,95.00%,98.00%,Moderate,News and Media,Sergei Kiselyov,Russian National Council for Combating Coronavirus,https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617,6/27/2020,6/17/2021,Verified
200626_Moscow_CityofMoscow,"June 26, 2020",Local,Russian Federation,Russian Federation; Central Russia; Moscow,"June 5, 2020","June 18, 2020",Household and community samples,Not reported,90000,19.90%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Jonny Tickle,City of Moscow,https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA,7/31/2020,6/17/2021,Verified
201007_MinistryofHealthofRussianFederation_employees,"October 7, 2020",Local,Russian Federation,Russian Federation,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),1589,8.90%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),LV Krechetova,Ministry of Health of Russia,http://dx.doi.org/10.18565/aig.2020.7.122-128,1/16/2021,6/17/2021,Verified
210205_Ekaterinburg_RussianAcademyOfSciences_overall,"February 5, 2021",Local,Russian Federation,Russian Federation,"May 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),157,11.50%,,,Convenience,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Sarapultseva,Russian Academy of Sciences,https://dx.doi.org/10.1177/2380084421993099,2/20/2021,7/6/2021,Verified
200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall,"September 16, 2020",Regional,Russian Federation,Russian Federation; Northwestern Federal District,"June 23, 2020","June 26, 2020",Household and community samples,Multiple groups,3130,20.70%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1371/1150#,3/11/2021,8/5/2021,Verified
201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall,"October 10, 2020",Regional,Russian Federation,Russian Federation; Irkutsk Region,"June 28, 2020","July 19, 2020",Household and community samples,Multiple groups,2674,5.80%,5.35%,6.25%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute,https://journal.microbe.ru/jour/article/view/1370/1149,3/14/2021,6/17/2021,Verified
200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall,"September 23, 2020",Local,Russian Federation,Russian Federation,"June 15, 2020","June 20, 2020",Household and community samples,Multiple groups,2713,26.00%,24.30%,27.70%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1372/1151,3/20/2021,6/17/2021,Verified
201001_TyumenRegion_SaintPetersburgPasteurInstitute,"October 1, 2020",Regional,Russian Federation,Russian Federation; Tyumen region,"June 7, 2020","June 20, 2020",Household and community samples,Multiple groups,2758,24.50%,22.90%,26.10%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/890/520,3/20/2021,6/17/2021,Verified
210119_Kaliningrad_RussianAcademyOfSciences_overall,"January 19, 2021",Regional,Russian Federation,Russian Federation; Kaliningrad Region,"August 3, 2020","August 7, 2020",Household and community samples,Multiple groups,2939,50.20%,49.03%,51.10%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),A Yu Popova,The Russian Academy of Sciences ,http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71,3/25/2021,6/17/2021,Verified
20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall,"October 14, 2020",Regional,Russian Federation,Russian Federation; Central Russia; Moscow Region,"June 22, 2020","July 11, 2020",Household and community samples,Multiple groups,2688,21.00%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),A Popova,Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky,http://dx.doi.org/10.20953/1729-9225-2020-4-17-26,4/26/2021,6/17/2021,Verified
210101_MurmanskRegion_StPetersburgPasteurInstitute_Overall,"January 1, 2021",Regional,Russian Federation,Russian Federation; Murmansk Region,"August 3, 2020","August 11, 2020",Household and community samples,Multiple groups,3117,31.20%,30.40%,32.00%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St. Petersburg Pasteur Institute,https://hiv.bmoc-spb.ru/jour/article/view/605#,5/5/2021,6/17/2021,Verified
210328_RussianFederation_StPetersburgPasteurInstitute,"March 28, 2021",National,Russian Federation,Russian Federation,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,74158,19.50%,10.00%,25.60%,Unclear,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Anna Popova,St Peterburg Pasteur Institute,https://www.iimmun.ru/iimm/article/view/1684#,5/18/2021,8/2/2021,Verified
201021_RepublicOfTartarstan_SaintPetersburgPasteurInstitute_overall,"October 21, 2020",Regional,Russian Federation,Russian Federation; Republic of Tartarstan,"September 20, 2020","September 27, 2020",Household and community samples,Multiple groups,2946,31.30%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Yu Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/940?locale=en_US,5/18/2021,6/19/2021,Verified
201228_Moscow_SaintPetersburgPasteurInstitute_primary,"April 6, 2021",Local,Russian Federation,Russian Federation,"July 1, 2020","July 30, 2020",Household and community samples,Multiple groups,2688,22.10%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Popova A Yu,Saint-Petersburg Pasteur Institute,http://dx.doi.org/10.20953/1729-9225-2020-4-8-16,5/19/2021,6/17/2021,Verified
200619_StPetersburg_EuropeanUniversityAtStPetersburg_Testadj,"June 19, 2020",Local,Russian Federation,Russian Federation; Northwestern; St Petersburg,"May 27, 2020","June 15, 2020",Household and community samples,Multiple groups,487,5.70%,3.50%,7.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,News and Media,Alla Samoletova,European University at St Petersburg,https://eusp.org/en/news/press-release-6-of-people-in-st-petersburg-russia-have-had-covid-19-0,6/22/2021,6/22/2021,Unverified
210621_SaintPetersburg_EuropeanUniversity_ELISA_Overall_PopTestAdj,"June 21, 2021",Local,Russian Federation,Russian Federation; Northwestern; Saint Petersburg,"May 27, 2020","June 26, 2020",Household and community samples,Multiple groups,990,7.40%,5.70%,9.20%,Simplified probability,Abbott Laboratories,CLIA,IgG,99.60%,100.00%,Moderate,Journal Article (Peer-Reviewed),Anton Barchuk,European University at St. Petersburg,https://dx.doi.org/10.1038/s41598-021-92206-y,7/6/2021,7/6/2021,Unverified
210625_Ekaterinburg_DentalCollegeYamunanagar,"June 25, 2021",Local,Russian Federation,Russian Federation; Ural; Ekaterinburg,"May 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),157,12.10%,,,Convenience,Vector BEST,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Neeraj Gugnani,Dental College Yamunanagar,https://dx.doi.org/10.1038/s41432-021-0171-5,7/6/2021,7/7/2021,Unverified
210629_StPetersburg_Saint-PetersburgStateUniversityHospital_overall,"June 29, 2021",Local,Russian Federation,Russian Federation,"May 27, 2020","March 19, 2021",Household and community samples,Adults (18-64 years),180,15.56%,,,Unclear,EUROIMMUN AG,ELISA,IgA,,,Unclear,Journal Article (Peer-Reviewed),Andrei Ivanov,B.P.Konstantinov St Petersburg Nuclear Physics Institute,https://dx.doi.org/10.1002/jmv.27166,7/6/2021,7/15/2021,Verified
210609_Chelyabinsk_SouthUralStateUniversity_HighRisk_testadj,"June 9, 2021",Local,Russian Federation,Russian Federation,"September 28, 2020","December 30, 2020",Health care workers and caregivers,Adults (18-64 years),1091,17.23%,17.17%,17.29%,Unclear,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexandr Zurochka,South Ural State University,http://dx.doi.org/10.3390/vaccines9060627,7/7/2021,7/7/2021,Unverified
200424_Romania_MedLife_HCW,"April 24, 2020",National,Romania,"Romania; Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov; Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti","March 24, 2020","April 21, 2020",Health care workers and caregivers,Multiple groups,371,2.96%,,,Convenience,"Abbott Laboratories,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd),Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,Unclear,Institutional Report,MedLife,MedLife,https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a,6/27/2020,8/4/2021,Verified
210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj,"January 4, 2021",Local,Romania,Romania,"May 17, 2020","December 1, 2020",Multiple populations,Adults (18-64 years),546,6.00%,,,Convenience,DiaSorin SpA,CLIA,"IgG,IgM",90.70%,98.60%,High,Preprint,Corina Manolea,Carol Davila University of Medicine and Pharmacy,10.20944/preprints202101.0024.v1,1/23/2021,6/23/2021,Verified
210107_Romania_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Romania,Romania; NR; NR,"May 14, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),124,0.81%,0.14%,4.30%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210106_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall,"January 6, 2021",Local,Romania,Romania,"July 8, 2020","September 1, 2020",Blood donors,Adults (18-64 years),2115,1.51%,1.07%,2.13%,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Tudor Rares Olariu,Victor Babes University of Medicine and Pharmacy,http://dx.doi.org/10.1016/j.cmi.2020.12.027,3/18/2021,7/17/2021,Verified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_Patients_Unadj,"July 27, 2021",Local,Romania,Romania,"May 17, 2020","December 1, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),516,6.80%,,,Convenience,DiaSorin SpA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,8/3/2021,8/4/2021,Unverified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_HCW_Unadj,"July 27, 2021",Local,Romania,Romania,"May 17, 2020","December 1, 2020",Health care workers and caregivers,Adults (18-64 years),30,23.30%,,,Convenience,DiaSorin SpA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,8/3/2021,8/4/2021,Unverified
200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total,"July 9, 2020",National,Republic of Korea,Republic of Korea; Korea,,"July 9, 2020",Household and community samples,Not reported,3055,0.03%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Ock Hyun-ju,Korea Centers for Disease Control and Prevention,https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw,7/31/2020,6/17/2021,Verified
200716_Daegu_DaeguCatholicUniversityHospital_Overall,"July 16, 2020",Local,Republic of Korea,Republic of Korea; North Gyeongsang; Daegu,"May 25, 2020","June 5, 2020",Multiple populations,Multiple groups,198,7.60%,,,Convenience,Shin Jin Medics Inc,LFIA,IgG,100.00%,92.00%,High,Journal Article (Peer-Reviewed),Suk-Kyoon Song,Daegu Catholic University Hospital,https://dx.doi.org/10.3346/jkms.2020.35.e269,9/26/2020,8/4/2021,Verified
200824_Seoul_KoreaUniversity_Overall,"August 24, 2020",Local,Republic of Korea,Republic of Korea,"May 25, 2020","May 29, 2020",Residual sera,Multiple groups,1500,0.07%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ji Noh,Korea University,https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311,10/4/2020,7/16/2021,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1,"November 20, 2020",National,Republic of Korea,Republic of Korea,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),309,0.32%,,,Convenience,PCL Inc,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,6/17/2021,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1,"November 20, 2020",National,Republic of Korea,Republic of Korea,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),123,0.00%,,,Convenience,PCL Inc,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,6/17/2021,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop,"November 23, 2020",National,Republic of Korea,Republic of Korea,"August 15, 2020","October 15, 2020",Household and community samples,Multiple groups,1379,0.22%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,6/17/2021,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_military,"November 23, 2020",National,Republic of Korea,Republic of Korea,"August 15, 2020","October 15, 2020",Essential non-healthcare workers,Adults (18-64 years),6900,0.36%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,8/4/2021,Verified
210424_SouthKorea_KoreaAssociationofHealthPromotion,"April 24, 2021",National,Republic of Korea,"Republic of Korea; N/A; Seoul (Dongbu), Chuncheon, Chungju, Daegu (Dong-gu), Daegu (Buk-gu), Ulsan, Busan, Changwon, Kwangju, Jeonju, Daejeon, Suwon, Seoul (Kangnam), Incheon, Seoul (Seobu), Jeju ","September 24, 2020","December 9, 2020",Household and community samples,Multiple groups,4085,0.39%,0.20%,0.58%,Stratified probability,Roche Diagnostics,CLIA,IgG,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Eun Hee Nah,Korea Association of Health Promotion,https://bmjopen.bmj.com/content/11/4/e049837.abstract,5/17/2021,7/17/2021,Unverified
210428_SouthKorea_ChungbukNationalUniversity_NonEpicenter,"April 28, 2021",Regional,Republic of Korea,Republic of Korea; Chungbuk Province; N/A,"May 1, 2020","July 17, 2020",Residual sera,Multiple groups,3981,0.91%,0.69%,1.13%,Sequential,NA,Other,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://pubmed.ncbi.nlm.nih.gov/33907974/,5/17/2021,7/6/2021,Unverified
210428_SouthKorea_ChungbukNationalUniversity_Epicenter,"April 28, 2021",Local,Republic of Korea,Republic of Korea; N/A; Daegu city,"May 1, 2020","July 17, 2020",Residual sera,Multiple groups,3268,1.27%,1.01%,1.53%,Sequential,NA,Other,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://pubmed.ncbi.nlm.nih.gov/33907974/,5/18/2021,7/6/2021,Unverified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_July1_overall,"May 24, 2021",National,Republic of Korea,Republic of Korea,"April 21, 2020","June 16, 2020",Residual sera,Multiple groups,1500,0.00%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,Moderate,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/7/2021,7/6/2021,Unverified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_November3_TestAdj,"May 24, 2021",National,Republic of Korea,Republic of Korea,"August 14, 2020","October 31, 2020",Residual sera,Multiple groups,1379,0.62%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,Moderate,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/7/2021,7/6/2021,Unverified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_September2,"May 24, 2021",National,Republic of Korea,Republic of Korea,"June 10, 2020","August 13, 2020",Residual sera,Multiple groups,1440,0.07%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,Moderate,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/7/2021,7/6/2021,Unverified
210630_Hwaseong_DongtanSacredHeartHospital,"June 30, 2021",Local,Republic of Korea,Republic of Korea; Gyeonggi; Hwaseong,"March 4, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),298,0.00%,,,Convenience,GenScript,Neutralization,"IgG,IgM,Neutralizing ",95.40%,90.80%,Moderate,Journal Article (Peer-Reviewed),Seri Jeong,Dongtan Sacred Heart Hospital,https://dx.doi.org/10.1128/JCM.01105-21,7/7/2021,7/7/2021,Unverified
201124_Qatar_MinistryofPublicHealth_Overall_popadj,"November 24, 2020",National,Qatar,Qatar,"July 26, 2020","September 9, 2020",Non-essential workers and unemployed persons,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,95.00%,99.80%,Moderate,Preprint,Mohamed H Al Thani,Ministry of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1,1/23/2021,7/16/2021,Verified
210106_Qatar_HamadMedicalCorporation_overall,"January 6, 2021",Local,Qatar,Qatar,"May 12, 2020","September 9, 2020",Residual sera,Multiple groups,112941,13.30%,13.10%,13.60%,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Preprint,Peter V Coyle,Hamad Medical Corporation,10.1101/2021.01.05.21249247,2/2/2021,7/17/2021,Unverified
210309_Qatar_HamadMedicalCorporation_MortuaryWorkers,"March 9, 2021",Local,Qatar,Qatar; NR; NR,"September 17, 2020","September 17, 2020",Essential non-healthcare workers,Adults (18-64 years),32,25.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/16/2021,7/17/2021,Verified
210309_Qatar_HamadMedicalCorporation_CemetaryWorkers,"March 9, 2021",Local,Qatar,Qatar; NR; NR,"September 1, 2020","September 1, 2020",Essential non-healthcare workers,Adults (18-64 years),64,34.38%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/16/2021,7/17/2021,Verified
210318_Qatar_MinistryofPublicHealth_overall,"March 18, 2021",National,Qatar,Qatar,"May 12, 2020","July 12, 2020",Residual sera,Multiple groups,32970,24.00%,23.30%,24.60%,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",,100.00%,Moderate,Journal Article (Peer-Reviewed),Laith J Abu Raddad,Ministry of Public Health,https://dx.doi.org/10.1038/s41598-021-85428-7,5/18/2021,7/23/2021,Verified
210501_Qatar_CornellUniversity,"May 1, 2021",National,Qatar,Qatar,"June 21, 2020","September 9, 2020",Essential non-healthcare workers,Adults (18-64 years),4970,64.40%,63.00%,65.70%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Andrew Jeremijenko,Cornell University ,https://pubmed.ncbi.nlm.nih.gov/33900174/,5/23/2021,7/17/2021,Unverified
210604_Qatar_CornellUniversity_Overall1,"June 4, 2021",National,Qatar,Qatar,"July 26, 2020","September 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),394,46.50%,41.60%,51.40%,Convenience,"Shenzhen Mindray Bio-Medical Electronics Co.,Biomerieux,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Gheyath K Nasrallah,Cornell University,https://dx.doi.org/10.1038/s41598-021-91235-x,6/16/2021,8/4/2021,Verified
201123_PuertoRico_PuertoRicoPublicHealthTrust_Primary,"November 23, 2020",National,Puerto Rico,Puerto Rico,"November 20, 2020","November 23, 2020",Household and community samples,Multiple groups,1816,2.80%,,,Stratified probability,NA,Not reported,"IgM,IgG",,,High,Institutional Report,Puerto Rico Public Health Trust,Puerto Rico Public Health Trust,https://sites.google.com/view/casperpr/análisis-y-resultados?authuser=0,5/21/2021,7/22/2021,Verified
200902_Lisbon_UniversityofLisbon_Overall,"September 2, 2020",Local,Portugal,Portugal; Estremadura; Lisbon,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2571,1.50%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",94.74%,98.00%,Moderate,Preprint,Patricia Figueiredo Campos,University of Lisbon,https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1,10/19/2020,6/17/2021,Verified
201218_Lisbon_NovaUniversityofLisbon,"December 18, 2020",Local,Portugal,Portugal; Lisboa Region; Lisbon,"June 15, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1636,3.05%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,Moderate,Journal Article (Peer-Reviewed),Juliana Goncalves,NOVA University of Lisbon,https://dx.doi.org/10.3389/fmed.2020.603996,1/23/2021,7/6/2021,Verified
201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall,"October 21, 2020",Local,Portugal,Portugal,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2715,2.60%,,,Convenience,NA,ELISA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Patricia Figueiredo Campos,Universidade de Lisboa,https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970,3/22/2021,6/17/2021,Verified
210426_Portugal_DepartmentofEpidemiologyandInfectiousDiseasesoftheNationalInstitutesofHealth,"April 26, 2021",National,Portugal,Portugal,"February 2, 2021","March 31, 2021",Household and community samples,Multiple groups,8463,15.50%,,,Convenience,NA,Unclear,"IgG,IgM",,,Unclear,News and Media,Pedro Simas,Department of Epidemiology and Infectious Diseases of the National Institutes of Health (INSA),https://newsline.news/the-second-national-serological-survey-showed-that-15-5-of-the-portuguese-population-has-antibodies-against-sars-cov-2/,5/17/2021,7/6/2021,Unverified
210428_RegiãodoCentro_SorbonneUniversité_4,"April 28, 2021",Regional,Portugal,Portugal; Região do Centro,"July 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,526,1.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/30/2021,8/4/2021,Unverified
210621_Portugal_LosAlamosNationalLaboratory_overall_PopAdj_TestAdj,"June 21, 2021",National,Portugal,Portugal,"March 1, 2021","March 17, 2021",Household and community samples,Multiple groups,2435,17.30%,15.80%,18.80%,Stratified probability,Siemens,CLIA,Total Antibody,98.10%,99.90%,Moderate,Preprint,Luisa Canto e Castro,Los Alamos National Laboratory,10.21203/rs.3.rs-603060/v1,7/2/2021,7/30/2021,Verified
210630_Porto_UniversidadeDoPorto_primary,"June 30, 2021",Local,Portugal,Portugal; Norte; Porto,"May 21, 2020","July 31, 2020",Essential non-healthcare workers,Multiple groups,4592,2.50%,0.10%,5.30%,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Paula Meireles, Universidade do Porto,https://dx.doi.org/10.1136/oemed-2021-107519,7/6/2021,8/4/2021,Verified
210616_Lisbon_ UniversidadeNOVAdeLisboa_primary,"June 16, 2021",Local,Portugal,Portugal,"June 15, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1624,3.10%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,High,Journal Article (Peer-Reviewed),David G. Lopes, Universidade NOVA de Lisboa,https://dx.doi.org/10.3389/fpubh.2021.689919,7/15/2021,7/15/2021,Unverified
201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall,"October 11, 2020",Regional,Poland,Poland; Mazowieckie Province,"June 22, 2020","July 8, 2020",Essential non-healthcare workers,Multiple groups,5082,4.30%,3.70%,4.90%,Stratified probability,Vircell S.L.,ELISA,IgG,97.00%,94.00%,Moderate,Journal Article (Peer-Reviewed),Mariusz Gujski,Medical University of Warsaw,http://dx.doi.org/10.3390/jcm9103245,1/29/2021,8/4/2021,Verified
210205_Poland_CentralClinicalHospital_IBDPatients_IgG,"February 5, 2021",National,Poland,Poland,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,432,4.60%,,,Sequential,Vircell S.L.,ELISA,IgG,88.00%,99.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/23/2021,6/17/2021,Verified
210205_Poland_CentralClinicalHospital_HCWs_IgG,"February 5, 2021",National,Poland,Poland,"May 1, 2020","June 15, 2020",Health care workers and caregivers,Not reported,432,1.60%,,,Stratified non-probability,Vircell S.L.,ELISA,IgG,85.00%,98.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/23/2021,6/17/2021,Verified
201222_Warsaw_CentralClinicalHospitalMSWiA,"December 22, 2020",Local,Poland,Poland,"April 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),61,16.39%,,,Sequential,Vircell S.L.,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Piotr Ciechanowicz,Central ClinicalHospital MSWiA,https://dx.doi.org/10.1080/09546634.2020.1861177,3/7/2021,8/4/2021,Verified
210401_Warsaw_Children’sMemorialHealthInstitute_HCW,"April 1, 2021",Local,Poland,Poland,"July 1, 2020","August 9, 2020",Health care workers and caregivers,Adults (18-64 years),1879,0.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Beata Kasztelewicz,Children’s Memorial Health Institute,https://dx.doi.org/10.1371/journal.pone.0249550,5/2/2021,6/17/2021,Unverified
210331_Poznań_PolishAcademyofSciences_Primary,"March 31, 2021",Local,Poland,Poland; Greater Poland; Poznań,"July 15, 2020","September 15, 2020",Household and community samples,Multiple groups,1500,0.93%,0.56%,1.56%,Simplified probability,"EUROIMMUN AG,Polycheck",Multiple Types,"IgG,IgA",,,Moderate,Preprint,Dagny Lorent,Polish Academy of Sciences,https://www.medrxiv.org/content/10.1101/2021.03.29.21254544v1.full,5/15/2021,8/4/2021,Verified
210317_SilesianVoivodeship_JanKochanowskiUniversity,"March 17, 2021",Regional,Poland,Poland; Silesian Voivodeship,"May 15, 2020","June 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),516,1.94%,,,Convenience,"Nanjing Vazyme Medical Technology Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Rafal Krygier, Jan Kochanowski University,https://dx.doi.org/10.13075/ijomeh.1896.01756,5/18/2021,7/15/2021,Verified
210419_Lublin_MedicalUniversityofLublin_JIA,"April 19, 2021",Local,Poland,Poland; Lublin Voivodeship; Lublin,"June 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),62,4.00%,2.00%,13.00%,Sequential,EUROIMMUN AG,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,5/19/2021,7/7/2021,Unverified
210419_Lublin_MedicalUniversityofLublin_HealthyControls,"April 19, 2021",Local,Poland,Poland; Lublin Voivodeship; Lubli,"June 1, 2020","September 30, 2020",Household and community samples,Children and Youth (0-17 years),32,6.30%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,5/19/2021,6/19/2021,Unverified
210420_Bytom1_UniversityofOpole,"April 20, 2021",Local,Poland,Poland; Silesian; Bytom,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),90,10.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,6/17/2021,Unverified
210420_MiasteczkoSlaskie2_UniversityofOpole,"April 20, 2021",Local,Poland,Poland; Silesian; Miasteczko Slaskie,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),25,4.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,6/17/2021,Unverified
210420_Opole3_UniversityofOpole,"April 20, 2021",Local,Poland,Poland; Opole; Opole,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),84,1.19%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,6/17/2021,Unverified
210415_Poland_MedicalUniversityOfSilesiaInKatowice_Overall,"April 21, 2021",Regional,Poland,"Poland; Silesian Voivodeship; Katowice, Gliwice, Sosnowiec","October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,5479,22.90%,,,Self-referral,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Małgorzata Kowalska,Medical University of SilesiaIn Katowice,https://dx.doi.org/10.3390/vaccines9050415,5/28/2021,8/4/2021,Verified
210608_Warsaw_CentralClinicalHospitalOfTheMinistryOfInterior,"June 8, 2021",Local,Poland,Poland; Mazovia; Warsaw,"April 21, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),1572,22.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Radosław Rzeplinski,Central Clinical Hospital of the Ministry of Interior and Administration,https://dx.doi.org/10.20452/pamw.16025,6/19/2021,8/4/2021,Unverified
210625_Wroclaw_RegionalSpecialistHospitalInWrocław_overall,"June 25, 2021",Local,Poland,Poland; Silesia; Wroclaw,"May 15, 2021","May 22, 2021",Household and community samples,Multiple groups,501,59.10%,,,Unclear,TestLine Clinical Diagnostics,Other,"IgG,IgA",,,High,Preprint,Wiktoria Budziar,Regional Specialist Hospital in Wrocław,10.1101/2021.06.22.21258711,7/6/2021,8/4/2021,Unverified
200726_Peru_NationalCenterforEpidemiology_Overall,"July 27, 2020, July 27, 2020, July 26, 2020",Local,Peru,"Peru; Lima, Callao; Lima, Callao","June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3118,21.60%,18.70%,24.60%,Stratified probability,NA,LFIA,"IgG,IgM",40.00%,,High,"News and Media, News and Media, News and Media","Peruvian Government, Centro Nacional de Epidemiologia, Ministerio de Salud","National Center for Epidemiology, Prevention and Control of Diseases","https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/, https://www.dge.gob.pe/portalnuevo/informativo/prensa/estudio-de-prevalencia-determina-que-el-253-de-la-poblacion-de-lima-y-callao-adquirio-la-infeccion-por-sars-cov2/, https://www.gob.pe/institucion/minsa/noticias/216013-estudio-de-prevalencia-determina-que-el-25-3-de-la-poblacion-de-lima-y-callao-estaria-infectada-de-covid-19",10/20/2020,6/17/2021,Verified
201129_Lima_INS_unadj,"September 9, 2020",Local,Peru,Peru; Lima; Lima,"April 23, 2020","May 2, 2020",Household and community samples,Multiple groups,236,53.00%,,,Stratified non-probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,Moderate,Preprint,Yolanda Angulo Bazan,National Institute of Health (INS),https://www.medrxiv.org/content/10.1101/2020.09.06.20189456v2,1/13/2021,6/23/2021,Verified
210120_Cusco_UniversidadCientíficadelSur_PopAdj,"January 20, 2021",Regional,Peru,Peru; Cusco,"September 12, 2020","September 27, 2020",Household and community samples,Multiple groups,1924,33.10%,30.10%,36.40%,Stratified probability,Roche Diagnostics,CLIA,"IgM,IgG",99.80%,99.50%,Low,Preprint,Charles Huamani,Universidad Científica del Sur,https://www.medrxiv.org/content/10.1101/2021.01.17.21249990v1,2/6/2021,7/17/2021,Unverified
210120_Iquitos_DIRESA_1monthFollowUp_overall_adj,"January 20, 2021",Local,Peru,Peru,"August 13, 2020","August 18, 2020",Household and community samples,Multiple groups,621,66.00%,62.00%,70.10%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Carlos Alvarez Antonio,Universidad de Ingeniería y Tecnología,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/12/2021,7/7/2021,Unverified
210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj,"March 31, 2021",Local,Peru,Peru; Lima and Callao; Lima metropolitan area,"June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3212,20.80%,17.20%,23.50%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",96.94%,96.23%,Low,Journal Article (Peer-Reviewed),Mary F Reyes Vega,Peruvian Ministry of Health,https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20,4/10/2021,7/14/2021,Verified
200624_Cusco_ RegionalHealthDirectorateOfCusco_overall,"June 25, 2020",Regional,Peru,Peru; Cusco,"June 8, 2020","June 20, 2020",Household and community samples,Multiple groups,491,2.65%,,,Stratified probability,NA,LFIA,Not reported,,,High,News and Media,Regional Health Directorate of Cusco, Regional Health Directorate of Cusco,https://web.archive.org/web/20201220094258/http://www.diresacusco.gob.pe/new/archivos/4335,5/3/2021,7/6/2021,Unverified
210312_Lima_InstitutoNacionalDeSalud_Overall,"March 12, 2021",Local,Peru,Peru,"April 23, 2020","May 2, 2020",Contacts of COVID patients,Multiple groups,236,53.00%,,,Stratified non-probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Yolanda Angulo Bazan,Instituto Nacional de Salud,https://dx.doi.org/10.1590/0102-311X00238720,5/12/2021,7/22/2021,Verified
200808_Lima_NationalMaternalPerinatalInstitute_overall,"August 8, 2020",Local,Peru,Peru; Lima Province; Lima,"April 15, 2020","May 15, 2020",Pregnant or parturient women,Adults (18-64 years),2419,7.00%,6.10%,8.10%,Sequential,NA,LFIA,"IgG,IgM",97.60%,98.80%,Moderate,Journal Article (Peer-Reviewed),Enrique Guevara Rios,"National Maternal Perinatal
Institut",http://www.scielo.org.pe/scielo.php?pid=S2304-51322020000300002&script=sci_abstract&tlng=en,5/18/2021,6/19/2021,Verified
210406_Lambayeque_UniversidadParticulardeChiclayo_PopTestAdj,"April 6, 2021",Regional,Peru,Peru; Lambayeque Province,"June 24, 2020","July 10, 2020",Household and community samples,Multiple groups,2010,29.50%,27.60%,31.50%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",66.00%,97.00%,Low,Journal Article (Peer-Reviewed),Cristian Diaz Velez,Universidad Particular de Chiclayo,https://dx.doi.org/10.7717/peerj.11210,5/19/2021,7/28/2021,Verified
210421_Lima_HarvardMedicalSchool_Market1,"April 21, 2021",Local,Peru,Peru; Lima Province; Lima,"June 5, 2020","July 18, 2020",Essential non-healthcare workers,Adults (18-64 years),1285,45.00%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,5/20/2021,7/6/2021,Unverified
210421_Lima_HarvardMedicalSchool_BusDepot2,"April 21, 2021",Local,Peru,Peru; Lima Province; Lima,"June 5, 2020","July 18, 2020",Essential non-healthcare workers,Adults (18-64 years),477,36.33%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,5/20/2021,7/6/2021,Unverified
200901_Loreto_HospitalRegionaldeLoreto_primary,"September 1, 2020",Local,Peru,Peru,"May 19, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),1147,58.30%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricci Alonso Chafloque Vasquez,Hospital Regional de Loreto,https://amp.cmp.org.pe/index.php/AMP/article/view/1050,5/21/2021,6/17/2021,Verified
210901_LimaPeru_HospitalNacionalDocenteMadreNinoSanBartolome_primary,"September 1, 2020",Local,Peru,Peru,"April 15, 2020","July 15, 2020",Pregnant or parturient women,Adults (18-64 years),1869,18.50%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Edy Martin Vera Loyola,Hospital Nacional Docente Madre Nino San Bartolome ,http://www.spog.org.pe/web/revista/index.php/RPGO/article/download/2265/pdf,6/6/2021,7/8/2021,Verified
210701_LaRinconada_GrenobleAlpesUniversity_overall,"July 1, 2021",Local,Peru,Peru; Puno; La Riconanda,"October 11, 2020","October 18, 2020",Household and community samples,Multiple groups,159,48.40%,40.50%,56.40%,Sequential,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Benoit Champigneulle,Grenoble Alpes University,http://dx.doi.org/10.1089/ham.2021.0020,7/29/2021,7/29/2021,Verified
201215_CiudaddelEste_MinisteriodeSaludPública_primary,"December 15, 2020",Local,Paraguay,Paraguay,"November 29, 2020","December 15, 2020",Household and community samples,Multiple groups,1675,30.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Not reported,Ministerio de Salud Pública,https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html,4/22/2021,6/17/2021,Verified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors,"March 2, 2021",Local,Panama,Panama,"April 30, 2020","July 7, 2020",Blood donors,Multiple groups,255,13.33%,,,Unclear,NA,LFIA,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,"Instituto de Investigaciones Científicas y
Servicios de Alta Tecnología",https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,7/6/2021,Unverified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs,"March 2, 2021",Local,Panama,Panama,"April 30, 2020","July 7, 2020",Health care workers and caregivers,Multiple groups,351,12.82%,,,Unclear,NA,LFIA,"IgG,IgM",87.01%,98.89%,Moderate,Journal Article (Peer-Reviewed),Alcibiades Villarreal,"Instituto de Investigaciones Científicas y
Servicios de Alta Tecnología",https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,7/6/2021,Unverified
200720_Lahore_ChughtaiInstituteofPathology_Overall,"August 19, 2020",Local,Pakistan,Pakistan,"May 20, 2020","May 30, 2020",Essential non-healthcare workers,Adults (18-64 years),154,15.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.77%,99.00%,High,Journal Article (Peer-Reviewed),Omar Chughtai,Chughtai Institute of Pathology,https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan,10/3/2020,7/31/2021,Verified
200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall,"August 24, 2020",Local,Pakistan,Pakistan; Sindh; Karachi,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),370,34.60%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Amber Younas,National Institute of Blood Diseases & Bone Marrow Transplantation,https://dx.doi.org/10.1016/j.transci.2020.102923,10/20/2020,7/16/2021,Verified
201109_ Peshawar_HayatabadMedicalComplex_Overall,"November 9, 2020",Local,Pakistan,Pakistan; Khyber Pakhtunkhwa; Peshawar,"July 13, 2020","July 15, 2020",Health care workers and caregivers,Multiple groups,1011,30.76%,,,Stratified probability,Roche Diagnostics,Not reported,"IgG,IgM",87.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Noor,Hayatabad Medical Complex,https://dx.doi.org/10.7759/cureus.11389,1/17/2021,7/16/2021,Verified
200930_PeshawarCity_RiphahInternationalUniversity_Overall,"September 30, 2020",Local,Pakistan,Pakistan; Khyber Pakhtunkhwa; Peshawar City,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),1011,30.70%,27.80%,33.60%,Stratified non-probability,Roche Diagnostics,Not reported,Total Antibody,98.80%,100.00%,Moderate,Preprint,Mohsina Haq,Riphah International University,https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1,1/19/2021,7/16/2021,Verified
210103_Pakistan_LiaquatUniversity_primary,"January 3, 2021",Local,Pakistan,Pakistan,"June 15, 2020","August 15, 2020",Residual sera,Multiple groups,728,10.80%,,,Convenience,NA,ELISA,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Sheeba Ansari,Liaquat University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/,2/19/2021,6/23/2021,Verified
210101_Pakistan_ColSultan’sLab_Overall,"January 1, 2021",Local,Pakistan,Pakistan; NR; NR,"June 13, 2020","July 8, 2020",Residual sera,Not reported,453,63.80%,,,Self-referral,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Sidra Ghazanfer,Col Sultan’s Lab,https://dx.doi.org/10.29271/jcpsp.2021.01.S55,4/11/2021,7/17/2021,Verified
200814_Pakistan_GetzPharma_Overall,"August 14, 2020",Regional,Pakistan,"Pakistan; NR; Karachi, Lahore, Multan, Peshawar and Quetta",,"July 6, 2020",Household and community samples,Adults (18-64 years),24210,17.50%,,,Simplified probability,Getz Pharma,Other,"IgG,IgM",,,Moderate,Preprint,Wajiha Javed,Getz Pharma,https://www.medrxiv.org/content/10.1101/2020.08.13.20173914v1,5/17/2021,6/19/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase1Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District Malir,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.20%,0.00%,0.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase1East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District East,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.40%,0.00%,1.30%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase2Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District Malir,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,504,8.70%,5.10%,13.10%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase2East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District East ,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,500,15.10%,9.40%,21.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase3Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District Malir,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,501,12.80%,8.30%,17.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210321_Karachi_AgaKhanUniversity_Phase3East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,Pakistan; Karachi; District East ,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,500,21.50%,15.60%,28.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/17/2021,7/22/2021,Verified
210421_Pakistan_MemorialCancerHospitalandResearchCenter_overall,"April 21, 2021",Local,Pakistan,Pakistan,"July 29, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),2162,39.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Salma Abbas,Shaukat Khanum Memorial Cancer Hospital and Research Centre,https://dx.doi.org/10.1177/10105395211011010,5/19/2021,7/17/2021,Unverified
200930_Karachi_NationalInstituteOfBloodDiseasesAndBoneMarrowTransplantation,"September 30, 2020",Local,Pakistan,Pakistan; Sindh; Kararchi,"August 30, 2020","September 12, 2020",Household and community samples,Adults (18-64 years),2404,55.00%,,,Convenience,NA,CLIA,"IgG,IgM,IgA",,,High,Preprint,Faiza Rezwan,National Institute of Blood Diseases and Bone Marrow Transplantation,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3700931,5/20/2021,6/17/2021,Unverified
210525_Pakistan_RiphahInternationalUniversity,"May 25, 2021",National,Pakistan,Pakistan,"July 15, 2020","July 31, 2020",Household and community samples,Multiple groups,15390,42.40%,41.50%,43.14%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohsina Haq,Riphah International University ,https://dx.doi.org/10.1007/s15010-021-01629-2,6/7/2021,7/17/2021,Unverified
210529_Pakistan_CombinedMilitaryHospitalKharianMedicalCollege,"May 29, 2021",National,Pakistan,Pakistan,"September 1, 2020","September 30, 2020",Non-essential workers and unemployed persons,Multiple groups,442,16.96%,,,Convenience,Boditech Med Inc.,LFIA,IgG,95.80%,96.70%,High,Journal Article (Peer-Reviewed),Iffat Naiyar,Combined Military Hospital Kharian Medical College,https://dx.doi.org/10.1016/j.jtumed.2021.04.004,6/17/2021,8/4/2021,Unverified
210427_Oman_Directorate-GeneralforDiseasesSurveillanceandControl,"April 27, 2021",National,Oman,"Oman; Al Dakhilia, North Batinah, and South Batinah goveronates","September 14, 2020","September 28, 2020",Health care workers and caregivers,Adults (18-64 years),1078,21.00%,,,Simplified probability,DiaSorin SpA,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amal Al Maani,Directorate-General for Diseases Surveillance and Control,https://dx.doi.org/10.1016/j.ijid.2021.04.071,5/31/2021,7/6/2021,Unverified
210107_WestBank_ArabAmericanUniversity_Households_overall_adj,"January 7, 2021",Local,occupied Palestinian territory (including east Jerusalem),occupied Palestinian territory (including east Jerusalem),"June 15, 2020","June 30, 2020",Household and community samples,Multiple groups,1355,0.00%,0.00%,0.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,83.87%,100.00%,Low,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,7/17/2021,Verified
210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj,"January 7, 2021",Local,occupied Palestinian territory (including east Jerusalem),occupied Palestinian territory (including east Jerusalem),"May 1, 2020","July 9, 2020",Residual sera,Multiple groups,1136,0.35%,0.13%,1.16%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,83.87%,High,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,7/17/2021,Verified
200615_Bergen_UniversityofBergen_HouseholdMembers,"June 15, 2020",Local,Norway,Norway; Western Norway; Bergen,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Not reported,77,31.17%,,,Convenience,NA,ELISA,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Rebecca Cox,University of Bergen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/,7/19/2020,7/6/2021,Verified
200626_Norway_NorwegianInstituteofPublicHealth_OverallAdj,"June 26, 2020",National,Norway,Norway,"April 20, 2020","May 17, 2020",Residual sera,Multiple groups,900,1.00%,0.10%,2.40%,Sequential,NA,Other,IgG,86.00%,100.00%,Moderate,Institutional Report,Gro Tunheim,Norwegian Institute of Public Health,https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2020/covid-19/seroprevalence-of-sars-cov-2-in-the-norwegian-population_report-26-06-2020.pdf,10/6/2020,8/4/2021,Verified
201128_Bergen_UniversityofBergen_primaryest_HCW,"November 28, 2020",Local,Norway,Norway; Midhordland; Bergen,"March 6, 2020","April 9, 2020",Health care workers and caregivers,Multiple groups,607,5.27%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mai Chi Trieu,University of Bergen,https://dx.doi.org/10.1093/infdis/jiaa737,1/29/2021,7/6/2021,Verified
210115_Norway_NorwegianArmedForcesJointMedicalServices_primary,"January 15, 2021",National,Norway,Norway,"April 19, 2020","April 27, 2020",Essential non-healthcare workers,Adults (18-64 years),1170,0.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Einar Kristian Borud,Norwegian Armed Forces Joint Medical Services,https://dx.doi.org/10.1002/hsr2.233,2/27/2021,7/17/2021,Verified
210223_Lorenskog_AkershusUniversityHospital_Overall,"February 23, 2021",Local,Norway,Norway,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),360,3.30%,,,Convenience,"DiaSorin SpA,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nina Handal,Akershus University Hospital,https://dx.doi.org/10.1080/23744235.2021.1885734,3/23/2021,8/4/2021,Verified
210331_Bergen_UniversityOfBergen_overall_unadj,"March 31, 2021",Local,Norway,Norway,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Multiple groups,179,45.00%,38.00%,53.00%,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Kanika Kuwelker,University of Bergen ,https://dx.doi.org/10.1016/j.lanepe.2020.100014,5/17/2021,8/4/2021,Verified
210326_Norway_ArcticUniversityOfNorway_PopAdj_TestAdj,"March 26, 2021",National,Norway,Norway,"November 25, 2020","February 15, 2021",Household and community samples,Multiple groups,27700,0.90%,0.70%,1.00%,Stratified probability,"EUROIMMUN AG,NA",Multiple Types,IgG,,,Low,Preprint,Erik Anda,Arctic University of Norway,https://www.medrxiv.org/content/10.1101/2021.03.23.21253730v1,5/18/2021,8/4/2021,Verified
201201_Norway_NorwegianPublicHealth_poptestadj,"December 15, 2020",National,Norway,Norway,"July 20, 2020","September 13, 2020",Residual sera,Multiple groups,1812,0.60%,0.20%,1.20%,Convenience,NA,Other,IgG,86.00%,99.90%,Moderate,Institutional Report,Gro Tunheim,Norwegian Institute of Public Health,https://www.fhi.no/en/publ/2020/Seroprevalence-of-SARS-CoV-2-in-Norwegian-population-measured-in-residual-sera-collected-in-late-summer-2020/,5/21/2021,8/4/2021,Verified
210531_Skopje_InstituteForTransfusionMedicine,"May 31, 2021",Local,North Macedonia,North Macedonia; Skopje; Skopje,"November 1, 2020","March 31, 2021",Blood donors,Multiple groups,9773,25.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tatjana Makarovska Bojadjieva, Institute for Transfusion Medicine,http://dx.doi.org/10.1111/vox.13117,7/1/2021,7/6/2021,Unverified
200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1,"July 24, 2020",Local,Nigeria,Nigeria; Cross River State; Calabar,"June 17, 2020","June 24, 2020",Multiple populations,Adults (18-64 years),66,26.00%,,,Unclear,Healgen,LFIA,IgG,,,High,Preprint,Marcus Inyama Asuquo,Joseph Ukpo Hospitals and Research Institutes,https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2,9/27/2020,8/5/2021,Verified
200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj,"August 5, 2020",Regional,Nigeria,Nigeria; Niger State,"June 26, 2020","June 30, 2020",Household and community samples,Multiple groups,185,25.41%,,,Stratified probability,Cambridge Network,LFIA,IgG,100.00%,100.00%,Moderate,Preprint,Hussaini Majiya,Ibrahim Badamasi Babangida University,https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf,10/14/2020,8/5/2021,Verified
210121_Abuja_MolecularPathologyInstituteEnugu,"January 21, 2021",Local,Nigeria,"Nigeria; NR; Abuja, Enugu","August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),113,42.00%,34.00%,52.00%,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,100.00%,100.00%,High,Preprint,Ijeoma Ifeorah,Molecular Pathology Institute,https://www.researchsquare.com/article/rs-151037/v1,5/22/2021,7/6/2021,Unverified
210719_AnambraState_StateMinistryOfHealth_Primary,"July 19, 2021",Regional,Nigeria,Nigeria; Anambra State,"December 8, 2020","December 15, 2020",Household and community samples,Multiple groups,3142,17.60%,16.26%,18.98%,Stratified probability,"Hangzhou Realy Tech Co., Ltd",RDT,"IgG,IgM",98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),OgoChukwu Vincent Okpala,Anambra State Ministry of Health,https://www.sciencedirect.com/science/article/pii/S1201971221005968,8/3/2021,8/3/2021,Unverified
210301_Nicaragua_NationalAutonomousUniversityofNicaragua_overall_unadj,"March 1, 2021",Local,Nicaragua,Nicaragua,"September 15, 2020","October 15, 2020",Household and community samples,Multiple groups,1351,33.75%,,,Unclear,NA,ELISA,"IgG,IgA,IgM",,,Moderate,Preprint,Fredman Gonzalez,National Autonomous University of Nicaragua,https://dx.doi.org/10.1101/2021.02.25.21252447,4/3/2021,7/9/2021,Verified
210419_NewZealand_UniversityOfAuckland_BloodDonors,"April 19, 2021",National,New Zealand,New Zealand,"December 3, 2020","January 6, 2021",Blood donors,Adults (18-64 years),9806,0.10%,0.09%,0.12%,Sequential,"EUROIMMUN AG,GenScript",Multiple Types,IgG,81.70%,100.00%,Moderate,Preprint,Lauren Carlton,University of Auckland,https://www.medrxiv.org/content/10.1101/2021.04.12.21255282v1,5/20/2021,8/5/2021,Unverified
210518_NewZealand_SouthernCommunityLaboratories_MostAdj,"May 18, 2021",Regional,New Zealand,New Zealand; Southern Region,"June 4, 2020","August 4, 2020",Contacts of COVID patients,Multiple groups,1127,0.90%,0.40%,1.70%,Convenience,"Abbott Laboratories,NA,Beijing Wantai Biological,EUROIMMUN AG,GenScript",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Alyson Craigie,Southern Community Laboratories,https://dx.doi.org/10.1016/j.pathol.2021.04.001,6/20/2021,8/4/2021,Unverified
201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,"November 12, 2020",National,Netherlands,Netherlands,"April 1, 2020","April 15, 2020",Blood donors,Multiple groups,7361,3.40%,,,Sequential,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",100.00%,99.10%,Moderate,Journal Article (Peer-Reviewed),Ed Slot,Amsterdam UMC,https://www.nature.com/articles/s41467-020-19481-7,5/25/2020,6/17/2021,Verified
200824_Rotterdam_ErasmusMedicalCentre_1_March,"August 24, 2020",Local,Netherlands,Netherlands,"March 2, 2020","March 6, 2020",Residual sera,Multiple groups,879,0.10%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,6/17/2021,Verified
200824_Rotterdam_ErasmusMedicalCentre_2_April,"August 24, 2020",Local,Netherlands,Netherlands,"April 3, 2020","April 7, 2020",Residual sera,Multiple groups,729,2.30%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,6/17/2021,Verified
201128_Netherlands_CentreforInfectiousDiseaseControl_genpop_overall,"November 28, 2020",National,Netherlands,Netherlands,"March 31, 2020","May 11, 2020",Household and community samples,Multiple groups,2637,2.80%,2.10%,3.70%,Stratified probability,NA,ELISA,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,6/17/2021,Verified
201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall,"November 28, 2020",National,Netherlands,Netherlands,"March 31, 2020","May 11, 2020",Household and community samples,Multiple groups,570,2.90%,1.40%,6.30%,Stratified probability,NA,ELISA,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,6/17/2021,Verified
210312_Amsterdam_PublicHealthServiceOfAmsterdam_overall,"March 12, 2021",Local,Netherlands,Netherlands,"June 24, 2020","October 9, 2020",Household and community samples,Multiple groups,2483,9.10%,,,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",,,High,Preprint,Liza Coyer,Public Health Service of Amsterdam,10.1101/2021.03.08.21252788,4/3/2021,6/24/2021,Verified
210316_Netherlands_SanquinResearch_blooddonors,"March 16, 2021",National,Netherlands,Netherlands,"May 11, 2020","May 18, 2020",Blood donors,Multiple groups,3676,6.50%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,98.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Katj van den HUrk,Sanquin Research,https://dx.doi.org/10.1016/j.xcrm.2021.100222,5/10/2021,7/9/2021,Verified
210212_Netherlands_NationalInstituteforPublicHealthandtheEnvironment,"February 12, 2021",National,Netherlands,Netherlands,"June 9, 2020","August 24, 2020",Household and community samples,Multiple groups,6813,4.50%,3.80%,5.20%,Stratified probability,NA,Other,IgG,94.30%,99.90%,Low,Preprint,Eric Vos,National Institute for Public Health and the Environment ,10.1101/2021.02.10.21251477,5/22/2021,6/17/2021,Verified
210430_Amsterdam_AmsterdamUniversityMedicalCenter,"April 30, 2021",Local,Netherlands,Netherlands; North Holland; Amsterdam,"July 31, 2020","December 18, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),546,11.70%,,,Convenience,NA,Not reported,Not reported,98.10%,99.50%,High,Journal Article (Peer-Reviewed),Zoe L E van Kempen,Amsterdam University Medical Center,https://dx.doi.org/10.1001/jamaneurol.2021.1364,5/25/2021,7/6/2021,Unverified
210323_Budel_MaastrichtUniversity_Overall,"March 23, 2021",Local,Netherlands,Netherlands; North Brabant; Budel,"June 4, 2020","June 16, 2020",Health care workers and caregivers,Adults (18-64 years),240,39.17%,,,Convenience,Beijing Wantai Biological,Not reported,"IgA,IgG,IgM",96.10%,98.00%,High,Journal Article (Peer-Reviewed),Joyce Heffels,Maastricht University,https://dx.doi.org/10.36613/tgg.1875-6832/2021.01.01,6/8/2021,7/23/2021,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_COVIDCare3,"July 28, 2021",Local,Netherlands,Netherlands,"March 23, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),439,13.20%,9.90%,16.40%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Jonne J Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/2/2021,8/2/2021,Unverified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NonCOVIDCare2,"July 28, 2021",Local,Netherlands,Netherlands,"June 25, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),164,6.70%,2.80%,10.50%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Jonne J Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/2/2021,8/2/2021,Unverified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NoPatientCare1,"July 28, 2021",Local,Netherlands,Netherlands,"March 23, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),198,3.60%,0.90%,6.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Jonne J Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/2/2021,8/2/2021,Unverified
210404_Nepal_GovernmentOfNepal_overall_PopAdj,"April 4, 2021",National,Nepal,Nepal,"October 9, 2020","October 22, 2020",Household and community samples,Multiple groups,3040,14.40%,11.80%,17.00%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Low,Institutional Report,Government of Nepal,Government of Nepal,https://mohp.gov.np/attachments/article/708/First%20Sero-prevalence_final_report_04-04-2021.pdf,5/22/2021,7/21/2021,Verified
210623_KathmanduValley_NepalHealthResearchCouncil_TestAdj,"June 23, 2021",Regional,Nepal,Nepal; Bagmati Pradesh Province; Kathmandu Valley,"December 3, 2020","December 25, 2020",Health care workers and caregivers,Adults (18-64 years),800,38.99%,29.08%,43.91%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,89.30%,99.20%,Moderate,Preprint,Kiran Raj Pandey,Nepal Health Research Council,10.21203/rs.3.rs-626260/v1,7/5/2021,7/5/2021,Unverified
210706_Kathmandu_ManmohanMemorialMedicalCollege_primary,"July 6, 2021",Local,Nepal,Nepal,"November 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),185,22.20%,,,Convenience,,Other,"IgM,IgG",,,High,Preprint,Suraj Aryal,Manmohan Memorial Medical College,10.1101/2021.07.01.21259884,7/13/2021,7/16/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Overall,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Household and community samples,Multiple groups,1360,2.50%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,5/20/2021,6/25/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Household and community samples,Multiple groups,9756,1.40%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,5/20/2021,7/12/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Genpop_Primary,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Household and community samples,Multiple groups,1577,7.40%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,5/21/2021,7/24/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_Genpop_Primary,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Household and community samples,Multiple groups,3974,5.50%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,5/21/2021,7/24/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Household and community samples,Multiple groups,1769,5.00%,4.00%,6.00%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,5/21/2021,7/12/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Household and community samples,Multiple groups,4717,3.79%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,5/21/2021,7/18/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Household and community samples,Multiple groups,4940,5.20%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,5/21/2021,7/12/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Household and community samples,Multiple groups,1946,0.70%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,5/21/2021,7/17/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Household and community samples,Multiple groups,5394,3.56%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,5/21/2021,7/18/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Household and community samples,Multiple groups,5069,2.50%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,5/21/2021,7/17/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Household and community samples,Multiple groups,1635,0.30%,,,Stratified probability,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,5/22/2021,7/17/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_Genpop_Primary,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Household and community samples,Multiple groups,4932,3.70%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,5/22/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_Genpop_Primary,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Household and community samples,Multiple groups,2451,5.30%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,5/22/2021,7/24/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_HealthProfessionals,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),506,5.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,7/17/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Vendors/Merchants,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),928,6.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,7/17/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Essential non-healthcare workers,Adults (18-64 years),248,4.80%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,8/4/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenseForces,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Essential non-healthcare workers,Adults (18-64 years),513,3.70%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,8/5/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),369,5.40%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,7/17/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Fishermen,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),80,5.00%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,7/17/2021,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DisplacedPeople,"July 27, 2020",Local,Mozambique,Mozambique; Cabo Delgado; Pemba,"July 6, 2020","July 13, 2020",Persons experiencing homelessness,Multiple groups,66,6.10%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,7/17/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Non-essential workers and unemployed persons,Multiple groups,188,6.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,7/17/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Essential non-healthcare workers,Multiple groups,324,2.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,8/4/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Health care workers and caregivers,Multiple groups,787,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,7/17/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Essential non-healthcare workers,Multiple groups,473,8.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,8/4/2021,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 15, 2020",Local,Mozambique,Mozambique; Sofala; Beira,"September 21, 2020","October 2, 2020",Non-essential workers and unemployed persons,Multiple groups,1585,8.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,7/17/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Refugees,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Persons experiencing homelessness,Multiple groups,221,6.00%,2.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,7/17/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),250,5.00%,2.00%,7.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,7/17/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),564,6.00%,4.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,7/31/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1427,7.00%,6.00%,9.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,8/4/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),554,3.00%,1.00%,4.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,7/31/2021,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_MerchantsVendors,"July 7, 2020",Local,Mozambique,Mozambique; Nampula; Nampula,"June 17, 2020","June 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1493,10.00%,8.00%,11.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,7/17/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Essential non-healthcare workers,Adults (18-64 years),287,1.00%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,8/4/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Health care workers and caregivers,Adults (18-64 years),380,1.30%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,7/17/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Essential non-healthcare workers,Adults (18-64 years),407,4.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,8/4/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),172,4.70%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,7/17/2021,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"November 27, 2020",Local,Mozambique,Mozambique; Manica Province; Chimoio,"November 2, 2020","November 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),643,1.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,7/17/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),871,0.20%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/17/2021,7/17/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Essential non-healthcare workers,Adults (18-64 years),230,0.40%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/17/2021,8/4/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Health care workers and caregivers,Adults (18-64 years),454,1.80%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/17/2021,7/17/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Essential non-healthcare workers,Adults (18-64 years),471,1.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/17/2021,8/4/2021,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 19, 2020",Local,Mozambique,Mozambique; Niassa; Lichinga,"September 28, 2020","October 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),122,0.00%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/17/2021,7/17/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),200,1.00%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,7/17/2021,7/17/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),367,7.40%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,7/17/2021,8/4/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),390,3.10%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,7/17/2021,8/4/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1123,1.60%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,7/17/2021,7/17/2021,Verified
201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,"October 3, 2020",Local,Mozambique,Mozambique; Zambezia; Quelimane,"August 10, 2020","August 21, 2020",Health care workers and caregivers,Adults (18-64 years),543,3.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf,7/17/2021,7/17/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Essential non-healthcare workers,Adults (18-64 years),554,2.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/17/2021,8/4/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Essential non-healthcare workers,Adults (18-64 years),334,1.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/17/2021,8/4/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1556,0.80%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/17/2021,7/17/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Health care workers and caregivers,Adults (18-64 years),569,0.70%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/17/2021,7/17/2021,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"September 24, 2020",Local,Mozambique,Mozambique; Tete; Tete,"August 31, 2020","October 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),404,0.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/17/2021,7/17/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),323,5.88%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,7/18/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1288,4.97%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,7/18/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),456,4.39%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,8/4/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),793,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,7/18/2021,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"October 21, 2020",Local,Mozambique,Mozambique; Maputo; Matolo,"September 14, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),282,3.19%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,8/4/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1246,5.22%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,7/18/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),595,4.54%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,7/18/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),559,3.94%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,8/4/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Airport&PortWorkers,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),362,3.31%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,8/4/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Health care workers and caregivers,Adults (18-64 years),1443,2.63%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,7/18/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),623,2.25%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,8/4/2021,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_NursingHomeWorkers,"August 31, 2020",Local,Mozambique,Mozambique,"August 3, 2020","August 21, 2020",Health care workers and caregivers,Adults (18-64 years),85,1.18%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,7/18/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_DefenceForcesy,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Essential non-healthcare workers,Multiple groups,174,9.20%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,8/5/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_TransportationWorkers,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),153,4.60%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,8/4/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_VendorsMerchants,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1001,4.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_CommercialEstablishments,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),255,3.50%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_HCW,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Maxixe,"November 7, 2020","November 21, 2020",Health care workers and caregivers,Adults (18-64 years),342,2.00%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_DefenceForces,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Essential non-healthcare workers,Adults (18-64 years),116,18.10%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,8/5/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_TransportationWorkers,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Essential non-healthcare workers,Adults (18-64 years),34,5.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,8/4/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Vendors/Merchants,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),517,8.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_CommercialEstablishments,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),128,10.90%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_HCW,"December 16, 2020",Local,Mozambique,Mozambique; Inhambane; Massinga,"November 26, 2020","December 3, 2020",Health care workers and caregivers,Adults (18-64 years),131,6.10%,,,Convenience,"Qingdao Hightop Biotech Co., Ltd ",LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_VendorsMerchants,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),460,5.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_TransporationWorkers,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Essential non-healthcare workers,Adults (18-64 years),209,3.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,8/4/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_HCWs,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Health care workers and caregivers,Adults (18-64 years),281,5.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_DefenceForces,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Essential non-healthcare workers,Adults (18-64 years),116,1.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,8/4/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_CommercialEstablishments,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Xai-Xai,"November 2, 2020","November 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),272,3.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_VendorsMerchants,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),472,6.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_TransporationWorkers,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),112,16.10%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,8/4/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_HCWs,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Health care workers and caregivers,Adults (18-64 years),165,10.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_CommercialEstablishments,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),145,7.50%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,7/24/2021,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_DefenceForces,"December 8, 2020",Local,Mozambique,Mozambique; Gaza; Chokwe,"November 16, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),67,10.40%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,8/4/2021,Verified
201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_TestAdj,"November 2, 2020",Local,Mexico,Mexico; Nuevo Leon; Guadalupe,"July 9, 2020","July 23, 2020",Multiple populations,Multiple groups,3268,5.70%,4.90%,6.60%,Convenience,Roche Diagnostics,CLIA,"IgM,IgG",99.50%,99.80%,Moderate,Preprint,Cristina Diaz-Salazar,Universidad Autonoma de Nuevo Leon,https://www.researchsquare.com/article/rs-84890/v1,11/27/2020,8/5/2021,Verified
201021_VeracruzCity_UniversidadVeracruzana_unadj,"October 21, 2020",Local,Mexico,Mexico,"June 1, 2020","July 31, 2020",Residual sera,Multiple groups,2174,29.50%,27.59%,31.47%,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Preprint,Jose Maria Remes-Troche,Universidad Veracruzana,https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1,1/17/2021,6/17/2021,Verified
201130_NuevoLeon_AutonomousUniversityofNuevoLeon_primary,"November 30, 2020, June 24, 2021",Regional,Mexico,Mexico; Nuevo Leon,"January 1, 2020","December 15, 2020",Blood donors,Adults (18-64 years),2068,5.30%,,,Sequential,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,High,"Preprint, Journal Article (Peer-Reviewed)","Natalia Martinez Acuna, Natalia Martinez-Acu a",Autonomous University of Nuevo Leon,"https://www.medrxiv.org/content/10.1101/2020.11.28.20240325v1.full, https://dx.doi.org/10.3390/v13071225",2/4/2021,7/12/2021,Verified
210305_MexicoCity_InstitutoNacionaldeRehabilitacion_primary_ELISA,"March 5, 2021",Local,Mexico,Mexico,"August 10, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),299,13.00%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,,,High,Preprint,Esteban Cruz Arenas, Instituto Nacional de Rehabilitacion,https://www.medrxiv.org/content/10.1101/2020.11.30.20241331v2,4/8/2021,6/17/2021,Unverified
210415_Mexico_InstitutodeSaludparaelBienestar,"April 15, 2021",National,Mexico,Mexico,"February 10, 2020","December 31, 2020",Residual sera,Multiple groups,24273,15.90%,,,Stratified non-probability,"DiaSorin SpA,GenScript",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Jose Munoz Medina,Instituto de Salud para el Bienestar,https://dx.doi.org/10.3390/microorganisms9040850,5/19/2021,8/4/2021,Unverified
210423_Monterrey_UniversidadAutónomaDeNuevoLeón,"April 23, 2021",Local,Mexico,Mexico; Nuevo Leon; Monterrey,"May 22, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,154,11.70%,,,Sequential,Healgen,LFIA,"IgG,IgM",90.11%,98.46%,High,Journal Article (Peer-Reviewed),Giovanna Yazmin Arteaga Muller,Universidad Autónoma de Nuevo León,https://dx.doi.org/10.1007/s11255-021-02852-4,5/21/2021,6/17/2021,Unverified
201216_Mexico_GovernmentOfMexico_overall,"December 16, 2020",National,Mexico,Mexico,"August 15, 2020","November 15, 2020",Household and community samples,Multiple groups,7098,25.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Secretaria de Salud ,Government of Mexico,https://www.gob.mx/salud/prensa/255-secretaria-de-salud-presenta-resultados-preliminares-de-la-encuesta-nacional-de-salud-y-nutricion-covid-19?idiom=es,6/6/2021,7/16/2021,Verified
210607_NuevoLeon_HealthServicesOfTheStateOfNuevoLeon_Overall,"June 7, 2021",Regional,Mexico,Mexico; Nuevo Leon,"August 15, 2020","November 15, 2020",Household and community samples,Multiple groups,4495,27.10%,25.80%,28.40%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Edgar Rodriguez-Vidales,Health Services of the State of Nuevo Leon,https://dx.doi.org/10.1002/jmv.27131,6/22/2021,6/22/2021,Unverified
210415_Mexico_InstitutodeSaludparaelBienestar_Feb10-Feb27,"April 15, 2021",National,Mexico,Mexico,"February 10, 2020","February 27, 2020",Residual sera,Multiple groups,1057,3.78%,,,Stratified non-probability,DiaSorin SpA,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jose Munoz Medina,Instituto de Salud para el Bienestar,https://dx.doi.org/10.3390/microorganisms9040850,7/5/2021,8/4/2021,Unverified
210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall,"January 18, 2021",Local,Mauritania,Mauritania,"May 5, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),835,1.67%,,,Convenience,"Xiamen Biotime Biotechnology Co., Ltd",LFIA,"IgG,IgM",96.40%,98.70%,High,Journal Article (Peer-Reviewed),Mohamed Lemine Ould Salem,Centre Hospitalier National de Nouakchott,http://dx.doi.org/10.11604/pamj.2021.38.55.24259,4/13/2021,6/17/2021,Verified
210429_Mali_UniversityofSciences_Visit2_Overall_adj,"April 29, 2021",Local,Mali,Mali,"December 14, 2020","January 29, 2021",Household and community samples,Multiple groups,2353,54.70%,44.40%,65.00%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Preprint,Issaka Sagara,University of Sciences ,https://www.medrxiv.org/content/10.1101/2021.04.26.21256016v1,5/22/2021,7/7/2021,Unverified
200813_Selangor_UniversityMalaya_OverallPopAdj,"August 13, 2020",Regional,Malaysia,Malaysia; Selangor; Kuala Lumpur,"January 29, 2020","June 6, 2020",Residual sera,Multiple groups,588,0.40%,0.00%,0.93%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),I Ching Sam,University Malaya,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426,10/2/2020,7/6/2021,Verified
210321_KlangValley_MalaysianMinistryofHealth_HCW,"March 21, 2021",Local,Malaysia,Malaysia; Klang Valley,"April 13, 2020","May 12, 2020",Health care workers and caregivers,Adults (18-64 years),400,0.00%,0.00%,0.01%,Self-referral,GenScript,Neutralization,Not reported,91.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuan Liang Woon,Malaysian Ministry of Health,https://dx.doi.org/10.1016/j.lanwpc.2021.100123,4/18/2021,7/16/2021,Verified
200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj,"August 5, 2020",National,Malawi,Malawi; Southern Region Malawi; Blantyre,"May 22, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),500,12.30%,8.20%,16.50%,Convenience,Omega diagnostics,ELISA,IgG,88.10%,93.20%,High,Preprint,Marah Chibwana,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf,8/8/2020,6/20/2021,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMarch_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"March 1, 2020","March 30, 2020",Blood donors,Adults (18-64 years),496,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,8/4/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoApril_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),157,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,8/4/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMay_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),598,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,8/4/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJune_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),308,2.80%,2.70%,2.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJuly_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),428,35.40%,35.20%,35.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoAugust_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"August 1, 2020","August 30, 2020",Blood donors,Adults (18-64 years),432,41.30%,41.10%,41.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoSeptember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),481,43.50%,43.30%,43.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoOctober_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),495,43.20%,43.00%,43.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoNovember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),502,38.00%,37.90%,38.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJune_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),82,43.70%,43.10%,44.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJuly_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),182,51.20%,50.80%,51.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaAugust_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),227,49.20%,48.90%,49.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaSeptember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),213,36.20%,35.90%,36.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaOctober_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),199,33.00%,32.60%,33.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaNovember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),282,23.30%,23.10%,23.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/16/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJune_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),129,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJuly_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"July 1, 2020","July 30, 2020",Blood donors,Adults (18-64 years),142,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaAugust_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),120,10.40%,10.20%,10.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaSeptember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),173,21.90%,21.60%,22.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaOctober_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),152,18.70%,18.50%,18.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaNovember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),172,16.20%,16.00%,16.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJune_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),50,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJuly_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),98,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaAugust_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),107,44.50%,44.10%,44.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaSeptember_Adj ,"June 4, 2021",Local,Madagascar,Madagascar,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),53,26.00%,25.90%,26.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaOctober_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),26,29.60%,28.90%,30.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaNovember_Adj ,"June 4, 2021",Local,Madagascar,Madagascar,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),30,21.50%,20.90%,22.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJune_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),87,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJuly_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),147,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraAugust_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),167,7.90%,7.70%,8.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraSeptember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),185,24.20%,23.90%,24.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraOctober_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),139,27.70%,27.30%,28.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraNovember_Adj,"June 4, 2021",Local,Madagascar,Madagascar,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),199,23.50%,23.20%,23.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,6/17/2021,Unverified
200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,"May 18, 2020",National,Luxembourg,Luxembourg,"April 15, 2020","May 5, 2020",Household and community samples,Multiple groups,1820,2.09%,1.37%,2.82%,Stratified probability,EUROIMMUN AG,ELISA,IgG,85.70%,97.80%,Moderate,Preprint,Chantal Snoeck,Luxembourg Institute of Health,https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1,7/12/2020,6/17/2021,Verified
210107_Lithuania_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Lithuania,Lithuania; NR; NR,"June 1, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),300,0.66%,0.18%,2.40%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIA,"February 6, 2021",Local,Lithuania,Lithuania,"June 15, 2020","September 21, 2020",Health care workers and caregivers,Multiple groups,432,1.16%,,,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Laura Pereckaite,The Hospital of Lithuanian University of Health Sciences Kauno Klinikos,https://dx.doi.org/10.3390/medicina57020148,3/16/2021,6/17/2021,Verified
210118_Lithuania_210118_Lithuania_LithuanianUniversityofHealthSciences_TestAdj,"January 18, 2021",National,Lithuania,"Lithuania; Vilnius County, Kaunas county, Klaipėda County, Tauragė County, Utena county
; Vilnius, Kaunas, Klaipėda
","August 10, 2020","September 10, 2020",Household and community samples,Multiple groups,3089,1.40%,0.92%,1.99%,Simplified probability,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",92.00%,99.40%,Moderate,Journal Article (Peer-Reviewed),Kastytis Smigelskas, Lithuanian University of Health Sciences,https://www.journals.vu.lt/AML/article/view/22344,5/13/2021,7/6/2021,Unverified
210212_Kaunas_LithuanianUniversityOfHealthSciences_HidradenitisSuppurativa,"February 12, 2021",Local,Lithuania,Lithuania,"August 12, 2020","December 30, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,26,7.70%,2.13%,24.14%,Convenience,"EUROIMMUN AG,EUROIMMUN",ELISA,"IgG,IgM",,,High,Presentation or Conference,Vaiva Jariene,Lithuanian University of Health Sciences,https://www.researchgate.net/publication/349992124_SARS-CoV-2_Seroprevalence_in_Patients_with_Hidradenitis_Suppurativa_in_Lithuania,7/5/2021,7/16/2021,Verified
201209_Liechtenstein_KantonsspitalGraubunden_Overall,"December 9, 2020",National,Liechtenstein,Liechtenstein,"June 2, 2020","October 6, 2020",Multiple populations,Not reported,1159,7.80%,6.40%,9.50%,Convenience,"Roche Diagnostics,NA",Multiple Types,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Anna Schaffner,Kantonsspital Graunbunden,https://dx.doi.org/10.3390/jcm9123989,1/28/2021,8/5/2021,Verified
200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,"May 26, 2020",Local,Libya,Libya; Libya; Alzintan City,"April 2, 2020","May 18, 2020",Health care workers and caregivers,Multiple groups,77,0.00%,,,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,6/17/2021,Verified
200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,"May 26, 2020",Local,Libya,Libya; Libya; Alzintan City,"April 2, 2020","May 18, 2020",Multiple populations,Multiple groups,142,4.23%,,,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,8/5/2021,Verified
200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall,"September 29, 2020",Local,Libya,Libya,"May 2, 2020","May 7, 2020",Household and community samples,Multiple groups,600,0.00%,,,Stratified probability,NA,LFIA,"IgG,IgM",81.70%,96.70%,Moderate,Journal Article (Peer-Reviewed),Amal A Elfakhri,The Center of Infectious Diseases- Benghazi,https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf,4/26/2021,6/17/2021,Verified
210107_Latvia_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Latvia,Latvia; NR; NR,"May 19, 2020","June 20, 2020",Health care workers and caregivers,Adults (18-64 years),177,0.00%,0.00%,2.14%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210713_LaoPDR_InstitutPasteurDuLaos_GeneralCommunity_Primary,"July 13, 2021",National,Lao People's Democratic Republic,Lao People's Democratic Republic,"August 12, 2020","September 25, 2020",Household and community samples,Multiple groups,2433,5.20%,4.20%,6.50%,Stratified probability,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/28/2021,Unverified
210713_LaoPDR_InstitutPasteurDuLaos_HCW_Primary,"July 13, 2021",National,Lao People's Democratic Republic,Lao People's Democratic Republic,"August 12, 2020","September 25, 2020",Health care workers and caregivers,Adults (18-64 years),666,1.90%,1.10%,3.30%,Convenience,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/28/2021,Unverified
210713_LaoPDR_InstitutPasteurDuLaos_WildlifeContacts_Primary,"July 13, 2021",National,Lao People's Democratic Republic,Lao People's Democratic Republic,"August 12, 2020","September 25, 2020",Non-essential workers and unemployed persons,Multiple groups,74,20.30%,12.60%,31.00%,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/28/2021,Unverified
201205_Kuwait_KuwaitUniversity_Overall_unadj,"December 5, 2020",National,Kuwait,Kuwait,"May 23, 2020","June 26, 2020",Essential non-healthcare workers,Adults (18-64 years),525,38.10%,34.00%,42.30%,Stratified probability,Biozek,LFIA,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Walid Q Alali,University of Kuwait,https://dx.doi.org/10.1093/jtm/taaa223,1/23/2021,8/5/2021,Verified
210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,"February 17, 2021",National,Kenya,Kenya,"September 30, 2020","October 23, 2020",Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NA,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,E Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1,3/16/2021,6/17/2021,Verified
210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj,"February 8, 2021",Local,Kenya,Kenya; Nairobi; Nairobi,"July 30, 2020","August 25, 2020",Pregnant or parturient women,Adults (18-64 years),196,49.90%,42.70%,58.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,4/15/2021,6/19/2021,Verified
210208_Kenya_KEMRI-WellcomeTrust_Kilifi_Overall_TestAdj,"February 8, 2021",Local,Kenya,Kenya; Kilifi; Kilifi,"November 1, 2020","November 24, 2020",Pregnant or parturient women,Adults (18-64 years),154,11.00%,6.20%,16.70%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,4/15/2021,7/23/2021,Verified
210421_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,"April 24, 2021",National,Kenya,"Kenya; Central, Coastal, Western","July 30, 2020","December 4, 2020",Health care workers and caregivers,Adults (18-64 years),684,20.80%,17.50%,24.40%,Convenience,NA,ELISA,IgG,92.70%,99.00%,Moderate,Journal Article (Peer-Reviewed),Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1093/cid/ciab346,5/23/2021,6/19/2021,Unverified
210517_Nairobi_WashingtonStateUniversity_TestAdjPopAdj,"May 17, 2021",Local,Kenya,Kenya,"November 2, 2020","November 23, 2020",Household and community samples,Multiple groups,1164,34.70%,31.80%,37.60%,Simplified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",94.40%,100.00%,Low,Preprint,Isaac Ngere,Washington State University,10.2139/ssrn.3844795,6/1/2021,6/17/2021,Unverified
210208_Kenya_KEMRI-WellcomeTrust_KilifiOct_TestAdj,"February 8, 2021",Local,Kenya,Kenya; NR; Kilifi,"October 1, 2020","October 31, 2020",Pregnant or parturient women,Adults (18-64 years),183,1.50%,0.07%,4.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,6/23/2021,7/23/2021,Verified
210208_Kenya_KEMRI-WellcomeTrust_KilifiSept_TestAdj,"February 8, 2021",Local,Kenya,Kenya,"September 18, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),82,1.30%,0.04%,4.70%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,6/23/2021,7/23/2021,Verified
210625_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj,"June 25, 2021",National,Kenya,Kenya,"April 30, 2020","September 30, 2020",Blood donors,Adults (18-64 years),9922,7.90%,6.70%,9.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Low,Journal Article (Peer-Reviewed),Ifedayo M. O. Adetifa,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1038/s41467-021-24062-3,7/7/2021,7/7/2021,Unverified
210707_Kenya_KEMRI-WellcomeTrustResearchProgramme_PopAdjTestAdj,"July 7, 2021",National,Kenya,Kenya,"January 3, 2021","March 15, 2021",Blood donors,Adults (18-64 years),3018,48.50%,45.20%,52.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,Sophie Uyoga,KEMRI-Wellcome Trust Research Programme,10.1101/2021.07.06.21260038,7/15/2021,7/15/2021,Unverified
210726_Dagahaley_MédecinsSansFrontières_Patients_Overall,"July 26, 2021",Local,Kenya,"Kenya; NR; Dagahaley camp, Daadab Refugee Complex","March 1, 2021","April 14, 2021",Multiple populations,Multiple groups,619,6.90%,,,Sequential,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,8/3/2021,8/5/2021,Unverified
210726_Dagahaley_MédecinsSansFrontières_FamilyMembers,"July 26, 2021",Local,Kenya,"Kenya; NR; Dagahaley camp, Daadab Refugee Complex","March 1, 2021","April 14, 2021",Multiple populations,Multiple groups,587,9.20%,,,Convenience,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,8/3/2021,8/5/2021,Unverified
210416_Jordan_KingHusseinCancerCenter_Grp3_January_TestAdj,"April 19, 2021",National,Jordan,"Jordan; North, Center, South","January 28, 2021","February 5, 2021",Blood donors,Adults (18-64 years),292,27.30%,22.50%,32.90%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,7/23/2021,Verified
210416_Jordan_KingHusseinCancerCenter_Grp2_September,"April 19, 2021",National,Jordan,"Jordan; North, Center, South","September 1, 2020","September 15, 2020",Blood donors,Adults (18-64 years),348,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,7/23/2021,Verified
210416_Jordan_KingHusseinCancerCenter_Grp1_June,"April 19, 2021",National,Jordan,"Jordan; North, Center, South","January 15, 2020","June 15, 2020",Blood donors,Adults (18-64 years),736,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,8/4/2021,Verified
210710_Jordan_WorldHealthOrganization_August2020_,"July 10, 2021",National,Jordan,Jordan,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,4704,0.30%,0.20%,0.40%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,7/29/2021,Unverified
210710_Jordan_WorldHealthOrganization_October2020,"July 10, 2021",National,Jordan,Jordan,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,5044,34.20%,33.80%,34.60%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,8/5/2021,Unverified
210710_Jordan_WorldHealthOrganization_January2021,"July 10, 2021",National,Jordan,Jordan,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,5470,7.00%,6.80%,7.20%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,7/29/2021,Unverified
200707_Jersey_StatisticsJersey_Round3_TestAdj_PopAdj,"July 7, 2020",National,Jersey,Jersey,"June 21, 2020","June 27, 2020",Household and community samples,Multiple groups,1386,4.00%,2.80%,5.20%,Simplified probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,99.39%,Low,Institutional Report,Statistics Jersey,Statistics Jersey,https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200707%20SJ.pdf,4/30/2021,6/17/2021,Unverified
210419_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj,"April 19, 2021",Local,Japan,Japan; Hyogo Prefecture; Kobe,"March 31, 2020","April 7, 2020",Residual sera,Multiple groups,1000,2.70%,1.80%,3.90%,Simplified probability,Kurabo Industries Ltd,LFIA,IgG,76.38%,100.00%,High,Journal Article (Peer-Reviewed),Asaka Doi,Kobe City Medical Center General Hospital,https://dx.doi.org/10.1016/j.cegh.2021.100747,5/1/2020,8/4/2021,Verified
200621_Japan_SoftBank_HCW,"June 21, 2020, June 10, 2020",Local,Japan,Japan,"May 12, 2020","May 18, 2020",Health care workers and caregivers,Not reported,5850,1.79%,,,Convenience,NA,Not reported,Not reported,,,Unclear,"News and Media, News and Media","Simon Denyer, Kyodo Jiji",SoftBank,"https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw, https://www.japantimes.co.jp/news/2020/06/10/national/softbank-coronavirus-antibody-tests/",6/27/2020,6/23/2021,Verified
200721_Tokyo_NavitasClinicTachikawa_Overall,"June 4, 2020, July 21, 2020",Local,Japan,"Japan; Kantō, Chūbu ; Tokyo, Kangawa, Saitama, Chiba, Yamanashi","April 20, 2020","May 20, 2020",Household and community samples,Multiple groups,1071,3.83%,2.76%,5.16%,Self-referral,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,"Preprint, Journal Article (Peer-Reviewed)","Morihito Takita, Morihito Takita",Navitas Clinic Tachikawa,"https://www.medrxiv.org/content/10.1101/2020.06.03.20121020v1, https://dx.doi.org/10.1177/2150132720942695",7/17/2020,8/5/2021,Verified
210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche,"February 26, 2021",Local,Japan,Japan; Honshu; Morioka,"May 18, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),1000,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Alfa Scientific Designs",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital,https://dx.doi.org/10.5387/fms.2020-21,7/17/2020,8/4/2021,Verified
200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_popadj,"July 26, 2020",Local,Japan,Japan; Kantō; Utsunomiya City,"June 14, 2020","July 5, 2020",Household and community samples,Multiple groups,742,1.23%,0.17%,1.23%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Moderate,Preprint,Nobutoshi Nawa,Tokyo Medical and Dental University,https://www.medrxiv.org/content/10.1101/2020.07.20.20155945v1,9/24/2020,6/17/2021,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,"July 30, 2020",Local,Japan,Japan; Hokkaido; Sapporo,"May 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.00%,0.00%,0.00%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,7/16/2021,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,"July 30, 2020",Local,Japan,Japan; Hokkaido; Sapporo,"March 1, 2020","March 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.30%,0.00%,1.80%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,7/16/2021,Verified
200911_Osaka_ToyonakaMunicipalHospital_Overall,"September 11, 2020",Local,Japan,Japan; Kansai; Osaka,"June 12, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Tsutomu Nishida,Toyonaka Municipal Hospital,https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1,10/22/2020,7/6/2021,Verified
201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff,"October 8, 2020",Local,Japan,Japan; Kanagawa; Fujisawa,"June 1, 2020","July 30, 2020",Health care workers and caregivers,Adults (18-64 years),806,0.74%,0.27%,1.61%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Unclear,Journal Article (Peer-Reviewed),M Hibino,Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.1016/j.jhin.2020.10.001,11/24/2020,6/17/2021,Verified
201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter,"December 7, 2020",Local,Japan,Japan; Kansai; Kyoto,"April 10, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),92,5.40%,,,Convenience,"CTK Biotech, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kohei Fujita,National Hospital Organization Kyoto Medical Center,https://dx.doi.org/10.3389/fpubh.2020.595348,2/1/2021,6/17/2021,Verified
201120_Japan_TokyoNationalHospital_overall,"November 20, 2020",Local,Japan,Japan,"June 1, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),93,16.10%,,,Convenience,"GenBody Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Shomi Oka,Tokyo National Hospital,https://www.researchsquare.com/article/rs-112294/v1,2/7/2021,8/4/2021,Verified
210113_Wakayama_WakayamaMedicalUniversity_overall,"January 13, 2021",Local,Japan,Japan,"July 7, 2020","September 15, 2020",Health care workers and caregivers,Multiple groups,1528,0.79%,0.34%,1.22%,Convenience,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,Preprint,Sadahiro Iwabuchi,Wakayama Medical University,https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1,2/7/2021,6/17/2021,Unverified
201230_Fukushima_ HirataCentralHospital_CLIA_IgG,"December 30, 2020",Local,Japan,Japan; Fukushima Prefecture; Hirata,"May 8, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,637,0.94%,,,Unclear,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yurie Kobashi, Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2020.107360,2/16/2021,6/17/2021,Verified
210120_Japan_ResearchInstituteOfTuberculosis_GenPop,"January 20, 2021",National,Japan,Japan,"June 1, 2020","June 7, 2020",Household and community samples,Multiple groups,7950,0.10%,0.04%,0.20%,Stratified probability,Roche Diagnostics,CLIA,"Total Antibody,IgG",,,Low,Journal Article (Peer-Reviewed),Takashi Yoshiyama,Government of Japan,https://dx.doi.org/10.3201/eid2702.204088,2/28/2021,8/4/2021,Verified
210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall,"January 29, 2021",Regional,Japan,Japan; Kansai,"August 6, 2020","October 1, 2020",Residual sera,Multiple groups,10377,0.60%,,,Sequential,"Sysmex,Roche Diagnostics",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Koichi Furukawa,Kobe University Graduate School of Medicine,https://dx.doi.org/10.31662/jmaj.2020-0094,3/20/2021,8/4/2021,Verified
210128_Tokyo_NationalCenterforGlobalHealthandMedicine_EitherTest,"January 28, 2021",Local,Japan,Japan; Kantō; Tokyo,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1228,0.16%,0.02%,0.59%,Unclear,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Akihito Tanaka,National Center for Global Health and Tropical Medicine,http://dx.doi.org/10.1016/j.jinf.2021.01.010,3/24/2021,8/4/2021,Verified
210206_YokohamaCity_YokohamaCityUniversity,"February 6, 2021",Local,Japan,Japan; Kanagawa Prefecture; Yokohama City,"June 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),432,3.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Shigeta Miyake,Yokohama City University,http://dx.doi.org/10.1111/den.13945,4/5/2021,6/17/2021,Verified
200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall,"September 9, 2020",Local,Japan,Japan,"February 14, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),49,0.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tetsuya Suzuki,National Center for Global Health and Medicine,http://dx.doi.org/10.1016/j.jiac.2020.09.006,4/11/2021,8/4/2021,Verified
210330_Tokyo_JapanMinistryOfHealth1_overall,"March 30, 2021",Regional,Japan,Japan; Tokyo Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,3399,1.35%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/7/2021,Unverified
210330_Osaka_JapanMinistryOfHealth2_overall,"March 30, 2021",Regional,Japan,Japan; Osaka Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2746,0.69%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/7/2021,Unverified
210330_ Aichi_JapanMinistryOfHealth3_overall,"March 30, 2021",Regional,Japan,Japan; Aichi Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2960,0.71%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/7/2021,Unverified
210330_Miyagi_JapanMinistryOfHealth4_overall,"March 30, 2021",Regional,Japan,Japan; Miyagi Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2860,0.14%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/7/2021,Unverified
210330_ Fukuoka_JapanMinistryOfHealth5_overall,"March 30, 2021",Regional,Japan,Japan; Fukuoka Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,3078,0.42%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/7/2021,Unverified
200727_Japan_HealthandWelfareDepartment_primary,"July 27, 2020",Regional,Japan,Japan; prefecture 3,"June 15, 2020","June 28, 2020",Residual sera,Multiple groups,3000,0.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Okuda,Health and Welfare Department,http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587,4/22/2021,6/17/2021,Verified
210212_Hiroshima_HiroshimaUniversity_overall,"February 12, 2021",Regional,Japan,"Japan; Hiroshima Prefecture; Hiroshima, Fukuyama, Miyoshi, and Higashi-Hiroshima","October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,2396,0.25%,,,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Institutional Report,Prefecture of Hiroshima,Hiroshima University ,https://www.chugoku-np.co.jp/local/news/article.php?comment_id=726622&comment_sub_id=0&category_id=256,4/30/2021,7/17/2021,Verified
210320_Japan_NationalCenterForGlobalHealthAndMedicine,"March 20, 2021",National,Japan,Japan,"February 14, 2020","March 13, 2020",Health care workers and caregivers,Adults (18-64 years),10,0.00%,,,Convenience,NA,Multiple Types,Not reported,,,High,Preprint,Tetsuya Suzuki,National Center for Global Health and Medicine,10.1101/https://www.medrxiv.org/content/10.1101/2021.03.17.21251964v1,5/5/2021,8/4/2021,Unverified
210315_FukuokaCity_KanenokumaHospital_Staff,"March 15, 2021",Local,Japan,Japan,"April 23, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),40,0.00%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co., Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,5/13/2021,8/4/2021,Verified
201216_Utsunomiya_TokyoMedicalandDentalUniversity_PopAdj,"December 16, 2020",Local,Japan,Japan; Tochigi Prefecture; Utsunomiya City,"June 14, 2020","July 5, 2020",Household and community samples,Multiple groups,742,1.23%,0.17%,2.28%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Nobutoshi Nawa,Tokyo Medical and Dental University,https://onlinelibrary.wiley.com/doi/full/10.1002/jgf2.408,5/13/2021,6/17/2021,Verified
210315_FukuokaCity_KanenokumaHospital_Residents,"March 15, 2021",Local,Japan,Japan,"April 23, 2020","June 15, 2020",Assisted living and long-term care facilities,Seniors (65+ years),76,7.89%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co., Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,5/13/2021,8/4/2021,Verified
210405_Japan_SOUSEIKAI_Overall,"April 5, 2021",Local,Japan,"Japan; Fukuoka, Kumamoto, Tokyo","August 15, 2020","October 15, 2020",Health care workers and caregivers,Multiple groups,2160,1.70%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tatsuya Yoshihara,SOUSEIKAI Medical Group,http://dx.doi.org/10.3390/ijerph18073786,5/14/2021,6/17/2021,Unverified
210324_Morioka_IwatePrefecturalCentralHospital_hcw,"March 24, 2021",Local,Japan,Japan; Tonoku; Morioka,"May 18, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),1404,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital ,https://onlinelibrary.wiley.com/doi/10.1002/jmv.26962,5/16/2021,8/4/2021,Verified
210416_Tokyo_JuntendoUniversity_HCW_Overall_testadj,"April 16, 2021",Local,Japan,Japan; Kantō; Tokyo,"July 6, 2020","August 21, 2020",Health care workers and caregivers,Multiple groups,4147,0.38%,0.22%,0.63%,Convenience,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Hiroshi Fukuda,Juntendo Univesity,https://dx.doi.org/10.1038/s41598-021-87688-9,5/22/2021,7/26/2021,Verified
210223_Osaka_KyotoUniversity_RLA_Overall,"February 23, 2021",Local,Japan,Japan; Honshu; Osaka,"July 8, 2020","July 22, 2020",Health care workers and caregivers,Adults (18-64 years),1000,0.40%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Hidenori Matsunaga,Kyoto University,https://www.mdpi.com/1999-4915/13/2/347,5/23/2021,7/8/2021,Verified
210417_Itami_ItamiCityHospital,"April 17, 2021",Local,Japan,Japan; Kansai; Itami,"May 15, 2020","November 20, 2020",Residual sera,Multiple groups,592,2.20%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tsuyoshi Nakai,Itami City Hospital,https://dx.doi.org/10.1016/j.jos.2021.02.017,5/25/2021,6/17/2021,Unverified
210430_Tokyo_NationalCenterForGlobalHealthAndMedicine,"April 30, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1228,0.08%,0.02%,0.45%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Shohei Yamamoto,National Center for Global Health and Medicine,https://dx.doi.org/10.35772/ghm.2021.01022,5/30/2021,6/17/2021,Unverified
200515_Tokyo_UniversityOfTokyo,"May 15, 2020",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"May 1, 2020","May 2, 2020",Residual sera,Multiple groups,500,0.60%,,,Convenience,NA,CLIA,"IgG,IgM",,,High,Presentation or Conference,Tatsuhiko Kodama,University of Tokyo,https://www.rcast.u-tokyo.ac.jp/ja/news/release/20200515.html,6/2/2021,7/6/2021,Unverified
20210524_NCGM_Japan_hcw,"May 24, 2021",Regional,Japan,Japan,"October 1, 2020","December 31, 2020",Essential non-healthcare workers,Adults (18-64 years),2563,0.70%,0.42%,1.11%,Convenience,"Abbott Laboratories,EUROIMMUN AG,Roche Diagnostics",Multiple Types,IgG,,,Unclear,Journal Article (Peer-Reviewed),Shohei Yamamoto,The National Center for Global Health and Medicine (NCGM),https://dx.doi.org/10.1016/j.jinf.2021.05.017,6/6/2021,8/4/2021,Unverified
210504_Okinawa_OkinawaInstituteOfScienceAndTechnology,"May 4, 2021",Local,Japan,Japan; Okinawa Prefecture; Okinawa,"August 1, 2020","August 31, 2020",Multiple populations,Adults (18-64 years),675,0.00%,,,Convenience,NA,ELISA,Not reported,92.50%,100.00%,,Journal Article (Peer-Reviewed),Melissa M Matthews,Okinawa Institute of Science and Technology,https://dx.doi.org/10.1038/s41598-021-88850-z,6/7/2021,6/17/2021,Verified
210528_Tokyo_NationalCancerCenterHospital_HCW_primary,"May 28, 2021",Local,Japan,Japan,"September 1, 2020","October 30, 2020",Health care workers and caregivers,Multiple groups,1190,0.67%,0.29%,1.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,6/7/2021,8/4/2021,Unverified
210528_Tokyo_NationalCancerCenterHospital_patients_primary,"May 28, 2021",Local,Japan,Japan,"August 3, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,500,1.00%,0.33%,2.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,6/7/2021,8/4/2021,Unverified
210608_Tokyo_BostonChildrensHospital_May26-June9,"June 8, 2021",Local,Japan,Japan,"May 26, 2020","June 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),51,5.88%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_June10-June23,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"June 10, 2020","June 23, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),119,5.00%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_June24-July7,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"June 24, 2020","July 7, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),187,25.67%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_July8-July21,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"July 8, 2020","July 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),256,37.10%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_July22-August4,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"July 22, 2020","August 4, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),175,38.86%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_August5-August18,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"August 5, 2020","August 18, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),115,41.74%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210608_Tokyo_BostonChildrensHospital_August19-September2,"June 8, 2021",Local,Japan,Japan; Tokyo Prefecture; Tokyo,"August 19, 2020","September 2, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),62,46.77%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Boston Children's Hospital,10.21203/rs.3.rs-564670/v1,6/21/2021,7/6/2021,Unverified
210201_Yamagata_YamagataUniversity_Overall,"February 1, 2021",Local,Japan,Japan; Yamagata prefecture; Yamagata,"June 1, 2020","June 4, 2020",Residual sera,Not reported,1009,0.50%,0.06%,0.93%,Sequential,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Institutional Report,Keita Morikane,Yamagata University,https://dx.doi.org/10.5365/wpsar.2020.11.3.012,6/23/2021,7/17/2021,Verified
210625_Osaka_ ToyonakaMunicipalHospital_Overall,"June 25, 2021",Local,Japan,Japan; Osaka Prefecture; Osaka,"June 12, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Tsutomu Nishida, Toyonaka Municipal Hospital,https://dx.doi.org/10.1097/MD.0000000000026433,6/30/2021,8/4/2021,Verified
210612_Tokyo_TheUniversityOfTokyo_overall,"June 12, 2021",Local,Japan,Japan,"June 11, 2020","October 28, 2020",Multiple populations,Multiple groups,6609,0.48%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihisa Mitani,The University of Tokyo,https://dx.doi.org/10.1016/j.jiac.2021.06.008,6/30/2021,7/7/2021,Unverified
210619_Tokyo_KeioUniversityHealthCenter,"June 19, 2021",Local,Japan,Japan,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),2320,0.86%,0.53%,1.33%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tomoyasu Nishimura,Keio University Health Center,https://dx.doi.org/10.2169/internalmedicine.7033-21,7/7/2021,7/7/2021,Unverified
0614_Fukushima_HirataCentralHospital_May_CLIA_IgG,"June 14, 2021",Local,Japan,Japan; Fukushima; Ishikawa District,"May 8, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,515,0.97%,0.32%,2.25%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,7/19/2021,8/4/2021,Unverified
0614_Fukushima_HirataCentralHospital_Oct_CLIA_IgG,"June 14, 2021",Local,Japan,Japan; Fukushima; Ishikawa District,"October 5, 2020","October 23, 2020",Health care workers and caregivers,Multiple groups,515,0.39%,0.05%,1.40%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,7/19/2021,7/19/2021,Unverified
210719_Kanagawa_OsakaCityUniversity,"July 19, 2021",Local,Japan,Japan; Kanagawa; Yokohama City,"June 30, 2020","July 2, 2020",Health care workers and caregivers,Adults (18-64 years),377,7.16%,,,Convenience,"Abbott Laboratories,GenScript",Multiple Types,"IgG,Neutralizing ,IgM",,,High,Preprint,Yu Nakagama,Osaka City University,10.1101/2021.07.15.21260585,7/28/2021,8/4/2021,Unverified
210727_Tokyo_MusashinoRed CrossHospital_Baseline,"July 27, 2021",Local,Japan,Japan,"March 15, 2021","May 15, 2021",Essential non-healthcare workers,Multiple groups,59,0.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Shun Kaneko,Musashino Red Cross Hospital,https://dx.doi.org/10.1002/jmv.27231,8/4/2021,8/4/2021,Unverified
210211_Kingston_UniversityOfTheWestIndies_Overall,"February 11, 2021",Local,Jamaica,Jamaica,"March 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),249,14.86%,,,Sequential,Abbott Laboratories,CLIA,IgG,80.00%,96.15%,High,Preprint,TeAnne Chisolm,University of the West Indies,10.1101/2021.02.08.21251367,3/18/2021,7/7/2021,Verified
200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,"May 8, 2020",Local,Italy,Italy; Puglia; Bari,"March 26, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),606,0.33%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,IgG,,,High,Preprint,Angelo Virgilio Paradiso,Istituto Tumori G. Paolo II,https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1,5/14/2020,8/4/2021,Verified
210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,"February 3, 2021",Local,Italy,Italy; Lombardy; Milan,"February 24, 2020","April 8, 2020",Blood donors,Adults (18-64 years),789,5.10%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti, Fondazione IRCCS Ca' Granda Ospedale Maggiore ,https://dx.doi.org/10.2450/2021.0324-20,5/21/2020,6/17/2021,Verified
200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1,"April 30, 2020",Local,Italy,"Italy; Lombardy; Alzano, Nembro","April 23, 2020","April 28, 2020",Household and community samples,Not reported,750,61.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,ATS Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,6/17/2021,Verified
200430_Bergamo_HospitalofBergamo_HCW,"April 30, 2020",Local,Italy,Italy; Lombardy; Bergamo,,"April 24, 2020",Health care workers and caregivers,Adults (18-64 years),3000,13.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,Hospital of Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,8/5/2021,Verified
200609_Milan_UniMilan_OverallAb,"June 9, 2020",Local,Italy,Italy; Lombardy; Milan,"March 30, 2020","March 31, 2020",Household and community samples,Adults (18-64 years),197,10.15%,,,Self-referral,"Beijing Wantai Biological,EUROIMMUN AG",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf,6/23/2020,8/4/2021,Verified
200609_Bergamo_HealthAgency_GenPop,"June 9, 2020",Regional,Italy,Italy; Lombardy,"April 23, 2020","June 3, 2020",Household and community samples,Not reported,9965,57.00%,,,Simplified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Angelo Amante,Bergamo Health Agency,https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw,7/6/2020,6/17/2021,Verified
200617_Italy_D.CotugnoHospital_HCW_IgG,"June 17, 2020",Local,Italy,Italy; Campania; Naples,"March 23, 2020","April 2, 2020",Health care workers and caregivers,Adults (18-64 years),115,1.74%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesco Fusco,D. Cotugno’ Hospital,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext,7/18/2020,8/4/2021,Verified
200619_Rome_UniversityofRome_IgG,"June 19, 2020",Local,Italy,Italy; Lazio; Rome,"April 7, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),1084,0.70%,,,Convenience,Medical Systems,CLIA,IgG,50.00%,99.10%,High,Journal Article (Peer-Reviewed),Edith Lahner,University of Rome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/,7/22/2020,7/6/2021,Verified
200707_Turin_University of Turin_PregnantWomen_IgGonly,"July 7, 2020",Local,Italy,Italy; Piedmont; Turin,"April 16, 2020","June 4, 2020",Pregnant or parturient women,Adults (18-64 years),138,5.80%,,,Sequential,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267,8/1/2020,6/17/2021,Verified
200808_Italy_UniversityofTurin_CLLPatients_Overall,"August 8, 2020",Local,Italy,"Italy; Piedmont; Turin, Novara, Alessandria, Verbania","March 8, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),24,12.50%,,,Convenience,"Medical Systems,DiaSorin SpA,In3diagnostic",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Marco Denina ,University of Turin,http://dx.doi.org/10.1016/j.jaad.2020.08.021,9/25/2020,8/4/2021,Verified
200813_Foggia_UniversityofFoggia_OverallIgG/IgM,"August 13, 2020",Local,Italy,Italy;  Apulia; Foggia,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),904,0.99%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jose Ramon Fiore,University of Foggia,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425,9/27/2020,6/17/2021,Verified
200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall,"August 4, 2020",Regional,Italy,Italy; Tuscany,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),17098,3.10%,,,Convenience,"Screen Italia S.R.L,Zhejiang Orient Gene Biotech",LFIA,"IgG,IgM",,,High,Preprint,Francesca Carozzi,Arezzo Hospital,https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1,9/27/2020,8/4/2021,Verified
200721_Arezzo_OspedaleSanDonato_Total,"July 21, 2020",Local,Italy,Italy; Tuscany; Arezzo,"March 17, 2020","March 21, 2020",Residual sera,Adults (18-64 years),516,13.00%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",37.00%,94.00%,High,Journal Article (Peer-Reviewed),Alessandro Pancrazzi,Ospedale San Donato,http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002,9/28/2020,6/17/2021,Verified
200728_Prato_SantoStefanoHospital_Overall,"July 28, 2020",Local,Italy,Italy; Tuscany; Prato,"April 4, 2020","May 16, 2020",Pregnant or parturient women,Adults (18-64 years),134,4.48%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anna Cavaliere,Santo Stefano Hospital,http://dx.doi.org/10.1080/14767058.2020.1793317,9/29/2020,6/17/2021,Verified
200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,"July 29, 2020",Local,Italy,Italy; Lombardy; Milan,"April 2, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),202,7.40%,3.80%,11.00%,Convenience,"BioMedomics, Inc.",LFIA,IgG,88.70%,90.60%,High,Journal Article (Peer-Reviewed),Giovanni Sotgiu,Università degli Studi di Milano ,https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0,9/29/2020,6/17/2021,Verified
200803_Italy_ItalianMinistryOfHealth_Overall,"August 3, 2020, August 3, 2020",National,Italy,"Italy; Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto","May 25, 2020","July 15, 2020",Household and community samples,Multiple groups,64660,2.50%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Unclear,"News and Media, Institutional Report","Italian Ministry of Health, Instituto Nazionale di Statistica",Italian Ministry of Health,"http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4998, https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf",10/4/2020,8/5/2021,Verified
200907_Bari_PoliclinicoHospital_Overall,"September 7, 2020",Local,Italy,Italy;  Apulia; Bari,"March 23, 2020","April 21, 2020",Residual sera,Multiple groups,819,8.55%,,,Sequential,"VivaChek Biotech (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",35.10%,97.30%,High,Journal Article (Peer-Reviewed),Daniela Loconsole,Policlinico Hospital,https://dx.doi.org/10.3390/ijerph17186493,10/14/2020,6/17/2021,Verified
200823_Bergamo_HospitalPapaGiovanniXXIII_Overall,"August 26, 2020",Local,Italy,Italy; Lombardy; Bergamo,"March 4, 2020","July 10, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,90,21.10%,,,Convenience,"VivaChek Biotech (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lorenzo Norsa,Papa Giovani XXII,http://dx.doi.org/10.1053/j.gastro.2020.08.046,10/15/2020,6/17/2021,Verified
200827_LiguriaLombardia_UniversityofGenoa_Overall,"August 27, 2020",Regional,Italy,"Italy; Lombardy, Liguria","March 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),3609,11.00%,10.00%,12.10%,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd),Hangzhou Realy Tech Co., Ltd,Biosynex",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonio Vena,University of Genoa,https://dx.doi.org/10.3390/jcm9092780,10/15/2020,8/4/2021,Verified
200818_Brescia_UniversityofBrescia_Overall,"August 18, 2020",Local,Italy,Italy; Lombardy; Brescia,"April 27, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),76,11.80%,,,Convenience,DiaSorin SpA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Alberto Dalla Volta,University of Brescia,http://dx.doi.org/10.3389/fonc.2020.01574,10/15/2020,6/17/2021,Verified
200806_Milan_UniversityofMilan_Overall,"August 6, 2020",Local,Italy,Italy; Lombardy; Milan,"April 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),663,5.13%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Antonella Amendola,University of Milan,http://dx.doi.org/10.1017/ice.2020.401,10/25/2020,6/17/2021,Verified
200919_Castiglioned'Adda_UniversityofMilan_Overall,"September 19, 2020",Local,Italy,Italy; Lombardy; Castiglione D’Adda,"May 18, 2020","June 7, 2020",Household and community samples,Multiple groups,509,22.60%,17.20%,29.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1016/j.jinf.2020.09.021,11/9/2020,6/17/2021,Verified
201006_Turin_UniversityofTorino_TotalHCWs,"October 6, 2020",Local,Italy,Italy; Piemonte; Torino (Turin),"April 17, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),5444,6.90%,,,Convenience,DiaSorin SpA,CLIA,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Calcagno,University of Torino,https://dx.doi.org/10.3201/eid2701.203027,12/10/2020,6/17/2021,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers,"September 15, 2020",Local,Italy,Italy; Campania; Naples,"April 3, 2020","May 29, 2020",Multiple populations,Not reported,1397,0.43%,,,Convenience,"VivaChek Biotech (Hangzhou) Co., Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,8/5/2021,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW,"September 15, 2020",Local,Italy,Italy; Campania; Naples,"April 3, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),249,2.01%,,,Convenience,"VivaChek Biotech (Hangzhou) Co., Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,8/4/2021,Verified
201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,"November 3, 2020",Local,Italy,Italy; Sardinia; Cagliari,"March 31, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),86,5.80%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabio Medas, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2020.11.006,1/9/2021,6/17/2021,Verified
201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG,"October 27, 2020",Local,Italy,Italy; Umbria; Perugia,"May 4, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,270,3.70%,,,Sequential,Screen Italia S.R.L,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,1/10/2021,6/17/2021,Verified
201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG,"October 31, 2020",Local,Italy,Italy; Lombardy; Milan,"March 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),40,5.00%,,,Convenience,"PRIMA Lab S.A.,DiaSorin SpA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Diana Canetti,San Raffaele Scientific Institute,https://pubmed.ncbi.nlm.nih.gov/33135083/,1/12/2021,8/4/2021,Verified
201021_Italy_IRCCS_Overall_IgG_unadj,"October 21, 2020",Regional,Italy,Italy; Lombardy,"March 30, 2020","May 11, 2020",Multiple populations,Multiple groups,166,41.57%,,,Convenience,PRIMA Lab S.A.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Antonio Marra,Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS),https://dx.doi.org/10.1016/j.annonc.2020.10.473,1/16/2021,8/5/2021,Verified
201008_Udine_UniversityofUdine_SCTrecipients,"October 8, 2020",Local,Italy,Italy; Udine; Udine,"April 1, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,70,1.43%,,,Sequential,Cellex Inc.,LFIA,"IgG,IgM",93.75%,96.40%,High,Journal Article (Peer-Reviewed),Alessandra Sperotto,The University of Udine,https://dx.doi.org/10.1002/jmv.26586,1/18/2021,6/17/2021,Verified
201111_Italy_IstitutoNazionaleTumori_primaryest,"November 11, 2020",National,Italy,Italy,"September 1, 2019","March 10, 2020",Residual sera,Multiple groups,959,11.60%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,1/21/2021,8/4/2021,Verified
200806_Lombardy_BrunoKesslerFoundation,"August 6, 2020",Regional,Italy,Italy; Lombardy,"April 16, 2020","May 25, 2020",Contacts of COVID patients,Multiple groups,4120,53.10%,,,Stratified non-probability,DiaSorin SpA,Not reported,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383,1/21/2021,6/17/2021,Verified
201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall,"October 31, 2020",Local,Italy,Italy; Abruzzo; Villa Caldari,"April 18, 2020","April 19, 2020",Household and community samples,Multiple groups,667,10.90%,8.80%,13.50%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Francesa Cito,Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale ,https://dx.doi.org/10.3390/microorganisms8111711,1/22/2021,6/17/2021,Verified
201222_Rome_EleemosynariaApostolica_overall,"December 22, 2020",Local,Italy,Italy; Lazio; Rome,"April 14, 2020","July 31, 2020",Multiple populations,Multiple groups,173,1.80%,,,Convenience,Biozek,LFIA,"IgG,IgM",96.00%,96.00%,High,Journal Article (Peer-Reviewed),Massimo Ralli,Eleemosynaria Apostolica,https://dx.doi.org/10.4081/jphr.2020.1986,1/23/2021,8/5/2021,Verified
201219_Tuscany_UniversityOfFlorence_Overall,"December 19, 2020",Regional,Italy,Italy; Prato,"May 1, 2020","May 31, 2020",Multiple populations,Multiple groups,4656,3.00%,2.50%,3.50%,Convenience,"Hangzhou Laihe Biotech Co., Ltd",LFIA,"IgG,IgM",100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Vieri Lastrucci,University of Florence,https://dx.doi.org/10.3390/vaccines8040778,1/23/2021,8/5/2021,Verified
201119_Italy_UniversityofCagliari_Milano1_IBDPatients,"November 19, 2020",Local,Italy,Italy,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,354,2.30%,0.80%,3.80%,Convenience,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,6/17/2021,Verified
201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop,"November 19, 2020",Local,Italy,Italy; Lombardy; Milan,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,129,7.00%,4.40%,9.60%,Sequential,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,6/17/2021,Verified
201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj,"November 27, 2020",Regional,Italy,Italy; Trento,"May 5, 2020","May 15, 2020",Household and community samples,Multiple groups,6075,25.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Paola Stefanelli,Azienda Provinciale per i Servizi Sanitari,https://dx.doi.org/10.1016/j.cmi.2020.11.013,1/23/2021,6/17/2021,Verified
201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S,"November 20, 2020",Local,Italy,Italy; Lombardy ; Milan,"May 11, 2020","July 5, 2020",Residual sera,Multiple groups,2753,3.34%,,,Sequential,"Abbott Laboratories,DiaSorin SpA",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Valeria Cento,Universita degli Studi di Milano,http://dx.doi.org/10.1371/journal.pone.0242765,1/23/2021,8/4/2021,Verified
201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall,"December 1, 2020",Local,Italy,Italy; Veneto; Verona,"April 25, 2020","May 8, 2020",Household and community samples,Multiple groups,1515,2.70%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Massimo Guerriero,Instituto di Ricovero e Cura A Caratterre,https://dx.doi.org/10.3201/eid2701.202740,1/30/2021,6/17/2021,Verified
201126_Naples_UniversityofNaples_MS,"November 26, 2020",Local,Italy,Italy; Campania; Naples,"May 11, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),310,2.90%,,,Sequential,"Shanghai Kehua Bio-engineering Co., Ltd",LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,6/17/2021,Verified
201126_Naples_UniversityofNaples_LowRisk,"November 26, 2020",Local,Italy,Italy; Campania;  Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),862,1.30%,,,Convenience,"Shanghai Kehua Bio-engineering Co., Ltd",LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,6/17/2021,Verified
201126_Naples_UniversityofNaples_HighRisk,"November 26, 2020",Local,Italy,Italy; Campania; Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),235,10.60%,,,Convenience,"Shanghai Kehua Bio-engineering Co., Ltd",LFIA,"IgG,IgM",66.00%,96.60%,High,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,6/17/2021,Verified
210109_GiglioIsland_UniversitàdegliStudidiMilano,"January 9, 2021",Local,Italy,Italy; Tuscany; Giglio Island,"April 29, 2020","May 3, 2020",Household and community samples,Adults (18-64 years),723,0.41%,,,Self-referral,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,High,Preprint,Antonio Bognanni,Università degli Studi di Milano,https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1,1/31/2021,6/17/2021,Verified
201217_Naples_UniversityofCampania_ELISA,"December 17, 2020",Local,Italy,Italy; Campania; Naples,"March 27, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),65,0.00%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Antonio Russo,University of Campania,https://dx.doi.org/10.2147/IDR.S282652,2/1/2021,6/17/2021,Verified
201223_Bergamo_OspedalePapaGiovanniXXIII_overall,"December 23, 2020",Local,Italy,Italy; Lombardy; Bergamo,"April 1, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,560,31.00%,,,Sequential,nal von minden GmbH,LFIA,"IgG,IgM",92.10%,99.20%,High,Journal Article (Peer-Reviewed),Alberto Zambelli,Ospedale Papa Giovanni XXIII,https://dx.doi.org/10.1002/onco.13654,2/3/2021,6/17/2021,Verified
210111_Pavia_University of Pavia_overall,"January 13, 2021",Local,Italy,Italy,"May 4, 2020","June 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),104,13.46%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Giulia Mallucci,University of Pavia,https://doi.org/10.1016/j.msard.2021.102754,2/3/2021,7/17/2021,Verified
201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW,"December 13, 2020",Local,Italy,"Italy; Apulia, Province of Foggia; Foggia","March 17, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),3242,1.90%,1.40%,2.30%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",97.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Armando De Carlo,Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia,https://dx.doi.org/10.3390/ijerph17249324,2/5/2021,6/17/2021,Verified
201101_ Borgosesia_ASLVercelli_overall,"November 1, 2020",Local,Italy,Italy; Piedmont; Borgosesia,"May 23, 2020","May 24, 2020",Household and community samples,Multiple groups,4987,4.90%,4.33%,5.55%,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Daniela Alessi,ASL Vercelli,https://dx.doi.org/10.19191/EP20.5-6.S2.119,2/8/2021,6/17/2021,Verified
210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall,"March 6, 2021",Local,Italy,Italy,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Multiple groups,4694,1.19%,,,Convenience,EUROIMMUN AG,ELISA,IgG,78.79%,99.36%,High,Journal Article (Peer-Reviewed),Giuseppe Vetrugno,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph18052650,2/9/2021,6/17/2021,Verified
210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall,"February 4, 2021",Local,Italy,Italy,"March 4, 2020","March 12, 2020",Health care workers and caregivers,Adults (18-64 years),679,0.40%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,6/17/2021,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseIII,"February 4, 2021",Local,Italy,Italy,"May 20, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),629,4.60%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,6/17/2021,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseII,"February 4, 2021",Local,Italy,Italy,"April 14, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),608,4.20%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,6/17/2021,Unverified
201231_Modena_OspedaleCivileS.AgostinoEstense_overall,"December 31, 2020",Local,Italy,Italy; Emilia-Romagna Region; Modena,"March 30, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),7711,5.00%,,,Convenience,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Valentina Pecoraro,Ospedale Civile S.Agostino Estense,https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696,2/12/2021,7/7/2021,Verified
210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall,"January 5, 2021",Local,Italy,Italy,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,245,0.88%,,,Convenience,"Shanghai Kehua Bio-engineering Co., Ltd,Tecan",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabrizio Bossa,Fondazione Casa Sollievo della Sofferenza,http://dx.doi.org/10.1016/j.dld.2020.12.120,2/13/2021,8/4/2021,Verified
210127_Merano_FranzTappeinerHospital_patients_primary,"January 27, 2021",Local,Italy,Italy,"June 22, 2020","July 17, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,250,0.80%,,,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,6/17/2021,Verified
210127_Merano_FranzTappeinerHospital_HCW_primary,"January 27, 2021",Local,Italy,Italy,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),36,5.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,6/17/2021,Unverified
201027_Perugia_UniversityofPerugia_HIVNegative2_Overall,"October 27, 2020",Local,Italy,Italy; Umbria; Perugia,"May 4, 2020","May 31, 2020",Multiple populations,Multiple groups,2843,5.40%,,,Unclear,Screen Italia S.R.L,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,2/27/2021,8/5/2021,Verified
210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall,"January 12, 2021",Local,Italy,Italy; Province of Avellino in the Campania region; Ariano Irpino,"May 16, 2020","May 19, 2020",Household and community samples,Multiple groups,13218,5.60%,5.20%,6.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Pellegrino Cerino,The Zoo-Prophylactic Institute of Southern Italy,https://www.future-science.com/doi/10.2144/fsoa-2020-0203,3/4/2021,7/17/2021,Verified
210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj,"January 27, 2021",Local,Italy,Italy; Puglia; Bari,"April 8, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),2407,2.37%,,,Convenience,Abbott Laboratories,CLIA,IgG,50.00%,97.99%,High,Journal Article (Peer-Reviewed),Luigi Vimercati,University of Bari,https://dx.doi.org/10.1016/j.envres.2021.110793,3/11/2021,6/17/2021,Verified
210209_Catania_UniversityofCatania,"February 9, 2021",Local,Italy,Italy; Sicily; Catania,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),133,3.00%,,,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Caterina Ledda ,University of Catania,https://dx.doi.org/10.3390/tropicalmed6010021,3/14/2021,6/17/2021,Verified
201031_Veneto_NationalAssociationofCompanyandCompetentDoctors,"October 31, 2020",Local,Italy,Italy; Veneto,"April 11, 2020","April 29, 2020",Essential non-healthcare workers,Adults (18-64 years),1267,1.58%,,,Convenience,"NA,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Danilo Bontadi,National Association of Company and Competent Doctors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/,3/16/2021,8/4/2021,Verified
210204_Milan_UniversityOfMilan_Overall,"February 4, 2021",Local,Italy,Italy; Lombardy; Milan,"June 13, 2020","August 6, 2020",Contacts of COVID patients,Children and Youth (0-17 years),49,16.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marco Farronato ,University of Milan,https://dx.doi.org/10.3390/ijerph18041488,3/19/2021,6/17/2021,Verified
210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall,"March 2, 2021",Local,Italy,Italy,"April 9, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Simplified probability,Diagnostic Bioprobes Srl ,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Chiara Maura Ciniselli,Fondazione IRCCS Istituto Nazionale dei Tumori (INT),http://dx.doi.org/10.3390/cancers13051035,3/24/2021,7/9/2021,Verified
210224_NortheastItaly_PaduaUniversityHospital_HCW,"February 24, 2021",Local,Italy,Italy; Veneto Region; Padua,"April 8, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),344,7.85%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",91.21%,97.30%,High,Preprint,F Barbaro,Padua University Hospital ,https://doi.org/10.1101/2021.02.23.21249481,3/25/2021,6/17/2021,Verified
210301_SouthernItaly_GragnanoHospital_Patients,"March 1, 2021",Local,Italy,Italy; Naples; Naples,"June 25, 2020","July 12, 2020",Residual sera,Not reported,2740,1.40%,,,Unclear,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),C Coppola,Gragnano Hospital,http://dx.doi.org/10.1016/j.dld.2020.12.018,3/26/2021,6/17/2021,Unverified
201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence,"October 20, 2020",Local,Italy,Italy; Tuscany; Florence,"May 11, 2020","May 17, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1145,2.30%,,,Sequential,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Francesca Martella ,Azienda Usl Toscana Centro Oncology,http://dx.doi.org/10.1177/0300891620953388,3/27/2021,6/17/2021,Verified
201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall,"October 20, 2020",Local,Italy,Italy; Lombardy; Milan,"April 15, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,42,9.50%,,,Unclear,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,3/27/2021,8/4/2021,Verified
210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall,"February 20, 2021",Local,Italy,Italy; Lazio; Rome,"May 25, 2020","August 10, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),202,1.50%,,,Convenience,Siemens,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Fabio Del Zompo,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.dld.2021.02.015,3/27/2021,7/6/2021,Verified
210303_Lodi_IRCCSPoliclinico_overall_CLIA,"March 3, 2021",Local,Italy,Italy; Lombardy region; Lodi,"March 18, 2020","June 24, 2020",Blood donors,Not reported,1922,19.70%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Irene Cassaniti,IRCCS Policlinico,https://dx.doi.org/10.1016/j.cmi.2021.01.030,3/31/2021,7/9/2021,Verified
210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj,"February 22, 2021",Local,Italy,Italy; Lombardy; Milan,"April 27, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,4055,6.40%,,,Convenience,DiaSorin SpA,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Lombardi,Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1136/bmjopen-2020-047216,4/3/2021,6/29/2021,Verified
201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall,"October 20, 2020",Local,Italy,Italy; Lombardy; Sondrio,"March 1, 2020","October 19, 2020",Health care workers and caregivers,Adults (18-64 years),220,11.36%,,,Convenience,nal von minden GmbH,LFIA,"IgG,IgM",94.10%,99.20%,Unclear,Journal Article (Peer-Reviewed),G Caponigro ,"ASST della Valtellina 
Alto Lario-Oncologia Medica Sondrio",http://dx.doi.org/10.1177/0300891620953388,4/4/2021,6/19/2021,Verified
210202_Turin_UniversityofTurin_Overall,"February 2, 2021",Local,Italy,Italy; Piedmont; Turin,"April 15, 2020","June 15, 2020",Pregnant or parturient women,Adults (18-64 years),164,10.40%,,,Sequential,"Boditech Med Inc.,DiaSorin SpA,NA",Multiple Types,"IgG,IgM,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.1016/j.jri.2021.103285,4/5/2021,8/4/2021,Verified
200826_Veneto_UniversityHospitalOfPadova,"August 26, 2020",Regional,Italy,Italy; Veneto,"February 22, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),8285,4.60%,4.10%,5.00%,Unclear,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",73.00%,98.00%,High,Journal Article (Peer-Reviewed),Mario Plebani,University Hospital Of Padova,https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html,4/8/2021,6/17/2021,Verified
210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW,"March 24, 2021",Local,Italy,Italy; Piedmont; Vercelli,"May 8, 2020","June 3, 2020",Health care workers and caregivers,Adults (18-64 years),2250,17.11%,15.55%,18.67%,Convenience,"DiaSorin SpA,NA",Not reported,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università degli Studi del Piemonte Orientale,http://dx.doi.org/10.3390/ijerph18073343,4/9/2021,8/4/2021,Verified
210226_Turin_UniversityofTurin_Pharmacists,"February 26, 2021",Regional,Italy,Italy; Turin,"July 1, 2020","July 31, 2020",Essential non-healthcare workers,Adults (18-64 years),286,3.50%,,,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Francesca Baratta,University of Turin,https://dx.doi.org/10.3390/ijerph18052302,4/9/2021,6/17/2021,Verified
210325_Rome_UniversityofRomeTorVergata_IBDPatients,"March 25, 2021",Local,Italy,Italy,"May 27, 2020","July 21, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),218,1.37%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ludovica Scucchi,University of Rome Tor Vergata,https://dx.doi.org/10.26355/eurrev_202103_25283,4/9/2021,6/25/2021,Verified
201105_Italy_UniversityofVerona_overall_unadj,"November 5, 2020",National,Italy,"Italy; Veneto, Lazio and Friuli-Venezia Giulia","May 18, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,339,1.47%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,http://dx.doi.org/10.1182/blood-2020-140032,4/12/2021,6/17/2021,Verified
210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall,"January 25, 2021",Local,Italy,Italy; Le Marche Region; Municipality of Terre Roveresche,"March 15, 2020","June 15, 2020",Household and community samples,Multiple groups,341,14.40%,,,Convenience,Diagnostic Bioprobes Srl ,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mauro De Santi,University of Urbino Carlo Bo,https://dx.doi.org/10.23750/abm.v92i1.10847,4/13/2021,6/17/2021,Verified
210225_Brescia_UniversityofBrescia_HCW,"February 25, 2021",Local,Italy,Italy; Lombardy; Brescia,"April 26, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1893,22.90%,,,Convenience,DiaSorin SpA,CLIA,IgG,95.70%,98.50%,Moderate,Journal Article (Peer-Reviewed),Agnese Comelli,University of Brescia,https://dx.doi.org/10.3390/microorganisms9030488,4/15/2021,6/19/2021,Verified
210224_Castiglioned'Adda_UniversityofMilan_Overall,"February 24, 2021",Local,Italy,Italy; Lombardy; Castiglione D’Adda,"May 18, 2020","June 7, 2020",Household and community samples,Multiple groups,4143,22.20%,,,Entire sample,PRIMA Lab S.A.,LFIA,IgG,100.00%,96.00%,Low,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1371/journal.pone.0246513,4/17/2021,6/17/2021,Verified
210226_UniversityOfTurin_Turin,"February 26, 2021",Local,Italy,Italy; Piedmont; Turin,"April 16, 2020","June 22, 2020",Pregnant or parturient women,Adults (18-64 years),164,9.70%,,,Convenience,Boditech Med Inc.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.3390/diagnostics11030398,4/17/2021,7/16/2021,Verified
201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall,"October 20, 2020",Local,Italy,Italy; Lombardy; Milan,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,34,5.88%,,,Convenience,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,4/20/2021,8/4/2021,Verified
200721_Lodi_A.S.S.T.Lodi_HCW_overall,"July 21, 2020",Local,Italy,Italy; Lombardy Region,"April 23, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),2415,16.80%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T. Lodi ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/21/2021,8/5/2021,Verified
200721_Lodi_A.S.S.T.Lodi_genpop,"July 21, 2020",Local,Italy,Italy; Lombardy region; Lodi,"April 23, 2020","May 5, 2020",Household and community samples,Multiple groups,1792,29.80%,,,Simplified probability,DiaSorin SpA,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T.Lodi,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/21/2021,6/17/2021,Verified
210309_Benevento_UniversitàdegliStudidelSannio_Overall,"March 9, 2021",Local,Italy,Italy; Campania; NR,"September 1, 2020","September 30, 2020",Household and community samples,Seniors (65+ years),1383,4.70%,,,Unclear,Beijing Lepu Medical Technology,LFIA,"IgG,IgM",98.60%,97.60%,Moderate,Journal Article (Peer-Reviewed),Immacolata Polvere,Università degli Studi del Sannio,https://dx.doi.org/10.3390/diagnostics11030483,4/21/2021,6/28/2021,Verified
210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay,"April 4, 2021",Local,Italy,Italy; Marche; Ancona,"July 1, 2020","October 26, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,949,0.70%,,,Sequential,"Zhejiang Orient Gene Biotech,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Cantini,Università Politecnica delle Marche,http://dx.doi.org/10.3390/jcm10071503,4/21/2021,8/4/2021,Verified
210324_Milan_UniversityofMilan_UniversityEmployees,"March 24, 2021",Local,Italy,Italy,"May 13, 2020","June 23, 2020",Non-essential workers and unemployed persons,Multiple groups,1826,11.30%,,,Convenience,NA,ELISA,IgG,85.70%,98.10%,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://dx.doi.org/10.1136/bmjopen-2020-046800,4/24/2021,6/17/2021,Unverified
210331_Naples_IstitutoNazionaleTumori_CancerPatients,"March 31, 2021",Local,Italy,Italy,"March 30, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,885,5.42%,,,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,4/30/2021,8/4/2021,Unverified
210331_Naples_IstitutoNazionaleTumori_HCWs,"March 31, 2021",Local,Italy,Italy,"March 30, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1050,4.60%,3.30%,5.90%,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,4/30/2021,8/4/2021,Unverified
210402_Italy_FondazioneIstitutoStomatologicoItaliano_DentalStaff,"April 2, 2021",National,Italy,"Italy; Como, Lecco, Monza-Brianza, Sondrio, Varese, Bergamo, Brescia  Cremona, Lodi, Mantova, Pavia, Milan","May 28, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),499,10.80%,,,Convenience,"Shanghai Kehua Bio-engineering Co., Ltd",LFIA,"IgM,IgG",95.10%,99.30%,Moderate,Journal Article (Peer-Reviewed),Silvano Gallus,Fondazione Istituto Stomatologico Italiano,http://dx.doi.org/10.3390/ijerph18073711,5/2/2021,7/7/2021,Unverified
210320_GardenaValley_HospitalOfBolzano_PopAdj_TestAdj,"March 20, 2021",Local,Italy,Italy,"May 26, 2020","June 8, 2020",Household and community samples,Multiple groups,2106,26.90%,25.20%,28.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Low,Preprint,Roberto Melotti,Hospital of Bolzano,10.1101/2021.03.19.21253883,5/12/2021,7/29/2021,Verified
200803_Italy_InstitutoNazionaleDiStatistica_overall ,"August 3, 2020, August 3, 2020",National,Italy,Italy,"May 25, 2020","July 15, 2020",Household and community samples,Multiple groups,64660,2.50%,2.30%,2.60%,Stratified probability,NA,Multiple Types,IgG,,,Moderate,"Institutional Report, News and Media","Instituto Nazionale di Statistica, Italian Ministry of Health",The Institute for National Statistics,"https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf, http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4998",5/13/2021,8/4/2021,Verified
210320_Cogne_UniversitàDiTorino_genpop_overall,"March 20, 2021",Local,Italy,Italy; Valle D'Aosta; Cogne,"June 4, 2020","June 5, 2020",Household and community samples,Multiple groups,857,3.38%,,,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,Low,Preprint,F Truc,Università di Torino,https://www.medrxiv.org/content/10.1101/2021.03.19.21253962v1.full-text,5/14/2021,7/23/2021,Verified
210317_Bolzano_HospitalofBolzano,"March 17, 2021",Local,Italy,Italy; Trentino-Alto Adige/Südtirol; Bolzano,"October 29, 2020","December 28, 2020",Residual sera,Multiple groups,3033,34.50%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Thomas Mueller,Hospital of Bolzano,https://dx.doi.org/10.1016/j.cca.2021.03.007,5/17/2021,7/15/2021,Verified
210312_Venice_TheVenetoEyeBankFoundation,"March 27, 2021",Local,Italy,Italy; Veneto region; Venice,"March 15, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,30,3.33%,,,Sequential,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonella Franch,The Veneto Eye Bank Foundation,https://dx.doi.org/10.1177/11206721211006565,5/18/2021,8/4/2021,Verified
201007_Turin_UniversityofTurin_primary,"April 1, 2021",Local,Italy,Italy,"February 22, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),225,9.30%,,,Convenience,"Boditech Med Inc.,DiaSorin SpA",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,http://dx.doi.org/10.1016/j.ajog.2020.10.005,5/18/2021,8/4/2021,Verified
210419_Turin_AziendaOspedalieraOrdineMauriziano_Primary,"April 19, 2021",Local,Italy,Italy; Piedmont; Turin,"May 8, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1562,9.80%,,,Convenience,DiaSorin SpA,CLIA,IgG,84.10%,93.70%,High,Journal Article (Peer-Reviewed),Marco Daperno,Azienda Ospedaliera Ordine Mauriziano,https://onlinelibrary.wiley.com/doi/10.1111/imj.15201,5/20/2021,6/17/2021,Verified
210420_Foggia_UniversityOfFoggia,"April 20, 2021",Local,Italy,Italy; Apulia; Foggia,"March 15, 2020","June 15, 2020",Blood donors,Adults (18-64 years),1797,1.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Mariantonietta Di Stefano,University of Foggia,https://www.karger.com/Article/Abstract/515258,5/20/2021,8/4/2021,Unverified
210425_Florence_UniversityofFlorence_HD,"April 25, 2021",Local,Italy,Italy; Tuscany; Florence,"November 4, 2019","March 9, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,56,3.60%,,,Sequential,"CHiL,MP Biomedical",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),L Gragnani,University of Florence,https://dx.doi.org/10.26355/eurrev_202104_25746,5/21/2021,8/4/2021,Unverified
210425_Florence_UniversityofFlorence_BloodDonors,"April 25, 2021",Local,Italy,Italy; Tuscany; Florence,"January 22, 2020","March 9, 2020",Blood donors,Multiple groups,234,4.30%,,,Sequential,"CHiL,MP Biomedical",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),L Gragnani,University of Florence,https://dx.doi.org/10.26355/eurrev_202104_25746,5/21/2021,8/4/2021,Unverified
201221_Lombardy_ATSMilan_cohabitants,"December 21, 2020",Regional,Italy,Italy; Lombardy,"April 1, 2020","April 30, 2020",Family of essential workers,Adults (18-64 years),755,24.40%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://pubmed.ncbi.nlm.nih.gov/33349254/,5/21/2021,7/6/2021,Verified
201221_Lombardy_ATSMilan_staff,"December 21, 2020",Regional,Italy,Italy; Lombardy,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),108,15.70%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://pubmed.ncbi.nlm.nih.gov/33349254/,5/21/2021,7/6/2021,Verified
201221_Lombardy_ATSMilan_peds,"December 21, 2020",Regional,Italy,Italy; Lombardy,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),377,14.90%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://pubmed.ncbi.nlm.nih.gov/33349254/,5/21/2021,7/6/2021,Verified
210415_Campania_UniversityofNapoli,"April 15, 2021",Regional,Italy,Italy; Campania,"May 11, 2020","May 18, 2020",Household and community samples,Multiple groups,388,1.80%,0.69%,2.91%,Simplified probability,NovaTec Immundiagnostics GmbH,ELISA,IgG,94.90%,96.20%,High,Journal Article (Peer-Reviewed),Valeria Caturano ,University of Napoli ,https://dx.doi.org/10.1186/s12879-021-06054-2,5/22/2021,6/17/2021,Unverified
210324_UniversiteCatholiquedeLouvain_Piedmont_workers,"March 24, 2021",Regional,Italy,Italy; PIedmont,"June 20, 2020","July 23, 2020",Multiple populations,Multiple groups,6033,4.80%,,,Convenience,"ZenTech, Angleur, Belgium",LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Omar Nyabi,Université Catholique de Louvain,http://dx.doi.org/10.3390/ijerph18073372,5/22/2021,7/8/2021,Verified
210429_SouthernItaly_UniversityofCampania,"April 29, 2021",Regional,Italy,"Italy; Southern Italy; Caserta, Naples","September 21, 2020","December 31, 2020",Multiple populations,Multiple groups,2394,5.85%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,DiaSorin SpA",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Francesco Napolitano,University of Campania,https://www.mdpi.com/1660-4601/18/9/4761,5/22/2021,8/4/2021,Unverified
201202_Rome_UniversitàCattolicaDelSacroCuore_overall,"December 2, 2020",Local,Italy,Italy; Lazio; Rome,"December 1, 2019","February 29, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,451,0.00%,0.00%,0.01%,Convenience,"Eagle Bioscience,Palex",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Lombardi,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.1016/j.cmi.2020.11.026,5/27/2021,8/4/2021,Verified
210501_Rome_SapienzaUniversity,"May 1, 2021",Local,Italy,Italy; Lazio; Rome,"May 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),17377,1.22%,,,Convenience,"DiaSorin SpA,Roche Diagnostics",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Guido Antonelli,Sapienza University,https://dx.doi.org/10.1016/S2666-5247(21)00083-5,5/28/2021,8/4/2021,Unverified
210504_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,"May 4, 2021",Local,Italy,Italy; Sardinia; Cagliari,"September 1, 2020","December 10, 2020",Residual sera,Multiple groups,121,10.70%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Federico Cappellacci, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2021.102375,5/29/2021,7/6/2021,Unverified
210428_EmiliaRomagna_SorbonneUniversité_3,"April 28, 2021",Regional,Italy,Italy; Emilia Romagna,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,522,1.50%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/30/2021,8/4/2021,Unverified
210528_Bari_IRCCSIstitutoTumoriGiovanniPaoloII_Baseline,"May 28, 2021",Local,Italy,Italy; Puglia; Bari,"March 26, 2020","March 31, 2020",Health care workers and caregivers,Multiple groups,606,1.10%,,,Convenience,"VivaChek Biotech (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Angelo Virgilio Paradiso,IRCCS Istituto Tumori “Giovanni Paolo II” ,https://dx.doi.org/10.3390/diagnostics11060975,6/8/2021,8/4/2021,Unverified
210614_Verona_UniversityofVerona,"June 14, 2021",Local,Italy,Italy; Province of Verona; Verona ,"April 28, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),5299,6.00%,5.30%,6.60%,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Stefano Porru,University of Verona,http://dx.doi.org/10.3390/ijerph18126446,6/21/2021,7/6/2021,Unverified
210607_Italy_UniversityofMilan_Patients1,"June 7, 2021",National,Italy,Italy,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),178,1.70%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/21/2021,7/6/2021,Unverified
210610_Lombardy_HumanitasUniversity_overall,"June 10, 2021",Regional,Italy,"Italy; Lombardy ; Milan, Rozzano, Varese, Castellanza and Bergamo","April 28, 2020","May 16, 2020",Health care workers and caregivers,Multiple groups,3985,13.00%,,,Convenience,DiaSorin SpA,CLIA,IgG,90.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Maria Teresa Sandri,Humanitas University,https://dx.doi.org/10.1038/s41598-021-91773-4,6/21/2021,8/4/2021,Unverified
210607_Italy_UniversityofMilan_Siblings2,"June 7, 2021",National,Italy,Italy,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),90,7.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/21/2021,7/6/2021,Unverified
210607_Italy_UniversityofMilan_Cohabitants3,"June 7, 2021",National,Italy,Italy,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),271,3.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/21/2021,7/6/2021,Unverified
210505_Trieste_ItalianNationalInstituteOfHealth,"June 5, 2021",Regional,Italy,Italy; NR; Trieste,"January 5, 2021","January 31, 2021",Blood donors,Children and Youth (0-17 years),169,9.50%,,,Sequential,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Manola Comar,Italian National Institute of Health,https://dx.doi.org/10.1186/s13052-021-01074-9,6/21/2021,7/6/2021,Unverified
201111_Italy_IstitutoNazionaleTumori_Sept2019,"November 11, 2020",National,Italy,Italy,"September 1, 2019","September 30, 2019",Residual sera,Multiple groups,162,14.20%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,8/4/2021,Verified
201111_Italy_IstitutoNazionaleTumori_Feb2020,"November 11, 2020",National,Italy,Italy,"February 1, 2020","March 10, 2020",Residual sera,Multiple groups,105,20.00%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,7/6/2021,Verified
201111_Italy_IstitutoNazionaleTumori_Oct2019,"November 11, 2020",National,Italy,Italy,"October 1, 2019","October 31, 2019",Residual sera,Multiple groups,166,16.30%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,8/4/2021,Verified
201111_Italy_IstitutoNazionaleTumori_Nov2019,"November 11, 2020",National,Italy,Italy,"November 1, 2019","November 30, 2019",Residual sera,Multiple groups,273,9.50%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,8/4/2021,Verified
201111_Italy_IstitutoNazionaleTumori_Dec2019,"November 11, 2020",National,Italy,Italy,"December 1, 2019","December 31, 2019",Residual sera,Multiple groups,147,7.50%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,7/6/2021,Verified
201111_Italy_IstitutoNazionaleTumori_Jan2020,"November 11, 2020",National,Italy,Italy,"January 1, 2020","January 31, 2020",Residual sera,Multiple groups,106,2.80%,,,Sequential,NA,ELISA,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,6/30/2021,7/6/2021,Verified
210603_Italy_UniversityHospitalCittaDellaSalute_University,"June 3, 2021",Local,Italy,Italy; Piedmont; Turin,"June 29, 2020","July 29, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1185,3.30%,2.40%,4.50%,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,7/5/2021,7/6/2021,Unverified
210603_Italy_UniversityHospitalCittaDellaSalute_Healthcare,"June 3, 2021",Local,Italy,Italy; Piedmont; Turin,"May 4, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),8769,7.60%,7.10%,8.20%,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,7/5/2021,7/6/2021,Unverified
210611_Padova_UniversityOfPadova_SpAPatients_Overall,"June 11, 2021",Local,Italy,Italy; Province of Padova; Padova,"June 1, 2020","August 7, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,200,12.50%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,7/6/2021,7/7/2021,Unverified
210611_Padova_UniversityOfPadova_HCW_Overall,"June 11, 2021",Local,Italy,Italy; Province of Padova; Padova,"June 1, 2020","August 7, 2020",Health care workers and caregivers,Multiple groups,95,8.40%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,7/6/2021,7/7/2021,Unverified
210628_Lombardy_UniversityofPavia_patients_primary,"June 28, 2021",Local,Italy,Italy,"May 15, 2020","May 31, 2020",Assisted living and long-term care facilities,Adults (18-64 years),36,36.10%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,7/12/2021,8/4/2021,Unverified
210628_Lombardy_UniversityofPavia_staff_primary,"June 28, 2021",Local,Italy,Italy,"May 15, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),35,34.30%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,7/12/2021,8/4/2021,Unverified
210703_Rome_FondazionePoliclinicoUniversitario_Primary,"July 3, 2021",Local,Italy,Italy,"March 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1106,0.72%,,,Sequential,"Siemens,EUROIMMUN AG",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Lombardi,Fondazione Policlinico Universitario,https://dx.doi.org/10.3390/diagnostics11071154,7/12/2021,8/4/2021,Unverified
210626_Torno_SaccoUniversityHospital_Residents1,"June 26, 2021",Local,Italy,Italy; Lombardy; Torno,"June 1, 2020","June 22, 2020",Assisted living and long-term care facilities,Seniors (65+ years),74,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,7/12/2021,8/4/2021,Unverified
210626_Torno_SaccoUniversityHospital_Staff2,"June 26, 2021",Local,Italy,Italy; Lombardy; Torno,"June 1, 2020","June 22, 2020",Health care workers and caregivers,Adults (18-64 years),51,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,7/12/2021,8/4/2021,Unverified
210625_Emilia-Romagna_UniversityofMilan_primary,"June 25, 2021",Regional,Italy,"Italy; Calerno, Parma, Spilamberto","June 1, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),815,3.80%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Susanna Esposito,University of Milan,https://dx.doi.org/10.3389/fpubh.2021.628098,7/19/2021,7/19/2021,Unverified
210715_Foggia_UniversityHospitalOfFoggia_May-Sept1_Primary,"July 15, 2021",Local,Italy,Italy; Foggia; Foggia,"May 1, 2020","September 30, 2020",Blood donors,Multiple groups,4018,0.50%,0.00%,0.51%,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Francescopaolo Antonucci,University Hospital of Foggia,10.1101/2021.07.12.21260358,7/20/2021,8/4/2021,Unverified
210715_Foggia_UniversityHospitalOfFoggia_Oct-Mar2_Primary,"July 15, 2021",Local,Italy,Italy; Foggia; Foggia,"October 1, 2020","March 31, 2021",Blood donors,Multiple groups,4165,11.90%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Francescopaolo Antonucci,University Hospital of Foggia,10.1101/2021.07.12.21260358,7/20/2021,8/4/2021,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Residents1,"July 24, 2021",Local,Italy,Italy; Province of Brescia; Brescia,"May 19, 2020","June 30, 2020",Assisted living and long-term care facilities,Multiple groups,246,24.00%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,7/20/2021,8/4/2021,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Staff2,"July 24, 2021",Local,Italy,Italy; Province of Brescia; Brescia,"April 23, 2020","May 14, 2020",Health care workers and caregivers,Multiple groups,286,16.78%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,7/20/2021,8/4/2021,Unverified
210706_Lombardy_BrunoKesslerFoundation_HCW,"July 6, 2021",Regional,Italy,Italy; Lombardy region,"April 1, 2020","June 26, 2020",Health care workers and caregivers,Multiple groups,82961,12.20%,12.00%,12.40%,Convenience,DiaSorin SpA,CLIA,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,https://dx.doi.org/10.1001/jamanetworkopen.2021.15699,7/21/2021,8/4/2021,Unverified
210720_Italy_UniversityofGenoa,"July 20, 2021",National,Italy,Italy,"March 4, 2021","July 9, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1022,11.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Maria Pia Sormani,University of Genoa,10.2139/ssrn.3886420,7/28/2021,8/4/2021,Unverified
210719_Vo_UniversityOfPadova_Overall_Abbott,"July 19, 2021",Local,Italy,Italy; Padova; Vo,"May 1, 2020","May 31, 2020",Household and community samples,Multiple groups,2457,3.90%,3.10%,4.70%,Entire sample,Abbott Laboratories,CLIA,IgG,93.90%,100.00%,Low,Journal Article (Peer-Reviewed),Ilaria Dorigatti,University of Padova,https://dx.doi.org/10.1038/s41467-021-24622-7,7/29/2021,7/29/2021,Unverified
210727_Modena_UniversityofModenaandReggioEmilia_Overall,"July 27, 2021",Regional,Italy,Italy; Modena,"May 18, 2020","October 5, 2020",Essential non-healthcare workers,Adults (18-64 years),246608,0.45%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alberto Modenese,University of Modena and Reggio Emilia,http://dx.doi.org/10.3390/ijerph18157948,8/2/2021,8/2/2021,Unverified
200601_Israel_PandemicTaskForce_GenPop,"June 2, 2020, June 2, 2020",National,Israel,Israel; Israel,,"June 2, 2020",Household and community samples,Multiple groups,1700,2.50%,,,Stratified probability,NA,Not reported,IgG,,,Moderate,"News and Media, News and Media","Ido Efrati, Michael Bachner",Israeli Pandemic Task Force,"https://www.google.com/url?rct=j&sa=t&url=https://www.haaretz.com/israel-news/.premium-up-to-270-000-israelis-had-coronavirus-new-study-concludes-1.8888435&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNExqw1wlJNVBFrKKUd7hGTplMnR5A, https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg",6/3/2020,6/17/2021,Verified
201008_BneiBrak_CentralBureauofStatistics_primary,"October 8, 2020",Local,Israel,Israel,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,3500,14.60%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Aaron Rabinowitz,The Central Bureau of Statistics ,https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689,4/23/2021,6/17/2021,Verified
210421_Israel_MinistryofHealth_genpop_primary,"April 21, 2021",National,Israel,Israel,"June 28, 2020","September 14, 2020",Household and community samples,Multiple groups,54357,4.60%,4.40%,4.80%,Convenience,"Abbott Laboratories,DiaSorin SpA",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shay Reicher,Ministry of Health,https://dx.doi.org/10.1007/s10654-021-00749-1,5/20/2021,8/4/2021,Verified
210412_TelAviv_TelAvivUniversity,"April 12, 2021",Local,Israel,Israel,"May 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,242,2.07%,,,Sequential,EUROIMMUN AG,ELISA,"IgG,IgA",100.00%,98.50%,High,Journal Article (Peer-Reviewed),Tali Eviatar ,Tel Aviv University,https://dx.doi.org/10.1111/imj.15202,5/22/2021,8/4/2021,Verified
210416_Safed_ZivMedicalCentre_overall_unadj,"April 16, 2021",Local,Israel,Israel,"December 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),725,3.45%,,,Convenience,"Abbott Laboratories,DiaSorin SpA",Not reported,IgG,,,High,Preprint,Kamal Abu Jabal,Ziv Medical Centre,10.1101/2021.04.11.21255273,5/22/2021,8/4/2021,Verified
210624_Modiin_IsraelMinistryOfHealth_Primary,"June 24, 2021",Local,Israel,Israel,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,283,16.61%,,,Entire sample,"Abbott Laboratories,DiaSorin SpA,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Yael Gozlan,Israel Ministry of Health,http://dx.doi.org/10.1017/S0950268821001369,7/14/2021,8/4/2021,Unverified
210624_Israel_TelAvivUniversity_overall,"June 24, 2021",National,Israel,Israel,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),874,1.10%,0.60%,2.10%,Convenience,"EUROIMMUN AG,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Khitam Muhsen,Tel Aviv University,https://dx.doi.org/10.3389/fmed.2021.689994,7/20/2021,8/4/2021,Unverified
210715_Israel_ShaareZedekMedicalCenter_Primary,"July 15, 2021",Local,Israel,Israel,"October 18, 2020","January 12, 2021",Residual sera,Children and Youth (0-17 years),1138,10.00%,,,Convenience,"Abbott Laboratories,DiaSorin SpA",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Adin Breuer,Shaare Zedek Medical Center,http://dx.doi.org/10.1111/apa.16031,8/3/2021,8/5/2021,Unverified
200817_Ireland_HPSC_genpop_popadj,"August 17, 2020",National,Ireland,"Ireland; Connaught, Leinster; Dublin, Sligo","June 22, 2020","July 16, 2020",Household and community samples,Adults (18-64 years),1733,1.70%,1.10%,2.40%,Stratified probability,"Abbott Laboratories,Fortress Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,Derval Igoe ,HSE Health Protection Surveillance Centre (HPSC) ,https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/scopi/SCOPI%20report%20preliminary%20results%20final%20version.pdf,10/18/2020,8/4/2021,Verified
210212_Dublin_RotundaHospital,"February 12, 2021",Local,Ireland,Ireland; Leinster; Dublin,"May 12, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),51,4.00%,,,Convenience,Trinity Biotech,ELISA,IgG,95.92%,100.00%,High,Preprint,Joanna Griffin,Rotunda Hospital,https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text,3/26/2021,6/17/2021,Verified
210427_Ireland_St.Jame'sHospital,"April 27, 2021",Local,Ireland,Ireland,"October 14, 2020","October 23, 2020",Health care workers and caregivers,Multiple groups,5788,10.00%,,,Convenience,"Abbott Laboratories,Beijing Wantai Biological,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Niamh Allen,St. Jame's Hospital,https://dx.doi.org/10.1017/S0950268821000984,5/21/2021,8/4/2021,Unverified
210602_Dublin_UniversityCollegeDublin_overall_Unadj,"June 2, 2021",Local,Ireland,Ireland; Leinster; Dublin,"June 15, 2020","September 15, 2020",Multiple populations,Adults (18-64 years),109,0.92%,,,Unclear,"EUROIMMUN AG,Fortress Diagnostics,DIAsource,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Emma Heffernan,University College Dublin,https://dx.doi.org/10.1177/00045632211012728,5/22/2021,8/4/2021,Verified
210518_Mid-WestIreland_UniversityofLimerick_Staff1,"May 18, 2021",Regional,Ireland,Ireland; Munster,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,172,11.10%,4.00%,19.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,6/1/2021,7/7/2021,Unverified
210518_Mid-WestIreland_UniversityofLimerick_Patients2,"May 18, 2021",Regional,Ireland,Ireland; Munster,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,799,12.60%,8.00%,17.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,6/2/2021,7/7/2021,Unverified
210526_Ireland_TrinityCollege,"May 26, 2021",Regional,Ireland,Ireland,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),5787,9.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Niamh Allen,"Trinity College, University of Dublin",https://europepmc.org/article/PPR/PPR347943,6/7/2021,7/17/2021,Unverified
210608_SouthWestOfIreland_CorkUniversityHospital,"June 8, 2021",Regional,Ireland,Ireland; Munster; Cork,"May 27, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),404,1.49%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eamonn Faller,Cork University Hospital,http://dx.doi.org/10.1136/bmjopen-2021-051415,6/30/2021,6/30/2021,Unverified
210630_Dublin_TrinityCollegeDublin_Overall,"June 30, 2021",Local,Ireland,Ireland,"July 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),1176,17.90%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Ann Leonard,Trinity College Dublin,https://dx.doi.org/10.1007/s11845-021-02690-4,7/5/2021,7/17/2021,Verified
210707_Dublin_StJames'sHospital,"July 7, 2021",Local,Ireland,Ireland; Leinster; Dublin,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),49,29.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Colm Kerr,St. James’s Hospital,https://dx.doi.org/10.1007/s11845-021-02700-5,7/14/2021,8/4/2021,Unverified
210709_Dublin_HSENationalDrugTreatmentCentre_overall,"July 9, 2021",Local,Ireland,Ireland,"July 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),103,1.90%,,,Convenience,"Abbott Laboratories,DiaSorin SpA,Fortress",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fiona Fenton,HSE National Drug Treatment Centre,https://dx.doi.org/10.1007/s11845-021-02660-w,7/18/2021,8/4/2021,Unverified
210326_Duhok_UniversityOfDuhok_Overall,"March 26, 2021",Local,Iraq,Iraq,"January 10, 2021","January 30, 2021",Household and community samples,Multiple groups,743,62.58%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Preprint,Nawfal Hussein,University of Duhok,10.1101/2021.03.23.21254169,4/9/2021,7/29/2021,Verified
200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall,"September 1, 2020",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"February 20, 2020","March 20, 2020",Multiple populations,Multiple groups,178,17.98%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shahrzad Ossareh,Iran University of Medical Sciences,http://www.ijkd.org/index.php/ijkd/article/view/5832/1205,10/30/2020,8/5/2021,Verified
201221_Guilan_TehranUniversityofMedicalSciences_overall,"December 21, 2020",Regional,Iran (Islamic Republic of),Iran (Islamic Republic of); Guilan,"April 11, 2020","April 19, 2020",Household and community samples,Multiple groups,528,22.20%,16.40%,28.50%,Stratified probability,"VivaChek Biotech (Hangzhou) Co., Ltd",LFIA,"IgG,IgM",83.30%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maryam Shakiba,Tehran University of Medical Sciences,https://dx.doi.org/10.3201/eid2702.201960,1/23/2021,8/5/2021,Verified
201110_Tehran_TehranUniversityofMedicalSciences_unadj,"November 10, 2020",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"March 20, 2020","May 20, 2020",Essential non-healthcare workers,Adults (18-64 years),243,41.56%,,,Convenience,Karma Azma Andish Co.,LFIA,"IgM,IgG",71.10%,58.70%,High,Journal Article (Peer-Reviewed),Peyman Saberian,Tehran University of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/,1/23/2021,8/4/2021,Verified
201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine,"December 6, 2020",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"April 20, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),475,29.40%,,,Convenience,"Hanghzhou AllTest Biotech Co., Ltd",LFIA,"IgG,IgM",99.90%,98.00%,High,Journal Article (Peer-Reviewed),Shahnaz Armin,High Institute for Research and Education in Transfusion Medicine,https://sites.kowsarpub.com/jjm/articles/108592.html,1/27/2021,6/17/2021,Verified
201223_RafsanjanCounty_UniversityofPecs,"December 23, 2020",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Kerman,"March 1, 2020","April 30, 2020",Contacts of COVID patients,Multiple groups,238,15.55%,,,Sequential,NA,Not reported,"IgG,IgM",,,High,Preprint,Reza Vazirinejad,University of Pecs,https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-,2/2/2021,6/17/2021,Verified
201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj,"December 15, 2020",National,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 17, 2020","June 2, 2020",Household and community samples,Multiple groups,3530,17.10%,14.60%,19.50%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,6/24/2021,Verified
210120_Tehran_TehranUniversityofMedicalSciences_InPatients,"January 20, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 15, 2020","October 31, 2020",Residual sera,Multiple groups,1375,21.20%,,,Convenience,IDEAL TASHKHIS Atieh Co,ELISA,"IgG,IgM",82.00%,,High,Preprint,Zeinab Tabanejad,Tehran University of Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.01.18.20248911v1.full-text,2/6/2021,7/7/2021,Unverified
201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj ,"December 15, 2020",National,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 17, 2020","June 2, 2020",Multiple populations,Multiple groups,5372,20.00%,18.50%,21.70%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,8/5/2021,Verified
2101_Zahedan_TehranUniversityofMedicalSciences,"January 1, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan,"July 1, 2020","July 31, 2020",Persons experiencing homelessness,Adults (18-64 years),167,9.70%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,3/14/2021,6/17/2021,Verified
2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers,"January 1, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),134,4.80%,,,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,3/14/2021,6/17/2021,Verified
210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj,"January 5, 2021",Regional,Iran (Islamic Republic of),Iran (Islamic Republic of); Mazandaran,"March 15, 2020","May 15, 2020",Household and community samples,Multiple groups,1588,17.29%,14.84%,17.79%,Stratified probability,Danesh Bonyan Pishtaz Teb Company,ELISA,"IgG,IgM",59.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Seyed Abbas Mousavi,Mazandaran University of Medical Sciences,https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi,3/17/2021,6/17/2021,Verified
210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall,"February 17, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Fars; Shiraz City,"July 13, 2020","August 5, 2020",Health care workers and caregivers,Multiple groups,494,5.90%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kamran Bagheri Lankarani,Shiraz University of Medical Sciences,http://dx.doi.org/10.5812/semj.112681 ,4/16/2021,6/24/2021,Verified
210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_IgG,"March 1, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran Province; Tehran,"April 4, 2020","April 6, 2020",Multiple general populations,Not reported,2021,14.40%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sahar Mortezagholi,Shahid Beheshti University Of Medical Sciences,https://dx.doi.org/10.22034/iji.2021.88168.1851,4/27/2021,6/23/2021,Unverified
210413_Tabiz_TabrizUniversityOfMedicalSciences_overall_unadj_IgG_anti-S,"April 13, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),609,6.07%,,,Unclear,NA,ELISA,"IgG,IgM",93.75%,98.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Sadegh Soltani Zangbar,Tabriz University of Medical Sciences,https://dx.doi.org/10.1016/j.genrep.2021.101140,5/19/2021,6/17/2021,Unverified
210323_Tabriz_TabrizUniversityofMedicalSciences,"March 23, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of); East Azerbaijan Province; Tabriz,"June 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,10.10%,,,Sequential,NA,ELISA,"IgG,IgM",93.00%,98.00%,High,Journal Article (Peer-Reviewed),Jalal Etemadi,Tabriz University of Medical Sciences,https://dx.doi.org/10.1080/08820139.2021.1899202,5/21/2021,7/23/2021,Verified
210420_Iran_TehranUniversityOfMedicalSciences,"April 20, 2021",National,Iran (Islamic Republic of),Iran (Islamic Republic of),"September 15, 2020","October 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1243,17.90%,,,Entire sample,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",79.40%,97.30%,Moderate,Journal Article (Peer-Reviewed),Bahar Hassanmirzaei,Tehran University of Medical Sciences,https://dx.doi.org/10.1136/postgradmedj-2021-140176,5/27/2021,6/17/2021,Unverified
210605_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_Overall,"June 5, 2021",Local,Iran (Islamic Republic of),Iran (Islamic Republic of),"June 15, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,168,17.26%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",100.00%,,High,Journal Article (Peer-Reviewed),Maliheh Arab,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.31557/APJCP.2021.22.6.1667,7/6/2021,8/4/2021,Unverified
210607_Iran_TehranUniversityofMedicalSciences_Primary,"June 7, 2021",National,Iran (Islamic Republic of),Iran (Islamic Republic of),"August 3, 2020","October 31, 2020",Household and community samples,Multiple groups,11256,14.20%,13.30%,15.20%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,IgG,74.00%,98.00%,Low,Journal Article (Peer-Reviewed),Kazem Khalagi ,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/j.cmi.2021.06.002,7/7/2021,7/30/2021,Verified
210714_Iran_TarbiatModaresUniversity_primary,"July 14, 2021",National,Iran (Islamic Republic of),Iran (Islamic Republic of),"May 30, 2020","June 17, 2020",Multiple populations,Multiple groups,716,17.30%,8.80%,25.80%,Unclear,Pishtaz Teb Diagnostics,ELISA,IgG,94.10%,98.30%,High,Preprint,Nazila Hajiahmadi,Tarbiat Modares University,10.1101/2021.07.11.21260336,7/20/2021,8/4/2021,Unverified
210506_EastJava_KobeUniversityGraduateSchoolofMedicine,"May 6, 2021",Regional,Indonesia,"Indonesia; East Java; Surabaya, Jombang","June 15, 2020","December 15, 2020",Household and community samples,Multiple groups,1819,11.40%,,,Convenience,"Nanjing Vazyme Medical Technology Co., Ltd",Not reported,IgG,91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Ni Luh Ayu Megasari,Kobe University Graduate School of Medicine,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251234,5/18/2021,7/7/2021,Unverified
200622_India_IndianCouncilofMedicalResearch_GenPop,"June 22, 2020, May 25, 2020, June 8, 2020, June 16, 2020",National,India,"India; Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Odisha, Punjab, Haryana, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, Uttarakhand, Himachal Pradesh, West Bengal, Jammu, Kashmir","May 11, 2020","May 25, 2020",Household and community samples,Not reported,26400,0.73%,,,Stratified probability,Zydus Diagnostics,ELISA,IgG,,,Moderate,"News and Media, News and Media, News and Media, News and Media","Swatee Kher, Rhythma Kaul, Sumi Dutta, Jacob Koshy",Indian Council of Medical Research,"https://timesofindia.indiatimes.com/city/pune/6-maha-districts-have-higher-ncov-prevalence-than-nations-finding/articleshow/76500273.cms, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/over-24k-samples-collected-for-random-antibody-tests/story-Pec8jZE03DMQ0zOQwr4KEN.html&ct=ga&cd=CAAYDTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGcW3JvLyfXSvgW5ufbrsvCZIK5Cg, https://www.google.com/url?rct=j&sa=t&url=https://www.newindianexpress.com/nation/2020/jun/08/15-30-people-in-containment-areas-exposed-to-covid-19-icmrs-serosurvey-2153893.html&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG7hdULnqHWatDy0FOZfa_fab9k9g, https://www.google.com/url?rct=j&sa=t&url=https://www.thehindu.com/news/national/news-analysis-india-may-have-undercounted-cases/article31822079.ece&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH2njMg_YAc93gwu8ZxyGEMwYvnnQ",6/24/2020,6/17/2021,Verified
200606_Bengaluru_SJICSR_Staff,"June 6, 2020",Local,India,India; Karnataka; Bengaluru,"May 23, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),1000,1.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Sunitha Rao,Sri Jayadeva Institute of Cardiovascular Sciences and Research,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q,6/27/2020,8/4/2021,Verified
200614_Thiruvananthapuram_HealthDepartment_GenPop,"June 14, 2020",Local,India,India; Kerala; Thiruvananthapuram,"June 9, 2020","June 12, 2020",Household and community samples,Multiple groups,450,2.67%,,,Unclear,NA,Not reported,"IgM,IgG",,,Unclear,News and Media,Aswin Kumar,Thiruvanathapuram Health Department,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg,7/6/2020,6/17/2021,Verified
200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop,"July 21, 2020, July 21, 2020",Regional,India,"India; Haryana; Gurugram, Faridabad, Ambala, Panchkula, Sonipat","June 21, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),1544,12.00%,,,Stratified probability,NA,ELISA,IgG,,,High,"News and Media, News and Media","Archana Mishra, Prayag Arora Desai",Haryana Health Department,"https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/gurugram/sero-survey-1-544-tested-180-found-with-covid-19-antibodies-in-haryana/story-k7DUZ8WH4jYqAzCsUmXkEJ.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHS65YBS1xHpw-8TGWw9ZqDMQDIog, https://www.hindustantimes.com/gurugram/pvt-lab-says-16-20-sero-prevalence-in-gurugram-health-dept-distances-itself-from-data/story-265qYKX4XhRPeMVc5HrKEO.html",7/31/2020,6/17/2021,Verified
200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors,"July 19, 2020",Local,India,India; Uttar Pradesh; Lucknow,"July 5, 2020","July 19, 2020",Blood donors,Not reported,1235,3.70%,,,Convenience,NA,Not reported,IgG,,,High,News and Media,Yusra Husain,King George's Medical University,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA,8/1/2020,6/17/2021,Verified
200723_Delhi_IndianCentreforDiseaseControl_GenPop,"July 23, 2020, July 21, 2020",Regional,India,India; NCT Delhi,"June 27, 2020","July 10, 2020",Household and community samples,Multiple groups,21387,23.48%,,,Stratified probability,Zydus Diagnostics,ELISA,IgG,98.70%,100.00%,Moderate,"News and Media, Institutional Report","Astha Saxena , Ministry of Health and Family Welfare",Indian Center for Disease Control,"https://www.google.com/url?rct=j&sa=t&url=https://indianexpress.com/article/cities/delhi/delhi-coronavirus-latest-updates-sero-surveys-6518032/&ct=ga&cd=CAAYJjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGCf7pxljsAyKyKKRtaj_xafKiFPw, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137",8/2/2020,6/17/2021,Verified
200723_India_Thyrocare_GenPop,"July 23, 2020, July 22, 2020",National,India,India,"June 28, 2020","July 19, 2020",Household and community samples,Not reported,53000,15.00%,,,Simplified probability,NA,Multiple Types,Not reported,,,High,"News and Media, News and Media","India com News Desk, HT Correspondent",Thyrocare,"https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/15-per-cent-population-may-have-virus-antibodies-says-private-lab-data/story-mUddIj9kxI4vRzYu4KMUiI.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEuq1rkJ7vFZU1Rp4WmYN2Cr32JNA",8/4/2020,6/17/2021,Verified
200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj,"August 26, 2020",Local,India,India; Punjab; New Delhi,"June 8, 2020","August 8, 2020",Residual sera,Multiple groups,212,19.80%,14.70%,25.80%,Convenience,NA,ELISA,IgG,88.24%,99.79%,High,Preprint,Animesh Ray,All India Institute of Medical Sciences,https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2,10/13/2020,6/17/2021,Verified
200914_PaschimMedinipur_MedicalCollegeKolkata_Overall,"September 14, 2020",Regional,India,India; West Bengal,"July 26, 2020","August 8, 2020",Household and community samples,Multiple groups,458,4.15%,2.52%,6.40%,Stratified probability,Calbiotech Inc.,ELISA,IgG,98.30%,98.10%,Moderate,Preprint,Parthasarathi Satpati,Medical College Kolkata,https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1,11/5/2020,8/5/2021,Verified
200903_NewDelhi_MaxSuperSpecialtyHospital_Overall,"September 3, 2020",Local,India,India; NCT Delhi; New Delhi,"April 15, 2020","August 15, 2020",Multiple populations,Multiple groups,780,19.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,94.50%,99.40%,High,Preprint,Samreen Siddiqui,Max Super Specialty Hospital,https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1,11/6/2020,8/5/2021,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj,"September 22, 2020",Local,India,India; NCT Delhi; New Delhi,"June 26, 2020","July 10, 2020",Household and community samples,Not reported,21387,23.48%,22.96%,24.01%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,6/17/2021,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj,"September 22, 2020",Local,India,India; NCT Delhi; New Delhi,"August 1, 2020","August 7, 2020",Household and community samples,Not reported,15311,29.10%,28.51%,29.95%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,6/17/2021,Verified
200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj,"September 17, 2020",National,India,India,"May 11, 2020","June 4, 2020",Household and community samples,Multiple groups,28000,0.73%,0.34%,1.13%,Stratified probability,"Zydus Diagnostics,EUROIMMUN AG",ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.4103/ijmr.IJMR_3290_20,11/26/2020,8/4/2021,Verified
201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest,"December 7, 2020",Local,India,India; Maharashtra; Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),208,12.50%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Tanu Singhal,Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute,https://dx.doi.org/10.4103/ijmm.IJMM_20_308,1/12/2021,8/4/2021,Verified
201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall,"November 9, 2020",Local,India,India; West Bengal; Kolkata,"July 12, 2020","August 23, 2020",Health care workers and caregivers,Adults (18-64 years),1122,11.94%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india,1/18/2021,6/17/2021,Verified
201104_India_HindujaHospital_GenPop,"November 4, 2020",Local,India,India; Maharashtra; Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,801,11.10%,9.10%,13.50%,Unclear,Roche Diagnostics,Not reported,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Nishant Kumar,Postgraduate Institute of Medical Education and Research,https://dx.doi.org/10.1016/j.vaccine.2020.10.094,1/18/2021,7/16/2021,Verified
201130_DrDYPatilMedicalCollege_Pimpri-Chinchwad_DashboardPrimary,"November 30, 2020",Local,India,India; Maharashtra; Pune ,"October 7, 2020","October 17, 2020",Household and community samples,Multiple groups,5000,34.04%,31.30%,36.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Preprint,Amitav Banerjee,Dr DY Patil Medical College ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3729394,1/23/2021,6/17/2021,Verified
201211_Karnatka_IndianInstituteofPublicHealth_primary_adj,"December 11, 2020",Regional,India,India; Karnatka,"September 3, 2020","September 16, 2020",Household and community samples,Multiple groups,15624,16.40%,15.10%,17.70%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.10%,99.77%,Moderate,Preprint,Giridhara R Babu,Indian Institute of Public Health,https://www.medrxiv.org/content/10.1101/2020.12.04.20243949v1.full,1/29/2021,8/5/2021,Verified
201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall,"November 9, 2020",Local,India,India; West Bengal; Kolkata,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,http://dx.doi.org/10.1002/jgh3.12447,1/30/2021,6/17/2021,Verified
201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary,"December 14, 2020",Local,India,India; Gujarat; Ahmedabad,"June 16, 2020","July 7, 2020",Residual sera,Multiple groups,29891,17.61%,17.18%,18.04%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash, Municipal Medical College ,https://dx.doi.org/10.1136/bmjopen-2020-044101,2/2/2021,8/5/2021,Verified
210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall,"January 4, 2021",Local,India,India; Tamil Nadu; Chennai,"July 30, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),95,16.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Manoj Madhusudan,"Kanchi Kamakoti CHILDS Trust Hospital,",https://pubmed.ncbi.nlm.nih.gov/33408287/,2/4/2021,6/17/2021,Unverified
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre,"September 16, 2020",Local,India,India; Kerala,"July 11, 2020","July 24, 2020",Health care workers and caregivers,Multiple groups,635,0.00%,,,Convenience,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Anil Kumar,Amrita Institute of Medical Sciences & Research Centre,http://dx.doi.org/10.1016/j.cmi.2020.09.013,2/6/2021,8/4/2021,Verified
201214_Delhi_MaulanaAzadMedicalCollege_Oct_PopTestAdj,"December 14, 2020",Regional,India,India; NCT Delhi,"October 15, 2020","October 21, 2020",Household and community samples,Multiple groups,15015,24.71%,24.01%,25.42%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,6/17/2021,Verified
201214_Delhi_MaulanaAzadMedicalCollege_Sept_PopTestAdj,"December 14, 2020",Regional,India,India; NCT Delhi,"September 1, 2020","September 7, 2020",Household and community samples,Multiple groups,17409,24.08%,23.43%,24.74%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,6/17/2021,Verified
201214_Delhi_GovernmentofNationalCapitalTerritory_Aug1_PopTestAdj,"December 14, 2020",Regional,India,India; NCT Delhi,"August 1, 2020","August 7, 2020",Household and community samples,Multiple groups,15046,28.39%,27.65%,29.14%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.10%,97.70%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,6/17/2021,Verified
211104_Karnataka_Mapmygenome_primary_adj,"February 4, 2021",Regional,India,India; Karnataka,"June 15, 2020","August 29, 2020",Household and community samples,Multiple groups,1197,46.70%,43.30%,50.00%,Stratified probability,NA,ELISA,IgG,84.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Mohanan,Mapmygenome,https://dx.doi.org/10.1001/jama.2021.0332,2/8/2021,7/6/2021,Verified
201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj,"November 30, 2020",Local,India,India; Maharashtra; Pune,"July 20, 2020","August 5, 2020",Household and community samples,Multiple groups,1659,51.30%,39.90%,62.40%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Aurnab Ghose,Indian Institute of Science Education and Research,https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text,2/12/2021,7/6/2021,Verified
210114_Puducherry_JawaharlalInstitute_August_primary,"January 14, 2021",Regional,India,India; Puducherry,"August 11, 2020","August 16, 2020",Household and community samples,Multiple groups,869,4.90%,3.50%,6.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,7/17/2021,Unverified
210114_Puducherry_JawaharlalInstitute_Sep_primary,"January 14, 2021",Regional,India,India; Puducherry,"September 10, 2020","September 16, 2020",Household and community samples,Multiple groups,898,20.70%,18.00%,23.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,7/17/2021,Unverified
210114_Puducherry_JawaharlalInstitute_Oct_primary,"January 14, 2021",Regional,India,India; Puducherry,"October 12, 2020","October 16, 2020",Household and community samples,Multiple groups,900,34.50%,31.50%,37.70%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,7/17/2021,Unverified
210120_Chennai_NationalInstituteOfEpidemiology_primary_adj,"January 20, 2021",Local,India,India,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,12405,18.40%,14.80%,22.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Sriram Selvaraju,National Institute of Epidemiology,https://dx.doi.org/10.3201/eid2702.203938,2/21/2021,6/17/2021,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj,"November 13, 2020",Local,India,India; Maharashtra; Mumbai,"June 29, 2020","July 19, 2020",Persons living in slums,Multiple groups,4202,58.30%,56.80%,59.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,7/23/2021,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj,"November 13, 2020",Local,India,India; Maharashtra; Mumbai,"June 29, 2020","July 19, 2020",Household and community samples,Multiple groups,2702,17.10%,15.80%,18.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,7/23/2021,Verified
210131_Thissur_JubileeMissionHospital_primary,"January 31, 2021",Local,India,India; Kerala; Thrissur,"September 5, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),423,8.75%,6.23%,11.86%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Preprint,Aboobacker Mohamed Rafi,Jubilee Mission Hospital,https://www.medrxiv.org/content/10.1101/2021.01.27.21250502v1,2/28/2021,6/17/2021,Verified
210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG,"February 1, 2021",Local,India,India; Tamil Nadu; Chennai,"June 1, 2020","September 30, 2020",Residual sera,Children and Youth (0-17 years),463,19.60%,15.40%,22.50%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Aishwarya Venkataraman,Bristol Royal Hospital for Children,https://www.medrxiv.org/content/10.1101/2021.01.29.21250660v1,3/3/2021,6/17/2021,Verified
201031_Bhubaneswar_RegionalMedicalResearchCentre_overall,"October 31, 2020",Local,India,India,"October 16, 2020","October 18, 2020",Household and community samples,Not reported,1403,50.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Riyan Ramanath,The Regional Medical Research Centre in Bhubaneswar,https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms,3/7/2021,6/17/2021,Verified
201027_DistrictSrinagar_GovernmentMedicalCollege_Overall,"October 27, 2020",Local,India,India; Kashmir,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),2905,2.50%,2.00%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Moderate,Preprint,Muhammad Salim Khan,Government Medical College,https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text,3/16/2021,6/17/2021,Verified
210127_India_ICRM_overall_adj,"January 27, 2021",National,India,India,"August 18, 2020","September 20, 2020",Household and community samples,Multiple groups,29082,6.60%,5.80%,7.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,The Indian Council of Medical Research (ICMR),https://dx.doi.org/10.1016/S2214-109X(20)30544-1,3/17/2021,6/17/2021,Verified
210205_India_ICRM_overall,"February 5, 2021",National,India,India,"December 17, 2020","January 8, 2021",Household and community samples,Multiple groups,28589,21.50%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,BBC News,The Indian Council of Medical Research (ICMR),https://www.bbc.com/news/world-asia-india-55945382,3/17/2021,6/17/2021,Verified
210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,"March 1, 2021",Local,India,India; NCT Delhi; New Delhi,"June 22, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),3739,13.02%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ritu Gupta,All India Institute of Medical Sciences,https://pubmed.ncbi.nlm.nih.gov/33642348/,3/24/2021,6/17/2021,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall,"March 11, 2021",Local,India,India; Tamil Nadu,"July 6, 2020","August 20, 2020",Household and community samples,Multiple groups,501,2.20%,0.80%,3.40%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/30/2021,8/4/2021,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall ,"March 11, 2021",Local,India,India; Tamil Nadu,"November 6, 2020","November 20, 2020",Household and community samples,Multiple groups,200,22.00%,16.30%,27.70%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/30/2021,8/4/2021,Verified
210212_Gurugram_Medanta-TheMedicity,"February 12, 2021",Local,India,India; Haryana; Gurugram,"January 12, 2021","February 13, 2021",Health care workers and caregivers,Adults (18-64 years),3258,46.20%,44.40%,47.90%,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Preprint,Sushila Kataria,Madanta- The Medicity,https://www.medrxiv.org/content/10.1101/2021.02.10.21251543v1,3/30/2021,6/17/2021,Verified
201111_Srinagar_GovernmentMedicalCollegeSrinagar,"November 11, 2020",Regional,India,India; Srinagar; District Srinagar,"July 1, 2020","July 15, 2020",Residual sera,Multiple groups,2906,3.60%,2.90%,4.30%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),S Muhammad Salim Khan,Government Medical College Srinagar,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303,4/9/2021,8/5/2021,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW,"March 26, 2021",Local,India,India,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),128,12.50%,7.30%,19.50%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,4/9/2021,8/2/2021,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW,"March 26, 2021",Local,India,India,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),164,38.40%,30.90%,46.30%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,4/9/2021,8/2/2021,Verified
210411_India_BanarasHinduUniversity_Overall,"April 11, 2021",National,India,India,"September 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),2301,30.55%,28.70%,32.50%,Simplified probability,"Biosense Technologies, India",Not reported,"IgM,IgA,IgG,Total Antibody",100.00%,99.00%,Moderate,Preprint,Prajjval Singh,Banaras Hindu University,https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2,4/15/2021,7/6/2021,Unverified
210202_Delhi_DelhiGovernment,"February 2, 2021",Local,India,India,"January 15, 2021","January 23, 2021",Household and community samples,Not reported,28000,56.13%,,,Unclear,NA,CLIA,Not reported,,,Unclear,News and Media,Mallika Soni,Delhi Government,https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html,4/15/2021,7/6/2021,Verified
210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall,"February 15, 2021",Local,India,India; Bihar; Patna,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),919,13.30%,11.20%,15.60%,Convenience,Siemens,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Mala Mahto,All India Institute of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/,4/15/2021,6/17/2021,Verified
210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall,"March 1, 2021",Local,India,India; Gujarat; Ahmedabad,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1333,27.76%,,,Unclear,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jemil Makadia,Smt NHL Municipal Medical College,http://dx.doi.org/10.7860/JCDR/2021/46817.14599,4/17/2021,7/9/2021,Verified
210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall,"March 11, 2021",Local,India,India,"April 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1191,9.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hem Chandra Pandey,All India Institute of Medical Sciences ,https://dx.doi.org/10.1016/j.transci.2021.103118,4/18/2021,7/14/2021,Verified
201103_Haryan_TheHindu_primary,"November 3, 2020",Regional,India,India; Haryan,"October 18, 2020","October 24, 2020",Household and community samples,Multiple groups,16477,14.76%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ashok Kumar,Unclear,https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece,4/22/2021,7/6/2021,Verified
201017_Ujjain_TheTimesOfIndia_primary,"September 17, 2020",Regional,India,India; Madhya Pradesh,"August 27, 2020","August 30, 2020",Household and community samples,Multiple groups,3000,11.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Amarjeet Singh,The Times of India,https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms,4/22/2021,6/17/2021,Verified
200820_Punjab_PunjabSeroSurvey_genpop,"August 20, 2020",Regional,India,India; Punjab,"August 1, 2020","August 17, 2020",Household and community samples,Multiple groups,1250,27.70%,,,Simplified probability,NA,LFIA,"IgM,IgG",,,Unclear,News and Media,Express News Service,NR,https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/,4/26/2021,6/17/2021,Verified
200901_Aurangabad_GovernmentMedicalSchool_overall,"September 1, 2020",Local,India,India; Maharashtra,"August 10, 2020","August 19, 2020",Household and community samples,Multiple groups,6571,5.80%,,,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),J V Dixit,"Government Medical School, Aurangabad",https://ijcrt.org/papers/IJCRT2009467.pdf,4/26/2021,6/17/2021,Verified
20210406_Kashmir_GovernmentMedicalCollegeSringar_PopTestAdj,"April 6, 2021",Regional,India,India; Kashmir,"October 17, 2020","November 4, 2020",Household and community samples,Adults (18-64 years),6230,36.70%,34.30%,39.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Low,Journal Article (Peer-Reviewed),Muhammad Khan,Government Medical College Sringar,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3820632,4/26/2021,6/17/2021,Verified
210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj,"March 31, 2021",Local,India,India; Madya Pradesh; Jabalpur,"December 11, 2020","December 21, 2020",Household and community samples,Multiple groups,9279,29.42%,28.41%,30.42%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Sudarshan Ramaswamy,National Centre for Disease Control,https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536,4/27/2021,6/17/2021,Verified
200831_Mumbai_NITI-Aayog_Slums_overall,"August 31, 2020",Local,India,India,"August 16, 2020","August 29, 2020",Persons living in slums,Multiple groups,3024,44.90%,43.20%,46.70%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/6/2021,7/8/2021,Verified
200831_Mumbai_NITI-Aayog_Non-Slum_overall,"August 31, 2020",Local,India,India,"August 16, 2020","August 29, 2020",Household and community samples,Multiple groups,2176,17.50%,15.90%,19.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/6/2021,7/8/2021,Verified
200831_Mumbai_NITI-Aayog_HCW,"August 31, 2020",Local,India,India,"August 16, 2020","August 29, 2020",Health care workers and caregivers,Adults (18-64 years),728,27.30%,24.10%,30.60%,Unclear,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Unclear,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/6/2021,7/8/2021,Verified
201011_Assam_Srijanasom_overall,"October 11, 2020",Regional,India,India; Assam,"August 23, 2020","September 26, 2020",Household and community samples,Multiple groups,2390,23.70%,,,Unclear,NA,CLIA,IgG,,,Unclear,News and Media,Bikash Singh,Srijanasom,https://economictimes.indiatimes.com/news/politics-and-nation/assams-sero-survey-found-23-7-per-cent-seroprevalence-in-the-state/articleshow/78606153.cms,5/14/2021,7/7/2021,Verified
201104_Karnataka_GovernmentOfKarnataka,"November 4, 2020",Regional,India,India; Karnataka; N/A,"September 3, 2020","September 16, 2020",Household and community samples,Multiple groups,15624,16.40%,,,Unclear,Zydus Diagnostics,ELISA,IgG,,,Unclear,News and Media,Nolan Pinto,Government of Karnataka,https://www.indiatoday.in/coronavirus-outbreak/story/serosurvey-found-16-people-in-karnataka-have-covid-19-antibodies-health-minister-k-sudhakar-1738014-2020-11-04,5/18/2021,7/6/2021,Verified
210320_Ahmedabad_AMCMETMedicalCollege_Overall,"March 20, 2021",Local,India,India; Gujarat; Ahmedabad,"August 17, 2020","August 31, 2020",Contacts of COVID patients,Multiple groups,3973,31.92%,30.48%,33.38%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,https://pubmed.ncbi.nlm.nih.gov/33753682/,5/19/2021,7/31/2021,Verified
210401_Srinagar_GovernmentMedicalCollegeSrinagar,"April 1, 2021",Local,India,India; Kashmir; Srinagar,"October 17, 2020","October 20, 2020",Household and community samples,Multiple groups,2418,40.60%,38.70%,42.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Taha Ayub,Government Medical College Srinagar,https://www.ijcmph.com/index.php/ijcmph/article/view/7827,5/19/2021,6/17/2021,Unverified
210330_India_IndianCouncilOfMedicalResearch_GenPop_TestPopAdj,"March 30, 2021, July 1, 2021",National,India,India,"December 18, 2020","January 6, 2021",Household and community samples,Multiple groups,28598,24.10%,23.00%,25.30%,Stratified probability,"Siemens,Abbott Laboratories",Multiple Types,IgG,,,Low,"Preprint, Journal Article (Peer-Reviewed)","Manoj V Murhekar, Manoj V Murhekar",Indian Council of Medical Research,"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3810375, http://dx.doi.org/10.1016/j.ijid.2021.05.040",5/20/2021,8/4/2021,Unverified
210330_India_IndianCouncilOfMedicalResearch_HCWs_TestPopAdj,"March 30, 2021, July 1, 2021",National,India,India,"December 18, 2020","January 6, 2021",Health care workers and caregivers,Multiple groups,7385,25.60%,23.50%,27.80%,Stratified probability,Siemens,CLIA,IgG,100.00%,99.90%,Low,"Preprint, Journal Article (Peer-Reviewed)","Manoj V Murhekar, Manoj V Murhekar",Indian Council of Medical Research,"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3810375, http://dx.doi.org/10.1016/j.ijid.2021.05.040",5/20/2021,6/17/2021,Unverified
200930_Kerala_GovernmentOfKerala_August,"September 30, 2020",Regional,India,"India; Kerala; Ernakulam, Palakkad, Thrissur","August 24, 2020","August 26, 2020",Household and community samples,Multiple groups,1281,0.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,5/20/2021,7/6/2021,Verified
200930_Kerala_GovernmentOfKerala_May,"September 30, 2020",Regional,India,"India; Kerala; Ernakulam, Palakkad, Thrissur","May 18, 2020","May 23, 2020",Household and community samples,Multiple groups,1193,0.33%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,5/20/2021,7/6/2021,Verified
210321_Jamshedpur_TataMainHospital_OverallHCW,"March 21, 2021",Local,India,India; Jharkhand; Jamshedpur,"October 7, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),2110,43.80%,,,Convenience,Beckman Coulter,CLIA,IgG,100.00%,98.60%,Moderate,Journal Article (Peer-Reviewed),Minakshi Mishra,Tata Main Hospital,https://pubmed.ncbi.nlm.nih.gov/33898113/,5/21/2021,7/9/2021,Verified
210501_Ahmedabad_MunicipalMedicalCollege_primary,"May 1, 2021",Local,India,India,"October 15, 2020","October 31, 2020",Household and community samples,Multiple groups,21126,24.20%,23.57%,24.85%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,5/22/2021,7/7/2021,Unverified
210324_India_UniversityofToronto_genpop_overall_unadj,"March 24, 2021",National,India,"India; Maharashtra; West Bengal; Tamil Nadu; Karnataka; Gujarat; Rajasthan; Bihar; Andhra Pradesh; Mumbia, Delhi, Kolkata, Chennai, Bangalore, Ahmedabad, Pune, Surat, Jaipur, Nagpur, Coimbatore, Visakhapatnam","June 12, 2020","December 31, 2020",Household and community samples,Multiple groups,448518,31.00%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Preprint,Arokiaswamy Velumani,University of Toronto ,10.1101/2021.03.19.21253429,5/22/2021,8/4/2021,Verified
210418_Delhi_CouncilofScientificandIndustrialResearchInstituteofGenomicsandIntegrativeBiology_HCW,"April 18, 2021",Regional,India,India; Delhi,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),307,42.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Preprint,Rajat Ujjainia,Council of Scientific and Industrial Research Institute of Genomics and Integrative Biology,https://www.medrxiv.org/content/10.1101/2021.02.28.21252621v3,5/23/2021,7/6/2021,Unverified
210420_Kashmir_GovernmentMedicalCollege,"April 20, 2021",Regional,India,India; Kashmir,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Multiple groups,2905,2.50%,2.00%,3.10%,Convenience,NA,ELISA,IgG,100.00%,99.00%,High,Journal Article (Peer-Reviewed),Muhammad Salim Khan,Government Medical College,https://dx.doi.org/10.12788/jhm.3609,5/26/2021,6/19/2021,Unverified
210521_Bengaluru_BangaloreMedicalCollege,"May 21, 2021",Local,India,India; Karnataka; Bangalore,"April 15, 2021","April 22, 2021",Persons living in slums,Multiple groups,728,20.30%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Ranganath TS,Bangalore Medical College and Research Institute,https://timesofindia.indiatimes.com/city/bengaluru/one-in-five-has-antibodies-against-covid-in-slums-in-bengaluru-study/articleshow/82825325.cms,5/27/2021,7/6/2021,Unverified
210409_NewDelhi_MaulanaAzadMedicalCollege,"April 9, 2021",Local,India,India; National Capital Territory of Delhi; New Delhi,"August 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),1401,12.10%,10.40%,13.80%,Convenience,Zydus Diagnostics,ELISA,IgG,92.40%,97.90%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2021.12.2.06,5/31/2021,6/19/2021,Unverified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_PopAdj2,"May 18, 2021",Regional,India,"India; Odisha; Bhubaneswar, Berhampur, Rourkela","August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,4146,20.78%,19.56%,22.05%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-RegionalMedicalResearchCentre,https://dx.doi.org/10.1038/s41598-021-89877-y,6/3/2021,7/17/2021,Unverified
210508_Ahmedabad_GujaratUniversity,"May 8, 2021",Local,India,India; Gujarat; Ahmedabad,"August 15, 2020","August 31, 2020",Health care workers and caregivers,Multiple groups,1710,23.65%,21.70%,25.73%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,"Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Gujarat University",https://dx.doi.org/10.1016/j.cegh.2021.100766,6/3/2021,7/6/2021,Unverified
210408_Malegaon_MunicipalCorporationofMalegaon_genpop_overall,"April 8, 2021",Local,India,India,"July 25, 2020","August 20, 2020",Household and community samples,Multiple groups,336,40.00%,35.00%,45.00%,Stratified non-probability,NA,ELISA,IgG,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pallavi Saple,The Municipality of Malegaon ,https://dx.doi.org/10.4103/jfmpc.jfmpc_2191_20,6/6/2021,7/23/2021,Verified
210602_SouthEastAsia_MaulanaAzadMedicalCollege,"June 2, 2021",Local,India,India,"June 22, 2020","December 22, 2020",Contacts of COVID patients,Multiple groups,166,37.30%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Preprint,Mradul Kumar Daga,Maulana Azad Medical College,https://www.researchsquare.com/article/rs-540165/v1,6/7/2021,6/17/2021,Unverified
210521_Karnataka_IndianInstituteOfPublicHealth_Primary,"May 21, 2021",Regional,India,India; Karnataka,"September 3, 2020","September 16, 2020",Household and community samples,Multiple groups,15624,16.80%,15.50%,18.10%,Stratified probability,Zydus Diagnostics,ELISA,IgG,921.00%,97.70%,,Journal Article (Peer-Reviewed),Giridhara R Babu,Indian Institute of Public Health,http://dx.doi.org/10.1016/j.ijid.2021.05.043,6/8/2021,7/6/2021,Unverified
201708_Pune_AshokaUniversity_primary,"August 17, 2020",Local,India,India; Maharashtra; Pune,"July 20, 2020","August 5, 2020",Household and community samples,Multiple groups,1664,51.50%,,,Stratified probability,NA,Not reported,IgG,,,Unclear,News and Media,Anuradha Mascarenhas,Ashoka University,https://indianexpress.com/article/cities/pune/first-sero-survey-shows-extensive-spread-of-covid-19-from-36-1-to-65-4-in-selected-areas-sampled-in-pune-6558853/,6/17/2021,8/4/2021,Unverified
200829_Indore_NationalCentreForDiseaseControl,"August 29, 2020",Local,India,India,"August 11, 2020","August 23, 2020",Household and community samples,Multiple groups,7103,7.72%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Press Trust of India,National Centre for Disease Control,https://www.indiatoday.in/india/story/indore-sero-survey-antibodies-found-nearly-people-1716506-2020-08-29,6/22/2021,7/6/2021,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiUrban1,"June 16, 2021",Local,India,India; National Capital Territory of Delhi; New Delhi,"March 15, 2021","March 31, 2021",Household and community samples,Multiple groups,1001,74.70%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/22/2021,7/7/2021,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiRural2,"June 16, 2021",Local,India,"India; Haryana
; Faridabad
","April 12, 2021","May 22, 2021",Household and community samples,Multiple groups,1059,59.30%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/22/2021,7/6/2021,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_Bhubaneswar3,"June 16, 2021",Local,India,India; Odisha; Bhubaneswar,"March 22, 2021","May 7, 2021",Household and community samples,Multiple groups,1000,52.60%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/22/2021,7/6/2021,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_Gorakhpur4,"June 16, 2021",Local,India,India; Uttar Pradesh; Gorakhpur,"April 22, 2021","June 10, 2021",Household and community samples,Multiple groups,448,87.90%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/22/2021,7/7/2021,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_Agartala5,"June 16, 2021",Local,India,India; Tripura; Agartala,"March 26, 2021","June 1, 2021",Household and community samples,Multiple groups,1001,51.90%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/22/2021,7/6/2021,Unverified
200826_Andhra_CollegeOfVeterinarySciences_Krishna1,"August 26, 2020",Regional,India,India; Andhra,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,21.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/6/2021,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Anantapur2,"August 26, 2020",Regional,India,India; Andhra,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,16.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/6/2021,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_EastGodavari3,"August 26, 2020",Regional,India,India; Andhra,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,14.40%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/6/2021,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Nellore4,"August 26, 2020",Regional,India,India; Andhra,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,8.20%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/6/2021,Unverified
200903_Ahmedabad_AhmedabadMunicipalCorporation,"September 3, 2020",Local,India,India; Gujarat; Ahmedabad,"August 15, 2020","August 29, 2020",Household and community samples,Not reported,10310,23.24%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Express News Service ,Ahmedabad Municipal Corporation,https://indianexpress.com/article/cities/ahmedabad/second-survey-in-ahmedabad-sero-positivity-up-by-5-6-per-cent-since-june-no-herd-immunity-yet-6580951/,6/23/2021,7/6/2021,Unverified
210601_Chennai_GovernmentKilpaukMedicalCollege,"June 1, 2021",Local,India,India; Tamil Nadu; Chennai,"April 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),45,26.66%,,,Convenience,"J. Mitra & Co. Pvt., Ltd",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Therese Dhason,Government Kilpauk Medical College,http://dx.doi.org/10.7860/JCDR/2021/48889.14995,6/29/2021,7/6/2021,Unverified
210620_Delhi_AllIndiaInstituteOfMedicalScience,"June 20, 2021",Local,India,India,"September 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,164,14.00%,9.10%,20.30%,Convenience,Abbott Laboratories,CLIA,IgG,94.00%,100.00%,High,Preprint,Shivdas Rajaram Naik,All India Institute Of Medical Science,10.1101/2021.06.17.21259066,6/30/2021,7/7/2021,Unverified
210710_SouthIndia_AravindEyeHospital_Primary,"July 10, 2021",Regional,India,India; South India,"August 19, 2020","August 28, 2020",Health care workers and caregivers,Multiple groups,1313,15.80%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.10%,99.70%,Moderate,Journal Article (Peer-Reviewed),RajapandianSiva Ganesa Karthikeyan,Aravind Eye Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.06.014,7/19/2021,7/19/2021,Unverified
210721_India_IndianCouncilOfMedicalResearch_genpop_overall,"July 21, 2021",National,India,India,"June 20, 2021","July 10, 2021",Household and community samples,Multiple groups,28975,67.60%,,,Simplified probability,NA,Unclear,IgG,,,Unclear,News and Media,Rhythma Kaul,Indian Council of Medical Research,https://www.hindustantimes.com/india-news/antibodies-in-68-indians-101626804217418.html,7/26/2021,7/26/2021,Unverified
210722_Kolkata_IndianStatisticalInstitute_Primary,"July 22, 2021",Local,India,India; West Bengal; Kolkata,"November 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),313,40.00%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Preprint,Soma Sarkar,Indian Statistical Institute,10.1101/2021.07.20.21260278,7/28/2021,7/28/2021,Unverified
210722_Kerala_GovernmentMedicalCollegeThiruvananthapuram_TestAdj,"July 22, 2021",Local,India,India; Kerala; Thiruvananthapuram,"January 8, 2021","January 19, 2021",Health care workers and caregivers,Adults (18-64 years),940,21.20%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Preprint,S J Jessy,Government Medical College Thiruvananthapuram,10.1101/2021.07.19.21260792,7/29/2021,7/29/2021,Unverified
210722_Hyderabad_CSIR-CentreForCellularAndMolecularBiology_Primary,"July 22, 2021",Local,India,India; Telangana; Hyderabad,"January 8, 2021","January 24, 2021",Household and community samples,Multiple groups,9363,54.20%,53.20%,55.20%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Avula Laxmaiah,CSIR-CentreForCellularAndMolecularBiology,10.1101/2021.07.18.21260555,7/29/2021,7/29/2021,Unverified
210702_Ahmedabad_NHLMunicipalMedicalCollege_,"July 2, 2021",Local,India,India; Gujarat; Ahmedabad,"August 15, 2020","August 31, 2020",Household and community samples,Multiple groups,10310,23.24%,22.43%,24.06%,Stratified probability,Zydus Diagnostics,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Om Prakash,NHL Municipal Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_2062_20,8/4/2021,8/4/2021,Unverified
210702_Jodhpur_AllIndiaInstituteOfMedicalSciences_1,"July 2, 2021",Local,India,India; Rajasthan; Jodhpur,"July 28, 2020","July 28, 2020",Essential non-healthcare workers,Adults (18-64 years),22,2.44%,,,Unclear,"J. Mitra & Co. Pvt., Ltd",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,8/4/2021,8/4/2021,Unverified
210702_Jaipur_AllIndiaInstituteOfMedicalSciences_2,"July 2, 2021",Local,India,India; Rajasthan; Jaipur,"August 4, 2020","August 4, 2020",Essential non-healthcare workers,Adults (18-64 years),41,13.64%,,,Unclear,"J. Mitra & Co. Pvt., Ltd",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,8/4/2021,8/4/2021,Unverified
200901_Iceland_deCODEGenetics_OverallPopAdj,"September 1, 2020",National,Iceland,Iceland,"April 27, 2020","June 12, 2020",Household and community samples,Multiple groups,23452,0.30%,,,Convenience,"Roche Diagnostics,Beijing Wantai Biological",CLIA,"IgG,IgM,IgA",91.10%,,Moderate,Journal Article (Peer-Reviewed),Daniel Gudbjartsson,deCODE Genetics,http://dx.doi.org/10.1056/NEJMoa2026116,10/13/2020,8/4/2021,Verified
200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,"July 17, 2020",National,Hungary,Hungary,"May 1, 2020","May 16, 2020",Household and community samples,Multiple groups,10474,0.68%,0.50%,0.86%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bela Merkely,Semmelweis University,https://dx.doi.org/10.1007/s11357-020-00226-9,8/1/2020,7/31/2021,Verified
201217_Honduras_ColegioMédico_OverallGenpop,"December 17, 2020",National,Honduras,Honduras,"June 16, 2020","June 23, 2020",Household and community samples,Multiple groups,792,6.20%,,,Stratified probability,NA,LFIA,"IgG,IgM",93.40%,97.70%,Moderate,Journal Article (Peer-Reviewed),Mario Rene Mejia Nunez ,Colegio Médico,https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175,4/16/2021,6/19/2021,Verified
210308_Bissau_UniversityofSouthernDenmark_Overall,"March 8, 2021",Local,Guinea-Bissau,Guinea-Bissau; NR; Bissau,"November 9, 2020","November 24, 2020",Health care workers and caregivers,Adults (18-64 years),140,18.00%,,,Convenience,"CTK Biotech, Inc.",LFIA,IgG,90.00%,100.00%,High,Preprint,Christine Benn,University of Southern Denmark,https://www.medrxiv.org/content/10.1101/2021.03.06.21253046v1.full-text,4/18/2021,6/19/2021,Verified
200806_Greece_UniversityofThessaly_Overall,"August 6, 2020",National,Greece,"Greece; Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus","March 1, 2020","April 30, 2020",Residual sera,Multiple groups,6586,0.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369,10/3/2020,7/6/2021,Verified
200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj,"September 21, 2020",Local,Greece,Greece,"June 15, 2020","July 15, 2020",Non-essential workers and unemployed persons,Multiple groups,2500,0.93%,0.27%,2.09%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ourania Tsitsilonis ,National and Kapodistrian University of Athens,https://dx.doi.org/10.3390/life10090214,11/9/2020,7/16/2021,Verified
201027_Athens_NationalandKapodistrianUniversityofAthens_Overall,"October 27, 2020",Local,Greece,Greece; Attica; Athens,"April 25, 2020","May 10, 2020",Health care workers and caregivers,Adults (18-64 years),321,2.18%,,,Unclear,EUROIMMUN AG,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Panayiotis Vlachoyiannopoulosa,National and Kapodistrian University of Athens/Laiko University Hospital,http://dx.doi.org/10.1016/j.clim.2020.108619,1/12/2021,6/17/2021,Verified
201203_Athens_UniversityOfAthens_Overall_BothAdj,"December 3, 2020",Local,Greece,Greece; Attica; Athens,"April 13, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1495,1.26%,0.43%,3.26%,Convenience,GenBody Inc.,LFIA,"IgG,IgM",74.10%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mina Psichogiou,University of Athens,https://dx.doi.org/10.1371/journal.pone.0243025,2/7/2021,6/17/2021,Verified
210107_Greece_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Greece,Greece; NR; NR,"June 19, 2020","July 16, 2020",Health care workers and caregivers,Adults (18-64 years),77,1.30%,0.23%,7.00%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
210302_Athens_NationalandKapodistrianUniversityofAthens_PopTestAdj,"March 2, 2021",Local,Greece,Greece; Attica; Athens,"June 15, 2020","November 15, 2020",Non-essential workers and unemployed persons,Multiple groups,4996,1.60%,0.92%,2.54%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",100.00%,99.81%,Low,Journal Article (Peer-Reviewed),Ourania Tsitsilonis,National and Kapodistrian University of Athens,http://dx.doi.org/10.3390/vaccines9030207,5/14/2021,7/17/2021,Verified
210513_Greece_UniversityThessaly_TestPopAdj,"May 13, 2021",National,Greece,Greece,"May 1, 2020","August 31, 2020",Household and community samples,Multiple groups,20110,0.19%,0.08%,0.30%,Stratified probability,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Low,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://dx.doi.org/10.3390/vaccines9050504,6/7/2021,6/17/2021,Unverified
210623_Deskati_UniversityOfThessaly_Primary,"June 23, 2021",Local,Greece,Greece; West Macedonia; Deskati,"January 29, 2021","January 29, 2021",Household and community samples,Multiple groups,388,17.80%,,,Convenience,"Prognosis Biotech,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ourania S. Kotsiou,University of Thessaly,http://dx.doi.org/10.3390/jcm10132765,7/7/2021,8/4/2021,Verified
210430_AghiaSophiaChildrensHospital_Athens_hcw,"July 5, 2021",,Greece,Greece; Atica; Athens,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1216,0.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Elizabeth‑Barbara Tatsi,"The ""Aghia Sophia"" Children's Hospital ",https://dx.doi.org/10.1007/s15010-021-01653-2,7/13/2021,8/4/2021,Unverified
210706_Ghana_UniversityOfGhana_Phase1_Overall,"July 6, 2021",National,Ghana,"Ghana; Greater Acra Region, Central Region, Eastern Region, Upper East Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","July 27, 2020","September 14, 2020",Multiple general populations,Multiple groups,1305,19.00%,,,Convenience,"Wuhan UNscience Biotechnology Co., Ltd",LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/13/2021,7/14/2021,Unverified
210706_Ghana_UniversityOfGhana_Phase2_Overall,"July 6, 2021",National,Ghana,"Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","October 1, 2020","October 31, 2020",Multiple general populations,Multiple groups,395,15.20%,,,Convenience,"Wuhan UNscience Biotechnology Co., Ltd",LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/13/2021,7/14/2021,Unverified
210706_Ghana_UniversityOfGhana_Phase3_Overall,"July 6, 2021",National,Ghana,"Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","December 1, 2020","December 31, 2020",Multiple general populations,Multiple groups,393,9.70%,,,Convenience,"Wuhan UNscience Biotechnology Co., Ltd",LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/13/2021,7/14/2021,Unverified
210706_Ghana_UniversityOfGhana_Phase4_Overall,"July 6, 2021",National,Ghana,"Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","February 1, 2021","February 28, 2021",Multiple general populations,Multiple groups,636,22.80%,,,Convenience,"Wuhan UNscience Biotechnology Co., Ltd",LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/13/2021,7/14/2021,Unverified
200525_Frankfurt_Goethe-UniversityFrankfurt_Employees,"May 25, 2020",Local,Germany,Germany; Hesse; Frankfurt,"April 6, 2020","April 14, 2020",Essential non-healthcare workers,Adults (18-64 years),998,0.40%,0.16%,1.02%,Convenience,NA,ELISA,IgG,,99.20%,High,Preprint,Verena Kraehling, Goethe-University Frankfurt,https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1,5/27/2020,8/5/2021,Verified
200514_Saalfeld_Thuringia_IgG,"May 14, 2020",Local,Germany,Germany; Thuringia; Saalfeld,"April 16, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),18,0.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Igor Harsch,Thuringia Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf,6/19/2020,8/4/2021,Verified
200615_Germany_UniversityofHannover_hcw,"June 15, 2020",Local,Germany,Germany; Lower Saxony; Hannover,"April 20, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,385,2.86%,,,Convenience,EUROIMMUN AG,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Simone Schmidt,University of Hannover,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417,6/26/2020,8/4/2021,Verified
200717_Ilm-Kreis_JenaUniversityHospital_Overall,"July 17, 2020",Local,Germany,Germany; Thuringia,"May 12, 2020","May 22, 2020",Household and community samples,Multiple groups,620,8.39%,,,Convenience,"Epitope Diagnostics, Inc.,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd),DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Preprint,Sebastian Weis ,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1,7/18/2020,8/4/2021,Verified
200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA,"June 22, 2020",Local,Germany,Germany; Mecklenburg-Westpomerania; Rostock,"April 20, 2020","April 22, 2020",Household and community samples,Adults (18-64 years),401,0.00%,,,Self-referral,"EUROIMMUN AG,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Emil Reisinger ,Universitätsmedizin Rostock,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293,8/5/2020,8/4/2021,Verified
200807_Bavaria_UniversityHospitalMunich,"August 7, 2020",Regional,Germany,Germany; Bavaria; Dachau,"April 2, 2020","April 6, 2020",Health care workers and caregivers,Adults (18-64 years),151,2.60%,0.80%,7.10%,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Korbinian Lackermair,University Hospital Munich,http://dx.doi.org/10.1093/fampra/cmaa078,9/25/2020,6/17/2021,Verified
200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG,"September 4, 2020, June 10, 2020",Local,Germany,Germany; Lower Saxony; Hannover,"March 23, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),217,1.38%,,,Convenience,EUROIMMUN AG,ELISA,IgG,87.20%,99.30%,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Georg Behrens, Georg Behrens", Hannover Medical School,"https://link.springer.com/article/10.1007/s40121-020-00334-1, https://link.springer.com/article/10.1007%2Fs15010-020-01461-0",9/28/2020,6/24/2021,Verified
200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,"August 24, 2020",Local,Germany,Germany; Thuringia; Jena,"April 6, 2020","May 13, 2020",Pregnant or parturient women,Not reported,180,0.60%,0.00%,1.70%,Unclear,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Janine Zollkau,Universitätsklinikum Jena,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033,9/28/2020,6/17/2021,Verified
200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate,"July 16, 2020",Regional,Germany,"Germany; North Rhine-Westphalia, Lower Saxony, Hesse","March 9, 2020","June 3, 2020",Residual sera,Not reported,3186,0.91%,0.58%,1.24%,Sequential,"Abbott Laboratories,EUROIMMUN AG,DiaSorin SpA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bastian Fischer,Heart and Diabetes Center NRW,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,10/1/2020,8/4/2021,Verified
200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,"July 23, 2020",Local,Germany,Germany; Thuringia; Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),45,0.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/1/2020,8/5/2021,Verified
200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,"July 23, 2020",Local,Germany,Germany; Thuringia; Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/1/2020,8/5/2021,Verified
200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,"June 29, 2020",Local,Germany,Germany,"April 9, 2020","April 16, 2020",Multiple populations,Multiple groups,1780,0.96%,0.56%,1.53%,Unclear,EUROIMMUN AG,ELISA,IgG,93.80%,99.00%,High,Journal Article (Peer-Reviewed),Peter Kern,Universitätsmedizin Marburg,http://dx.doi.org/10.1055/a-1198-1243,10/11/2020,8/5/2021,Verified
200929_Jena_JenaUniversityHospital_Overall,"September 29, 2020",Local,Germany,Germany; Thuringia; Jena,"May 19, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),660,2.70%,,,Convenience,"Epitope Diagnostics, Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Preprint,Christina Bahrs,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.09.29.20203737v1,11/28/2020,8/4/2021,Verified
200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW,"September 29, 2020",Local,Germany,Germany; Brandenburg; Oberspreewald-Lausitz,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),156,1.30%,,,Convenience,NA,CLIA,Total Antibody,99.50%,99.80%,High,Preprint,Stephanie Hoffmann,Brandenburg University of Technology Cottbus-Senftenberg,https://doi.org/10.21203/rs.3.rs-84703/v1,11/28/2020,7/6/2021,Verified
200806_Regensburg_UniversityofRegensburg_12Wks,"August 6, 2020",Local,Germany,Germany; Bavaria; Regensburg,"March 15, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),139,0.00%,,,Convenience,"EUROIMMUN AG,Roche Diagnostics",ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Sara Malfertheiner,University of Regensburg,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf,12/2/2020,8/4/2021,Verified
200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall,"August 13, 2020",Regional,Germany,Germany; North Rhine-Westphalia,"March 26, 2020","June 4, 2020",Residual sera,Multiple groups,415,1.20%,,,Convenience,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Herrmann,Internal medicine and laboratory medicine specialist practice and laboratory,http://dx.doi.org/10.1007/s15006-020-0750-y,1/5/2021,6/17/2021,Verified
201103_Germany_UniversityofWitten,"November 3, 2020",National,Germany,Germany,"June 15, 2020","September 1, 2020",Residual sera,Children and Youth (0-17 years),731,11.20%,,,Convenience,"EUROIMMUN,Roche Diagnostics,EUROIMMUN AG",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Silke Schwarz,University of Witten,https://dx.doi.org/10.1007/s00112-020-01050-3,1/7/2021,8/4/2021,Verified
200610_Munich_TechnicalUniversityofMunich_hcw,"October 6, 2020",Local,Germany,Germany; Bavaria; Munich,"April 14, 2020","May 29, 2020",Health care workers and caregivers,Multiple groups,4554,2.40%,1.90%,2.90%,Convenience,NA,CLIA,IgG,,,High,Preprint,Johanna Erber,Technical University of Munich,https://www.medrxiv.org/content/10.1101/2020.10.04.20206136v1,1/8/2021,8/4/2021,Verified
201023_Berlin_CharitéUniversity_primary,"October 23, 2020",Local,Germany,Germany; Berlin; Berlin,"March 19, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,223,7.10%,,,Unclear,"EUROIMMUN AG,NA",Multiple Types,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Mira Choi,Charité University,https://pubmed.ncbi.nlm.nih.gov/33114149/,1/13/2021,8/4/2021,Verified
201126_Germany_RobertKochInstitute_BloodDonors_TestAdj,"November 26, 2020",National,Germany,Germany,"April 15, 2020","November 5, 2020",Blood donors,Multiple groups,48976,1.35%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Institutional Report,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102,1/14/2021,6/17/2021,Verified
201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3,"November 30, 2020",Local,Germany,Germany; Hamburg; Hamburg,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),1253,1.80%,1.00%,2.50%,Convenience,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Thomas Brehm,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1016/j.ijheh.2020.113671,1/21/2021,6/17/2021,Verified
210103_Munich_LudwigMaximillianUniversityofMunich_Overall,"January 3, 2021",Local,Germany,Germany,"March 24, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),300,4.67%,,,Convenience,"EUROIMMUN AG,DiaSorin SpA,Abbott Laboratories,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Tobias Weinberger,Ludwig Maximillian University of Munich,https://dx.doi.org/10.1093/cid/ciaa1935,1/23/2021,8/4/2021,Verified
201212_Bavaria_UniversityofRegensburg_overall,"December 12, 2020",Regional,Germany,Germany; Bavaria,"May 22, 2020","July 22, 2020",Household and community samples,Children and Youth (0-17 years),2832,5.70%,,,Convenience,"NA,Roche Diagnostics",Multiple Types,"IgA,IgG,IgM",,,Moderate,Preprint,Otto Laub,University of Regensburg,https://www.authorea.com/users/382535/articles/498454-coronavirus-antibody-screening-identifies-children-with-mild-to-moderate-courses-of-pmis,1/25/2021,8/4/2021,Verified
201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall,"November 19, 2020",Local,Germany,Germany; Thuringia,"May 13, 2020","May 16, 2020",Household and community samples,Multiple groups,620,8.40%,,,Self-referral,"Epitope Diagnostics, Inc.,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd),DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Weis,Friedrich Schiller University,https://dx.doi.org/10.1016/j.cmi.2020.11.009,1/27/2021,8/4/2021,Verified
201203_Tirschenreuth_MunichClinic_HCW_Overall,"December 3, 2020",Local,Germany,"Germany; Bavaria; Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,7/17/2021,Verified
201203_Tirschenreuth_MunichClinic_NMU_Overall,"December 3, 2020",Local,Germany,"Germany; Bavaria; Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Essential non-healthcare workers,Adults (18-64 years),986,3.70%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,High,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,8/5/2021,Verified
200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall,"October 16, 2020",Local,Germany,Germany; Schleswig-Holstein; Hamburg,"April 14, 2020","June 16, 2020",Health care workers and caregivers,Multiple groups,871,2.64%,,,Convenience,"Mikrogen GmbH,EUROIMMUN AG",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonas Herzberg,University Hospitals of the Ruhr‑University of Bochum,http://dx.doi.org/10.1016/j.ijid.2020.10.026,1/30/2021,8/4/2021,Verified
201204_Germany_SaarlandUniversity_overall,"December 4, 2020",National,Germany,Germany,"June 16, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1007,2.09%,1.37%,3.17%,Self-referral,"EUROIMMUN AG,NA,Roche Diagnostics",Multiple Types,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Dietrich Mack,Saarland University,https://dx.doi.org/10.1016/j.cmi.2020.11.033,1/31/2021,8/4/2021,Verified
201126_Kupferzell_RobertKochInstitute_OverallAdj,"November 26, 2020",Local,Germany,Germany; Baden-Württemberg; Kupferzell,"May 20, 2020","June 9, 2020",Household and community samples,Multiple groups,2203,12.00%,10.40%,14.00%,Simplified probability,EUROIMMUN AG,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Claudia Santos Hovener,Robert Koch Institute,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752,2/4/2021,8/5/2021,Verified
210102_Munich_MUCResearch,"January 2, 2021",Local,Germany,Germany,"May 29, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),500,1.50%,0.70%,3.13%,Sequential,Mikrogen GmbH,ELISA,IgG,99.50%,,Moderate,Journal Article (Peer-Reviewed),S Noe,MUC Research,https://dx.doi.org/10.1007/s15010-020-01564-8,2/5/2021,6/17/2021,Unverified
201216_Germany_Ruhr-UniversityBochum_overall,"December 16, 2020",Local,Germany,Germany,"April 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,99,3.03%,,,Sequential,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Constantin J Thieme,Ruhr-University Bochum,https://dx.doi.org/10.1016/j.transproceed.2020.12.001,2/6/2021,8/4/2021,Verified
210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG,"January 29, 2021",Local,Germany,Germany; North Rhine-Westphalia; Eschweiler,"April 27, 2020","May 20, 2020",Health care workers and caregivers,Multiple groups,1212,3.30%,,,Convenience,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler,https://dx.doi.org/10.1055/a-1322-5355,2/14/2021,6/24/2021,Verified
210122_Germany_HeidelbergUniversity_Parents_Overall_unadj,"January 22, 2021",Regional,Germany,"Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",Household and community samples,Adults (18-64 years),2482,1.90%,,,Convenience,"EUROIMMUN AG,Roche Diagnostics,NA",ELISA,IgG,,99.60%,Moderate,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,8/4/2021,Unverified
210122_Germany_HeidelbergUniversity_Children_Overall_unadj,"January 22, 2021",Regional,Germany,"Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",Students and Daycares,Children and Youth (0-17 years),2482,0.90%,,,Convenience,"EUROIMMUN AG,Roche Diagnostics,NA",ELISA,IgG,,99.60%,Moderate,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,8/4/2021,Unverified
210129_Berlin_UniversitätsmedizinBerlin_Students_Overall,"January 29, 2021",Local,Germany,Germany,"November 2, 2020","November 16, 2020",Students and Daycares,Children and Youth (0-17 years),347,2.00%,0.80%,4.10%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,6/17/2021,Verified
210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall ,"January 29, 2021",Local,Germany,Germany,"November 2, 2020","November 16, 2020",Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,6/17/2021,Verified
210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall,"January 29, 2021",Local,Germany,Germany,"November 2, 2020","November 16, 2020",Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,6/17/2021,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj,"February 3, 2021",Local,Germany,Germany,"November 2, 2020","November 23, 2020",Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",90.00%,99.80%,Low,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,7/17/2021,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj,"February 3, 2021",Local,Germany,Germany,"November 23, 2020","November 27, 2020",Essential non-healthcare workers,Adults (18-64 years),745,4.40%,3.10%,6.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",90.00%,99.80%,High,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,7/17/2021,Verified
200731_Bremen_UniversityOfBremen_IgG/IgA,"July 31, 2020",Local,Germany,Germany,"March 31, 2020","May 16, 2020",Multiple populations,Adults (18-64 years),281,2.13%,,,Unclear,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jan Neumann,University of Bremen,https://www.asu-arbeitsmedizin.com/node/153868/print,3/11/2021,8/5/2021,Verified
210219_Jena_JenaUniversityHospital_Overall,"February 19, 2021",Local,Germany,Germany; Urban district; Jena,"May 19, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),660,2.70%,1.60%,4.30%,Convenience,"Epitope Diagnostics, Inc.,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christina Bahrs,Jena University Hospital,https://dx.doi.org/10.1111/tbed.14041,3/13/2021,8/4/2021,Unverified
201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall,"October 1, 2020",Regional,Germany,Germany; Southwest,"March 15, 2020","June 15, 2020",Blood donors,Multiple groups,3880,0.90%,,,Unclear,Abbott Laboratories,CLIA,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Stefan Runkel,University Medical Center of The Johannes Gutenberg-University Mainz,https://pubmed.ncbi.nlm.nih.gov/33073955/,3/14/2021,6/17/2021,Verified
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall,"February 12, 2021",Regional,Germany,Germany; Bavaria,"April 1, 2020","June 30, 2020",Pregnant or parturient women,Adults (18-64 years),1916,0.47%,,,Convenience,NA,Other,Total Antibody,97.30%,100.00%,High,Journal Article (Peer-Reviewed),Markus Hippich, German Research Center for Environmental Health,https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/18/2021,6/17/2021,Unverified
201127_Germany_IfoInstitue_overall_PopAdj,"November 27, 2020",National,Germany,Germany,"October 26, 2020","November 18, 2020",Household and community samples,Multiple groups,9929,1.10%,0.92%,1.33%,Unclear,Roche Diagnostics,CLIA,Total Antibody,,99.80%,Unclear,Institutional Report,Clemens Fuest,ifo Institute,https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona,3/21/2021,7/16/2021,Verified
201216_Heidelberg_UniversityHospitalHeidelberg_Overall,"December 16, 2020",Local,Germany,Germany; Baden-Württemberg; Heidelberg,"May 5, 2020","August 6, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,219,3.20%,,,Sequential,EUROIMMUN AG,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Conrad Rauber,University Hospital Heidelberg,https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub,4/8/2021,6/17/2021,Verified
210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay,"February 3, 2021",Local,Germany,Germany,"April 9, 2020","April 9, 2020",Contacts of COVID patients,Multiple groups,42,61.90%,,,Convenience,NA,Neutralization,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Lisa Muller,University Hospital Dusseldorf,https://dx.doi.org/10.1007/s10096-021-04169-7,4/9/2021,7/7/2021,Verified
210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane,"March 10, 2021",Local,Germany,Germany; Bavaria; Wieden,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,13.40%,16.70%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/16/2021,7/17/2021,Verified
210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane,"March 10, 2021",Local,Germany,Germany; Brandenburg; NR,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),585,2.10%,1.20%,3.80%,Convenience,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/16/2021,8/4/2021,Verified
210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+,"February 23, 2021",Local,Germany,Germany; Bavaria; Regensberg,"April 9, 2020","April 30, 2020",Pregnant or parturient women,Adults (18-64 years),151,2.00%,,,Sequential,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Hausler,Hospital St Hedwig of the Order of St John,https://dx.doi.org/10.1515/jpm-2021-0001,4/18/2021,8/4/2021,Verified
210408_Germany_HeinrichHeineUniversityDuesseldorf_Physicians,"April 8, 2021",National,Germany,Germany,"June 16, 2020","July 2, 2020",Health care workers and caregivers,Adults (18-64 years),516,3.10%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Detlef Kindgen Milles,Heinrich-Heine University Duesseldorf,https://dx.doi.org/10.1371/journal.pone.0248813,4/24/2021,7/17/2021,Unverified
201117_Gangelt_UniversityofBonn_ v3_overall_TestAdj_IgG,"November 17, 2020",Local,Germany,Germany; Heinsberg; Gangelt,"March 31, 2020","April 6, 2020",Household and community samples,Multiple groups,919,14.11%,11.15%,17.27%,Simplified probability,EUROIMMUN AG,ELISA,IgG,90.90%,99.10%,,Journal Article (Peer-Reviewed),Hendrik Streeck,University of Bonn,https://www.nature.com/articles/s41467-020-19509-y,4/26/2021,6/17/2021,Verified
201211_BadFeilnbach_RobertKochInstitute_primary,"December 11, 2020",Local,Germany,Germany,"June 23, 2020","July 4, 2020",Household and community samples,Multiple groups,2152,9.10%,,,Simplified probability,NA,Not reported,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html,4/30/2021,6/17/2021,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_HCW,"March 31, 2021",Local,Germany,Germany; Schleswig-Holstein,"April 14, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),268,0.75%,,,Convenience,"EUROIMMUN AG,DiaSorin SpA,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,5/2/2021,8/4/2021,Unverified
210302_Dresden_TechnischeUniversitätDresden,"March 2, 2021",Local,Germany,Germany; Saxony; Dresden,"June 15, 2020","January 15, 2021",Contacts of COVID patients,Multiple groups,248,34.27%,,,Sequential,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Preprint,Lukas Galow,Technische Universität Dresden,10.2139/ssrn.3790443,5/3/2021,8/4/2021,Unverified
210408_Germany_BundeswehrInstituteofMicrobiology_overall,"April 8, 2021",Local,Germany,Germany,"April 2, 2020","April 8, 2020",Health care workers and caregivers,Multiple groups,198,3.50%,,,Convenience,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Katharina Muller,Bundeswehr Institute of Microbiology,http://dx.doi.org/10.3390/ijerph18083910,5/7/2021,8/4/2021,Unverified
210427_Germany_HelmholtzCentreForInfectionResearch,"April 27, 2021",National,Germany,Germany,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,13405,2.00%,,,Stratified probability,EUROIMMUN AG,ELISA,IgG,,,Moderate,Preprint,Daniela Gornyk,Helmholtz Centre for Infection Research,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3834300,5/10/2021,6/17/2021,Verified
210308_Berlin_UniversitatmedizinBerlin,"March 8, 2021",Local,Germany,Germany,"June 11, 2020","June 19, 2020",Multiple populations,Multiple groups,527,1.30%,,,Stratified non-probability,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Franziska Hommes,Universitatmedizin Berlin,http://dx.doi.org/10.3390/ijerph18052739,5/11/2021,7/7/2021,Unverified
210429_Munich_GermanResearchCenterForEnvironmentalHealth_overall_popadj_testadj,"April 29, 2021",Local,Germany,Germany,"November 2, 2020","January 31, 2021",Household and community samples,Multiple groups,4433,3.60%,2.90%,4.30%,Simplified probability,Roche Diagnostics,Not reported,Not reported,99.20%,98.70%,Low,Preprint,Katja Radon,German Research Center for Environmental Health,https://www.medrxiv.org/content/10.1101/2021.04.27.21256133v1,5/14/2021,7/17/2021,Unverified
210315_Thuringia_ThuringiaClinic_ICU_Overall,"March 15, 2021",Local,Germany,Germany; Thuringia; Saalfeld/Saale,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),50,0.00%,,,Convenience,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,5/14/2021,8/4/2021,Verified
210315_Thuringia_ThuringiaClinic_COVIDStaff_overall,"March 15, 2021",Local,Germany,Germany; Thuringia; Saalfeld/Saale,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),18,5.60%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,5/14/2021,7/15/2021,Verified
201215_Straubing_RobertKochInstitut_ELISA_poptestadj,"December 15, 2020",Local,Germany,Germany; Bavaria; Straubing,"September 8, 2020","September 26, 2020",Household and community samples,Multiple groups,2361,1.70%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html,5/16/2021,6/17/2021,Verified
210220_Dresden_DresdenUniversityOfTechnology_December,"March 24, 2021",Local,Germany,Germany; Saxony; Dresden,"December 10, 2020","December 11, 2020",Students and Daycares,Multiple groups,237,6.80%,3.80%,10.10%,Convenience,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Jakob Armann,Dresden University of Technology ,http://dx.doi.org/10.1136/bmjpo-2021-001036,5/17/2021,8/4/2021,Unverified
210317_Bavaria_LudwigMaximiliansUniversityMunich_Overall,"March 17, 2021",Local,Germany,Germany; Bavaria; Wasserburg,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),1342,8.80%,,,Convenience,NA,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),M Rentrop,Ludwig Maximilians University Munich,https://dx.doi.org/10.1007/s00115-021-01101-4,5/17/2021,7/22/2021,Verified
210217_Berlin-Mitte_RobertKochInstit_ELISA_testadj_popadj,"February 17, 2021",Local,Germany,Germany; Berlin; Berlin-Mitte,"November 17, 2020","December 5, 2020",Household and community samples,Multiple groups,2287,4.40%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,,,Moderate,News and Media,Robert Koch Institut,Robert Koch Institut,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html,5/18/2021,7/10/2021,Verified
210418_Dresden_TechnischeUniversitatDresden_200715-201115,"April 18, 2021",Local,Germany,Germany; Saxony; Dresden,"July 15, 2020","November 15, 2020",Multiple populations,Adults (18-64 years),443,0.50%,,,Convenience,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Preprint,Luise Haag,Technische Universitat Dresden,https://www.medrxiv.org/content/10.1101/2021.04.16.21255616v1,5/19/2021,8/4/2021,Unverified
210418_Dresden_TechnischeUniversitatDresden_201116-210131,"April 18, 2021",Local,Germany,Germany; Saxony; Dresden,"November 16, 2020","January 31, 2021",Multiple populations,Adults (18-64 years),424,11.30%,,,Convenience,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Preprint,Luise Haag,Technische Universitat Dresden,https://www.medrxiv.org/content/10.1101/2021.04.16.21255616v1,5/19/2021,8/4/2021,Unverified
210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_secondwave_primary,"April 2, 2021",Regional,Germany,Germany; Bavaria,"September 15, 2020","February 15, 2021",Household and community samples,Children and Youth (0-17 years),11380,3.92%,3.57%,4.29%,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Markus Hippich,German Research Center for Environmental Health,https://dx.doi.org/10.1016/j.medj.2021.03.019,5/19/2021,7/16/2021,Verified
210403_Mainz_JohannesGutenbergUniversity_overall_unadj,"April 3, 2021",Local,Germany,Germany; Rhineland-Palatinate; Mainz,"January 1, 2020","February 28, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,248,5.24%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Simone C Boedecker,Johannes Gutenberg University,http://dx.doi.org/10.3390/pathogens10040429,5/19/2021,8/4/2021,Verified
210404_Tirschenreuth_ FriedrichAlexanderUniversity_primary,"April 4, 2021",Local,Germany,Germany; Bavaria,"June 28, 2020","July 10, 2020",Household and community samples,Multiple groups,4201,8.64%,,,Simplified probability,"Shenzhen Yhlo Biotech Co. Ltd,NA,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Preprint,Ralf Wagner,Friedrich-Alexander University,https://www.medrxiv.org/content/10.1101/2021.03.29.21254343v1,5/19/2021,8/4/2021,Verified
200515_Regensburg_UniversityOfRegensburg,"May 15, 2020",Local,Germany,Germany; Bavaria; Regensburg,"March 1, 2020","March 31, 2020",Health care workers and caregivers,Adults (18-64 years),201,20.40%,,,Convenience,EUROIMMUN AG,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Susanne Brandstetter,University of Regensburg,https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13278?af=R,5/20/2021,8/4/2021,Unverified
210422_Brandenburg_MedicalSchoolTheodorFontane_baseline_primary,"April 22, 2021",Local,Germany,Germany,"March 30, 2020","April 7, 2020",Health care workers and caregivers,Adults (18-64 years),1013,2.10%,,,Convenience,EUROIMMUN AG,ELISA,IgG,95.00%,96.20%,High,Journal Article (Peer-Reviewed),Mark Reinwald ,Medical School Theodor Fontane,https://dx.doi.org/10.3390/healthcare9050498,5/20/2021,8/4/2021,Unverified
210422_Brandenburg_MedicalSchoolTheodorFontane_followup_primary,"April 22, 2021",Local,Germany,Germany,"March 30, 2020","April 7, 2020",Health care workers and caregivers,Adults (18-64 years),811,2.20%,,,Convenience,EUROIMMUN AG,ELISA,IgG,95.00%,96.20%,High,Journal Article (Peer-Reviewed),Mark Reinwald ,Medical School Theodor Fontane,https://dx.doi.org/10.3390/healthcare9050498,5/20/2021,8/4/2021,Unverified
210425_Essen_UniversityHospitalEssen,"April 25, 2021",Local,Germany,Germany; North Rhine-Westphalia; Essen,"October 1, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),315,5.10%,,,Convenience,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Johannes Korth,University Hospital Essen,https://dx.doi.org/10.3390/ijerph18094540,5/21/2021,6/17/2021,Unverified
210429_Germany_BoehringerIngelheim_primary,"April 29, 2021",National,Germany,Germany,"April 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),121,1.65%,,,Convenience,EUROIMMUN AG,ELISA,IgG,55.00%,100.00%,High,Journal Article (Peer-Reviewed),Petra C Moroni Zentgraf,Boehringer Ingelheim,https://dx.doi.org/10.1080/03007995.2021.1914943,5/22/2021,8/4/2021,Verified
210409_Bonn_UniversityOfBonn_RhinelandStudy1_overall_Unadj_ELISA,"April 9, 2021",Local,Germany,Germany; North Rhine-Westphalia; Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,4755,0.97%,0.72%,1.30%,Convenience,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,5/22/2021,6/17/2021,Unverified
210409_Bonn_UniversityOfBonn_Voluntary2_overall_Unadj_ELISA,"April 9, 2021",Local,Germany,Germany; North Rhine-Westphalia; Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,360,1.94%,0.84%,4.42%,Self-referral,EUROIMMUN AG,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,5/22/2021,6/24/2021,Unverified
210330_Munich_UniversityHospitalLMUMunich_TestAdj,"March 30, 2021",Local,Germany,Germany; Bavaria; Munich,"April 5, 2020","June 12, 2020",Household and community samples,Multiple groups,5313,1.82%,1.28%,2.37%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,88.60%,99.72%,Low,Journal Article (Peer-Reviewed),Michael Pritsch,University Hospital LMU Munich,https://dx.doi.org/10.3390/ijerph18073572,5/23/2021,7/17/2021,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_NonHCW,"March 31, 2021",Local,Germany,Germany; Schleswig-Holstein,"April 14, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),138,0.72%,,,Convenience,"EUROIMMUN AG,DiaSorin SpA,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,5/24/2021,8/4/2021,Unverified
210506_Berlin_FreieUniversitätBerlin,"May 6, 2021",Local,Germany,Germany; Berlin; Berlin,"September 28, 2020","October 2, 2020",Students and Daycares,Multiple groups,720,0.14%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marlene Thielecke,Freie Universität Berlin,https://dx.doi.org/10.1093/eurpub/ckab079,5/28/2021,7/6/2021,Unverified
210513_Ulm_UlmUniversity_Overall,"May 13, 2021",Local,Germany,Germany; Baden-Württemberg; Ulm,"November 15, 2020","March 7, 2021",Multiple populations,Adults (18-64 years),818,14.50%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,99.98%,Moderate,Preprint,Michael Schon,Ulm University,https://www.medrxiv.org/content/10.1101/2021.05.04.21256382v2.full-text,5/28/2021,6/23/2021,Unverified
210428_Nordrhein-Westfalen_SorbonneUniversité_2,"April 28, 2021",Regional,Germany,Germany; Nordrhein-Westfalen,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,624,0.80%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/30/2021,8/4/2021,Unverified
210413_Tubingen_EberhardKarlsUniversitatTubingen,"April 13, 2021",Local,Germany,Germany; Baden-Württemberg; Tubingen,"May 1, 2020","May 1, 2020",Essential non-healthcare workers,Adults (18-64 years),318,2.80%,1.50%,5.30%,Convenience,"Siemens,EUROIMMUN AG,Roche Diagnostics",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Focke Ziemssen,Eberhard Karls Universitat Tubingen,https://bmjophth.bmj.com/content/bmjophth/6/1/e000688.full.pdf,6/1/2021,8/4/2021,Unverified
210512_Lübeck_UniversityofLübeck_TotalStudy,"May 12, 2021",Local,Germany,Germany,"May 6, 2020","February 1, 2021",Household and community samples,Multiple groups,3051,3.44%,,,Self-referral,EUROIMMUN AG,ELISA,IgG,,,High,Preprint,Christine Klein,University of Lübeck,https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1.full-text,6/2/2021,7/22/2021,Verified
201212_Europe_UniversityOfGlasgow_Germany2,"December 12, 2020",National,Germany,Germany,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),137,2.92%,1.14%,7.27%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,6/17/2021,Verified
210610_Saxony_TechnischeUniversitätDresden_Students_SeptOct_2_overall,"June 10, 2021",Regional,Germany,Germany; Saxony,"September 15, 2020","October 13, 2020",Students and Daycares,Children and Youth (0-17 years),1334,0.82%,,,Convenience,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1136/bmjopen-2021-049876,6/22/2021,8/4/2021,Unverified
210610_Saxony_TechnischeUniversitätDresden_Teachers_SeptOct_4_overall,"June 10, 2021",Regional,Germany,Germany; Saxony,"September 15, 2020","October 13, 2020",Essential non-healthcare workers,Adults (18-64 years),445,0.22%,,,Convenience,"DiaSorin SpA,Abbott Laboratories,EUROIMMUN AG",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1136/bmjopen-2021-049876,6/22/2021,8/4/2021,Unverified
210618_Bonn_BonnUniversityHospital_primary,"June 18, 2021",Local,Germany,Germany,"December 15, 2020","January 15, 2021",Health care workers and caregivers,Multiple groups,118,14.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.50%,High,Journal Article (Peer-Reviewed),Kathrin van Bremen,Bonn University Hospital,https://dx.doi.org/10.1007/s15010-021-01641-6,7/6/2021,7/17/2021,Unverified
210625_Germany_RobertKochInstitute_overall,"June 25, 2021",National,Germany,Germany,"October 15, 2020","February 15, 2021",Household and community samples,Multiple groups,15122,1.30%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,,,Moderate,Preprint,Jens Hoebel,German Institute for Economic Research,https://www.medrxiv.org/content/10.1101/2021.06.21.21259001v1.full-text,7/7/2021,7/7/2021,Unverified
210701_Heilbronn_SLKClinicsHeilbronn_Primary,"July 1, 2021",Local,Germany,Germany; Baden-Württemberg; Heilbronn,"July 1, 2020","July 21, 2020",Health care workers and caregivers,Multiple groups,3066,3.10%,,,Convenience,"Siemens,Abbott Laboratories,DiaSorin SpA,EUROIMMUN AG",Multiple Types,"IgG,IgM",98.10%,,Moderate,Journal Article (Peer-Reviewed),Lionel Larribeere,SLK Clinics Heilbronn ,http://dx.doi.org/10.3390/ijerph18137057,7/14/2021,8/4/2021,Unverified
210714_Baden-Württemberg_UlmUniversityHospital_Residents1_overall,"July 14, 2021",Local,Germany,Germany; Baden-Württemberg; Alb-Danube district and Ulm ,"July 27, 2020","August 25, 2020",Assisted living and long-term care facilities,Not reported,100,1.00%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,7/18/2021,7/18/2021,Unverified
210714_Baden-Württemberg_UlmUniversityHospital_Employees2_overall,"July 14, 2021",Local,Germany,Germany; Baden-Württemberg; Alb-Danube district and Ulm ,"July 27, 2020","August 25, 2020",Health care workers and caregivers,Adults (18-64 years),394,0.25%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,7/18/2021,7/18/2021,Unverified
210520_NorthRhine-Westphalia_RuhrUniversityBochum,"May 20, 2021",Local,Germany,Germany; North Rhine-Westphalia,"July 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),907,1.43%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.00%,99.00%,High,Journal Article (Peer-Reviewed),Anke Hildebrandt ,Ruhr University Bochum,10.1016/j.ijheh.2021.113771,7/29/2021,7/29/2021,Unverified
200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj,"September 18, 2020",Local,Georgia,Georgia; Tbilisi; Tbilisi,"May 18, 2020","May 27, 2020",Household and community samples,Multiple groups,1086,1.02%,0.38%,2.18%,Convenience,Zhejiang Orient Gene Biotech,LFIA,IgG,93.10%,99.20%,Moderate,Preprint,Tengiz Tsertsvadze,"Infectious Diseases, AIDS and Clinical Immunology Research Center",https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1,11/22/2020,8/5/2021,Verified
210420_Libreville_CentreHospitalierUniversitaire(CHU)‐Mère‐Enfant_overall_unadj,"April 20, 2021",Local,Gabon,Gabon,"July 15, 2020","October 15, 2020",Residual sera,Multiple groups,1495,36.20%,,,Unclear,"Biomerieux,Roche Diagnostics",Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,Centre Hospitalier Universitaire (CHU) ‐ Mère‐ Enfant,https://dx.doi.org/10.1186/s13104-021-05570-3,5/19/2021,8/4/2021,Unverified
210506_Gabon_CHUMèreEnfantFondationJeanneEbori,"May 6, 2021",National,Gabon,Gabon,"March 15, 2020","August 15, 2020",Contacts of COVID patients,Not reported,319,55.00%,,,Convenience,NA,LFIA,Not reported,,,High,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,CHU Mère Enfant Fondation Jeanne Ebori,https://dx.doi.org/10.1038/s41598-021-87043-y,5/28/2021,6/17/2021,Unverified
200928_FrenchGuiana_InstitutPasteur_OverallPopAdj,"September 28, 2020",National,French Guiana,French Guiana,"July 15, 2020","July 23, 2020",Residual sera,Multiple groups,480,15.40%,9.30%,24.40%,Sequential,EUROIMMUN AG,ELISA,IgG,93.80%,97.90%,Moderate,Preprint,Claude Flamand,Institut Pasteur ,https://www.medrxiv.org/content/10.1101/2020.09.27.20202465v1,1/19/2021,6/17/2021,Verified
200902_Lille_InstitutPasteur_BloodDonors_ELISA-N,"September 2, 2020",Local,France,"France; Hauts-de-France; Clermont, Noyon, Lille","March 20, 2020","March 24, 2020",Blood donors,Not reported,200,0.00%,,,Sequential,NA,ELISA,"IgA,IgE,IgD,IgM,IgG,Total Antibody",,95.00%,High,Journal Article (Peer-Reviewed),Ludivine Grzelak,Institut Pasteur,https://stm.sciencemag.org/content/12/559/eabc3103,4/28/2020,7/6/2021,Verified
200629_Crepy-en-Valois_PasteurInstitute_Overall,"June 29, 2020",Local,France,France; Hauts-de-France; Crepy-en-Valois,"April 28, 2020","April 30, 2020",Multiple populations,Multiple groups,1340,10.40%,,,Convenience,NA,Other,Not reported,99.40%,100.00%,Moderate,Preprint,Arnaud Fontanet,Institut Pasteur,https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2,7/16/2020,8/4/2021,Verified
200501_France_ CentreLeonBerard_HCW,"May 1, 2020",Local,France,France; Auvergne-Rhône-Alpes; Lyon,"March 1, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),85,5.88%,,,Convenience,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,8/5/2021,Verified
200501_France_ CentreLeonBerard_CancerPatient,"May 1, 2020",Local,France,France; Auvergne-Rhône-Alpes; Lyon,"March 1, 2020","April 16, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,244,5.33%,,,Sequential,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,6/17/2021,Verified
200715_France_UnitedesVirusEmergents_BloodDonors,"July 15, 2020",National,France,"France; Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France","March 25, 2020","April 7, 2020",Blood donors,Adults (18-64 years),998,2.71%,,,Sequential,NA,Neutralization,Not reported,,100.00%,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unite des Virus Emergents,https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72,8/1/2020,7/6/2021,Verified
200722_France_PicardieUniversity_IBDPatients_Overall,"July 22, 2020",Local,France,France; Somme; Amiens,"March 25, 2020","May 11, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,146,4.80%,,,Convenience,DiaSorin SpA,CLIA,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Mathurin Fumery,Picardie University,https://dx.doi.org/10.1093/ecco-jcc/jjaa154,8/2/2020,6/17/2021,Verified
200827_Paris_RothschildFoundationHospital_HealthcareProfessionals,"August 27, 2020",Local,France,France; Paris; Paris,"June 8, 2020","June 22, 2020",Health care workers and caregivers,Adults (18-64 years),646,12.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Malcie Mesnil,Rothschild Foundation Hospital,http://dx.doi.org/10.1016/j.accpm.2020.08.003,10/21/2020,7/16/2021,Verified
200903_Paris_HopitalEuropeenGeorgesPompidou_Overall,"September 3, 2020",Local,France,France;  Île-de-France; Paris,"May 2, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),3569,11.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Helene Pere,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2020.104617,11/10/2020,6/17/2021,Verified
200918_France_ParisUniversity_Overall,"September 18, 2020",National,France,France,"May 4, 2020","June 23, 2020",Household and community samples,Multiple groups,14628,6.72%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,97.90%,97.70%,Moderate,Preprint,Fabrice Carrat,Paris University,https://www.medrxiv.org/content/10.1101/2020.09.16.20195693v1,1/13/2021,8/5/2021,Verified
201015_Paris_ParisSaclayUniversity_unadj,"October 15, 2020",Local,France,France; Paris; Paris,"May 4, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),249,8.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jeremie Mattern,Paris Saclay University,http://dx.doi.org/10.1371/journal.pone.0240782,1/16/2021,6/17/2021,Verified
201106_Lyon_UniversitéClaudeBernardLyon_Overall,"November 6, 2020",Local,France,France; Auvergne-Rhône-Alpes; Lyon,"April 10, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Unclear,"Biomerieux,Beijing Wantai Biological",Multiple Types,"Total Antibody,IgG",,,High,Preprint,Antonin Bal,Université Claude Bernard Lyon,https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1,1/17/2021,8/4/2021,Verified
201105_Corsica_UniversitédeCorse_Totaladj,"November 5, 2020",Regional,France,"France; Corsica; Ajaccio
Corte","April 16, 2020","June 15, 2020",Residual sera,Multiple groups,1973,5.46%,4.51%,6.57%,Sequential,EUROIMMUN AG,ELISA,IgG,86.40%,96.20%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://www.mdpi.com/2077-0383/9/11/3569,1/18/2021,6/17/2021,Verified
210205_IledeFrance_Epicentre_Shelters,"February 5, 2021",Local,France,France; Ile de France; Paris,"June 23, 2020","July 2, 2020",Persons experiencing homelessness,Multiple groups,818,52.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Thomas Roederer,Médecins sans Frontières (Epicentre) ,https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3,1/23/2021,8/4/2021,Verified
201104_Paris_CochinAPHP_HCW,"November 4, 2020",Local,France,France; Île-de-France; Paris,"May 14, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),4607,11.50%,10.60%,12.40%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chantal Delmas,Cochin APHP,https://dx.doi.org/10.1017/ice.2020.1309,1/23/2021,7/6/2021,Verified
201130_Strasbourg_StrasbourgUniversityHospital_Abbott,"November 30, 2020",Local,France,France; Grand-Est ; Strasbourg,"May 7, 2020","June 26, 2020",Contacts of COVID patients,Adults (18-64 years),11,0.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Floriane Gallais,Strasbourg University Hospital,https://dx.doi.org/10.3201/eid2701.203611,1/23/2021,6/17/2021,Verified
201210_ Paris_UniversitéParis-Saclay,"December 10, 2020",Local,France,France; Île-de-France; Paris ,"April 29, 2020","June 26, 2020",Pregnant or parturient women,Adults (18-64 years),529,4.70%,3.00%,6.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),Vassilis Tsatsarisa,Université Paris-Saclay,https://dx.doi.org/10.1016/j.jogoh.2020.102041,1/23/2021,6/17/2021,Verified
210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj,"February 8, 2021",National,France,"France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Students and Daycares,Children and Youth (0-17 years),327,3.70%,1.30%,6.80%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,2/19/2021,6/17/2021,Verified
200930_Toulouse_CentreHospitalierUniversitaireDeToulouse_HCW&Staff,"September 30, 2020",Local,France,France,"June 10, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),8758,3.20%,2.80%,3.50%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Chloe Dimeglio,Centre Hospitalier Universitaire (CHU) de Toulouse,http://dx.doi.org/10.1016/j.jinf.2020.09.035,2/20/2021,6/17/2021,Verified
210118_France_SorbonneUniversité_primary,"January 18, 2021",National,France,France; Île-de-France and Grand Est ,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,9782,3.46%,,,Simplified probability,"EUROIMMUN AG,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nathanael Lapidus,Sorbonne Université,https://dx.doi.org/10.1016/j.idnow.2020.12.007,2/26/2021,8/4/2021,Verified
201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children,"November 19, 2020",Local,France,France; Île-de-France; Paris,"April 14, 2020","May 12, 2020",Residual sera,Children and Youth (0-17 years),605,10.70%,8.40%,13.50%,Sequential,Biosynex,LFIA,"IgG,IgM",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Robert Cohen,Centre Hospitalier Intercommunal de Créteil,http://dx.doi.org/10.1136/bmjpo-2020-000887,2/28/2021,6/17/2021,Verified
210115_France_InstitutNationaldelaStatistiqueetdesÉtudesÉconomiques_Overall,"January 15, 2021",National,France,France,"May 2, 2020","June 2, 2020",Household and community samples,Multiple groups,12114,4.50%,3.90%,5.00%,Stratified probability,EUROIMMUN AG,ELISA,IgG,94.40%,100.00%,Low,Institutional Report,Josiane Warszawski,l’Institut national de la santé et de la recherche médicale (Inserm) ,https://drees.solidarites-sante.gouv.fr/sites/default/files/2021-01/er1167-en.pdf,3/11/2021,6/17/2021,Verified
210201_France_TissueBankofLille_overall_unadj,"February 1, 2021",Local,France,France,"November 1, 2019","March 16, 2020",Tissue donor,Multiple groups,235,1.70%,,,Sequential,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Nicolas Germain,CHU Lille,https://dx.doi.org/10.1007/s10561-021-09901-3,3/13/2021,8/4/2021,Verified
201223_Paris_InstitutCurie_overall,"December 23, 2020",Local,France,France;  Île-de-France; Paris,"April 28, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,1847,11.60%,10.20%,13.20%,Convenience,NA,Multiple Types,"IgG,Total Antibody",,99.00%,Moderate,Journal Article (Peer-Reviewed),Francois Anna, Institut Curie,https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058,3/19/2021,8/4/2021,Verified
210127_Nice_UniversitéCôted'Azur,"January 27, 2021",Local,France,France; Provence-Alpes-Côte d'Azur; Nice,"April 15, 2020","May 26, 2020",Health care workers and caregivers,Adults (18-64 years),196,15.00%,,,Convenience,EUROIMMUN AG,ELISA,"IgA,IgG",100.00%,,High,Journal Article (Peer-Reviewed),Marion Cremoni,Université Côte d'Azur,https://dx.doi.org/10.3389/fmed.2020.608804,3/27/2021,8/4/2021,Verified
210304_Rennes_UniversitéRennes,"March 4, 2021",Local,France,France; Brittany; Rennes,"May 29, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),3234,3.80%,,,Convenience,"Beijing Wantai Biological,NG Biotech Laboratoires",Multiple Types,IgG,,,High,Preprint,Christophe Paris,Université Rennes,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3795306,3/27/2021,8/4/2021,Verified
210312_Strasbourg_UniversityHospitalStrasbourg_overall,"March 12, 2021",Local,France,France,"February 18, 2021","February 25, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,241,10.80%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Ilies Benotmane,"University Hospital, Strasbourg",10.1101/2021.03.08.21252741,3/31/2021,6/17/2021,Verified
210212_Nancy_UniversitéDeLorraine_overall,"February 12, 2021",Local,France,France,"June 26, 2020","July 24, 2020",Household and community samples,Multiple groups,2006,2.50%,1.80%,3.30%,Stratified probability,"Biosynex,Bio-rad,EUROIMMUN AG",Multiple Types,"Total Antibody,IgM,IgG,IgA",,,Low,Preprint,Anne Gegout petit,Université de Lorraine,10.1101/2021.02.10.21250862,3/31/2021,8/4/2021,Verified
210312_Paris_SorbonneUniversite_M3,"March 12, 2021",Local,France,France,"June 16, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),938,13.00%,11.10%,15.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Pierre Hausfater,Sorbonne Universite ,10.1101/2021.03.09.21253200,4/1/2021,7/22/2021,Verified
210308_Perpignan_CentreHospitalierDePerpignan_Overall_PopAdj,"March 8, 2021",Local,France,France; Occitanie; Perpignan,"June 29, 2020","July 17, 2020",Household and community samples,Multiple groups,700,35.40%,30.20%,41.00%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,Low,Preprint,Adeline Beaumont,Centre Hospitalier de Perpignan,https://www.medrxiv.org/content/10.1101/2021.03.05.21252835v1.full-text,4/2/2021,6/19/2021,Verified
210206_France_ParisUniversity_ELISA,"February 6, 2021",National,France,France,"November 4, 2019","March 16, 2020",Residual sera,Multiple groups,9144,3.90%,,,Simplified probability,EUROIMMUN AG,ELISA,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Paris University,http://dx.doi.org/10.1007/s10654-020-00716-2,4/5/2021,8/4/2021,Unverified
210223_France_MontpellierUniversity_NursingHomeResidents,"February 23, 2021",Regional,France,France; Occitanie,"April 21, 2020","July 29, 2020",Assisted living and long-term care facilities,Seniors (65+ years),456,30.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hubert Blain, Montpellier University,https://dx.doi.org/10.1093/ageing/afab050,4/9/2021,6/29/2021,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall,"February 27, 2021",Local,France,France,"May 11, 2020","May 25, 2020",Health care workers and caregivers,Adults (18-64 years),663,1.80%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/18/2021,7/17/2021,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall,"February 27, 2021",Local,France,France,"May 25, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1011,1.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/18/2021,7/17/2021,Verified
210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients,"March 22, 2021",Local,France,France; Grand Est,,"September 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,780,6.20%,,,Convenience,"NA,Abbott Laboratories,EUROIMMUN AG,Biosynex,Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Sophie Caillard,Strasbourg University Hospital,https://dx.doi.org/10.1097/TP.0000000000003766,4/18/2021,8/4/2021,Verified
210415_France_InstitutPasteur_HighSchool1_overall,"April 15, 2021",Local,France,France; Hauts-de-France,"March 30, 2020","April 4, 2020",Students and Daycares,Multiple groups,664,25.10%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,5/6/2021,8/4/2021,Unverified
210415_France_InstitutPasteur_PrimarySchool2_overall,"April 15, 2021",Local,France,France; Hauts-de-France,"April 28, 2020","April 30, 2020",Students and Daycares,Multiple groups,1340,10.40%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,Moderate,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,5/6/2021,7/25/2021,Unverified
210208_Paris_JeanVerdierHospital_DaycareStaff2_Overall_TestAdj,"February 8, 2021",National,France,"France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Essential non-healthcare workers,Adults (18-64 years),197,6.80%,3.20%,11.50%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,5/10/2021,6/17/2021,Verified
210208_Paris_JeanVerdierHospital_HCW3_Overall_TestAdj,"February 8, 2021",National,France,"France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),164,5.00%,1.60%,9.80%,Unclear,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,5/10/2021,6/17/2021,Verified
210101_Montpellier_UniversityHospitalMontpellier_HCW,"October 30, 2020",Local,France,France,"April 21, 2020","June 3, 2020",Health care workers and caregivers,Adults (18-64 years),647,2.01%,0.93%,3.09%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Marie Bistoquet,University Hospital Montpellier,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30505-3/fulltext,5/20/2021,6/17/2021,Verified
210428_Île-de-France_SorbonneUniversité_1,"April 28, 2021",Regional,France,France; Île-de-France,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,593,7.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin SpA,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/28/2021,8/4/2021,Unverified
210513_Lyon_CentreHospitalierSaintJosephSaintLuc,"May 13, 2021",Local,France,France; Auvergne-Rhône-Alpes; Lyon,"June 8, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),971,9.00%,8.80%,9.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Emmanuel Vivier,Centre Hospitalier Saint Joseph Saint Luc,https://dx.doi.org/10.1186/s13613-021-00868-8,5/29/2021,7/17/2021,Unverified
210510_Paris_GroupeHospitalierNordEssonneLongjumeau,"May 10, 2021",Local,France,France; Île-de-France; Paris,"May 8, 2020","July 27, 2020",Contacts of COVID patients,Multiple groups,120,39.00%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Lorelei Charbonnier,Groupe Hospitalier Nord Essonne Longjumeau,https://dx.doi.org/10.3389/fped.2021.638502,6/5/2021,7/6/2021,Unverified
210531_Marseille_HôpitauxdeMarseille,"May 31, 2021",Local,France,France; Provence-Alpes-Côte d'Azur; Marseille,"June 1, 2020","August 5, 2020",Persons living in slums,Adults (18-64 years),1156,5.62%,2.90%,7.21%,Convenience,Biosynex,Not reported,"IgG,IgM",100.00%,99.50%,Moderate,Preprint,Sandrine Loubiere,Hôpitaux de Marseille,https://europepmc.org/article/PPR/PPR350578,6/7/2021,7/6/2021,Unverified
210521_France_SantePubliqueFrance_March1_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","March 9, 2020","March 15, 2020",Residual sera,Multiple groups,3834,0.40%,0.10%,0.90%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/7/2021,8/4/2021,Unverified
210521_France_SantePubliqueFrance_April2_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","April 6, 2020","April 12, 2020",Residual sera,Multiple groups,3595,4.10%,3.30%,5.00%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/7/2021,8/4/2021,Unverified
210521_France_SantePubliqueFrance_May3_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","May 11, 2020","May 17, 2020",Residual sera,Multiple groups,3592,4.90%,4.00%,5.90%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/7/2021,8/4/2021,Unverified
210525_Paris_SamusocialDeParis_Residents_Overall,"May 25, 2021",Local,France,France; Ile de France; Paris,"March 1, 2020","May 31, 2020",Persons experiencing homelessness,Multiple groups,96,69.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,6/29/2021,7/8/2021,Unverified
210525_Paris_SamusocialDeParis_Staff_Overall,"May 25, 2021",Local,France,France; Ile de France; Paris,"March 1, 2020","May 31, 2020",Essential non-healthcare workers,Multiple groups,81,18.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,6/29/2021,7/6/2021,Unverified
210604_Nancy_UniversiteDeLorraine,"June 4, 2021",Local,France,France; Grand Est; Nancy,"June 26, 2020","July 4, 2020",Household and community samples,Multiple groups,2006,2.50%,1.80%,3.30%,Convenience,"Bio-rad,Biosynex,EUROIMMUN AG",ELISA,"IgG,IgM,IgA,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Anne Gegout Petit,Université de Lorraine,http://dx.doi.org/10.3390/v13061076,6/30/2021,8/4/2021,Unverified
210623_Marseille_Aix-MarseilleUniversity,"June 23, 2021",Local,France,France; Provence; Marseille,"June 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),99,6.10%,,,Convenience,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Emilie Mosnier,Aix-Marseille University,https://dx.doi.org/10.1016/j.puhip.2021.100154,7/6/2021,7/6/2021,Unverified
210706_France_InstitutdeCancérologiedel’Ouest_patients_primary,"July 6, 2021",Regional,France,France; Nantes and Angers sites of the ICO Cancer Center (Western France); the Lorraine Cancer Center in Nancy (Eastern France); and the Jean Perrin Cancer Center in Clermont-Ferrand (Central France) ,"July 17, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,878,6.70%,,,Convenience,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,7/13/2021,7/21/2021,Unverified
210706_France_InstitutdeCancérologiedel’Ouest_HCW_primary,"July 6, 2021",Regional,France,France; Nantes and Angers sites of the ICO Cancer Center (Western France); the Lorraine Cancer Center in Nancy (Eastern France); and the Jean Perrin Cancer Center in Clermont-Ferrand (Central France) ,"July 17, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),940,7.80%,,,Self-referral,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,7/13/2021,7/13/2021,Unverified
210518_Paris_HopitalBichat-ClaudeBernard,"May 18, 2021",Local,France,France,"May 12, 2020","June 2, 2020",Health care workers and caregivers,Adults (18-64 years),72,15.30%,6.90%,23.70%,Convenience,"AAZ LMB,NG Biotech Laboratoires,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Charpentier,Hopital Bichat-Claude Bernard,https://dx.doi.org/10.1016/j.diagmicrobio.2021.115430,7/14/2021,8/4/2021,Unverified
210713_Strasbourg_HôpitauxUniversitairesdeStrasbourg_primary,"July 13, 2021",Local,France,France,"May 18, 2020","July 2, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,469,6.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Renaud Felten,Hôpitaux Universitaires de Strasbourg studied patienst with rare autoimmune diseases (n=469) and found a seroprevalence of 6.6%,https://dx.doi.org/10.1186/s13075-021-02565-0,7/20/2021,8/4/2021,Unverified
210721_Nancy_CHRUNancy_Primary,"July 21, 2021",Local,France,France,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,396,2.30%,,,Entire sample,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),C Hartard,Nancy University Hospital,https://dx.doi.org/10.1017/ice.2021.334,7/27/2021,7/27/2021,Unverified
210723_France_InstitutPasteur_overall_Luminex+Neut,"July 23, 2021",National,France,France,"February 15, 2020","August 15, 2020",Residual sera,Multiple groups,2399,5.29%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tom Woudenberg,Institut Pasteur,https://dx.doi.org/10.1016/j.ebiom.2021.103495,8/2/2021,8/5/2021,Unverified
210722_Lyon_UniversitéClaudeBernardLyon1_overall,"July 22, 2021",Local,France,France,"May 10, 2020","June 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Convenience,"Beijing Wantai Biological,bioMérieux",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Antonin Bal,Université Claude Bernard Lyon 1,https://dx.doi.org/10.1038/s41598-021-93828-y,8/3/2021,8/4/2021,Unverified
201213_Helsinki_UniversityofHelsinki_HCW_unadj,"December 13, 2020",Local,Finland,Finland; Uusimaa; Helsinki,"April 22, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),1095,3.00%,,,Convenience,"EUROIMMUN AG,Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Anu Kantele,University of Helsinki,https://dx.doi.org/10.1016/j.tmaid.2020.101949,2/1/2021,8/4/2021,Verified
200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj,"July 27, 2020",Regional,Faroe Islands,Faroe Islands; Faroe Islands,"April 27, 2020","May 1, 2020",Household and community samples,Adults (18-64 years),1075,0.70%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,University of the Faroe Islands,http://dx.doi.org/10.3201/eid2611.202736,9/27/2020,6/17/2021,Verified
200922_AddisAbaba_KuwaitUniversity_GenPop,"September 22, 2020",Local,Ethiopia,Ethiopia,"May 18, 2020","May 21, 2020",Residual sera,Multiple groups,99,3.00%,0.60%,8.60%,Convenience,Abbott Laboratories,Not reported,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),John Kempen,Kuwait University,https://dx.doi.org/10.4269/ajtmh.20-0816,12/6/2020,6/17/2021,Verified
201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj,"October 13, 2020",Local,Ethiopia,Ethiopia,"April 23, 2020","April 28, 2020",Household and community samples,Adults (18-64 years),301,8.80%,5.50%,11.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,Moderate,Preprint,Berhanu Alemu,"Ministry of Health, Ethiopia",https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1,12/11/2020,8/5/2021,Verified
210302_Diredawa_TheUniversityofSheffield_Overall,"March 2, 2021",Regional,Ethiopia,Ethiopia; Diredawa,"June 15, 2020","July 30, 2020",Household and community samples,Multiple groups,684,3.20%,1.00%,4.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Tamrat Shaweno,University of Sheffield,https://www.researchsquare.com/article/rs-266413/v1,3/31/2021,7/14/2021,Verified
210507_Ethiopia_EthiopianPublicHealthInstitute_AddisAbaba,"May 7, 2021",Local,Ethiopia,Ethiopia; Oromia Region; Addis Ababa,"July 22, 2020","September 2, 2020",Household and community samples,Multiple groups,956,3.50%,1.70%,5.40%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",67.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,5/29/2021,6/19/2021,Unverified
210507_Ethiopia_EthiopianPublicHealthInstitute_JimmaRegion,"May 7, 2021",Local,Ethiopia,Ethiopia; Oromia Region; Jimma,"July 22, 2020","September 2, 2020",Household and community samples,Multiple groups,900,0.60%,0.10%,1.60%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",67.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,5/29/2021,6/19/2021,Unverified
210621_Ethiopia_HaramayaUniversity_Overall,"June 21, 2021",Regional,Ethiopia,"Ethiopia; Oromia, Harari; Haramaya, Harar","April 1, 2020","March 31, 2021",Pregnant or parturient women,Multiple groups,1447,5.70%,4.60%,7.00%,Simplified probability,Beijing Wantai Biological,LFIA,IgG,100.00%,98.80%,High,Preprint,Nega Assefa,Haramaya University,10.1101/2021.06.17.21257323,7/1/2021,7/8/2021,Unverified
210706_Ethiopia_ArmauerHansenResearchInstitute_HCW,"July 6, 2021",National,Ethiopia,"Ethiopia; Oromiya, Sidama, Amhara; Addis Ababa","December 15, 2020","February 14, 2021",Health care workers and caregivers,Adults (18-64 years),1997,39.60%,37.40%,41.70%,Self-referral,NA,ELISA,IgG,100.00%,97.70%,High,Preprint,Tesfaye Gelanew,Armauer Hansen Research Institute,10.1101/2021.07.01.21259687,7/19/2021,7/21/2021,Unverified
210710_EthiopiaDireDawa_JimmaUniversityInstituteofHealth_Primary,"July 10, 2021",Local,Ethiopia,Ethiopia,"June 15, 2020","July 30, 2020",Household and community samples,Multiple groups,684,3.20%,2.00%,4.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Tamrat Shaweno,Jimma University Institute of Health,https://dx.doi.org/10.1186/s41182-021-00347-7,7/19/2021,7/29/2021,Verified
201023_Tallinn_UniversityofTartu_Overall,"October 23, 2020",Local,Estonia,Estonia,"May 8, 2020","July 31, 2020",Household and community samples,Multiple groups,1006,1.50%,0.90%,2.50%,Stratified probability,"Abbott Laboratories,DiaSorin SpA,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Preprint,Piia Jogi,University of Tartu,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,8/4/2021,Verified
201023_Saaremaa_UniversityofTartu_Overall,"October 23, 2020",Local,Estonia,Estonia,"May 8, 2020","July 31, 2020",Household and community samples,Multiple groups,954,6.30%,5.00%,7.90%,Stratified probability,"Abbott Laboratories,DiaSorin SpA,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Preprint,Piia Jogi,University of Tartu,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,8/4/2021,Verified
210226_Estonia_UniversityofTartu_primary,"June 22, 2021",National,Estonia,Estonia,"February 11, 2021","February 22, 2021",Household and community samples,Multiple groups,2626,11.49%,10.29%,12.77%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,2/26/2021,6/17/2021,Verified
210107_Estonia_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Estonia,Estonia; NR; NR,"June 10, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),130,0.00%,0.00%,2.87%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Verified
200924_Estonia_UniversityofTartu_overall,"September 24, 2020",National,Estonia,Estonia,"May 4, 2020","June 10, 2020",Pregnant or parturient women,Adults (18-64 years),433,0.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Piret Veerus,University of Tartu,https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995,3/20/2021,6/17/2021,Verified
210323_Estonia_UniversityOfTartu_overall,"June 22, 2021",National,Estonia,Estonia,"March 11, 2021","March 22, 2021",Household and community samples,Multiple groups,2382,21.41%,19.78%,23.11%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,3/25/2021,6/17/2021,Verified
210420_Estonia_UniversityOfTartu_overall,"June 22, 2021",National,Estonia,Estonia,"April 8, 2021","April 19, 2021",Household and community samples,Multiple groups,2491,35.87%,33.97%,37.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,4/21/2021,6/17/2021,Verified
210527_Estonia_UniversityOfTartu_overall,"June 22, 2021",National,Estonia,Estonia,"May 13, 2021","May 24, 2021",Household and community samples,Multiple groups,2290,49.52%,47.45%,51.59%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,5/29/2021,7/14/2021,Verified
210607_Estonia_UniversityOfTartu_overall,"June 7, 2021",National,Estonia,Estonia,"February 8, 2021","March 25, 2021",Residual sera,Multiple groups,2517,20.10%,18.50%,21.70%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Hiie Soeorg,University of Tartu,10.1101/2021.06.06.21258406,6/16/2021,6/23/2021,Unverified
210622_Estonia_UniversityOfTartu_june,"June 22, 2021",National,Estonia,Estonia,"June 10, 2021","June 21, 2021",Household and community samples,Multiple groups,2330,67.90%,65.96%,69.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,6/28/2021,7/14/2021,Verified
200721_Egypt_CairoUniversity_TotalHCW_Overall,"July 21, 2020",Local,Egypt,Egypt,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),74,12.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Abdel Meguid Kassem,Cairo University,https://dx.doi.org/10.1016/j.ajg.2020.07.005,9/29/2020,8/5/2021,Verified
210115_Cairo_CairoUniversity,"January 15, 2021",Local,Egypt,Egypt,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),203,18.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Reham Abdelmoniem,Cairo University ,https://dx.doi.org/10.1016/j.jcv.2020.104710,1/23/2021,6/17/2021,Verified
201023_Egypt_AinShamsUniversity_Overall,"October 23, 2020",Local,Egypt,Egypt; Cairo Governorate; Cairo,"April 22, 2020","May 14, 2020",Health care workers and caregivers,Multiple groups,4040,1.31%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",83.30%,100.00%,High,Journal Article (Peer-Reviewed),Aya Mostafa,Ain Shams University,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053,1/23/2021,6/17/2021,Verified
210402_Cairo_CairoUniversity_HCW,"April 2, 2021",Local,Egypt,Egypt,"May 5, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),455,7.90%,5.80%,10.80%,Convenience,"SD Biosensor,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Ahmed Mukhtar,Cairo University,https://dx.doi.org/10.4081/jphr.2021.2102,4/18/2021,8/4/2021,Verified
210311_Egypt_CenterofScientificExcellenceforInfluenzaViruses_October3,"March 11, 2021",National,Egypt,"Egypt; Sharkiyah Governorate, Gharbiyah Governorate, Kafr El Sheikh Governorate, Qalyubiyah Governorate, Fayyoum Governorate","October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,1260,34.80%,,,Simplified probability,NA,Neutralization,Neutralizing ,,,Unclear,Journal Article (Peer-Reviewed),Mokhtar R Gomaa,Center of Scientific Excellence for Influenza Viruses ,https://dx.doi.org/10.1371/journal.ppat.1009413,5/10/2021,7/6/2021,Verified
210610_Cairo_CairoUniversity_HCW1_overall,"June 10, 2021",Local,Egypt,Egypt,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),386,15.80%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,7/6/2021,7/6/2021,Unverified
210610_Cairo_CairoUniversity_GenPop2_overall_TotalAbCLIA,"June 10, 2021",Local,Egypt,Egypt,"June 1, 2020","June 14, 2020",Household and community samples,Adults (18-64 years),725,29.40%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,7/6/2021,7/6/2021,Unverified
210715_Egypt_NationalResearchCentre_Primary,"July 15, 2021",Local,Egypt,Egypt,"August 15, 2020","October 15, 2020",Multiple general populations,Multiple groups,888,30.00%,,,Convenience,NA,Neutralization,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Amira S. El Rifay,National Research Centre,https://dx.doi.org/10.1111/irv.12889,7/19/2021,7/19/2021,Unverified
210715_Cairo_Ain-ShamsUniversity_TestAdj,"July 15, 2021",Local,Egypt,Egypt; Cairo Governate; Cairo,"May 5, 2020","October 31, 2020",Residual sera,Multiple groups,2927,29.82%,28.16%,31.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Samia Girgis,Ain-Shams University,http://dx.doi.org/10.1371/journal.pone.0254581,8/3/2021,8/3/2021,Unverified
200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall,"July 27, 2020",Local,Ecuador,Ecuador; El Oro,"May 1, 2020","May 25, 2020",Household and community samples,Multiple groups,673,45.00%,,,Convenience,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Peruana Cayetano Heredia,http://dx.doi.org/10.1093/cid/ciaa1055,10/2/2020,6/17/2021,Verified
200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall,"September 29, 2020",Local,Ecuador,Ecuador,"June 25, 2020","June 30, 2020",Household and community samples,Adults (18-64 years),362,7.70%,,,Simplified probability,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar H Del Brutto,Universidad Peruana Cayetano Heredia,https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152,4/26/2021,6/17/2021,Verified
200923_Ecuador_UniversidadCatólicaDelEcuador_Patients,"September 23, 2020",National,Ecuador,Ecuador,"May 12, 2020","July 20, 2020",Household and community samples,Multiple groups,11540,19.00%,,,Self-referral,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Camilo Zurita Salinas,Universidad Católica Del Ecuador,https://www.researchgate.net/publication/344477310_SEROPREVALENCE_OF_ANTI-SARS-COV-2_IGG_ANTIBODIES_IN_ECUADORIAN_POPULATION,5/2/2021,6/17/2021,Verified
210427_Cuenca_UniversityOfAntwerp_overall_UnAdj,"April 27, 2021",Local,Ecuador,Ecuador; Azuay,"August 11, 2020","November 1, 2020",Household and community samples,Multiple groups,2457,13.20%,,,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",87.90%,94.30%,Moderate,Journal Article (Peer-Reviewed),David Acurio Paez,University of Antwerp,https://www.mdpi.com/1660-4601/18/9/4657,5/21/2021,6/17/2021,Unverified
210319_Ecuador_ InstitutoEcuatorianodeEnfermedadesDigestivas,"March 19, 2021",Local,Ecuador,Ecuador; Guayas; Guayaquil,"April 15, 2020","May 22, 2020",Residual sera,Adults (18-64 years),127,7.09%,,,Convenience,NA,Not reported,IgM,,,High,Journal Article (Peer-Reviewed),C Robles Medranda,Instituto Ecuatoriano de Enfermedades Digestivas,http://dx.doi.org/10.1055/s-0041-1724977,6/6/2021,7/23/2021,Verified
201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG,"December 2, 2020",National,Dominican Republic,Dominican Republic,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,12897,5.50%,,,Simplified probability,GenBody Inc.,LFIA,IgG,56.70%,100.00%,High,Journal Article (Peer-Reviewed),Robert Paulino Ramirez,Universidad Iberoamericana,https://dx.doi.org/10.4269/ajtmh.20-0907,1/12/2021,6/17/2021,Verified
200625_Denmark_GeneralPopTestAdj,"June 25, 2020",National,Denmark,Denmark,"April 6, 2020","May 3, 2020",Blood donors,Adults (18-64 years),20640,1.90%,0.80%,2.30%,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",82.58%,99.54%,Moderate,Journal Article (Peer-Reviewed),Christian Erikstrup,Copenhagen University Hospital,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661,6/26/2020,7/6/2021,Verified
200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_ANDOR_IgM_adj,"August 3, 2020",Regional,Denmark,Denmark; Capital Region of Denmark,"April 15, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),28792,4.36%,4.09%,4.65%,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",73.40%,99.90%,Low,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,9/30/2020,6/17/2021,Verified
200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,"August 3, 2020",Regional,Denmark,Denmark; Capital Region of Denmark,"April 15, 2020","April 22, 2020",Blood donors,Adults (18-64 years),4672,3.04%,2.58%,3.57%,Sequential,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",73.40%,99.90%,High,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,10/1/2020,6/17/2021,Verified
201003_Denmark_AarhusUniversity_HCW_testadj,"October 3, 2020",Regional,Denmark,Denmark; Central Denmark Region,"May 18, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),17948,3.36%,2.38%,3.82%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Senne Jespersen,Aarhus University Hospital,https://dx.doi.org/10.1093/cid/ciaa1471,12/19/2020,6/17/2021,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj,"October 27, 2020",Local,Denmark,Denmark; Capital Region of Denmark; Copenhagen,"April 4, 2020","July 3, 2020",Pregnant or parturient women,Adults (18-64 years),1313,2.60%,1.70%,4.00%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,6/17/2021,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj,"October 27, 2020",Local,Denmark,Denmark; Capital Region of Denmark; Copenhagen ,"April 4, 2020","July 3, 2020",Hospital visitors,Adults (18-64 years),1188,3.50%,2.30%,5.10%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,6/17/2021,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns,"October 27, 2020",Local,Denmark,Denmark; Capital Region of Denmark; Copenhagen ,"April 4, 2020","July 3, 2020",Perinatal,Children and Youth (0-17 years),1206,1.40%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,High,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/10/2021,6/17/2021,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj,"October 26, 2020",National,Denmark,Denmark,"June 2, 2020","June 19, 2020",Blood donors,Seniors (65+ years),1200,1.40%,0.30%,2.50%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/10/2021,6/17/2021,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj,"October 26, 2020",National,Denmark,Denmark,"June 1, 2020","June 26, 2020",Blood donors,Adults (18-64 years),1110,2.50%,1.30%,3.80%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/12/2021,6/17/2021,Verified
201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall,"December 27, 2020",Local,Denmark,Denmark; Copenhagen; Copenhagen,"April 14, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),36,0.00%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,1/15/2021,6/17/2021,Verified
201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM,"November 20, 2020",Local,Denmark,Denmark; Central Denmark Region; Aarhus,"June 1, 2020","June 4, 2020",Persons experiencing homelessness,Adults (18-64 years),129,4.70%,2.10%,9.80%,Convenience,NA,LFIA,"IgG,IgM",98.90%,97.60%,High,Journal Article (Peer-Reviewed),Signe Storgaard,Aarhus Department of Public Health ,"https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.",1/23/2021,6/17/2021,Verified
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall,"December 27, 2020",Local,Denmark,Denmark; Copenhagen; Copenhagen,"February 17, 2020","April 17, 2020",Pregnant or parturient women,Adults (18-64 years),1019,1.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,2/13/2021,6/17/2021,Verified
210121_Denmark_CopenhagenUniversityHospital_Denmark,"January 21, 2021",National,Denmark,Denmark,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),2024,2.80%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co., Ltd,Guangzhou Wondfo Biotech Co.， Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,8/4/2021,Verified
210212_Copenhagen_Herlev-GentofteHospital_Overall,"February 12, 2021",Local,Denmark,Denmark; Capital Region; Copenhagen,"October 19, 2020","October 26, 2020",Health care workers and caregivers,Adults (18-64 years),1096,34.58%,31.82%,37.45%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",97.00%,99.50%,Moderate,Preprint,Johannes R Madsen,Herlev-Gentofte Hospital,https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1,3/18/2021,7/2/2021,Verified
210401_Denmark_SlagelseSygehus_blooddonors_primary,"April 1, 2021",Regional,Denmark,Denmark; Capital Region and Region Zealand,"June 22, 2020","July 3, 2020",Blood donors,Adults (18-64 years),750,2.00%,1.10%,3.30%,Simplified probability,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,5/19/2021,7/27/2021,Verified
210401_Denmark_SlagelseSygehus_children_primary,"April 1, 2021",Regional,Denmark,Denmark; Capital Region and Region Zealand,"June 22, 2020","July 3, 2020",Residual sera,Children and Youth (0-17 years),1033,1.60%,1.00%,2.60%,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,5/19/2021,7/27/2021,Verified
210409_Denmark_StatensSerumInstitut_May_TestAdj,"April 9, 2021",National,Denmark,Denmark,"May 5, 2020","May 15, 2020",Household and community samples,Multiple groups,2512,1.50%,0.90%,2.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,99.50%,Low,Preprint,Laura Espenhain,Statens Serum Institut,https://www.medrxiv.org/content/10.1101/2021.04.07.21254703v1,5/19/2021,6/19/2021,Unverified
210409_Denmark_StatensSerumInstitut_August_TestAdj,"April 9, 2021",National,Denmark,Denmark,"August 15, 2020","September 30, 2020",Household and community samples,Multiple groups,11478,2.00%,1.70%,2.30%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,99.50%,Low,Preprint,Laura Espenhain,Statens Serum Institut,https://www.medrxiv.org/content/10.1101/2021.04.07.21254703v1,5/19/2021,6/19/2021,Unverified
210409_Denmark_StatensSerumInstitut_October_TestAdj,"April 9, 2021",National,Denmark,Denmark,"October 1, 2020","November 30, 2020",Household and community samples,Multiple groups,9654,2.40%,1.90%,2.80%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,99.50%,Low,Preprint,Laura Espenhain,Statens Serum Institut,https://www.medrxiv.org/content/10.1101/2021.04.07.21254703v1,5/19/2021,6/19/2021,Unverified
210409_Denmark_StatensSerumInstitut_December_TestAdj,"April 9, 2021",National,Denmark,Denmark,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,4044,4.30%,3.40%,5.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,99.50%,Low,Preprint,Laura Espenhain,Statens Serum Institut,https://www.medrxiv.org/content/10.1101/2021.04.07.21254703v1,5/19/2021,6/19/2021,Unverified
210512_Denmark_CopenhagenUniversityHospital_ShelterWorkers2_Overall,"May 12, 2021",National,Denmark,"Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","November 2, 2020","November 20, 2020",Essential non-healthcare workers,Adults (18-64 years),191,6.30%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,High,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,5/25/2021,7/6/2021,Verified
210512_Denmark_CopenhagenUniversityHospital_PEH1_Overall,"May 12, 2021",National,Denmark,"Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","November 2, 2020","November 20, 2020",Persons living in slums,Adults (18-64 years),628,6.80%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,Moderate,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,5/25/2021,7/6/2021,Verified
210510_Denmark_CopenhagenUniversityHospital_SHOverall,"May 10, 2021",National,Denmark,Denmark,"January 8, 2021","January 31, 2021",Household and community samples,Multiple groups,13279,17.30%,,,Stratified non-probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,100.00%,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,5/30/2021,6/19/2021,Unverified
210510_Denmark_CopenhagenUniversityHospital_BloodDonorsOverall,"May 10, 2021",National,Denmark,Denmark,"January 8, 2021","January 31, 2021",Blood donors,Multiple groups,22677,5.80%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,,,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,5/31/2021,6/19/2021,Unverified
201212_Europe_UniversityOfGlasgow_Denmark4,"December 12, 2020",National,Denmark,Denmark,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),34,2.94%,0.52%,14.91%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,6/17/2021,Verified
210531_Denmark_AarhusUniversity_CRDPatients1,"May 31, 2021",National,Denmark,Denmark,"June 8, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,365,0.30%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,High,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,6/7/2021,6/19/2021,Unverified
210531_Denmark_AarhusUniversity_BloodDonors2,"May 31, 2021",National,Denmark,Denmark,"June 8, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,513,1.90%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,6/7/2021,6/19/2021,Unverified
210609_CentralDenmarkRegion_AarhusUniversity,"June 9, 2021",Regional,Denmark,Denmark; Central Denmark Region,"May 18, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),11138,4.00%,,,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Agergard Kaspersen,Aarhus University,https://dx.doi.org/10.1016/j.ijid.2021.06.017,6/21/2021,6/21/2021,Unverified
210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA,"February 16, 2021",Local,Democratic Republic of the Congo,Democratic Republic of the Congo; South-Kivu; Bukavu,"July 2, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),359,41.20%,,,Convenience,EUROIMMUN AG,ELISA,IgG,61.70%,98.60%,High,Journal Article (Peer-Reviewed),Denis Mukwege ,Université Libre de Bruxelles (ULB),https://dx.doi.org/10.4269/ajtmh.20-1526,3/14/2021,6/17/2021,Verified
210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN,"February 17, 2021",Local,Democratic Republic of the Congo,Democratic Republic of the Congo; Kinhasa; Kinhasa,"July 17, 2020","August 13, 2020",Health care workers and caregivers,Adults (18-64 years),562,36.00%,,,Stratified probability,EUROIMMUN AG,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Antoine Nkuba Ndaye,Institut National de Recherche Biomedicale,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext,3/21/2021,6/27/2021,Verified
210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall,"January 27, 2021",Local,Democratic Republic of the Congo,Democratic Republic of the Congo,"May 15, 2020","August 30, 2020",Multiple populations,Multiple groups,684,40.79%,,,Self-referral,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,High,Journal Article (Peer-Reviewed),Philippe Bianga Katchunga,Clinique Saint-Luc de Bukavu,https://www.panafrican-med-journal.com/content/article/38/93/full/,4/15/2021,6/23/2021,Verified
210605_Kinshasa_InstitutNationaldeRechercheBiomédicale_primary,"June 5, 2021",Local,Democratic Republic of the Congo,Democratic Republic of the Congo,"October 22, 2020","November 8, 2020",Household and community samples,Multiple groups,1080,16.60%,14.00%,19.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Antoine N Nkuba,Institut National de Recherche Biomédicale,https://dx.doi.org/10.1093/cid/ciab515,6/17/2021,8/4/2021,Unverified
200714_CzechRepublic_ResearchCenterIBD_HCW,"July 14, 2020",Local,Czechia,Czechia; Central Bohemian; Prague,,"April 15, 2020",Health care workers and caregivers,Adults (18-64 years),92,2.17%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed), Karin Malickova,Clinical and Research Center for Inflammatory Bowel Disease,https://dx.doi.org/10.1080/00365521.2020.1791244,8/2/2020,8/4/2021,Verified
201112_Prague_CharlesUniversityandThomayer'sHospital_Roche,"November 12, 2020",Local,Czechia,Czechia; Prague; Prague,"July 3, 2020","August 19, 2020",Residual sera,Children and Youth (0-17 years),200,0.00%,0.00%,0.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Marketa Bloomfield,Charles University and Thomayer’s Hospital,http://dx.doi.org/10.3389/fped.2020.597736,1/23/2021,7/16/2021,Verified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Brno/South Moravian Region,"May 6, 2020",Regional,Czechia,Czechia; Brno / South Moravian,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,5049,0.08%,0.01%,0.15%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/6/2021,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Prague,"May 6, 2020",Local,Czechia,Czechia,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,5021,0.17%,0.05%,0.28%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/6/2021,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litomerice,"May 6, 2020",Local,Czechia,Czechia,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,3106,0.24%,0.07%,0.42%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/6/2021,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litovel_Unicov,"May 6, 2020",Local,Czechia,Czechia,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,2409,1.79%,1.24%,2.34%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/6/2021,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Olomouc/Olomouckykraj,"May 6, 2020",Regional,Czechia,Czechia; Olomouc / Olomouc ,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,6686,0.69%,0.48%,0.91%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/6/2021,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_Patients,"July 1, 2021",Local,Czechia,Czechia,"October 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1002,6.80%,,,Convenience,DiaSorin SpA,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,7/12/2021,7/21/2021,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_HCWs,"July 1, 2021",Local,Czechia,Czechia,"October 1, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),512,11.90%,,,Convenience,DiaSorin SpA,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,7/12/2021,7/12/2021,Unverified
200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos,"August 23, 2020",Local,Cuba,Cuba; Cienfuegos; Aguada de Pasajeros,"March 23, 2020","April 6, 2020",Contacts of COVID patients,Multiple groups,200,0.00%,,,Convenience,NA,Not reported,"IgM,IgG",,,Unclear,Journal Article (Peer-Reviewed),Alain Morejon Giraldoni,University of Medical Sciences of Cienfuegos,http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721,1/7/2021,6/17/2021,Verified
200515_Croatia_UniversityofSplit_IndustryWorkers_Overall,"May 15, 2020",Local,Croatia,Croatia,"April 23, 2020","April 28, 2020",Essential non-healthcare workers,Multiple groups,1494,1.27%,0.77%,1.98%,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgM,IgG",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Ivan Jerkovic,University of Split,https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx,7/17/2020,8/4/2021,Verified
200826_Croatia_UniversityofZagreb_HCWsIgG,"August 26, 2020",National,Croatia,Croatia,"April 25, 2020","May 24, 2020",Health care workers and caregivers,Adults (18-64 years),592,2.70%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic Cavlek,University of Zagreb,https://dx.doi.org/10.1590/0037-8682-0458-2020,10/17/2020,6/23/2021,Verified
201231_Zagreb_ZagrebUniversity_overall,"December 31, 2020",Local,Croatia,Croatia,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1678,0.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Lapic,Zagreb University,https://pubmed.ncbi.nlm.nih.gov/33410294/,2/1/2021,6/17/2021,Verified
201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff,"November 4, 2020",Local,Croatia,Croatia,"May 29, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),305,20.00%,,,Convenience,EUROIMMUN AG,ELISA,"IgA,IgG",,,Moderate,Preprint,Adriana Vince,Croatian Football Federation,https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1,2/6/2021,8/4/2021,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint1_primary,"April 15, 2021",Local,Croatia,Croatia,"May 13, 2020","May 29, 2020",Residual sera,Children and Youth (0-17 years),240,2.90%,,,Convenience,"Vircell S.L.,NA",Multiple Types,"IgA,IgM,IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,5/20/2021,8/4/2021,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint2_primary,"April 15, 2021",Local,Croatia,Croatia,"October 24, 2020","November 23, 2020",Residual sera,Children and Youth (0-17 years),308,8.40%,,,Convenience,"NA,Roche Diagnostics",Multiple Types,"IgG,IgM,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,5/20/2021,8/4/2021,Verified
210620_Croatia_CroatianInstituteOfPublicHealth_FirstWave_Overall,"June 20, 2021",National,Croatia,Croatia,"May 15, 2020","July 15, 2020",Multiple general populations,Multiple groups,1088,2.20%,1.40%,3.30%,Unclear,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,7/13/2021,8/4/2021,Unverified
210620_Croatia_CroatianInstituteOfPublicHealth_SecondWave_Overall,"June 20, 2021",National,Croatia,Croatia,"December 15, 2020","February 14, 2021",Multiple general populations,Multiple groups,1436,25.10%,22.80%,27.40%,Unclear,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,7/13/2021,8/4/2021,Unverified
210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall,"March 18, 2021",National,Côte d'Ivoire,Côte d'Ivoire,"July 15, 2020","October 13, 2020",Essential non-healthcare workers,Adults (18-64 years),1687,25.10%,,,Convenience,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jean Milleliri,Centre Hospitalier Regional d’Orleans,https://dx.doi.org/10.4269/ajtmh.21-0081,4/15/2021,6/19/2021,Unverified
201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall,"December 22, 2020",Local,Congo,Congo,"April 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),754,19.70%,,,Self-referral,"Wuhan UNscience Biotechnology Co., Ltd,Salofa Oy manufacturer, Finland",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Armel Batchi Bouyou,Fondation Congolaise pour la Recherche Médicale,https://dx.doi.org/10.1016/j.ijid.2020.12.065,1/30/2021,8/4/2021,Verified
200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj,"January 3, 2021",Local,Colombia,Colombia; Capital District Cundinamarca; Bogotá,"June 25, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),351,8.26%,5.81%,11.61%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Beatriz Ariza,Pontificia Universidad Javeriana,http://www.revistainfectio.org/index.php/infectio/article/view/938,10/6/2020,6/17/2021,Verified
201030_Colombia_UniversidadIndustrialdeSantander_primary,"October 30, 2020",National,Colombia,Colombia,"April 17, 2020","July 14, 2020",Non-essential workers and unemployed persons,Multiple groups,4234,4.00%,,,Unclear,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alvaro J Idrovo,Universidad Industrial de Santander,https://dx.doi.org/10.7705/biomedica.5829,1/23/2021,6/17/2021,Verified
201112_Monteria_UniversidaddeCórdoba_GenPopAdj,"November 12, 2020",Local,Colombia,Colombia; Caribbean Region; Monteria,"August 4, 2020","September 1, 2020",Household and community samples,Multiple groups,1368,55.30%,52.50%,57.80%,Stratified probability,Ingenasa,ELISA,"IgG,IgM,IgA",92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salim Mattar,Universidad de Córdoba,https://dx.doi.org/10.1093/ofid/ofaa550,2/5/2021,7/7/2021,Verified
210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj,"January 22, 2021",Local,Colombia,Colombia; Capital District Cundinamarca; Bogota,"June 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),212,16.03%,10.43%,21.62%,Convenience,Abbott Laboratories,CLIA,Total Antibody,85.50%,97.30%,High,Journal Article (Peer-Reviewed),Jeadran Malagon Rojas,Instituto Nacional de Salud,https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1,3/13/2021,6/17/2021,Verified
210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall,"March 17, 2021",Local,Colombia,Colombia; Capital District Cundinamarca; Bogotá,"November 23, 2020","December 6, 2020",Essential non-healthcare workers,Adults (18-64 years),237,13.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,John M Gonzalez,Universidad de Los Andes,https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1,3/29/2021,6/17/2021,Verified
210425_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj,"April 15, 2021",Local,Colombia,Colombia,"September 28, 2020","December 24, 2020",Essential non-healthcare workers,Adults (18-64 years),7045,19.50%,18.60%,20.40%,Stratified probability,Abbott Laboratories,CLIA,"IgG,IgM",85.20%,97.30%,Moderate,Journal Article (Peer-Reviewed),Claudia Colmenares Mejia ,Fundación Cardiovascular de Colombia,http://dx.doi.org/10.3390/ijerph18084172,5/22/2021,6/23/2021,Verified
210609_Cordoba_UniversidadDeCartagena,"June 9, 2021",Regional,Colombia,Colombia; Cordoba,"March 15, 2020","October 2, 2020",Household and community samples,Multiple groups,2447,40.80%,,,Stratified probability,Ingenasa,ELISA,"IgG,IgM,IgA",93.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Nelson Alvis Guzma,Universidad de Cartagena,https://dx.doi.org/10.1016/j.ijid.2021.06.018,6/21/2021,6/21/2021,Unverified
210629_Cordoba_ColombiaUniversidadDeCordoba_Overall,"June 29, 2021",Regional,Colombia,Colombia; Cordoba Department,"July 15, 2020","November 15, 2020",Household and community samples,Multiple groups,2564,40.80%,,,Stratified non-probability,Eurofins,ELISA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Evelin Garay,Colombia-Universidad de Córdoba,https://dx.doi.org/10.1093/trstmh/trab094,7/7/2021,7/7/2021,Unverified
200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers,"June 2, 2020",Local,China,China; Hubei; Wuhan,"February 12, 2020","March 17, 2020",Health care workers and caregivers,Adults (18-64 years),797,4.39%,,,Convenience,NA,ELISA,IgG,,,Unclear,Preprint,Shue Xiong,Huazhong University of Science and Technology,https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf,6/4/2020,6/17/2021,Verified
200605_China_NationalClinicalResearchCentre_CommunitySetting,"June 5, 2020",National,China,"China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Chengdu","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),10449,0.80%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,6/6/2020,8/4/2021,Verified
200602_Wuhan_SunYat-senUniversity_HCW_IgG,"June 10, 2020",Local,China,China; Hubei; Wuhan,"February 7, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),420,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,High,Journal Article (Peer-Reviewed),Min Liu,Sun Yat-sen University,https://www.bmj.com/content/369/bmj.m2195,6/12/2020,8/4/2021,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,"November 2, 2020",Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Health care workers and caregivers,Multiple groups,3832,4.00%,3.40%,4.70%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,6/17/2021,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,"November 2, 2020",Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Household and community samples,Multiple groups,19555,4.60%,4.30%,4.90%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,6/17/2021,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,"November 2, 2020",Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Residual sera,Multiple groups,1616,1.00%,0.50%,1.50%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,6/17/2021,Verified
200603_WuhantoUSAtravel_CDC_PassengersGenPop,"July 3, 2020",Local,China,China; Hubei; Wuhan,"January 28, 2020","January 28, 2020",Household and community samples,Multiple groups,186,0.54%,,,Convenience,SeraCare Life Sciences,ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Benjamin Hallowell,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article,7/7/2020,6/17/2021,Verified
200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients,"June 4, 2020",Local,China,China; Jiangsu; Nanjing,"February 19, 2020","February 19, 2020",Health care workers and caregivers,Adults (18-64 years),105,17.14%,,,Convenience,NA,ELISA,"IgG,IgM",93.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuxin Chen,Nanjing University Medical School,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270786/pdf/main.pdf,7/17/2020,8/4/2021,Verified
200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients,"April 20, 2020",Local,China,China; Hubei; Wuhan,"April 3, 2020","April 15, 2020",Residual sera,Not reported,381,10.49%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,6/17/2021,Verified
200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork,"April 20, 2020",Local,China,China; Hubei; Wuhan,"April 3, 2020","April 15, 2020",Essential non-healthcare workers,Adults (18-64 years),1021,9.60%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,7/31/2021,Verified
200605_China_NationalClinicalResearchCentre_HospitalSetting,"June 5, 2020",National,China,"China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),6919,2.46%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,7/25/2020,8/4/2021,Verified
200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM,"July 20, 2020",Local,China,China; Guangdong; Guangzhou,"January 20, 2020","April 30, 2020",Multiple populations,Multiple groups,8782,0.59%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,8/4/2021,Verified
200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,"July 20, 2020",Local,China,China; Hubei; Wuhan,"January 19, 2020","April 30, 2020",Multiple populations,Multiple groups,8272,2.14%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,8/4/2021,Verified
200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM,"July 3, 2020",Local,China,China; Hubei; Wuhan,"March 8, 2020","March 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1027,4.58%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hui Tang, Tongji Medical College,https://dx.doi.org/10.1053/j.ajkd.2020.06.008,8/2/2020,6/17/2021,Verified
200725_Wuhan_WuhanInstituteofVirology_IgG,"July 25, 2020",Local,China,China; Hubei; Wuhan,"March 19, 2020","March 20, 2020",Health care workers and caregivers,Adults (18-64 years),325,43.08%,,,Stratified probability,"Nanjing Vazyme Medical Technology Co., Ltd,NZK Biotech Co., Wuhan, China,Zhuhai Livzon Diagnostics Inc",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Danna Tu,Wuhan Institute of Virology ,http://dx.doi.org/10.1016/j.jinf.2020.07.023,9/29/2020,8/4/2021,Verified
200729_Wuhan_WuhanUniversity_Overall,"August 3, 2020",Local,China,China; Hubei; Wuhan,"January 14, 2020","February 21, 2020",Health care workers and caregivers,Not reported,1060,8.30%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Dong Zhao,Renmin Hospital of Wuhan University,https://dx.doi.org/10.1016/j.ijid.2020.07.082,10/1/2020,6/17/2021,Verified
200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders,"July 25, 2020",Local,China,China; Guangdong; Shenzhen,"February 29, 2020","March 18, 2020",Non-essential workers and unemployed persons,Multiple groups,1589,0.38%,,,Convenience,Shenzhen Sciarray Biotech Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Cantong Zhang,Shenzhen Second People's Hospital,http://dx.doi.org/10.1002/jmv.26355,10/4/2020,6/17/2021,Verified
200829_Hubei_HuazhongUniversity_HospitalizedChildren,"August 29, 2020",Local,China,"China; Hubei; Wuhan, Xiangyang","January 23, 2020","April 24, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),299,0.00%,,,Unclear,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Song mi Want,Huazhong University of Science and Technology,https://link.springer.com/article/10.1007/s11596-020-2228-7,10/4/2020,6/17/2021,Verified
200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay,"June 3, 2020",Regional,China,China; Hubei,"March 4, 2020","March 17, 2020",Household and community samples,Multiple groups,452,2.88%,,,Convenience,NA,ELISA,IgG,73.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,7/6/2021,Verified
200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay,"June 3, 2020",Regional,China,China; Hong Kong,"January 1, 2020","January 31, 2020",Residual sera,Multiple groups,580,2.59%,1.46%,4.23%,Sequential,NA,ELISA,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,7/6/2021,Verified
200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay,"June 3, 2020",Regional,China,China; Hong Kong,"February 1, 2020","February 13, 2020",Residual sera,Multiple groups,233,0.43%,0.01%,2.37%,Sequential,NA,ELISA,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,7/6/2021,Verified
200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG,"August 11, 2020",Local,China,China; Hubei; Wuhan,"January 23, 2020","March 27, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),44,0.00%,,,Sequential,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ai Zhang,Huazhong University of Science and Technology,https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424,10/9/2020,6/17/2021,Verified
200820_Hubei_NanjingUniversity_hcw_IgG,"August 20, 2020",Local,China,China; Hubei; Wuhan,"May 12, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),191,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Xin Tong,Nanjing University Medical School,https://dx.doi.org/10.1002/iid3.340,10/13/2020,6/17/2021,Verified
200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti,"August 19, 2020",Local,China,China; Guangdong; Guangzhou,"March 23, 2020","April 2, 2020",Blood donors,Adults (18-64 years),2199,0.32%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Ru Xu,Institute of Blood Transfusion,http://dx.doi.org/10.1002/jmv.26445,10/18/2020,6/23/2021,Verified
200824_Wuhan_WuhanUniversity_IgG_T2,"August 24, 2020",Local,China,China; Hubei; Wuhan,"May 13, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),1059,9.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lu He,Wuhan University,http://dx.doi.org/10.1016/j.jinf.2020.08.027,10/19/2020,6/17/2021,Verified
200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal,"September 14, 2020",Local,China,China; Hubei; Wuhan,"March 16, 2020","March 25, 2020",Health care workers and caregivers,Adults (18-64 years),3674,1.70%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fuling Zhou,Zhongnan Hospital of Wuhan University,http://dx.doi.org/10.1016/j.eclinm.2020.100510,10/29/2020,6/17/2021,Verified
200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall,"September 23, 2020",Local,China,China; Hubei; Wuhan,"February 10, 2020","March 22, 2020",Contacts of COVID patients,Multiple groups,300,47.67%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",97.10%,95.30%,High,Journal Article (Peer-Reviewed),Yaqing Li,National Center for Medical Service Administration,https://dx.doi.org/10.5858/arpa.2020-0310-SA,11/19/2020,6/17/2021,Verified
200923_Beijing_PekingUniversity_Overall,"September 23, 2020",Local,China,China; Hebei; Beijing,"April 15, 2020","April 18, 2020",Household and community samples,Multiple groups,2184,0.17%,,,Stratified probability,"Innovita Biological Technology Co. Ltd,Guangzhou Wondfo Biotech Co., Ltd,NA",LFIA,"IgG,IgM",,,Moderate,Preprint,Xiaoli Wang,Peking University,https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1,11/22/2020,8/4/2021,Verified
200921_Wuhan_TongjiMedicalCollege_Overall,"September 21, 2020",Local,China,China; Hubei; Wuhan,"February 17, 2020","April 28, 2020",Multiple populations,Multiple groups,11766,0.50%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgM,IgG",66.70%,99.50%,High,Journal Article (Peer-Reviewed),Qing Lei, Tongji Medical College,https://dx.doi.org/10.1111/all.14622,11/25/2020,8/5/2021,Verified
201119_Shanghai_FudanUniversity_Overall,"November 19, 2020",Local,China,China; Shanghai Municipality; Shanghai,"May 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,6414,0.31%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Preprint,Shengjie Li,Fudan University,https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2,11/30/2020,6/17/2021,Verified
200922_Wuhan_WuhanUniversity_IgM/IgG,"October 6, 2020",Local,China,China; Hubei; Wuhan,"May 15, 2020","May 26, 2020",Household and community samples,Multiple groups,61437,2.39%,2.27%,2.52%,Stratified probability,"Nanjing Vazyme Medical Technology Co., Ltd",LFIA,"IgG,IgM",91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Yunbao Pan,Wuhan University,https://dx.doi.org/10.1016/j.cmi.2020.09.044,12/8/2020,6/17/2021,Verified
201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj,"October 23, 2020",Local,China,China; Hubei; Wuhan,"March 27, 2020","May 26, 2020",Household and community samples,Multiple groups,35040,3.90%,3.70%,4.10%,Unclear,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anding Liu,Huazhong University of Science and Technology,https://dx.doi.org/10.1001/jamanetworkopen.2020.25717,1/23/2021,6/17/2021,Verified
201225_Wuhan_RenminHospitalofWuhanUniversity_Community,"December 25, 2020",Local,China,China; Hubei; Wuhan,"May 15, 2020","May 29, 2020",Household and community samples,Multiple groups,4454,2.90%,,,Unclear,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,6/17/2021,Verified
201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW,"December 25, 2020",Local,China,China; Hubei; Wuhan,"May 15, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),4614,3.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,6/17/2021,Verified
201228_Beijing_CapitalMedicalUniversity_IgG,"December 28, 2020",Local,China,China,"January 1, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),19797,0.06%,,,Sequential,Innovita Biological Technology Co. Ltd,LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ran Wang,Capital Medical University ,https://dx.doi.org/10.1002/ped4.12231,1/31/2021,6/17/2021,Verified
210107_China_WuhanUniversity,"January 7, 2021",Regional,China,China; Hubei,"March 6, 2020","May 3, 2020",Essential non-healthcare workers,Multiple groups,63107,0.74%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shuhui Duan,Wuhan University,https://dx.doi.org/10.1371/journal.pntd.0008975,2/7/2021,7/7/2021,Unverified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj,"January 19, 2021",Local,China,China,"April 12, 2020","May 4, 2020",Contacts of COVID patients,Multiple groups,880,4.10%,2.90%,5.70%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,6/17/2021,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj,"January 19, 2021",Local,China,China,"April 17, 2020","April 23, 2020",Household and community samples,Not reported,350,0.00%,0.00%,1.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,6/23/2021,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj,"January 19, 2021",Local,China,China,"April 17, 2020","April 23, 2020",Household and community samples,Not reported,50,0.00%,0.00%,6.80%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,6/17/2021,Verified
210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall,"January 9, 2021",Local,China,China; Taiwan; Taipei,"July 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),194,0.00%,,,Convenience,"Abbott Laboratories,Mikrogen GmbH,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Sung Ching Pan,National Taiwan University Hospital,https://dx.doi.org/10.1016/j.jfma.2021.01.002,3/14/2021,8/4/2021,Unverified
210206_China_ChineseCenterforDiseaseControlandPrevention_Overall,"February 6, 2021",National,China,China,"April 10, 2020","April 18, 2020",Household and community samples,Multiple groups,34857,1.23%,,,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd,Innovita Biological Technology Co. Ltd,Bioscience Diagnostics,NA",Multiple Types,"IgM,IgG,Neutralizing ,Total Antibody",,,Low,Journal Article (Peer-Reviewed),Zhongjie Li ,Chinese Center for Disease Control and Prevention,https://dx.doi.org/10.1016/j.lanwpc.2021.100094,3/24/2021,8/4/2021,Verified
210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche,"March 20, 2021",Regional,China,China; Wuhan,"April 14, 2020","April 15, 2020",Household and community samples,Multiple groups,9542,6.92%,6.41%,7.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Zhenyu He,Chinese Academy of Medical Sciences & Peking Union Medical College,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email,3/24/2021,7/17/2021,Verified
200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary,"August 25, 2020",Local,China,China; Hubei; Wuhan,"March 25, 2020","April 28, 2020",Household and community samples,Multiple groups,18712,3.27%,3.02%,3.52%,Self-referral,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",89.50%,99.00%,Moderate,Preprint,Ruijie Ling,Chinese Center for Disease Control and Prevention,https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3,4/8/2021,6/24/2021,Verified
210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj,"March 2, 2021",Local,China,China; Hubei Province; Wuhan,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),17794,2.66%,2.24%,3.07%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,8/4/2021,Verified
210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj,"March 2, 2021",Local,China,China,"January 15, 2020","April 15, 2020",Blood donors,Multiple groups,6810,0.03%,0.00%,0.27%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,8/4/2021,Unverified
210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj,"March 2, 2021",Local,China,China; Hebei Province; Shijiazhuang,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),13540,0.00%,0.00%,0.16%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,8/4/2021,Verified
210308_ZhongnanHospital_Wuhan,"March 8, 2021",Local,China,China; Hubei; Wuhan,"January 1, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),112,0.00%,,,Entire sample,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yin-xian Wen,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1111/os.12898,4/19/2021,8/4/2021,Verified
210408_Taiwan_NationalChengKungUniversityHospital_overall,"April 8, 2021",National,China,China; Taiwan,"August 15, 2020","September 13, 2020",Residual sera,Adults (18-64 years),969,0.00%,,,Convenience,"TONYAR Biotech Inc., Taiwan,Guangzhou Wondfo Biotech Co., Ltd,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ming Chi Li,National Cheng Kung University Hospital,https://dx.doi.org/10.1016/j.jmii.2021.03.018,5/19/2021,8/4/2021,Unverified
210419_Wuhan_ChineseAcademyofSciences,"April 19, 2021",Local,China,China; Hubei; Wuhan,"May 30, 2020","June 12, 2020",Essential non-healthcare workers,Adults (18-64 years),508,5.91%,,,Unclear,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Yang,Chinese Academy of Sciences,https://dx.doi.org/10.1080/22221751.2021.1919032,5/19/2021,7/12/2021,Verified
210421_Wuhan_WuhanUniversity_overall_adj,"April 21, 2021",Local,China,"China; Hubei; Wuhan
","April 23, 2020","May 24, 2020",Household and community samples,Multiple groups,35326,3.77%,3.58%,3.97%,Convenience,"Nanjing Vazyme Medical Technology Co., Ltd,Shenzhen Yhlo Biotech Co. Ltd",CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Huan Han,Wuhan University,https://pubmed.ncbi.nlm.nih.gov/33883260/,5/22/2021,8/4/2021,Unverified
210118_Hangzhou_ZhejiangUniversitySchoolofMedicine_Overall,"January 18, 2021",Local,China,China; Zhejiang; Hangzhou,"April 24, 2020","May 8, 2020",Multiple populations,Multiple groups,16043,0.46%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Nanjing Vazyme Medical Technology Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jun Huang,Zhejiang University School of Medicine,https://dx.doi.org/10.21037/atm-20-7163,5/28/2021,8/4/2021,Verified
210518_Taiwan_NationalTaiwanUniversity_GroupH1,"May 18, 2021",National,China,"China; Taiwan; Taipei, Zhubei","June 25, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),464,0.00%,0.00%,0.79%,Convenience,"Abbott Laboratories,Roche Diagnostics,Mikrogen GmbH",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,National Taiwan University,https://dx.doi.org/10.3389/fimmu.2021.626609,6/15/2021,8/4/2021,Unverified
210518_Taiwan_NationalTaiwanUniversity_GroupC2,"May 18, 2021",National,China,"China; Taiwan; Taipei, Zhubei","June 25, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),1142,0.09%,0.00%,0.49%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,Researchers at the National Taiwan University studied symptomatic patients with frontline healthcare workers (n=464) and found a stringently judged seroprevalence of 0%.,https://dx.doi.org/10.3389/fimmu.2021.626609,6/16/2021,8/4/2021,Unverified
201010_Taipei_TaipeiVeteransGeneralHospital_popadj,"October 10, 2020",Local,China,China,"May 25, 2020","July 8, 2020",Residual sera,Multiple groups,14765,0.05%,0.02%,0.10%,Sequential,"Academia Sinica,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Hsiang-Ling Ho,Taipei Veterans General Hospital,https://dx.doi.org/10.1016/j.lanwpc.2020.100041,7/7/2021,8/4/2021,Verified
210722_Wuhan_HospitalofHubeiProvince_pregnant_primary,"July 22, 2021",Local,China,China; Hubei; Wuhan,"April 1, 2020","December 30, 2020",Pregnant or parturient women,Adults (18-64 years),15953,0.66%,,,Entire sample,NA,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/27/2021,7/27/2021,Unverified
210722_Wuhan_HospitalofHubeiProvince_partners_primary,"July 22, 2021",Local,China,China; Hubei; Wuhan,"April 1, 2020","December 30, 2020",Multiple general populations,Adults (18-64 years),15671,0.73%,,,Entire sample,NA,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/27/2021,8/4/2021,Unverified
210722_Wuhan_HospitalofHubeiProvince_hcw_primary,"July 22, 2021",Local,China,China; Hubei; Wuhan,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),385,1.80%,,,Entire sample,NA,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/27/2021,7/27/2021,Unverified
200710_Santiago_UniversidadDeChile_AllStudents,"July 10, 2020",Local,Chile,Chile; Santiago; Vitacura,"May 4, 2020","May 19, 2020",Students and Daycares,Children and Youth (0-17 years),1009,9.90%,8.60%,11.50%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,6/17/2021,Verified
200710_Santiago_UniversidadDeChile_AllStaff,"July 10, 2020",Local,Chile,Chile; Santiago; Vitacura,"May 4, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),235,16.60%,12.10%,21.90%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,7/31/2021,Verified
210215_Chile_UniversityOfChile_HCW,"February 15, 2021",National,Chile,Chile,"September 11, 2020","October 24, 2020",Health care workers and caregivers,Multiple groups,85528,7.20%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Marcela Zuniga,Universidad de Chile,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3785998,5/22/2021,7/8/2021,Verified
210526_Chile_UniversidadDelDesarrollo_Overall2_Overall,"May 26, 2021",Local,Chile,Chile; Santiago; Santiago,"April 27, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,446,24.00%,20.20%,28.30%,Convenience,"Vircell S.L.,EUROIMMUN AG",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mirentxu Iruretagoyena,Universidad del Desarrollo,https://dx.doi.org/10.1186/s12879-021-06208-2,6/6/2021,8/4/2021,Verified
200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj,"July 15, 2020",Regional,Canada,Canada; British Columbia,"March 5, 2020","March 13, 2020",Residual sera,Multiple groups,869,0.28%,0.03%,0.95%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA,Siemens",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,8/4/2021,Verified
200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj,"July 15, 2020",Regional,Canada,Canada; British Columbia,"May 15, 2020","May 27, 2020",Residual sera,Multiple groups,885,0.55%,0.15%,1.37%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,8/4/2021,Verified
200819_Canada_CBS_BloodDonors_Overall_Adjusted,"August 19, 2020",National,Canada,Canada,"May 9, 2020","June 18, 2020",Blood donors,Multiple groups,37737,0.70%,0.60%,0.79%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://www.covid19immunitytaskforce.ca/wp-content/uploads/2020/09/COVID-19-Public-Report_2.pdf,10/3/2020,6/17/2021,Verified
201106_BC_BCChildrensHospital_Overall_Adj,"November 6, 2020",Local,Canada,Canada; British Columbia; Vancouver,"May 17, 2020","June 19, 2020",Multiple populations,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,Ortho Clinical Diagnostics Inc.,Multiple Types,"IgA,IgG,IgM,Total Antibody",,,High,Preprint,Abdelilah Majdoubi,BC Children’s Hospital ,https://www.medrxiv.org/content/10.1101/2020.10.05.20206664v7,11/24/2020,8/5/2021,Verified
210205_Ontario_PublicHealthOntario_July,"February 2, 2021",Regional,Canada,Canada; Ontario,"July 4, 2020","July 31, 2020",Residual sera,Multiple groups,7001,1.39%,,,Stratified non-probability,Abbott Laboratories,Not reported,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/7/2020,6/17/2021,Verified
210205_Ontario_PublicHealthOntario_August,"February 2, 2021",Regional,Canada,Canada; Ontario,"August 1, 2020","August 21, 2020",Residual sera,Multiple groups,5764,1.56%,,,Stratified non-probability,Abbott Laboratories,Not reported,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/7/2020,6/17/2021,Verified
201017_Vancouver_UniversityofBritishColumbia_LTCF_overall,"October 17, 2020",Local,Canada,Canada; British Columbia; Vancouver,"May 4, 2020","May 14, 2020",Assisted living and long-term care facilities,Multiple groups,291,39.00%,,,Convenience,"DiaSorin SpA,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Siemens",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Rohit Vijh,University of British Columbia,https://dx.doi.org/10.1016/j.ajic.2020.10.009,12/18/2020,8/4/2021,Verified
201027_Montreal_ShrinersHospital_children_unadj,"October 27, 2020",Local,Canada,Canada; Québec; Montreal,"June 10, 2020","July 27, 2020",Residual sera,Children and Youth (0-17 years),39,8.00%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/18/2020,7/30/2021,Verified
201027_Montreal_ShrinersHospital_accompanying_unadj,"October 27, 2020",Local,Canada,Canada; Québec; Montreal,"June 10, 2020","July 27, 2020",Hospital visitors,Adults (18-64 years),61,11.48%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/18/2020,7/30/2021,Verified
201027_Montreal_ShrinersHospital_employees_unadj,"October 27, 2020",Local,Canada,Canada; Québec; Montreal,"June 10, 2020","July 27, 2020",Health care workers and caregivers,Adults (18-64 years),99,12.00%,,,Convenience,Omega diagnostics,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/18/2020,7/30/2021,Verified
210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj,"January 12, 2021",National,Canada,Canada,"November 7, 2020","November 25, 2020",Blood donors,Multiple groups,17049,1.51%,1.31%,1.71%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a,1/20/2021,6/17/2021,Verified
201218_Canada_CBS_BloodDonors_Overall_PopTestAdj,"December 18, 2020",National,Canada,Canada,"October 12, 2020","October 31, 2020",Blood donors,Multiple groups,16811,0.88%,0.73%,1.04%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,1/21/2021,6/17/2021,Verified
201203_Edmonton_UniversityofAlberta_Children,"December 3, 2020",Local,Canada,Canada; Alberta; Edmonton,"August 14, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),565,1.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Preprint,Emilie Manny,University of Alberta,https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE,1/31/2021,6/17/2021,Verified
210205_Ontario_PublicHealthOntario_March_Apr_primary,"February 2, 2021",Regional,Canada,Canada; Ontario,"March 27, 2020","April 30, 2020",Residual sera,Multiple groups,827,0.60%,,,Stratified non-probability,Abbott Laboratories,Not reported,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,6/17/2021,Verified
210205_Ontario_PublicHealthOntario_June_primary,"February 2, 2021",Regional,Canada,Canada; Ontario,"June 5, 2020","June 30, 2020",Residual sera,Multiple groups,7023,1.50%,,,Stratified non-probability,Abbott Laboratories,Not reported,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,6/17/2021,Verified
210205_Ontario_PublicHealthOntario_May_primary,"February 2, 2021",Regional,Canada,Canada; Ontario,"May 5, 2020","May 30, 2020",Residual sera,Multiple groups,1061,1.90%,,,Stratified non-probability,Abbott Laboratories,Not reported,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,6/17/2021,Verified
210208_Canada_CBS_BloodDonors_Overall_PopTestAdj,"February 8, 2021",National,Canada,Canada,"December 10, 2020","December 23, 2020",Blood donors,Multiple groups,16961,1.37%,1.18%,1.56%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,2/19/2021,6/17/2021,Unverified
210125_Canada_UniversityofToronto_Phase1_Overall_Popdj_sp,"January 25, 2021",National,Canada,Canada,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,7068,1.70%,,,Stratified non-probability,NA,ELISA,IgG,,,Moderate,Preprint,Xuyang Tang,University of Toronto,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/23/2021,6/17/2021,Verified
210125_Canada_UniversityofToronto_Phase2_Overall_PopAdj,"January 25, 2021",National,Canada,Canada,"August 15, 2020","September 15, 2020",Household and community samples,Multiple groups,1899,1.87%,,,Stratified non-probability,NA,ELISA,IgG,,,Moderate,Preprint,Xuyang Tang,University of Toronto,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/27/2021,6/17/2021,Verified
201123_Quebec_InstitutNationaldeSantePublique_overall,"November 23, 2020",Regional,Canada,Canada; Québec,"July 6, 2020","September 24, 2020",Health care workers and caregivers,Multiple groups,2056,11.72%,,,Stratified non-probability,DiaSorin SpA,CLIA,IgG,88.40%,,High,Institutional Report,Nicholas Brousseau,Institut National de Sante Publique,https://www.inspq.qc.ca/publications/3084-etude-seroprevalence-travailleurs-sante-centres-hospitaliers-quebec-covid19,3/4/2021,7/30/2021,Verified
210131_Calgary_UniversityOfCalgary_overall,"January 31, 2021",Local,Canada,Canada; Alberta; Calgary,"July 30, 2020","November 18, 2020",Household and community samples,Children and Youth (0-17 years),911,0.30%,0.10%,1.00%,Self-referral,Abbott Laboratories,CLIA,IgG,76.10%,,Moderate,Institutional Report,James Kellner,University of Calgary,https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%20Aim%203%201st%20Interim%20Report-final.pdf?sequence=5&isAllowed=y,3/11/2021,6/24/2021,Unverified
210201_Canada_UniversityofOttawa_Overall_adj,"February 1, 2021",National,Canada,Canada,"May 9, 2020","July 21, 2020",Blood donors,Multiple groups,74642,0.70%,0.63%,0.76%,Entire sample,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Low,Journal Article (Peer-Reviewed),Sahar Saeed,University of Ottawa,http://dx.doi.org/10.1111/trf.16296,3/21/2021,6/24/2021,Unverified
210216_Toronto_UniversityHealthNetwork_Euroimmun+Microarray,"February 16, 2021",Local,Canada,Canada; Ontario; Toronto,"April 17, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),996,0.50%,,,Convenience,"EUROIMMUN AG,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Victor Ferreira,University Health Network,https://dx.doi.org/10.1371/journal.pone.0247258,3/22/2021,8/4/2021,Verified
210315_Vancouver_BCChildren’sHospitalResearchInstitute_Overall,"March 15, 2021",Local,Canada,Canada; British Columbia; Vancouver,"May 17, 2020","June 19, 2020",Household and community samples,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,"Meso Scale Discovery,Ortho Clinical Diagnostics Inc.",Multiple Types,Total Antibody,,,High,Journal Article (Peer-Reviewed),Abdelilah Majdoubi,BC Children’s Hospital Research Institute,https://dx.doi.org/10.1172/jci.insight.146316,4/11/2021,8/4/2021,Unverified
210517_Quebec_Héma-Québec_Primary,"May 17, 2021",Regional,Canada,Canada; Québec,"May 25, 2020","July 9, 2020",Blood donors,Adults (18-64 years),7691,2.20%,1.93%,2.61%,Convenience,NA,ELISA,"IgA,IgM,IgG",98.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Antoine Lewin,Héma-Québec,https://dx.doi.org/10.17269/s41997-021-00531-6,6/3/2021,7/30/2021,Unverified
210512_Canada_UniversityofAlberta_September2,"May 12, 2021",National,Canada,Canada,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),8999,2.67%,,,Simplified probability,NA,ELISA,IgG,89.10%,98.20%,Moderate,Preprint,Sahar Saeed,University of Alberta,https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1,6/4/2021,6/19/2021,Unverified
210510_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"May 10, 2021",National,Canada,Canada,"January 1, 2021","January 27, 2021",Blood donors,Multiple groups,33400,2.78%,2.58%,2.97%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,6/8/2021,6/17/2021,Verified
210611_Quebec_Héma-Québec_overall_PopAdj,"June 11, 2021",Regional,Canada,Canada; Québec,"January 25, 2021","April 22, 2021",Blood donors,Multiple groups,7924,14.72%,13.81%,15.63%,Sequential,NA,ELISA,Not reported,98.90%,98.50%,Moderate,Institutional Report,Hema-Quebec,Héma-Québec,https://www.hema-quebec.qc.ca/userfiles/file/coronavirus/COVID-rapport-final-ph2-11-06-2021.pdf,6/17/2021,7/6/2021,Verified
210618_Vancouver_UniversityOfBritishColumbia_TestAdj,"June 18, 2021",Local,Canada,Canada; British Columbia; Vancouver,"February 10, 2021","May 15, 2021",Essential non-healthcare workers,Adults (18-64 years),1556,2.30%,1.60%,3.20%,Self-referral,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,6/30/2021,8/4/2021,Unverified
210618_Vancouver_UniversityOfBritishColumbia_BloodDonors_TestAdj,"June 18, 2021",Local,Canada,Canada; British Columbia; Vancouver,"January 1, 2021","January 31, 2021",Blood donors,Adults (18-64 years),2502,2.30%,1.70%,3.00%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,6/30/2021,8/4/2021,Unverified
210706_Canada_StatisticsCanada_Overall,"July 6, 2021",National,Canada,Canada,"November 15, 2020","April 15, 2021",Household and community samples,Multiple groups,11124,3.60%,2.60%,4.20%,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Statistics Canada,Statistics Canada,N/A,7/31/2021,8/4/2021,Verified
210416_Yaoundé_HopitalCentraldeYaounde_PopTestAdj,"April 16, 2021",Local,Cameroon,Cameroon; Centre; Yaoundé,"October 14, 2020","November 26, 2020",Household and community samples,Multiple groups,971,29.20%,24.30%,34.10%,Simplified probability,Abbott Laboratories,LFIA,"IgG,IgM",91.50%,93.50%,Low,Preprint,Kenechukwu Nwos,Hopital Central de Yaoundé,https://www.researchsquare.com/article/rs-411135/v1,5/21/2021,6/17/2021,Unverified
210530_Cameroon_UniversityofYaoundé_primary,"May 30, 2021",Regional,Cameroon,Cameroon,"June 15, 2020","August 15, 2020",Multiple populations,Multiple groups,999,32.00%,27.00%,35.00%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Karl Njuwa Fai,University of Yaoundé,https://dx.doi.org/10.1016/j.sciaf.2021.e00802,6/16/2021,7/8/2021,Unverified
210108_CapeVerde_MestreEmSaúdeEDesenvolvimento_overall,"January 8, 2021",National,Cabo Verde,Cabo Verde,"June 26, 2020","July 4, 2020",Household and community samples,Multiple groups,5348,0.40%,,,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Lara Ferrero Gomez,Mestre em Saúde e Desenvolvimento,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3762489,4/29/2021,7/6/2021,Verified
200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,"May 27, 2020",Local,Bulgaria,Bulgaria; Varna;  Varna,"March 26, 2020","April 20, 2020",Residual sera,Multiple groups,586,4.80%,3.20%,6.80%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Denitsa Tsaneva-Damyanova,"Medical Diagnostic Laboratory ""STATUS"" ",https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true,7/20/2020,6/24/2021,Verified
200517_SaoPaolo_GrupoFleury_GenPop,"May 17, 2020",Local,Brazil,Brazil; São Paulo; São Paulo,"May 4, 2020","May 12, 2020",Household and community samples,Not reported,520,5.19%,,,Stratified probability,NA,Not reported,Not reported,90.00%,,Unclear,News and Media,Phillippe Watanabe,Grupo Fleury,https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml,6/2/2020,6/17/2021,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban,"June 16, 2020",Regional,Brazil,Brazil; Espírito Santo,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,4612,2.10%,1.67%,2.52%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,7/6/2021,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban,"June 16, 2020",Regional,Brazil,Brazil; Espírito Santo,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,1163,0.26%,0.05%,0.75%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,7/6/2021,Verified
200629_SaoPaulo_UniversidadedeSaoPaulo_GenPopulation,"June 29, 2020",Local,Brazil,Brazil; São Paulo; São Paulo,"May 4, 2020","May 12, 2020",Household and community samples,Multiple groups,517,4.70%,3.00%,6.60%,Simplified probability,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",100.00%,99.50%,Moderate,Preprint,Beatriz Tess,Universidade de São Paulo,http://medrxiv.org/cgi/content/short/2020.06.29.20142331,6/30/2020,6/17/2021,Verified
200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj,"July 6, 2020",Local,Brazil,Brazil; Rio de Janeiro; Rio de Janeiro,"April 14, 2020","April 27, 2020",Blood donors,Adults (18-64 years),2857,3.30%,2.60%,4.10%,Sequential,MedLevensohn,LFIA,"IgG,IgM",85.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Amorim Filho,Universidade do Estado do Rio de Janeiro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/,7/10/2020,7/6/2021,Verified
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round1_GenPop,"August 7, 2020",Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","April 11, 2020","April 13, 2020",Household and community samples,Multiple groups,4151,0.05%,0.01%,0.17%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariangela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,6/17/2021,Verified
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round2_GenPop,"August 7, 2020",Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","April 25, 2020","April 27, 2020",Household and community samples,Multiple groups,4501,0.14%,0.05%,0.29%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariangela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,6/17/2021,Verified
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round3_GenPop,"August 7, 2020",Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","May 9, 2020","May 11, 2020",Household and community samples,Multiple groups,4500,0.22%,0.11%,0.41%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariangela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"April 19, 2020","April 19, 2020",Household and community samples,Not reported,900,0.56%,0.18%,1.30%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"April 26, 2020","April 26, 2020",Household and community samples,Not reported,900,0.89%,0.39%,1.75%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"May 3, 2020","May 3, 2020",Household and community samples,Not reported,900,1.44%,0.77%,2.45%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"May 10, 2020","May 10, 2020",Household and community samples,Not reported,900,2.00%,1.19%,3.14%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"May 17, 2020","May 17, 2020",Household and community samples,Not reported,900,3.78%,2.63%,5.24%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"May 24, 2020","May 24, 2020",Household and community samples,Not reported,900,5.78%,4.30%,7.30%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31,"July 3, 2020",Local,Brazil,Brazil; Piaui; Teresina,"May 31, 2020","May 31, 2020",Household and community samples,Not reported,900,8.33%,6.61%,10.33%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,6/17/2021,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey1,"September 16, 2020",Local,Brazil,Brazil; Rio Grande do Sul; Lajeado,"May 30, 2020","June 4, 2020",Household and community samples,Multiple groups,1450,4.03%,3.08%,5.18%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,8/5/2021,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey2,"September 16, 2020",Local,Brazil,Brazil; Rio Grande do Sul; Lajeado,"June 13, 2020","June 17, 2020",Household and community samples,Multiple groups,1127,2.59%,1.75%,3.70%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,8/5/2021,Verified
200930_Sergipe_FederalUniversityofSergipe_OverallIgG,"September 30, 2020",Regional,Brazil,Brazil; Sergipe,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,471,13.59%,,,Convenience,Boditech Med Inc.,Other,IgG,95.80%,97.00%,High,Preprint,Monica de Melo,Federal University of Sergipe,https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf,11/23/2020,6/17/2021,Verified
201006_Brazil_FederalUniversityofSergipe_genpop_IgG,"October 6, 2020",Regional,Brazil,"Brazil; Sergipe; Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória","May 2, 2020","May 9, 2020",Household and community samples,Multiple groups,2635,8.30%,7.20%,9.40%,Convenience,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/,12/20/2020,6/17/2021,Verified
200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM,"September 1, 2020",Local,Brazil,Brazil; Rio de Janeiro; Petrópolis,"April 9, 2020","April 29, 2020",Health care workers and caregivers,Adults (18-64 years),61,4.91%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),P Ismael Amaral Silva,Centro de Terapia Oncológica,http://dx.doi.org/10.1016/j.annonc.2020.08.1825,1/4/2021,6/17/2021,Verified
201027_Cuiabá_UniversidadeFederaldeMatoGrosso_Overall,"October 27, 2020",Local,Brazil,Brazil; Mato Grosso; Cuiabá,"April 1, 2020","July 31, 2020",Residual sera,Multiple groups,6392,22.10%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Preprint,Cristiane Coimbra de Paula,Universidade Federal de Mato Grosso (UFMT),https://www.medrxiv.org/content/10.1101/2020.10.26.20219683v1,1/15/2021,6/17/2021,Verified
201021_SaoPaulo_AdolfoLutzCentralInstitute,"October 21, 2020",Local,Brazil,Brazil; State of Sao Paulo; Sao Paulo,"June 5, 2020","July 31, 2020",Multiple populations,Multiple groups,406,8.60%,,,Convenience,"Guangzhou Wondfo Biotech Co., Ltd,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Valeria Oliveira Silva,Adolfo Lutz Central Institute,https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1,1/17/2021,8/5/2021,Verified
201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall,"December 13, 2020",Local,Brazil,Brazil; São Paulo State; São Paulo ,"May 14, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),4987,14.10%,13.10%,15.00%,Convenience,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Silvia Costa,Faculdade De Medicina da Universidade,https://dx.doi.org/10.1093/cid/ciaa1845,1/23/2021,6/17/2021,Verified
201119_SaoPaulo_ClínicaDeReumatologia_RheumaticPatients,"November 19, 2020",Local,Brazil,Brazil; State of Sao Paulo; São Paulo,"March 15, 2020","August 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),100,21.00%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",,,High,Preprint,Felipe Santana,Clínica de Reumatologia,https://www.researchsquare.com/article/rs-97191/v1,1/23/2021,6/17/2021,Verified
201113_SaoPaulo_UniversidadeSaoPaulo_primary,"November 13, 2020",Local,Brazil,Brazil; State of Sao Paulo; Sao Paulo,"June 30, 2020","August 4, 2020",Residual sera,Multiple groups,439,13.90%,,,Convenience,"DiaSorin SpA,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Luanda Mara da Silva Oliveira,Universidade de São Paulo,https://dx.doi.org/10.1590/S1678-9946202062091,1/23/2021,8/4/2021,Verified
201130_Sergipe_FederalUniversityofSergipe_residualsera_primary,"November 30, 2020",Local,Brazil,Brazil; Sergipe; Aracaju,"January 15, 2020","April 15, 2020",Residual sera,Multiple groups,987,1.60%,,,Sequential,"NA,Boditech Med Inc.",LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Ricardo Queiroz Gurgel,Federal University of Sergipe,http://dx.doi.org/10.1016/j.jinf.2020.11.037,1/29/2021,8/4/2021,Verified
210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary,"January 6, 2021",Regional,Brazil,Brazil; Espírito Santo,"December 1, 2019","June 30, 2020",Representative patient population,Multiple groups,7370,2.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lorenzzo Lyrio Stringari,Secretaria de Estado da Saúde do Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0244937,1/30/2021,8/4/2021,Verified
210128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall,"January 28, 2021",Local,Brazil,Brazil; Pará; Xikrin of Bacaja Villages,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,100,73.00%,,,Unclear,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eliene Putira Sacuema Rodrigues,Instituto de Ciências Biológicas da Universidade Federal do Pará,https://dx.doi.org/10.1186/s12939-021-01392-8,3/9/2021,7/7/2021,Verified
210129_Botuacato_InstitutoButantan_Primary,"January 29, 2021",Local,Brazil,Brazil; Sao Paolo; Botucato,"June 22, 2020","July 8, 2020",Assisted living and long-term care facilities,Multiple groups,209,11.50%,7.10%,16.60%,Convenience,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Eliana Nogueira Castro de Barros,Instituto Butantan,https://dx.doi.org/10.1590/S1678-9946202163010,3/18/2021,6/17/2021,Verified
210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"May 20, 2020","May 22, 2020",Multiple populations,Multiple groups,938,5.80%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bruno Caramelli,University of São Paulo,https://dx.doi.org/10.7189/jogh.11.05001,3/27/2021,6/23/2021,Verified
210209_Sergipe_FederalUniversityofSergipe,"February 9, 2021",Regional,Brazil,"Brazil; Sergipe; Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao","September 15, 2020","October 6, 2020",Students and Daycares,Adults (18-64 years),276,22.50%,17.90%,27.70%,Convenience,"Boditech Med Inc.,Kovalent",LFIA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-3459,3/27/2021,8/4/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"February 7, 2020","February 13, 2020",Blood donors,Multiple groups,821,0.40%,0.00%,3.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"February 8, 2020","February 29, 2020",Blood donors,Multiple groups,799,1.00%,0.00%,2.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"March 6, 2020","March 12, 2020",Blood donors,Multiple groups,832,0.00%,0.00%,0.80%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"March 9, 2020","March 21, 2020",Blood donors,Multiple groups,2454,2.80%,1.80%,3.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"April 6, 2020","April 17, 2020",Blood donors,Multiple groups,829,5.00%,2.90%,7.40%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/7/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"April 8, 2020","April 30, 2020",Blood donors,Multiple groups,900,4.00%,1.80%,6.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"May 5, 2020","May 14, 2020",Blood donors,Multiple groups,901,43.40%,38.40%,48.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"May 8, 2020","May 21, 2020",Blood donors,Multiple groups,826,4.70%,2.60%,7.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"June 5, 2020","June 15, 2020",Blood donors,Multiple groups,911,55.40%,50.70%,60.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"June 8, 2020","June 20, 2020",Blood donors,Multiple groups,880,13.10%,10.30%,16.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"July 6, 2020","July 15, 2020",Blood donors,Multiple groups,1147,49.00%,44.20%,53.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"July 13, 2020","July 25, 2020",Blood donors,Multiple groups,879,10.60%,8.10%,13.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"July 1, 2020","July 31, 2020",Blood donors,Multiple groups,1000,13.30%,,,Unclear,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,8/4/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"August 8, 2020","August 19, 2020",Blood donors,Multiple groups,881,45.60%,41.10%,50.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"August 10, 2020","August 29, 2020",Blood donors,Multiple groups,906,15.50%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"September 5, 2020","September 14, 2020",Blood donors,Multiple groups,868,47.30%,42.10%,52.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"September 7, 2020","September 29, 2020",Blood donors,Multiple groups,933,15.10%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"October 10, 2020","October 17, 2020",Blood donors,Multiple groups,882,44.60%,39.30%,50.00%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj,"January 16, 2021",Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"October 12, 2020","October 24, 2020",Blood donors,Multiple groups,877,18.20%,15.00%,21.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,6/19/2021,Verified
210329_PortoAlegre_UniversidadeFederaldeCienciasdaSaudedePortoAlegre_HCW_July,"March 29, 2021",Local,Brazil,Brazil; Rio Grande do Sul; Porto Alegre,"July 20, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),1163,5.50%,,,Unclear,SD Biosensor,LFIA,"IgG,IgM",94.30%,95.10%,Moderate,Journal Article (Peer-Reviewed),Ana Dubiela,Universidade Federal de Ciencias da Saude de Porto Alegre,https://dx.doi.org/10.1017/ice.2021.139,4/17/2021,6/19/2021,Verified
210324_SaoPaulo_UniversityofSaoPaulo_overall,"March 24, 2021",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"June 17, 2020","July 8, 2020",Health care workers and caregivers,Adults (18-64 years),1996,5.51%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Maura Salaroli de Oliveira,University of São Paulo,https://dx.doi.org/10.1016/j.ajic.2021.03.010,4/19/2021,7/22/2021,Verified
210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino,"March 26, 2021",Local,Brazil,Brazil; Rio de Janeiro; Rio de Janeiro,"June 30, 2020","August 28, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),114,30.70%,,,Sequential,Beijing Lepu Medical Technology,Other,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Thais Cleto Yamane,Instituto D’Or de Pesquisa e Ensino,https://dx.doi.org/10.1007/s00431-021-04044-9,4/23/2021,7/6/2021,Unverified
200602_Biguacu_SecretariaMunicipaldeSaude_primary,"June 2, 2020",Local,Brazil,Brazil,"May 30, 2020","May 30, 2020",Household and community samples,Multiple groups,217,0.40%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ozias Alves Jr,Secretaria Municipal de Saude,http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/,4/23/2021,6/17/2021,Verified
201027_FernandoNoronha_UniversidadeFederaldoCeará,"October 27, 2020",Local,Brazil,Brazil; State of Pernambuco; Fernando de Noronha,"May 22, 2020","May 31, 2020",Household and community samples,Multiple groups,904,4.30%,3.20%,5.90%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",Not reported,"IgG,IgM",,,Moderate,Preprint,Mozart Julio Tabosa Sales,Universidade Federal do Ceará,https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text,4/27/2021,6/17/2021,Verified
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2,"September 28, 2020",Local,Brazil,Brazil; São Paulo state; Baixada Santista,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,2415,2.20%,,,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,4/28/2021,6/17/2021,Verified
200604_Goiania_CityOfGoiania_overall,"June 4, 2020",Local,Brazil,Brazil; Goiás; Goiania,"May 30, 2020","May 30, 2020",Household and community samples,Multiple groups,2400,0.75%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Mauro Junio,City of Goiania,https://www.goiania.go.gov.br/inquerito-aponta-que-1-das-pessoas-ja-tiveram-covid-19-em-goiania/,4/29/2021,7/6/2021,Verified
210322_Manaus_UniverdadedeFederaldoAmazona_Overall,"March 22, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"August 19, 2020","November 27, 2020",Household and community samples,Multiple groups,1631,13.06%,,,Convenience,NA,ELISA,IgG,94.28%,97.03%,Moderate,Preprint,Pritesh Lalwani,Universidade Federal do Amazonas,https://assets.researchsquare.com/files/rs-351589/v1_stamped.pdf,5/3/2021,7/6/2021,Verified
200527_RioGrandeDoSul_FederalUniversityOfPelotas_overall,"May 27, 2020",Regional,Brazil,Brazil; Rio Grande do Sul,"May 23, 2020","May 25, 2020",Household and community samples,Multiple groups,4500,0.18%,0.08%,0.35%,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,Governo do Estato do Rio Grande do Sul,Governo do Estato do Rio Grande do Sul,https://estado.rs.gov.br/quarta-etapa-de-pesquisa-aponta-estabilidade-no-total-de-infectados-por-coronavirus-no-rs,5/3/2021,7/6/2021,Verified
200629_Goiania_CityOfGoiania_overall,"June 29, 2020",Local,Brazil,Brazil; Goiás; Goiania,"June 10, 2020","June 10, 2020",Household and community samples,Multiple groups,2628,2.10%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,City of Goiania,Municipal Health Department of the City of Goiania,https://www.goiania.go.gov.br/pesquisa-aponta-que-31-838-mil-pessoas-ja-foram-infectadas-por-covid-19-em-goiania/,5/3/2021,7/6/2021,Verified
200626_BomJesus_InstitutoPiaunienseDeOpiniaoPubilca_overall,"June 26, 2020",Local,Brazil,Brazil; Piauí; Bom Jesus,"June 24, 2020","June 26, 2020",Household and community samples,Multiple groups,200,8.00%,,,Simplified probability,NA,Not reported,"IgG,IgM",,,High,Institutional Report,Instituto Piauniense de Opiniao Publica,Instituto Piauniense de Opinião Pública,https://portalpontox.com/wp-content/uploads/2020/06/PESQUISA-BOM-JESUS-COVID-24a26-06.2020.pdf,5/5/2021,7/14/2021,Verified
200812_Cajamar_MunicipalSecretariatOfCajamar_overall,"August 12, 2020",Local,Brazil,Brazil; São Paulo; Municipality of Cajamar,"July 21, 2020","July 27, 2020",Household and community samples,Multiple groups,1015,4.00%,,,Convenience,NA,LFIA,Not reported,,,High,News and Media,Municipal Secretariat of Cajamar,Municipal Secretariat of Cajamar,https://cajamar.sp.gov.br/noticias/2020/08/12/secretaria-de-saude-divulga-balanco-da-pesquisa-de-busca-ativa-de-anticorpos-para-sars-cov-2/,5/6/2021,7/7/2021,Verified
200831_Limeira_LimeriaCityHall_overall,"August 31, 2020",Local,Brazil,Brazil; São Paulo; Limeira,"August 24, 2020","August 29, 2020",Household and community samples,Multiple groups,1291,14.60%,11.90%,17.30%,Simplified probability,NA,Not reported,"IgG,IgM",,,High,News and Media,Redacao Educadora,Limeira City Hall,https://elimeira.com.br/noticias/limeira/estudo-sugere-que-quase-36-mil-moradores-de-limeira-tiveram-covid-19/,5/11/2021,7/27/2021,Verified
211006_Goiânia_MunicipalityofGoiâniaHealthDepartment,"October 6, 2020",Local,Brazil,Brazil; Goiás,"September 19, 2020","September 19, 2020",Household and community samples,Not reported,2436,13.96%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Prefeitura De Goiania,Health Department of the Municipality of Goiânia ,https://www.goiania.go.gov.br/inquerito-populacional-ajuda-identificar-areas-de-maior-concentracao-da-covid-19/,5/13/2021,6/23/2021,Verified
210210_Joinville_CityHallofJoinville_PopAdj,"February 10, 2021",Local,Brazil,Brazil; Santa Catarina; Joinville,"June 15, 2020","August 7, 2020",Household and community samples,Multiple groups,4403,4.84%,,,Stratified probability,Celer Technologies Inc.,Not reported,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Henrique Diegoli,City Hall of Joinville,https://www.medrxiv.org/content/10.1101/2021.02.08.21251009v1.full,5/13/2021,7/6/2021,Verified
201210_MatoGrosso_StateUniversityOfMatoGrosso,"December 20, 2020",Regional,Brazil,"Brazil; Mato Grosso; The municipalities participating in the research are: Água Boa, Alta Floresta, Barra do Garças, Cáceres, Cuiabá, Juína, Rondonópolis, Sinop, Tangará da Serra and Várzea Grande.","September 16, 2020","October 15, 2020",Household and community samples,Multiple groups,4206,12.50%,,,Simplified probability,NA,CLIA,IgC,,,High,News and Media,Lygia Lima,State University of Mato Gross,http://www.mt.gov.br/-/16042707-unemat-coordena-estudo-sobre-condicoes-de-saude-da-populacao-de-mt-durante-pandemia,5/17/2021,6/17/2021,Unverified
210422_RioGrandeDoSul_SantaCasaDeMisericordiaDePortoAlegre_police,"April 22, 2021",Regional,Brazil,"Brazil; Rio Grande do Sul State; Porto Alegre, Caxias do Sul, Canoas, Pelotas, Santa Maria, Passo Fundo, Uruguaiana, Santa Cruz do Sul, Ijui, and Lajeado ","July 23, 2020","July 25, 2020",Essential non-healthcare workers,Adults (18-64 years),1592,3.30%,,,Stratified probability,EUROIMMUN AG,ELISA,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Alessandro Pasqualotto,Molecular Biology Laboratory at Santa Casa de Misericordia de Porto Alegre,https://dx.doi.org/10.1371/journal.pone.0249672,5/17/2021,8/4/2021,Verified
210502_SergipeState_FederalUniversityofSergipe,"May 2, 2021",Regional,Brazil,Brazil; Sergipe; N/A,"December 1, 2020","December 20, 2020",Essential non-healthcare workers,Adults (18-64 years),113,24.70%,17.70%,33.50%,Convenience,NA,Not reported,"IgG,IgM",,,High,Preprint,Paulo Ricardo Martins Filho,"Federal University of Sergipe, Aracaju",https://www.medrxiv.org/content/10.1101/2021.04.29.21256360v1,5/18/2021,6/17/2021,Unverified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage1_overall_unadj,"April 19, 2021",Regional,Brazil,Brazil; Sergipe,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,5615,9.30%,8.50%,10.10%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,5/19/2021,8/4/2021,Unverified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage3_overall_unadj copy,"April 19, 2021",Regional,Brazil,Brazil; Sergipe,"February 18, 2021","March 30, 2021",Household and community samples,Multiple groups,5527,15.40%,14.50%,16.40%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,5/19/2021,8/4/2021,Unverified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage2_overall_unadj copy,"April 19, 2021",Regional,Brazil,Brazil; Sergipe,"August 11, 2020","November 17, 2020",Household and community samples,Multiple groups,5405,7.90%,6.80%,9.10%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,5/19/2021,8/4/2021,Unverified
201110_Maranhao_UniversidadeFederaldoMaranhao_Phase2_OverallPopAdj,"November 10, 2020",Regional,Brazil,Brazil; Maranhão,"October 19, 2020","October 30, 2020",Household and community samples,Multiple groups,4563,38.10%,34.80%,41.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Institutional Report,Antonio da Silva,Universidade Federal do Maranhao,https://www.saude.ma.gov.br/wp-content/uploads/2020/11/Inquerito-Sorologico-Maranhao-Fase-2.pdf,5/20/2021,7/22/2021,Verified
200821_Campinas_CampinasMunicipalHealthDepartment,"August 21, 2020",Local,Brazil,Brazil; Sao Paulo; Campinas,"August 3, 2020","August 15, 2020",Household and community samples,Multiple groups,1876,3.68%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Campinas City Hall,Campinas Municipal Health Department,https://covid-19.campinas.sp.gov.br/prefeitura-de-campinas-apresenta-segundo-inqu-rito-sorol-gico-da-covid-19,5/20/2021,7/6/2021,Verified
201013_SaoPaulo_CityOfSaoPaulo_Phase0,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,,"June 17, 2020",Household and community samples,Multiple groups,2651,9.50%,7.50%,11.00%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase1,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"June 17, 2020","July 2, 2020",Household and community samples,Multiple groups,2493,9.80%,7.90%,11.80%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase2,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"July 2, 2020","July 16, 2020",Household and community samples,Multiple groups,2328,11.10%,9.60%,12.90%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase3,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"July 16, 2020","July 30, 2020",Household and community samples,Multiple groups,2527,10.90%,9.20%,12.90%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase4,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"July 30, 2020","August 13, 2020",Household and community samples,Multiple groups,2448,11.00%,9.00%,13.00%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase5,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"August 13, 2020","August 27, 2020",Household and community samples,Multiple groups,2240,13.90%,11.80%,16.20%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase6,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"August 27, 2020","September 10, 2020",Household and community samples,Multiple groups,2125,11.90%,10.00%,14.00%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
201013_SaoPaulo_CityOfSaoPaulo_Phase7,"October 13, 2020",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"September 10, 2020","September 24, 2020",Household and community samples,Multiple groups,2016,13.60%,11.60%,15.80%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/2020_10_13_inq_soro_adulto.pdf,5/21/2021,7/6/2021,Unverified
210113_SaoPaulo_CidadeDeSaoPaolo_2021_Phase1_overall,"January 13, 2021",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"January 5, 2021","January 7, 2021",Household and community samples,Multiple groups,1960,14.10%,11.70%,16.80%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,Cidade de São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/coletiva_saude_14-01.pdf,5/21/2021,7/19/2021,Unverified
210204_SaoPaulo_CityOfSaoPaulo_2021_Phase2,"February 4, 2021",Local,Brazil,Brazil; Sao Paulo; Sao Paulo,"January 7, 2021","January 21, 2021",Household and community samples,Multiple groups,1841,13.90%,11.70%,16.40%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,City of Sao Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-02_2021.pdf/view,5/21/2021,7/19/2021,Unverified
210501_SãoPaulo_Ipec_overall_Unadj,"May 1, 2021",Local,Brazil,Brazil; São Paulo; São Paulo,"April 22, 2021","May 1, 2021",Household and community samples,Multiple groups,1187,41.60%,,,Stratified probability,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,Moderate,Institutional Report,Beatriz HC Tess,Inteligência em Pesquisa e Consultoria,https://www.monitoramentocovid19.org/resultados,5/22/2021,8/4/2021,Unverified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_firstfase_primary,"December 11, 2020",Local,Brazil,Brazil,"August 24, 2020","August 29, 2020",Household and community samples,Multiple groups,150,1.72%,0.51%,2.93%,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,5/22/2021,6/17/2021,Unverified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_secondfase_primary,"December 11, 2020",Local,Brazil,Brazil,"September 24, 2020","September 29, 2020",Household and community samples,Multiple groups,125,8.00%,,,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,5/22/2021,6/17/2021,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_IGHDCohort1,"April 16, 2021",Local,Brazil,Brazil; Sergipe; Itabaianinha,"October 1, 2020","October 3, 2020",Household and community samples,Multiple groups,27,3.70%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,5/22/2021,7/6/2021,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_ControlCohort2,"April 16, 2021",Local,Brazil,Brazil; Sergipe; Itabaianinha,"October 1, 2020","October 3, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,27,18.50%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,5/23/2021,8/4/2021,Unverified
210429_Fortaleza_StateUniversityofCearáCampusdoItaperi,"May 1, 2021",Local,Brazil,Brazil; Ceará; Fortaleza,"November 9, 2020","December 9, 2020",Household and community samples,Multiple groups,1559,26.70%,,,Simplified probability,Beijing Lepu Medical Technology,Not reported,"IgG,IgM",98.90%,97.60%,Moderate,Journal Article (Peer-Reviewed),Valdester Cavalcante Pinto Júnior,Institute of the Heart of Children and Adolescents (InCor Criança),https://dx.doi.org/10.1016/j.ijid.2021.04.086,5/27/2021,6/19/2021,Unverified
210518_Sergipe_FederalUniversityofSergipe_overall,"May 18, 2021",Regional,Brazil,Brazil; Sergipe,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,5615,9.26%,8.50%,10.10%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd,Boditech Med Inc.",Multiple Types,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araújo,Federal University of Sergipe,https://dx.doi.org/10.1017/S0950268821001163,5/31/2021,8/4/2021,Verified
210407_Manaus_InstitutoNacionaldePesquisadaAmazônia_Overall,"April 7, 2021",Local,Brazil,Brazil; Amazonas; Manaus,"October 10, 2020","October 14, 2020",Household and community samples,Multiple groups,280,64.64%,59.01%,70.28%,Simplified probability,EUROIMMUN AG,ELISA,"IgG,IgA",,,Moderate,Preprint,Gemilson Soares Pontes,Instituto Nacional de Pesquisa da Amazônia ,https://www.medrxiv.org/content/10.1101/2021.04.05.21254937v1,6/9/2021,7/29/2021,Verified
210609_SouthBrazil_UniversidadeFederaldoParaná,"June 9, 2021",Regional,Brazil,Brazil; Mato Grosso do Sul; Curitiba,"September 15, 2020","October 15, 2020",Pregnant or parturient women,Adults (18-64 years),195,8.70%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Preprint,Jullie Anne Chiste,Complexo Hospital de Clínicas da Universidade Federal do Paraná ,https://dx.doi.org/10.1515/jpm-2021-0173,6/17/2021,7/6/2021,Unverified
210620_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_PrimaryPhase1,"June 20, 2021",Regional,Brazil,Brazil; Greater São Paulo,"June 29, 2020","July 2, 2020",Household and community samples,Adults (18-64 years),2481,9.70%,7.90%,11.40%,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgM,IgG",84.80%,99.00%,Low,Preprint,Jose O M Albuquerque,Secretaria Municipal de Saude de Sao Paulo,10.1101/2021.06.16.21256530,7/2/2021,7/6/2021,Unverified
210624_Brazil_UniversidadeFederalDePelotas_overall,"June 24, 2021",National,Brazil,Brazil,"June 21, 2020","June 24, 2020",Household and community samples,Multiple groups,31869,2.70%,,,Stratified probability,"Guangzhou Wondfo Biotech Co., Ltd",LFIA,"IgG,IgM",84.80%,99.95%,Moderate,Journal Article (Peer-Reviewed),Ana M. B. Menezes,Universidade Federal de Pelotas,https://dx.doi.org/10.1038/s41598-021-92775-y,7/6/2021,7/6/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round1_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"April 11, 2020","April 13, 2020",Household and community samples,Multiple groups,4151,0.03%,0.00%,0.34%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,8/4/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round2_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"April 25, 2020","April 27, 2020",Household and community samples,Multiple groups,4660,0.10%,0.01%,0.38%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,8/4/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round3_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"May 9, 2020","May 11, 2020",Household and community samples,Multiple groups,4500,0.21%,0.06%,0.49%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,8/4/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round4_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"May 23, 2020","May 25, 2020",Household and community samples,Multiple groups,4500,0.15%,0.03%,0.44%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,8/4/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round5_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"June 26, 2020","June 28, 2020",Household and community samples,Multiple groups,4500,0.49%,0.27%,0.83%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,8/4/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round6_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"July 24, 2020","July 26, 2020",Household and community samples,Multiple groups,4500,1.07%,0.75%,1.48%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,7/6/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round7_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"August 14, 2020","August 16, 2020",Household and community samples,Multiple groups,4500,1.39%,1.01%,1.85%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,7/6/2021,Unverified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_round8_primary,"June 29, 2021",Regional,Brazil,Brazil; Rio Grande do Sul,"September 4, 2020","September 6, 2020",Household and community samples,Multiple groups,4500,1.57%,1.17%,2.06%,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,7/6/2021,7/6/2021,Unverified
210630_RioDeJaneiro_HospitalFederaldosServidoresdoEstado,"June 30, 2021",Local,Brazil,Brazil,"April 13, 2020","June 17, 2020",Pregnant or parturient women,Adults (18-64 years),115,23.50%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Maria de Lourdes Benamor Teixeira,Hospital Federaldo dos Servidores do Estado,https://dx.doi.org/10.3390/v13071277,7/12/2021,8/4/2021,Unverified
210701_RioDeJaneiro_OswaldoCruzFoundation_Primary,"July 1, 2021",Local,Brazil,Brazil; Rio de Janeira; Rio de Janeira,"May 18, 2020","September 24, 2020",Multiple general populations,Multiple groups,515,29.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pamella Lugon,Oswaldo Cruz Foundation,http://dx.doi.org/10.1542/peds.2021-050182,7/14/2021,7/14/2021,Unverified
210702_RibeiraoPreto_UniversidadedeSãoPaulo_Baseline,"July 2, 2021",Local,Brazil,Brazil; São Paulo; Ribeirão Preto (RP),"May 1, 2020","May 3, 2020",Household and community samples,Multiple groups,709,1.27%,,,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Edson Zangiacomi Martinez,Universidade de São Paulo,https://dx.doi.org/10.1590/0037-8682-0210-2021,7/14/2021,8/4/2021,Unverified
210312_SaoPaulo_CityOfSaoPaulo_2021_Phase4_overall,"March 12, 2021",Local,Brazil,Brazil; São Paulo; São Paulo,"February 16, 2021","February 18, 2021",Household and community samples,Multiple groups,1793,25.00%,21.70%,28.70%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd,EUROIMMUN AG",Multiple Types,"IgG,IgM",,,High,Institutional Report,City of Sao Paulo,City of São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-04_2021.pdf/,7/20/2021,8/4/2021,Unverified
210618_Brazil_UniversidadeFederaldePelotas_primary,"June 18, 2021",National,Brazil,Brazil,"May 14, 2020","June 23, 2020",Household and community samples,Multiple groups,89362,2.30%,,,Stratified probability,Guangzhou Wondfo Biotech Co.， Ltd,LFIA,Not reported,84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),Fernando C Barros,Universidade Federal de Pelotas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225319/,7/21/2021,7/22/2021,Unverified
210629_SaoPaulo_UniversidadeFederaldeSãoPaulo_Overall,"July 29, 2021",Local,Brazil,Brazil,"September 1, 2020","September 25, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,416,8.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Marina P Cristelli,Universidade Federal de São Paulo,https://dx.doi.org/10.1111/tid.13706,8/2/2021,8/4/2021,Unverified
210726_Chapecó_CommunityUniversityOfChapecóRegion_Primary,"July 26, 2021",Local,Brazil,Brazil; Santa Catarina; Chapecó,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,2179,22.20%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maria Joana Carvalho e Silva,Community University of Chapecó Region,https://rsdjournal.org/index.php/rsd/article/view/17996/16175,8/3/2021,8/3/2021,Unverified
210318_Sarajevo_InternationalBurchUniversity_DrAbdulahNakasGeneralHospital1_overall,"March 18, 2021",Local,Bosnia and Herzegovina,Bosnia and Herzegovina,"April 15, 2020","May 15, 2020",Residual sera,Multiple groups,1720,3.41%,,,Unclear,Artron Laboratories Inc.,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,5/29/2021,7/15/2021,Verified
210318_Sarajevo_InternationalBurchUniversity_EurofarmCentreLaboratory2_overall,"March 18, 2021",Local,Bosnia and Herzegovina,Bosnia and Herzegovina,"April 21, 2020","July 17, 2020",Residual sera,Multiple groups,1121,4.28%,,,Unclear,"Dynamiker Biotechnology (Tianjin) Co., Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,5/29/2021,7/15/2021,Verified
210604_Srpska_InstituteforTransfusionMedicine_Primary,"June 4, 2021",National,Bosnia and Herzegovina,Bosnia and Herzegovina,"June 17, 2020","July 16, 2020",Blood donors,Adults (18-64 years),807,2.70%,,,Unclear,Biomerieux,Other,IgG,,,High,Journal Article (Peer-Reviewed),Gordana Guzijan,Institute for Transfusion Medicine of the Republic of Srpska,http://dx.doi.org/10.2298/VSP200122059G,7/18/2021,7/18/2021,Unverified
200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,"June 15, 2020",Local,Belgium,Belgium; Limburg; Genk,"April 22, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),3056,6.40%,5.50%,7.30%,Convenience,Multi-G B.V.,LFIA,IgG,92.20%,97.00%,High,Journal Article (Peer-Reviewed),Deborah Steensels,ZiekenhuisOost-Limburg,https://jamanetwork.com/journals/jama/fullarticle/2767382,6/18/2020,6/17/2021,Verified
200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,"June 25, 2020",Local,Belgium,Belgium; Brussels; City of Brussels,"April 15, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),326,11.00%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Charlotte Martin,Université Libre de Bruxelles,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext,7/21/2020,8/4/2021,Verified
200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,"July 30, 2020",Local,Belgium,Belgium; Brussels; City of Brussels,"May 25, 2020","June 19, 2020",Health care workers and caregivers,Multiple groups,1485,14.61%,,,Convenience,DiaSorin SpA,CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Laurent Blairon,Iris Hospitals South,https://dx.doi.org/10.1016/j.jinf.2020.07.033,10/5/2020,6/17/2021,Verified
200811_Belgium_universitairesSaint-Luc_Overall,"August 10, 2020",Local,Belgium,Belgium,"April 16, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,149,2.70%,,,Convenience,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Silvia Berardis,Cliniques universitaires Saint-Luc,https://www.sciencedirect.com/science/article/pii/S1569199320308213,10/24/2020,6/17/2021,Verified
201018_Belgium_UniversityHospitalsLeuven_Overall_unadj,"October 18, 2020",Local,Belgium,Belgium; Limburg; Lanaken,"April 14, 2020","April 16, 2020",Multiple populations,Multiple groups,188,18.60%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",74.70%,95.10%,High,Journal Article (Peer-Reviewed),Frank Buntinx,University of Leuven,http://dx.doi.org/10.1080/17843286.2020.1834285,1/16/2021,8/5/2021,Verified
210120_Antwerp_UniversityofAntwerp_primary,"January 20, 2021",Local,Belgium,Belgium,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),431,3.20%,1.90%,5.40%,Convenience,NA,ELISA,IgG,80.00%,98.50%,High,Journal Article (Peer-Reviewed),Kawtar El Abdellati,University of Antwerp,https://dx.doi.org/10.1192/bjo.2020.172,2/6/2021,6/17/2021,Verified
210407_Belgium_UniversityofAntwerp_c1_PopAdj,"April 7, 2021",National,Belgium,Belgium,"March 30, 2020","April 5, 2020",Residual sera,Multiple groups,3910,1.83%,1.00%,2.61%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,8/4/2021,Unverified
210407_Belgium_UniversityofAntwerp_c2_PopAdj,"April 7, 2021",National,Belgium,Belgium,"April 20, 2020","April 26, 2020",Residual sera,Multiple groups,3397,5.25%,4.22%,6.35%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210407_Belgium_UniversityofAntwerp_c3_PopAdj,"April 7, 2021",National,Belgium,Belgium,"May 18, 2020","May 25, 2020",Residual sera,Multiple groups,3242,6.20%,5.05%,7.31%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210407_Belgium_UniversityofAntwerp_c4_PopAdj,"April 7, 2021",National,Belgium,Belgium,"June 8, 2020","June 13, 2020",Residual sera,Multiple groups,2960,4.74%,3.65%,5.85%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210407_Belgium_UniversityofAntwerp_c5_PopAdj,"April 7, 2021",National,Belgium,Belgium,"June 29, 2020","July 4, 2020",Residual sera,Multiple groups,3023,3.66%,2.64%,4.70%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210407_Belgium_UniversityofAntwerp_c6_PopAdj,"April 7, 2021",National,Belgium,Belgium,"September 7, 2020","September 12, 2020",Residual sera,Multiple groups,3047,3.28%,2.29%,4.32%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210407_Belgium_UniversityofAntwerp_c7_PopAdj,"April 7, 2021",National,Belgium,Belgium,"October 12, 2020","October 17, 2020",Residual sera,Multiple groups,2966,4.18%,3.12%,5.20%,Simplified probability,EUROIMMUN AG,ELISA,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/9/2021,6/19/2021,Unverified
210326_Flanders_UniversityofAntwerp_December,"March 26, 2021",Regional,Belgium,Belgium; Flanders,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),698,13.40%,10.80%,16.40%,Convenience,NA,ELISA,IgG,,99.00%,High,Preprint,Joachim Marlën,University of Antwerp,https://www.medrxiv.org/content/10.1101/2021.03.26.21254327v1,4/16/2021,8/4/2021,Verified
210227_Belgium_AntwerpUniversityHospital_PediatricCancer,"February 27, 2021",Local,Belgium,Belgium,"March 24, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),11,9.10%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,4/21/2021,7/6/2021,Unverified
210227_Belgium_AntwerpUniversityHospital_HCW,"February 27, 2021",Local,Belgium,Belgium,"March 24, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),92,12.00%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,4/21/2021,7/6/2021,Unverified
210415_Belgium_UniversiteCatholiquedeLouvain_T4_overall,"April 15, 2021",Local,Belgium,Belgium; Brussels; Brussels,"March 19, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,96,8.33%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Laura Labriola,University Catholique de Louvain,http://dx.doi.org/10.2215/CJN.12490720,5/18/2021,8/4/2021,Unverified
210227_Belgium_AntwerpUniversityHospital_Adult_nonCancer,"February 27, 2021",Local,Belgium,Belgium,"March 24, 2020","May 31, 2020",Residual sera,Multiple groups,90,5.60%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,5/24/2021,7/6/2021,Unverified
210227_Belgium_AntwerpUniversityHospital_AdultCancer,"February 27, 2021",Local,Belgium,Belgium,"March 24, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,827,6.20%,,,Convenience,DiaSorin SpA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,5/24/2021,7/6/2021,Unverified
210505_Brussels_CliniquesUniversitairesSaint-Luc,"May 5, 2021",Local,Belgium,Belgium; Brussels-Capital; City of Brussels,"June 19, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),3255,7.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Anais Scohy,Cliniques universitaires Saint-Luc,http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414,6/16/2021,7/17/2021,Unverified
210629_Belgium_Sciensano_Dec25 ,"June 29, 2021",National,Belgium,Belgium,"December 25, 2020","December 25, 2020",Health care workers and caregivers,Adults (18-64 years),308,19.70%,12.00%,30.60%,Stratified probability,EUROIMMUN AG,ELISA,IgG,93.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Laure Mortgat,Sciensano,https://dx.doi.org/10.1136/bmjopen-2021-050824,7/5/2021,7/6/2021,Unverified
210705_UniversitairZiekenhuisBrussel_Brussels_hcw,"July 5, 2021",Local,Belgium,Belgium,"May 19, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),2662,7.40%,6.40%,8.40%,Convenience,NA,Not reported,IgG,,,,Journal Article (Peer-Reviewed), Deborah De Geyter,Universitair Ziekenhuis Brussel,https://dx.doi.org/10.1017/S0950268821001540,7/13/2021,8/4/2021,Unverified
210326_Flanders_UniversityofAntwerp_October,"March 26, 2021",Regional,Belgium,Belgium; Flanders,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),698,8.10%,,,Convenience,NA,ELISA,IgG,,99.00%,High,Preprint,Joachim Marlën,University of Antwerp,https://www.medrxiv.org/content/10.1101/2021.03.26.21254327v1,7/15/2021,8/4/2021,Verified
210326_Flanders_UniversityofAntwerp_September,"March 26, 2021",Regional,Belgium,Belgium; Flanders,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),698,5.00%,,,Convenience,NA,ELISA,IgG,,99.00%,High,Preprint,Joachim Marlën,University of Antwerp,https://www.medrxiv.org/content/10.1101/2021.03.26.21254327v1,7/15/2021,8/4/2021,Verified
210326_Flanders_UniversityofAntwerp_June,"March 26, 2021",Regional,Belgium,Belgium; Flanders,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),698,4.60%,,,Convenience,NA,ELISA,IgG,,99.00%,High,Preprint,Joachim Marlën,University of Antwerp,https://www.medrxiv.org/content/10.1101/2021.03.26.21254327v1,7/15/2021,8/4/2021,Verified
210719_Brussels_UniversitéLibredeBruxelles,"July 19, 2021",Local,Belgium,Belgium; NR; Brussels,"March 15, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),75,20.00%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Anissa Messaaoui,Université Libre de Bruxelles,https://dx.doi.org/10.1515/jpem-2021-0289,7/29/2021,8/4/2021,Unverified
210722_Belgium_UniversityOfNamur_overall,"July 22, 2021",National,Belgium,Belgium,"January 16, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),200,29.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Julien Favresse,University of Namur,http://dx.doi.org/10.1080/22221751.2021.1953403,8/1/2021,8/4/2021,Unverified
210720_Sitakunda_InternationalCentreforDiarrhoealDiseaseResearch_Adj,"July 20, 2021",Local,Bangladesh,Bangladesh; NR; Chattogram,"March 27, 2021","April 13, 2021",Household and community samples,Multiple groups,664,63.10%,56.20%,69.80%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,87.30%,99.10%,,Preprint,Taufiqur Rahman Bhuiyan,International Centre for Diarrhoeal Disease Research,https://www.medrxiv.org/content/10.1101/2021.07.16.21260611v1.full-text,8/4/2021,8/4/2021,Unverified
200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,"July 20, 2020",Regional,Austria,Austria; Tyrol,"March 20, 2020","March 27, 2020",Health care workers and caregivers,Adults (18-64 years),377,0.30%,0.01%,1.50%,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dorothea Orth-Holler,Innsbruck Clinical Microbiology Laboratory,https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690,8/1/2020,8/5/2021,Verified
200822_Ischgl_MedicalUniversityofInnsbruck_GenPop,"August 22, 2020",Local,Austria,Austria; Tyrol; Ischgl,"April 21, 2020","April 27, 2020",Household and community samples,Multiple groups,1473,42.40%,39.80%,44.70%,Entire sample,"Abbott Laboratories,EUROIMMUN AG,NA",Multiple Types,IgG,,100.00%,Moderate,Preprint,Ludwig Knabl, Medical University of Innsbruck ,https://www.medrxiv.org/content/10.1101/2020.08.20.20178533v1,10/16/2020,8/4/2021,Verified
200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM,"August 19, 2020",Local,Austria,Austria,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),130,2.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Preprint,Klaus Hackner,Karl Landsteiner University of Health Sciences,https://www.researchsquare.com/article/rs-50887/v1,10/18/2020,6/17/2021,Verified
200808_Vienna_MedicalUniversityOfVienna_HCP,"September 2, 2020",Local,Austria,Austria; Vienna; Vienna,"April 1, 2020","June 4, 2020",Health care workers and caregivers,Adults (18-64 years),62,3.20%,0.40%,11.20%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,8/4/2021,Verified
200808_Vienna_MedicalUniversityOfVienna_Patients,"September 2, 2020",Local,Austria,Austria; Vienna; Vienna,"March 21, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,84,2.40%,0.30%,8.30%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,8/4/2021,Verified
201104_Austria_DanubePrivateUniversity_IgG_Overall,"November 4, 2020",Local,Austria,Austria,"June 1, 2020","June 15, 2020",Household and community samples,Multiple groups,835,8.50%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Dennis Ladage,Danube Private University,https://www.medrxiv.org/content/10.1101/2020.11.03.20219121v1,1/18/2021,6/17/2021,Verified
201222_Vienna_MedicalUniversityofVienna_overall,"December 22, 2020",Local,Austria,Austria; Vienna; Vienna,"April 2, 2020","April 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1655,10.15%,,,Convenience,EUROIMMUN AG,ELISA,"IgA,IgG",,,High,Preprint,Angelika Wagner,Medical University of Vienna,https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1,1/23/2021,8/4/2021,Verified
210129_Vienna_WroclawMedicalUniversity_overall,"January 29, 2021",Local,Austria,Austria; Vienna; Vienna,"May 18, 2020","July 2, 2020",Students and Daycares,Children and Youth (0-17 years),2042,1.20%,,,Convenience,"Beijing Wantai Biological,EUROIMMUN AG",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Zsolt Szepfalusi,Wroclaw Medical University,https://dx.doi.org/10.1111/pai.13459,2/16/2021,8/4/2021,Unverified
210203_Austria_MedicalUniversityOfVienna_Overall,"February 3, 2021",National,Austria,Austria,"May 11, 2020","December 21, 2020",Health care workers and caregivers,Adults (18-64 years),3301,0.51%,,,Convenience,"DiaSorin SpA,Roche Diagnostics",Multiple Types,"IgA,IgM,IgG",,,High,Preprint,Iris Leister,Medical University of Vienna,10.1101/2021.02.01.21250898,2/17/2021,8/4/2021,Verified
210107_Austria_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Austria,Austria,"July 17, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),196,0.00%,0.00%,1.92%,Convenience,"Epitope Diagnostics, Inc.,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,8/4/2021,Unverified
210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW,"January 8, 2021",Local,Austria,Austria; Upper Austria; Linz,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),1757,2.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Margot Egger,Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz  ,https://dx.doi.org/10.1515/cclm-2020-1681,3/19/2021,8/4/2021,Verified
210212_Ischgl_MedicalUniversityofInnsbruck_overall,"February 12, 2021",Local,Austria,Austria; Tyrol; Ischgl,"April 21, 2020","April 27, 2020",Household and community samples,Multiple groups,451,43.70%,,,Entire sample,"Abbott Laboratories,EUROIMMUN AG",Multiple Types,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jens Lehmann, Medical University of Innsbruck,https://dx.doi.org/10.1017/S0950268821000418,3/27/2021,8/4/2021,Verified
210409_Vienna_MedicalUniversityofVienna,"April 9, 2021",Local,Austria,Austria; Vienna; Vienna,"March 22, 2020","March 31, 2020",Health care workers and caregivers,Adults (18-64 years),235,25.50%,20.40%,31.50%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Reiter,Medical University of Vienna,https://dx.doi.org/10.1007/s00508-021-01848-5,4/23/2021,8/4/2021,Unverified
210404_Vienna_MedicalUniversityofVienna_Overall_2months,"April 15, 2021",Local,Austria,Austria; Vienna; Vienna,"April 1, 2020","June 1, 2020",Health care workers and caregivers,Multiple groups,599,1.50%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Lorenz Schubert,Medical University of Vienna,http://dx.doi.org/10.3390/ijerph18084201,5/17/2021,8/4/2021,Unverified
201211_Austria_StatistikAustria_overall_PopAdj,"December 11, 2020",National,Austria,Austria,"November 12, 2020","November 14, 2020",Household and community samples,Multiple groups,2229,4.70%,3.80%,5.60%,Simplified probability,NA,Multiple Types,Not reported,,,Moderate,Institutional Report,Statistik Austria,StatistikAustria,http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&dDocName=124957,5/21/2021,7/20/2021,Unverified
210428_Austria_HanuschHospital,"April 28, 2021",National,Austria,Austria,"July 1, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),7858,1.12%,0.90%,1.38%,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Johann Bartko,Hanusch Hospital,https://dx.doi.org/10.3390/jcm10091909,5/21/2021,8/4/2021,Unverified
210512_Vienna_LudwigBoltzmannInstituteForLungHealth_overall,"May 12, 2021",Local,Austria,Austria,"April 20, 2020","May 20, 2020",Household and community samples,Multiple groups,12419,1.31%,,,Stratified probability,"Roche Diagnostics,EUROIMMUN AG,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Marie Kathrin Breyer,Ludwig Boltzmann Institute for Lung Health,https://dx.doi.org/10.1038/s41598-021-89711-5,5/28/2021,8/4/2021,Unverified
210226_Vorarlberg_VorarlberbInstituteForVascularInvestigationAndTreatment_overall,"February 26, 2021",Regional,Austria,Austria; Vorarlberg,"June 26, 2020","January 20, 2021",Health care workers and caregivers,Adults (18-64 years),395,18.00%,,,Convenience,Technoclone,ELISA,IgG,,,High,Preprint,Michele Atzl,Vorarlberg Institute for Vascular Investigation and Treatment,https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v2,6/5/2021,6/17/2021,Verified
201212_Europe_UniversityOfGlasgow_Austria3,"December 12, 2020",National,Austria,Austria,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),72,2.78%,0.77%,9.58%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,6/17/2021,Verified
210524_Weibenkirchen_DanubePrivateUniversity,"May 24, 2021",Local,Austria,Austria; Lower Austria; Weißenkirchen,"June 1, 2020","June 30, 2020",Household and community samples,Multiple groups,835,8.50%,,,Convenience,EUROIMMUN AG,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dennis Ladage,Danube Private University,http://dx.doi.org/10.3389/fmed.2021.632942,6/19/2021,7/6/2021,Unverified
210527_Austria_UniversitätsklinikfürInnereMedizinII_HCWs_PeriodB,"May 27, 2021",Local,Austria,Austria; NR; NR,"September 8, 2020","January 14, 2021",Health care workers and caregivers,Adults (18-64 years),498,7.20%,5.30%,9.80%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Unclear,Presentation or Conference,M. Riesenhuber,"Universitätsklinik für Innere
Medizin II",https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf,6/20/2021,7/17/2021,Unverified
210527_Austria_UniversitätsklinikfürInnereMedizinII_Patients,"May 27, 2021",Local,Austria,Austria; NR; NR,"August 24, 2020","February 22, 2021",Residual sera,Multiple groups,6092,5.71%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Unclear,Presentation or Conference,M. Riesenhuber,Universitätsklinik für Innere Medizin II ,https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf,6/20/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_June1,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","June 5, 2020","July 4, 2020",Blood donors,Multiple groups,1678,1.80%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_July2,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","July 5, 2020","August 4, 2020",Blood donors,Multiple groups,6782,1.20%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_August3,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","August 5, 2020","September 4, 2020",Blood donors,Multiple groups,3375,2.00%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_September4,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","September 5, 2020","October 4, 2020",Blood donors,Multiple groups,2569,2.40%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_October5,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","October 5, 2020","November 4, 2020",Blood donors,Multiple groups,2513,3.00%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
210616_Austria_UniversityHospitalOfSalzburg_November6,"June 16, 2021",National,Austria,"Austria; Vienna, Lower Austria, Burgenland, Salzburg","November 5, 2020","December 4, 2020",Blood donors,Multiple groups,3311,5.40%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,6/21/2021,7/17/2021,Unverified
200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting,"August 3, 2020",Regional,Australia,Australia; New South Wales,"January 25, 2020","April 10, 2020",Contacts of COVID patients,Multiple groups,173,2.31%,,,Convenience,NA,Other,"IgG,IgA,IgM",91.30%,98.90%,Moderate,Journal Article (Peer-Reviewed),Kristine Macartney,University of Sydney,https://dx.doi.org/10.1016/S2352-4642(20)30251-0,10/16/2020,7/6/2021,Verified
200914_Australia_AustralianNationalUniversity_ElectiveSurgeryPatients_Overall_TestAdj,"October 3, 2020",National,Australia,Australia,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,2991,0.28%,0.00%,0.71%,Unclear,NA,ELISA,"IgG,IgM,IgA",100.00%,98.91%,Unclear,Journal Article (Peer-Reviewed),Sarah Hicks,Australian National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665523/pdf/jiaa623.pdf,2/13/2021,7/6/2021,Verified
210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj,"February 3, 2021",Local,Australia,Australia; New South Wales; Sydney,"April 20, 2020","May 22, 2020",Residual sera,Multiple groups,3231,0.15%,0.04%,0.41%,Stratified probability,NA,Other,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/18/2021,6/17/2021,Unverified
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,"February 3, 2021",Local,Australia,Australia; New South Wales; Sydney,"May 5, 2020","June 2, 2020",Blood donors,Adults (18-64 years),1548,0.29%,0.04%,0.75%,Stratified probability,NA,Other,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,6/17/2021,Unverified
210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj,"February 3, 2021",Local,Australia,Australia; New South Wales; Sydney,"May 4, 2020","May 23, 2020",Pregnant or parturient women,Adults (18-64 years),560,0.79%,0.04%,1.88%,Stratified probability,NA,Other,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,6/17/2021,Unverified
210109_Australia_AustralianNationalUniversity_overall_adj,"January 9, 2021",National,Australia,"Australia; New South Wales, South Australia, Victoria and Western Australia","June 2, 2020","July 17, 2020",Residual sera,Multiple groups,2991,0.16%,0.00%,0.47%,Sequential,NA,ELISA,IgG,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Nicholas Coatsworth ,Australian National University,https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564,3/19/2021,6/17/2021,Verified
210413_Melbourne_EasternHealth_OverallHCW,"August 1, 2021",Local,Australia,Australia; Victoria; Melbourne,"November 9, 2020","December 4, 2020",Health care workers and caregivers,Multiple groups,736,2.17%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jillian SY Lau,Eastern Health,https://dx.doi.org/10.1016/j.idh.2021.03.004,5/19/2021,8/5/2021,Verified
210703_Melbourne_RoyalChildrensHospital_Primary,"July 3, 2021",Local,Australia,Australia,"October 21, 2020","October 30, 2020",Health care workers and caregivers,Adults (18-64 years),318,2.20%,,,Self-referral,"DiaSorin SpA,EUROIMMUN AG,GenScript,Beijing Wantai Biological,NA",Multiple Types,"IgA,IgG,IgM",,,Low,Journal Article (Peer-Reviewed),Jane Tuckerman,Royal Children's Hospital,https://dx.doi.org/10.1111/jpc.15585,7/12/2021,8/4/2021,Unverified
200630_Yerevan_ArmeniaMinistryofHealth_HCWs,"June 30, 2020",Local,Armenia,Armenia; Yerevan; Yerevan,,"June 29, 2020",Health care workers and caregivers,Adults (18-64 years),380,16.05%,,,Convenience,NA,Not reported,Not reported,100.00%,99.80%,High,News and Media,Anna Grigoryan,Ministry of Health of the Republic of Armenia,https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA,8/1/2020,8/4/2021,Verified
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless","July 18, 2020",Local,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 10, 2020","July 1, 2020",Persons living in slums,Multiple groups,60,36.00%,,,Convenience,CONICET,ELISA,IgG,95.00%,100.00%,High,Preprint,Silvana Figar,"Minister of Health, Buenos Aires City",https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,7/17/2020,6/17/2021,Verified
200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall,"September 9, 2020",Local,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 3, 2020","July 6, 2020",Health care workers and caregivers,Multiple groups,738,0.75%,0.00%,8.13%,Stratified probability,CONICET,ELISA,"IgG,IgM",,,Moderate,Preprint,Andrea Silva,Instituto Nacional de Epidemiologia,https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1,11/10/2020,6/23/2021,Verified
201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall,"December 1, 2020",Local,Argentina,Argentina; Province of Buenos Aires; Autonomous City of Buenos Aires,"June 8, 2020","June 9, 2020",Health care workers and caregivers,Adults (18-64 years),116,0.90%,0.10%,5.50%,Simplified probability,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Claudia Insua,Hospital General de Niños Pedro de Elizalde,https://dx.doi.org/10.5546/aap.2020.eng.381,1/25/2021,7/21/2021,Verified
210107_BuenosAires_UniversityOfBuenosAires_Primary,"January 7, 2021",Local,Argentina,Argentina,"March 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),317,3.00%,2.00%,5.00%,Stratified non-probability,NA,ELISA,Not reported,85.00%,95.00%,High,Journal Article (Peer-Reviewed),Puia Sebastian ,University of Buenos Aires,https://dx.doi.org/10.1016/j.jobcr.2021.01.006,2/18/2021,6/17/2021,Verified
200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall,"August 28, 2020",Local,Argentina,Argentina; Buenos Aires; Quilmes,"July 15, 2020","July 16, 2020",Household and community samples,Multiple groups,284,14.80%,11.10%,19.50%,Stratified non-probability,COVIDAR,ELISA,IgG,95.00%,100.00%,Moderate,Preprint,Laura Munoz,Ministerio de Salud de la Provincia de Buenos Aires,https://preprints.scielo.org/index.php/scielo/preprint/view/1147,4/21/2021,8/5/2021,Verified
210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires,"January 21, 2021",Local,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 10, 2020","June 26, 2020",Persons living in slums,Multiple groups,873,53.40%,52.80%,54.10%,Simplified probability,CONICET,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Silvana Figar,Ministry of Health of the City of Buenos Aires,https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf,4/21/2021,7/8/2021,Verified
210122_BuenosAires_GovernmentOfTheProvinceOfBuenosAires,"January 22, 2021",Local,Argentina,Argentina; Buenos Aires; Metropolitan Area of Buenos Aires,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,9000,13.00%,,,Unclear,NA,ELISA,Not reported,,,High,News and Media,Government of the Province of Buenos Aires,Government of the Province of Buenos Aires,https://www.gba.gob.ar/saludprovincia/noticias/s%C3%B3lo_el_13_por_ciento_de_los_vecinos_y_vecinas_de_30_barrios_populares_del,5/17/2021,7/6/2021,Unverified
201230_ArgentinaHurlingham_UniversidadNacionalHurlingham,"December 30, 2020",Local,Argentina,Argentina,"December 1, 2020","December 30, 2020",Household and community samples,Multiple groups,1182,12.10%,,,Stratified probability,NA,ELISA,IgG,,,High,Institutional Report,Universidad Nacional De Hurlingham,Universidad Nacional De Hurlingham,http://www.unahur.edu.ar/es/se-presentaron-los-resultados-del-estudio-de-seroprevalencia-de-covid-19-que-realizo-la-universidad,5/21/2021,7/7/2021,Unverified
210615_SantaFe_UniversidadNacionalDelLitoral_genpop_overall,"June 15, 2021",Local,Argentina,Argentina,"July 1, 2020","November 30, 2020",Multiple general populations,Multiple groups,3000,8.83%,,,Convenience,COVIDAR,ELISA,IgG,96.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Luz Maria Rodeles,Universidad Nacional del Litoral,https://dx.doi.org/10.26633/RPSP.2021.66,7/5/2021,7/6/2021,Unverified
210506_Luanda_InstitutoNacionaldeInvestigaçãoemSaúde_IgG,"May 6, 2021",Local,Angola,Angola; Luanda Province; NR,"July 15, 2020","September 15, 2020",Residual sera,Multiple groups,660,1.10%,,,Convenience,Biomerieux,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cruz Sebastiao,Instituto Nacional de Investigação em Saúde,https://dx.doi.org/10.1002/hsr2.280,5/30/2021,7/22/2021,Verified
200611_Andorra_GovernmentOfAndorra_phase2_overall,"June 6, 2020",National,Andorra,Andorra,"May 14, 2020","May 24, 2020",Household and community samples,Multiple groups,66635,8.40%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",,100.00%,Low,Institutional Report,Government of Andorra,The Government of Andorra,https://www.govern.ad/comunicats/item/11629-els-tests-d-anticossos-permeten-diagnosticar-78-positius-de-la-covid-19-que-podrien-haver-contagiat-unes-360-persones,4/29/2021,7/14/2021,Verified
210521_Andorra_ISGlobal_Overall,"May 21, 2021",National,Andorra,Andorra; N/A; N/A,"May 4, 2020","May 28, 2020",Household and community samples,Multiple groups,72964,11.00%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",92.00%,100.00%,Low,Journal Article (Peer-Reviewed),Cristina Royo Cebrecos,ISGlobal,https://www.sciencedirect.com/science/article/pii/S266677622100096X,7/29/2021,7/30/2021,Verified
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults,"February 20, 2021",Local,Albania,Albania,"June 27, 2020","July 3, 2020",Household and community samples,Adults (18-64 years),266,7.50%,4.30%,10.70%,Stratified probability,EUROIMMUN AG,ELISA,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,6/25/2021,Verified
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults,"February 20, 2021",Local,Albania,Albania,"December 21, 2020","December 28, 2020",Household and community samples,Adults (18-64 years),815,48.20%,44.80%,51.70%,Stratified probability,EUROIMMUN AG,ELISA,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,6/25/2021,Verified
201220_Afghanistan_UnitedStatesAirForce,"December 31, 2020",Local,Afghanistan,Afghanistan; NR; NR,"April 17, 2020","June 1, 2020",Essential non-healthcare workers,Adults (18-64 years),1957,1.90%,,,Unclear,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Brian White,United States Air Force,http://dx.doi.org/10.1093/ofid/ofaa439.666,5/2/2021,8/4/2021,Verified
200801_Afghanistan_AfghanistanMinistryofPublicHealth,"August 1, 2020",National,Afghanistan,Afghanistan,"June 1, 2020","June 15, 2020",Household and community samples,Multiple groups,9514,31.50%,,,Stratified probability,NA,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Sayed Ataullah Saeedzai,Afghanistan Ministry of Public Health ,https://moph.gov.af/sites/default/files/2020-08/Final%20COVID-19%20Survey%20English%20Report.pdf,5/19/2021,6/19/2021,Verified